SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain and Structure information: based on WT protein Annotated databases Deep learning-based pathogenicity predictions Folding stability-based pathogenicity predictions Sequence/structure-based pathogenicity predictions Phase Separation Evolutionary/physical properties Molecular Dynamics-based analysis DOI
Domain IUPred2 ANCHOR2 AlphaFold MobiDB PhosphoSitePlus ClinVar gnomAD ESM1b AlphaMissense FoldX Rosetta Foldetta PremPS REVEL PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PSMutPred PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation
Score Prediction Score Prediction pLDDT disorder disorder LTP HTP KL PTM Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences IP RF SP RF Prediction PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.3986T>G
L1329R
2D
AIThe SynGAP1 missense variant L1329R is catalogued in gnomAD (ID 6‑33451860‑T‑G) but has no ClinVar submission. Functional prediction tools cluster into two groups: benign predictions from REVEL, ESM1b, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized returns an uncertain result. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive due to a 2‑to‑2 split. No Foldetta stability assessment is available. Overall, the majority of high‑confidence predictors (five pathogenic vs three benign) lean toward a pathogenic effect. Because ClinVar contains no classification, there is no conflict with existing clinical annotations. Thus, based on current in silico evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.930790Disordered0.924905Binding0.3360.7480.8756-33451860-T-G-3.636Likely Benign0.923Likely PathogenicAmbiguous0.141Likely Benign-3.16Deleterious0.994Probably Damaging0.990Probably Damaging3.05Benign0.00Affected3.7750.15940.1547-2-3-8.343.03
c.3994A>C
T1332P
2D
AIThe SynGAP1 missense variant T1332P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas a majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default) predict a pathogenic impact; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is tied 2‑2 and thus unavailable, and Foldetta results are not provided. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict any existing ClinVar status because the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.915074Disordered0.948427Binding0.4420.7540.875-3.404Likely Benign0.918Likely PathogenicAmbiguous0.238Likely Benign-3.12Deleterious0.994Probably Damaging0.981Probably Damaging2.95Benign0.00Affected0.21850.53080-1-0.9-3.99
c.3998A>G
E1333G
2D
AIThe SynGAP1 missense variant E1333G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized remains uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a 2‑vs‑2 tie and therefore unavailable; Foldetta, which would evaluate protein‑folding stability, has no result for this variant. Overall, more tools predict pathogenicity than benignity, and no ClinVar entry contradicts this assessment. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.930790Disordered0.953319Binding0.3470.7460.750-4.504Likely Benign0.801Likely PathogenicAmbiguous0.260Likely Benign-4.31Deleterious0.994Probably Damaging0.968Probably Damaging2.83Benign0.00Affected0.31010.62170-23.1-72.06
c.3998A>T
E1333V
2D
AIThe SynGAP1 E1333V missense change is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect are REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (two pathogenic vs two benign votes), and Foldetta results are unavailable. Overall, the majority of evidence (six pathogenic vs three benign) points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.930790Disordered0.953319Binding0.3470.7460.750-4.322Likely Benign0.974Likely PathogenicLikely Pathogenic0.289Likely Benign-4.30Deleterious0.994Probably Damaging0.981Probably Damaging2.81Benign0.00Affected0.09940.7615-2-27.7-29.98
c.4015A>C
N1339H
2D
AIThe SynGAP1 missense variant N1339H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, SGM‑Consensus likewise indicates likely benign, while Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Based on the preponderance of evidence from both general and high‑accuracy predictors, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.771762Disordered0.977585Binding0.3960.6871.000-3.487Likely Benign0.338Likely BenignLikely Benign0.234Likely Benign-2.98Deleterious0.994Probably Damaging0.987Probably Damaging2.87Benign0.00Affected0.15850.7644210.323.04
c.4015A>T
N1339Y
2D
AIThe SynGAP1 missense variant N1339Y is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta data are unavailable. Overall, the majority of conventional predictors lean toward pathogenicity, but the single high‑accuracy benign prediction and the inconclusive consensus leave the variant’s impact uncertain. Thus, the variant is most likely pathogenic based on the current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.771762Disordered0.977585Binding0.3960.6871.000-3.808Likely Benign0.578Likely PathogenicLikely Benign0.319Likely Benign-4.83Deleterious0.994Probably Damaging0.990Probably Damaging2.87Benign0.00Affected0.06970.6573-2-22.249.07
c.4016A>T
N1339I
2D
AIThe SynGAP1 missense variant N1339I is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions (five pathogenic vs four benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic based on current computational evidence, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.771762Disordered0.977585Binding0.3960.6871.000-3.104Likely Benign0.740Likely PathogenicLikely Benign0.306Likely Benign-5.25Deleterious0.994Probably Damaging0.987Probably Damaging2.87Benign0.00Affected0.07470.6271-2-38.0-0.94
c.653T>G
F218C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218C is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33435295‑T‑G). Prediction tools that agree on a benign effect include only FATHMM, whereas the majority of tools (REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default) predict a pathogenic impact. Results that are uncertain or unavailable are FoldX, ESM1b, AlphaMissense‑Optimized, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic prediction (2 pathogenic vs. 1 benign votes); and Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for F218C, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.281712Structured0.408725Uncertain0.8480.2720.0006-33435295-T-G16.20e-7-7.234In-Between0.948Likely PathogenicAmbiguous1.49Ambiguous0.12.20Destabilizing1.85Ambiguous1.02Destabilizing0.744Likely Pathogenic-4.92Deleterious0.994Probably Damaging0.667Possibly Damaging5.78Benign0.03Affected3.41130.23300.1321-2-4-0.3-44.04
c.659T>G
F220C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F220C is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.219301Structured0.429422Uncertain0.8980.2950.000-12.948Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.67Destabilizing0.05.03Destabilizing4.35Destabilizing2.22Destabilizing0.941Likely Pathogenic-6.72Deleterious0.994Probably Damaging0.753Possibly Damaging4.03Benign0.00Affected0.22640.2012-4-2-0.3-44.04
c.73C>T
R25W
2D
AIThe SynGAP1 missense variant R25W is listed in ClinVar with an “Uncertain” status (ClinVar ID 2993054.0) and is present in gnomAD (ID 6‑33423482‑C‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign, while Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this is not in conflict with the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.461924Structured0.438941Uncertain0.3730.8900.375Uncertain 26-33423482-C-T63.72e-6-5.133Likely Benign0.549AmbiguousLikely Benign0.158Likely Benign-1.60Neutral0.994Probably Damaging0.919Probably Damaging3.92Benign0.00Affected4.3210.12240.3938-323.630.03
c.765C>A
D255E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change D255E is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include premPS, SIFT, ESM1b, and FATHMM. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is also inconclusive. Overall, the majority of available predictions (seven pathogenic vs. four benign) point to a likely pathogenic impact. This conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.501700Disordered0.219132Uncertain0.8010.2730.250-6.876Likely Benign0.989Likely PathogenicLikely Pathogenic0.80Ambiguous0.30.90Ambiguous0.85Ambiguous0.15Likely Benign0.508Likely Pathogenic-2.98Deleterious0.994Probably Damaging0.978Probably Damaging5.89Benign0.08Tolerated0.13650.5067320.014.03
c.765C>G
D255E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D255E is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include premPS, SIFT, ESM1b, and FATHMM, whereas those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The remaining tools (FoldX, Rosetta, Foldetta) provide uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign), and Foldetta is also inconclusive. Overall, the majority of available predictions (7 pathogenic vs. 4 benign) indicate a pathogenic effect. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.501700Disordered0.219132Uncertain0.8010.2730.250-6.876Likely Benign0.989Likely PathogenicLikely Pathogenic0.80Ambiguous0.30.90Ambiguous0.85Ambiguous0.15Likely Benign0.509Likely Pathogenic-2.98Deleterious0.994Probably Damaging0.978Probably Damaging5.89Benign0.08Tolerated0.13650.5067320.014.03
c.76G>A
G26R
2D
AIThe SynGAP1 missense variant G26R is listed in ClinVar as a benign alteration (ClinVar ID 1521495.0) and is present in the gnomAD database (gnomAD ID 6‑33423485‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of computational evidence supports a benign impact, aligning with the ClinVar designation and indicating no contradiction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.438291Uncertain0.3510.8780.375Benign 16-33423485-G-A31.86e-6-2.946Likely Benign0.678Likely PathogenicLikely Benign0.189Likely Benign-2.22Neutral0.994Probably Damaging0.990Probably Damaging3.87Benign0.00Affected4.3210.10970.4407-3-2-4.199.14
c.76G>C
G26R
2D
AIThe SynGAP1 missense variant G26R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of the four high‑accuracy tools) also yields benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence—including the high‑accuracy consensus—indicates that G26R is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.438291Uncertain0.3510.8780.375-2.946Likely Benign0.678Likely PathogenicLikely Benign0.189Likely Benign-2.22Neutral0.994Probably Damaging0.990Probably Damaging3.87Benign0.00Affected4.3210.10970.4407-3-2-4.199.14
c.778G>A
V260I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260I missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome, while ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts benign. Overall, the consensus of the majority of tools, including the high‑accuracy methods, points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.254060Structured0.382651Uncertain0.8880.2590.250-7.525In-Between0.104Likely BenignLikely Benign-0.16Likely Benign0.10.27Likely Benign0.06Likely Benign-0.14Likely Benign0.404Likely Benign-0.85Neutral0.994Probably Damaging0.970Probably Damaging5.83Benign0.19Tolerated0.05590.3704430.314.03
c.778G>C
V260L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260L missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from FoldX, Rosetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, polyPhen‑2 (HumDiv and HumVar) and ESM1b. The high‑accuracy assessment shows AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, and Foldetta predicts a benign effect on protein stability. No prediction is missing or inconclusive. Overall, the evidence points to a benign effect for V260L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-8.785Likely Pathogenic0.416AmbiguousLikely Benign-0.26Likely Benign0.10.15Likely Benign-0.06Likely Benign0.25Likely Benign0.532Likely Pathogenic-1.84Neutral0.994Probably Damaging0.970Probably Damaging5.90Benign0.11Tolerated0.07300.436021-0.414.03
c.778G>T
V260L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the aggregate predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-8.785Likely Pathogenic0.416AmbiguousLikely Benign-0.26Likely Benign0.10.15Likely Benign-0.06Likely Benign0.25Likely Benign0.532Likely Pathogenic-1.84Neutral0.994Probably Damaging0.970Probably Damaging5.90Benign0.11Tolerated0.07300.436021-0.414.03
c.779T>C
V260A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260A missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, the SGM‑Consensus (majority vote), and Foldetta. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Two tools (premPS and AlphaMissense‑Default) give uncertain results. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus, and Foldetta—all indicate a benign outcome. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.254060Structured0.382651Uncertain0.8880.2590.250-3.271Likely Benign0.407AmbiguousLikely Benign0.38Likely Benign0.00.02Likely Benign0.20Likely Benign0.81Ambiguous0.487Likely Benign-1.41Neutral0.994Probably Damaging0.970Probably Damaging5.87Benign0.33Tolerated0.26760.190300-2.4-28.05
c.77G>A
G26E
2D
AIThe SynGAP1 missense variant G26E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.438291Uncertain0.3510.8780.375-3.966Likely Benign0.481AmbiguousLikely Benign0.199Likely Benign-2.08Neutral0.994Probably Damaging0.986Probably Damaging3.90Benign0.00Affected0.16230.42380-2-3.172.06
c.77G>T
G26V
2D
AIThe SynGAP1 missense variant G26V is reported in gnomAD (variant ID 6‑33423486‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: the benign‑predicted set includes REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the pathogenic‑predicted set contains polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The high‑accuracy consensus methods reinforce the benign assessment: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Benign.” No Foldetta stability result is available, so it does not influence the conclusion. Overall, the majority of evidence points to a benign effect for G26V, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.438291Uncertain0.3510.8780.3756-33423486-G-T16.20e-7-3.499Likely Benign0.165Likely BenignLikely Benign0.197Likely Benign-2.34Neutral0.994Probably Damaging0.990Probably Damaging3.89Benign0.00Affected4.3210.13440.4333-3-14.642.08
c.783C>A
D261E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The high‑accuracy consensus from AlphaMissense‑Optimized and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) both indicate a benign outcome, while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is inconclusive. Overall, the majority of evidence points to a benign impact. This assessment is consistent with the absence of ClinVar annotation and does not contradict any existing database status. Based on the predictions, the variant is most likely benign, and this does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.422514Uncertain0.8830.2640.125-2.646Likely Benign0.268Likely BenignLikely Benign1.44Ambiguous0.80.79Ambiguous1.12Ambiguous-0.03Likely Benign0.377Likely Benign0.20Neutral0.994Probably Damaging0.978Probably Damaging5.88Benign1.00Tolerated0.09630.4359320.014.03
c.783C>G
D261E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Protein‑stability calculations from FoldX and Rosetta are uncertain. Overall, the majority of evidence points to a benign impact, which is consistent with the absence of a ClinVar claim and gnomAD observation. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.422514Uncertain0.8830.2640.125-2.646Likely Benign0.268Likely BenignLikely Benign1.44Ambiguous0.80.79Ambiguous1.12Ambiguous-0.03Likely Benign0.377Likely Benign0.20Neutral0.994Probably Damaging0.978Probably Damaging5.88Benign1.00Tolerated0.09630.4359320.014.03
c.787G>C
V263L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are Rosetta (Uncertain) and premPS (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.599Likely Benign0.275Likely BenignLikely Benign-0.16Likely Benign0.1-0.63Ambiguous-0.40Likely Benign0.66Ambiguous0.453Likely Benign-1.26Neutral0.994Probably Damaging0.970Probably Damaging5.85Benign0.18Tolerated0.07590.395021-0.414.03
c.787G>T
V263L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are Rosetta (Uncertain) and premPS (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.599Likely Benign0.275Likely BenignLikely Benign-0.16Likely Benign0.1-0.63Ambiguous-0.40Likely Benign0.66Ambiguous0.453Likely Benign-1.26Neutral0.994Probably Damaging0.970Probably Damaging5.85Benign0.18Tolerated0.07590.395021-0.414.03
c.788T>C
V263A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from Rosetta, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), and SIFT. Predictions marked “Uncertain” include FoldX, Foldetta, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of evidence points to a benign effect. Thus, the variant is most likely benign based on current predictions, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.877Likely Benign0.530AmbiguousLikely Benign1.40Ambiguous0.10.00Likely Benign0.70Ambiguous1.26Destabilizing0.622Likely Pathogenic-2.17Neutral0.994Probably Damaging0.970Probably Damaging5.97Benign0.04Affected0.25650.182200-2.4-28.05
c.827C>G
P276R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P276R missense variant is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (gnomAD ID 6‑33437732‑C‑G). Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Stability‑based predictors (FoldX, Rosetta, premPS, Foldetta) are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification; this conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.037156Structured0.338937Uncertain0.7240.2300.2506-33437732-C-G74.34e-6-10.983Likely Pathogenic0.714Likely PathogenicLikely Benign1.78Ambiguous0.21.02Ambiguous1.40Ambiguous0.78Ambiguous0.498Likely Benign-4.52Deleterious0.994Probably Damaging0.892Possibly Damaging1.89Pathogenic0.01Affected3.38190.14450.2828-20-2.959.07
c.956C>G
A319G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A319G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict pathogenicity, while Rosetta remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports benign. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.179055Structured0.410405Uncertain0.8790.2540.125-6.505Likely Benign0.148Likely BenignLikely Benign0.11Likely Benign0.40.56Ambiguous0.34Likely Benign0.39Likely Benign0.219Likely Benign-1.83Neutral0.994Probably Damaging0.900Possibly Damaging1.89Pathogenic0.09Tolerated0.23450.453210-2.2-14.03
c.958G>T
V320F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant V320F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on benign impact include REVEL, premPS, and SIFT, whereas tools that agree on pathogenic impact include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as inconclusive, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as inconclusive. Because the majority of available predictions and the SGM‑Consensus favor pathogenicity, the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for V320F.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.419626Uncertain0.9050.2660.125-9.958Likely Pathogenic0.877Likely PathogenicAmbiguous1.49Ambiguous1.41.55Ambiguous1.52Ambiguous0.44Likely Benign0.237Likely Benign-3.26Deleterious0.994Probably Damaging0.944Probably Damaging1.79Pathogenic0.06Tolerated0.04730.3064-1-1-1.448.04
c.989A>T
D330V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D330V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and premPS, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, and AlphaMissense‑Default. Uncertain predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are treated as unavailable. High‑accuracy assessments show that the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. AlphaMissense‑Optimized and Foldetta provide inconclusive results and are therefore not considered evidence. Overall, the preponderance of evidence points to a pathogenic effect for D330V, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-13.176Likely Pathogenic0.950Likely PathogenicAmbiguous2.06Destabilizing0.50.57Ambiguous1.32Ambiguous0.45Likely Benign0.428Likely Benign-6.40Deleterious0.994Probably Damaging0.892Possibly Damaging0.89Pathogenic0.01Affected0.08620.4633-2-37.7-15.96
c.1234T>G
L412V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L412V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.122885Structured0.331108Uncertain0.9370.1960.000-11.726Likely Pathogenic0.962Likely PathogenicLikely Pathogenic3.65Destabilizing0.03.52Destabilizing3.59Destabilizing1.54Destabilizing0.231Likely Benign-2.76Deleterious0.995Probably Damaging0.970Probably Damaging3.25Benign0.01Affected0.12750.3378210.4-14.03
c.1245G>C
E415D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E415D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. Predictions that are inconclusive or uncertain are FoldX, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while Foldetta predicts a benign effect. Overall, the balance of evidence leans toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.100716Structured0.330366Uncertain0.9150.2360.000-7.766In-Between0.952Likely PathogenicAmbiguous0.75Ambiguous0.10.21Likely Benign0.48Likely Benign0.49Likely Benign0.220Likely Benign-2.60Deleterious0.995Probably Damaging0.960Probably Damaging3.22Benign0.04Affected0.17770.2075320.0-14.03
c.1245G>T
E415D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E415D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are FoldX, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta indicates a benign effect. Overall, the majority of standard tools lean toward pathogenicity, and the high‑accuracy consensus also supports a pathogenic classification. Therefore, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.100716Structured0.330366Uncertain0.9150.2360.000-7.766In-Between0.952Likely PathogenicAmbiguous0.75Ambiguous0.10.21Likely Benign0.48Likely Benign0.49Likely Benign0.220Likely Benign-2.60Deleterious0.995Probably Damaging0.960Probably Damaging3.22Benign0.04Affected0.17770.2075320.0-14.03
c.1246C>G
L416V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L416V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact for the variant. This conclusion is not contradicted by any ClinVar annotation, as the variant is not present in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.104810Structured0.336105Uncertain0.9350.2270.000-7.861In-Between0.310Likely BenignLikely Benign1.46Ambiguous0.01.78Ambiguous1.62Ambiguous0.45Likely Benign0.124Likely Benign-1.47Neutral0.995Probably Damaging0.970Probably Damaging3.42Benign0.53Tolerated0.15630.3550210.4-14.03
c.1257G>C
E419D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and FATHMM. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain or inconclusive predictions come from Foldetta, AlphaMissense‑Optimized, ESM1b, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain (treated as unavailable), the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta remains uncertain (unavailable). Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.102787Structured0.371949Uncertain0.9610.2610.000-7.036In-Between0.869Likely PathogenicAmbiguous0.17Likely Benign0.10.87Ambiguous0.52Ambiguous0.48Likely Benign0.170Likely Benign-2.40Neutral0.995Probably Damaging0.960Probably Damaging3.33Benign0.10Tolerated0.19660.4906320.0-14.03
c.1257G>T
E419D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and FATHMM. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain or inconclusive predictions come from Foldetta, AlphaMissense‑Optimized, ESM1b, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain (treated as unavailable), the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta remains uncertain (unavailable). Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.102787Structured0.371949Uncertain0.9610.2610.000-7.036In-Between0.869Likely PathogenicAmbiguous0.17Likely Benign0.10.87Ambiguous0.52Ambiguous0.48Likely Benign0.170Likely Benign-2.40Neutral0.995Probably Damaging0.960Probably Damaging3.33Benign0.10Tolerated0.19660.4906320.0-14.03
c.1266G>C
E422D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E422D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. ESM1b is uncertain. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors pathogenic; whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of tools (six benign vs five pathogenic) lean toward a benign effect, but the two most accurate predictors and the consensus vote indicate a pathogenic tendency. Thus, the variant is most likely benign based on the broader tool set, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.067594Structured0.426709Uncertain0.9650.2550.000-7.092In-Between0.969Likely PathogenicLikely Pathogenic0.39Likely Benign0.0-0.03Likely Benign0.18Likely Benign0.21Likely Benign0.199Likely Benign-2.76Deleterious0.995Probably Damaging0.960Probably Damaging3.38Benign0.07Tolerated0.16860.2864320.0-14.03
c.1266G>T
E422D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E422D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. ESM1b is uncertain. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors pathogenic; whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of tools (six benign vs five pathogenic) lean toward a benign effect, but the two most accurate predictors and the consensus vote indicate a pathogenic tendency. Thus, the variant is most likely benign based on the broader tool set, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.067594Structured0.426709Uncertain0.9650.2550.000-7.092In-Between0.969Likely PathogenicLikely Pathogenic0.39Likely Benign0.0-0.03Likely Benign0.18Likely Benign0.21Likely Benign0.199Likely Benign-2.76Deleterious0.995Probably Damaging0.960Probably Damaging3.38Benign0.07Tolerated0.16860.2864320.0-14.03
c.1270G>T
V424F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant V424F is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools (FoldX, Foldetta, premPS, AlphaMissense‑Optimized) yield uncertain or unavailable results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-10.947Likely Pathogenic0.939Likely PathogenicAmbiguous1.99Ambiguous0.3-0.37Likely Benign0.81Ambiguous0.55Ambiguous0.275Likely Benign-3.66Deleterious0.995Probably Damaging0.775Possibly Damaging3.40Benign0.01Affected0.08160.2094-1-1-1.448.04
c.1273A>G
T425A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. Two tools (premPS and AlphaMissense‑Optimized) give uncertain results and are treated as unavailable. High‑accuracy assessments show SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign, and AlphaMissense‑Optimized as uncertain. Overall, the balance of evidence leans toward pathogenicity, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-8.945Likely Pathogenic0.799Likely PathogenicAmbiguous-0.31Likely Benign0.1-0.05Likely Benign-0.18Likely Benign0.70Ambiguous0.372Likely Benign-4.17Deleterious0.995Probably Damaging0.960Probably Damaging3.42Benign0.09Tolerated0.29710.2572102.5-30.03
c.1291C>A
L431M
2D
AIThe SynGAP1 missense variant L431M (ClinVar ID 4327026) is not found in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, FATHMM, AlphaMissense‑Optimized, and Foldetta, whereas premPS, polyPhen‑2 (HumDiv and HumVar), and SIFT all predict a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a benign majority; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. No predictions or stability results are missing or inconclusive. Overall, the majority of computational evidence indicates that the variant is most likely benign, which contradicts the ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.094817Structured0.374755Uncertain0.9590.3000.0001-7.471In-Between0.375AmbiguousLikely Benign0.18Likely Benign0.30.50Ambiguous0.34Likely Benign1.07Destabilizing0.102Likely Benign-1.50Neutral0.995Probably Damaging0.849Possibly Damaging2.94Benign0.02Affected0.07480.312142-1.918.03
c.1303T>G
L435V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L435V has no ClinVar assertion and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and AlphaMissense‑Default. ESM1b is uncertain. High‑accuracy assessments further support a pathogenic bias: AlphaMissense‑Optimized predicts benign, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic)—favors pathogenicity. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. With the preponderance of pathogenic calls from both general and high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.229226Structured0.333584Uncertain0.9540.2920.000-7.134In-Between0.571Likely PathogenicLikely Benign2.97Destabilizing0.12.33Destabilizing2.65Destabilizing1.36Destabilizing0.217Likely Benign-2.80Deleterious0.995Probably Damaging0.970Probably Damaging3.23Benign0.06Tolerated0.12160.2628210.4-14.03
c.1307A>T
E436V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E436V variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include premPS and FATHMM, while the remaining evaluated algorithms (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Based on the preponderance of pathogenic predictions and the high‑accuracy tools’ results, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.239899Structured0.321046Uncertain0.9340.2890.000-13.364Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.45Ambiguous0.01.62Ambiguous1.54Ambiguous0.30Likely Benign0.875Likely Pathogenic-6.63Deleterious0.995Probably Damaging0.967Probably Damaging4.64Benign0.03Affected0.07270.5952-2-27.7-29.98
c.1337A>T
E446V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E446V missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include Rosetta, premPS, and FATHMM, while those that agree on a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evaluated tools (8 pathogenic vs. 3 benign) indicate a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.000-12.231Likely Pathogenic0.884Likely PathogenicAmbiguous1.72Ambiguous0.70.34Likely Benign1.03Ambiguous0.37Likely Benign0.513Likely Pathogenic-6.55Deleterious0.995Probably Damaging0.983Probably Damaging3.19Benign0.00Affected0.06180.6433-2-27.7-29.98
c.1351C>G
L451V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L451V is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Rosetta is uncertain and does not contribute to the consensus. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic; and Foldetta predicts pathogenic. Overall, the preponderance of evidence points to a pathogenic effect for L451V. This conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.314017Uncertain0.9780.2320.000-10.732Likely Pathogenic0.635Likely PathogenicLikely Benign2.83Destabilizing0.11.81Ambiguous2.32Destabilizing1.39Destabilizing0.325Likely Benign-2.90Deleterious0.995Probably Damaging0.970Probably Damaging2.54Benign0.01Affected0.10650.2856210.4-14.03
c.1357C>T
H453Y
2D
AIThe SynGAP1 missense variant H453Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign calls come from REVEL, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic calls come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus. Predictions from FoldX, Rosetta, and Foldetta are uncertain. High‑accuracy methods provide a mixed picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus predicts likely pathogenic, and Foldetta is inconclusive. Overall, the majority of evidence points toward a pathogenic effect, aligning with the SGM‑Consensus but opposing the benign predictions from several tools. Because ClinVar contains no entry for this variant, there is no conflict with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-12.060Likely Pathogenic0.753Likely PathogenicLikely Benign-0.52Ambiguous0.7-0.68Ambiguous-0.60Ambiguous0.09Likely Benign0.320Likely Benign-5.93Deleterious0.995Probably Damaging0.961Probably Damaging3.41Benign0.04Affected0.08150.3843021.926.03
c.1363C>G
L455V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L455V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and FATHMM, whereas the remaining 11 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict pathogenicity. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Taken together, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is consistent with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.310377Uncertain0.9630.1680.000-12.773Likely Pathogenic0.946Likely PathogenicAmbiguous2.89Destabilizing0.12.38Destabilizing2.64Destabilizing1.41Destabilizing0.276Likely Benign-2.83Deleterious0.995Probably Damaging0.970Probably Damaging3.29Benign0.02Affected0.11490.3056210.4-14.03
c.1372A>G
T458A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T458A missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM. Those that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give uncertain results: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts benign. Overall, the majority of reliable predictors (six pathogenic vs. five benign) indicate a pathogenic effect. This conclusion does not contradict ClinVar status, as the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.185198Structured0.294848Uncertain0.9150.1440.000-10.734Likely Pathogenic0.924Likely PathogenicAmbiguous0.36Likely Benign0.00.31Likely Benign0.34Likely Benign0.56Ambiguous0.358Likely Benign-4.27Deleterious0.995Probably Damaging0.960Probably Damaging3.40Benign0.15Tolerated0.41370.4257102.5-30.03
c.1396T>C
S466P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S466P is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect; the only inconclusive result is from premPS (Uncertain). High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.311707Structured0.322353Uncertain0.9330.2270.000-13.107Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.67Destabilizing0.22.83Destabilizing2.75Destabilizing0.95Ambiguous0.811Likely Pathogenic-3.02Deleterious0.995Probably Damaging0.986Probably Damaging-1.55Pathogenic0.04Affected0.16170.49151-1-0.810.04
c.1397C>T
S466L
2D
AIThe SynGAP1 missense variant S466L is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include FoldX, while the majority of tools predict a pathogenic impact: REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score. Tools with uncertain or inconclusive results are AlphaMissense‑Optimized, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for S466L. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.311707Structured0.322353Uncertain0.9330.2270.000-9.417Likely Pathogenic0.806Likely PathogenicAmbiguous-0.36Likely Benign1.6-1.60Ambiguous-0.98Ambiguous-0.52Ambiguous0.768Likely Pathogenic-3.05Deleterious0.995Probably Damaging0.991Probably Damaging-1.56Pathogenic0.03Affected0.06660.4884-3-24.626.08
c.1442A>T
H481L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H481L missense variant is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or stability result is missing or inconclusive. Overall, the majority of tools (seven benign vs five pathogenic) lean toward a benign interpretation, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign, though a subset of high‑accuracy predictors suggest pathogenicity, indicating some uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-9.097Likely Pathogenic0.587Likely PathogenicLikely Benign-0.58Ambiguous0.10.15Likely Benign-0.22Likely Benign0.29Likely Benign0.349Likely Benign-5.91Deleterious0.995Probably Damaging0.986Probably Damaging3.41Benign0.48Tolerated0.06610.4678-2-37.0-23.98
c.1562A>T
E521V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E521V missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy AlphaMissense‑Optimized score is pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenicity. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign outcome. Overall, the majority of evidence points to a pathogenic impact for E521V, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.086953Structured0.062387Uncertain0.8650.3490.000-10.297Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.31Likely Benign0.10.49Likely Benign0.40Likely Benign0.21Likely Benign0.413Likely Benign-5.15Deleterious0.995Probably Damaging0.996Probably Damaging3.26Benign0.05Affected0.09130.7104-2-27.7-29.98
c.1565A>T
E522V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E522V missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus—consistently predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.046216Uncertain0.8230.3760.000-11.985Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.09Likely Benign0.20.00Likely Benign0.05Likely Benign0.18Likely Benign0.751Likely Pathogenic-6.59Deleterious0.995Probably Damaging0.996Probably Damaging-1.31Pathogenic0.01Affected0.05370.4514-2-27.7-29.98
c.1745A>T
E582V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E582V is not reported in ClinVar and is absent from gnomAD. Computational predictors show a split: benign calls from REVEL, Rosetta, premPS, SIFT, and FATHMM; pathogenic calls from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; and two uncertain calls from FoldX and AlphaMissense‑Optimized. High‑accuracy methods give a pathogenic consensus: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is uncertain due to conflicting inputs. Overall, the computational evidence leans toward pathogenicity, and this assessment does not contradict ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.033838Uncertain0.8450.2350.000-10.737Likely Pathogenic0.842Likely PathogenicAmbiguous0.87Ambiguous0.1-0.13Likely Benign0.37Likely Benign0.24Likely Benign0.251Likely Benign-3.92Deleterious0.995Probably Damaging0.996Probably Damaging3.15Benign0.10Tolerated0.05640.4186-2-27.7-29.98
c.1771G>C
A591P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A591P is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools largely converge on a pathogenic effect: pathogenic predictions come from FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (Likely Pathogenic). Benign predictions are limited to REVEL and FATHMM. High‑accuracy assessments reinforce the pathogenic view: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. Consequently, the variant is most likely pathogenic, a conclusion that contrasts with its ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018787Structured0.093848Uncertain0.8820.1850.000Uncertain 1-14.479Likely Pathogenic0.991Likely PathogenicLikely Pathogenic3.78Destabilizing0.37.29Destabilizing5.54Destabilizing1.45Destabilizing0.404Likely Benign-4.41Deleterious0.995Probably Damaging0.853Possibly Damaging3.35Benign0.01Affected3.37350.18720.30871-1-3.426.04191.5-10.10.20.10.40.1XPotentially PathogenicThe methyl group of the Ala591 side chain, located in the middle of an α helix (res. Glu582-Met603), packs against hydrophobic residues (e.g., Ile483, Phe484) of an opposing partially helical loop (res. Phe476-Asn487).In the variant simulations, Pro591 lacks a free backbone amide group and, therefore, cannot form a hydrogen bond with the backbone carbonyl of Arg587 as Ala591 does in the WT. This notably weakens the α helix integrity and compromises the continuity of the helix. In reality, the effect on the structure during protein folding could be more severe.
c.1834C>G
Q612E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q612E is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). In silico predictors that agree on a benign effect include REVEL, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Predictors that agree on a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. FoldX, Rosetta, and Foldetta are inconclusive, with Foldetta specifically yielding an uncertain stability change. High‑accuracy tools give a mixed picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus predicts pathogenic, and Foldetta remains uncertain. Overall, the majority of consensus‑based and high‑accuracy predictions lean toward pathogenicity. Thus, the variant is most likely pathogenic, and this assessment does not contradict the current ClinVar status, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.203988Uncertain0.8220.2630.000-12.179Likely Pathogenic0.338Likely BenignLikely Benign0.52Ambiguous0.41.01Ambiguous0.77Ambiguous1.03Destabilizing0.423Likely Benign-2.89Deleterious0.995Probably Damaging0.981Probably Damaging-1.17Pathogenic0.26Tolerated0.13930.2099220.00.98
c.1893G>C
Q631H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q631H is reported in gnomAD (6‑33440945‑G‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors (Rosetta, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus score (Likely Pathogenic) all indicate a pathogenic impact. Uncertain results come from FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.038963Uncertain0.9480.2300.0006-33440945-G-C21.24e-6-13.282Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.84Ambiguous0.22.21Destabilizing1.53Ambiguous0.84Ambiguous0.475Likely Benign-4.98Deleterious0.995Probably Damaging0.986Probably Damaging2.75Benign0.00Affected3.37340.08340.1757030.39.01
c.1893G>T
Q631H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q631H is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign predictions come from REVEL and FATHMM, whereas the majority of algorithms—including AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, Rosetta, and the SGM Consensus—classify the change as pathogenic. Predictions from FoldX, Foldetta, and premPS are inconclusive. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, while Foldetta’s stability analysis is uncertain. Overall, the preponderance of evidence points to a pathogenic impact for Q631H, which is consistent with the absence of a benign ClinVar annotation and the lack of population data in gnomAD.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.038963Uncertain0.9480.2300.000-13.282Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.84Ambiguous0.22.21Destabilizing1.53Ambiguous0.84Ambiguous0.475Likely Benign-4.98Deleterious0.995Probably Damaging0.986Probably Damaging2.75Benign0.00Affected3.37340.08340.1757030.39.01
c.1912A>G
K638E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K638E is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are uncertain or unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification; this conclusion does not contradict ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.098064Uncertain0.9370.2600.000-13.390Likely Pathogenic0.927Likely PathogenicAmbiguous0.57Ambiguous0.01.00Ambiguous0.79Ambiguous0.32Likely Benign0.363Likely Benign-3.70Deleterious0.995Probably Damaging0.947Probably Damaging3.50Benign0.12Tolerated0.30360.0790010.40.94
c.1950T>A
N650K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N650K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, FoldX, Foldetta, and FATHMM, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Rosetta and premPS. High‑accuracy assessments give a pathogenic verdict from AlphaMissense‑Optimized and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), while Foldetta predicts a benign effect on protein stability. Overall, the majority of evidence points to a pathogenic impact, and this conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.086953Structured0.361944Uncertain0.9610.3570.000-13.078Likely Pathogenic0.998Likely PathogenicLikely Pathogenic-0.33Likely Benign0.10.66Ambiguous0.17Likely Benign0.92Ambiguous0.269Likely Benign-5.98Deleterious0.995Probably Damaging0.807Possibly Damaging3.02Benign0.03Affected3.37300.30280.336001-0.414.07
c.1950T>G
N650K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N650K is not reported in ClinVar and is present in gnomAD (ID 6‑33441209‑T‑G). Prediction tools that indicate a benign effect include REVEL, FoldX, FATHMM, and Foldetta, whereas a majority of tools predict pathogenicity: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools (premPS and Rosetta) give uncertain results. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of predictions lean toward pathogenicity, indicating the variant is most likely pathogenic, and this is consistent with the lack of a ClinVar entry; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.086953Structured0.361944Uncertain0.9610.3570.0006-33441209-T-G-13.078Likely Pathogenic0.998Likely PathogenicLikely Pathogenic-0.33Likely Benign0.10.66Ambiguous0.17Likely Benign0.92Ambiguous0.269Likely Benign-5.98Deleterious0.995Probably Damaging0.807Possibly Damaging3.02Benign0.03Affected3.37300.30280.336001-0.414.07
c.1954T>G
F652V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F652V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, whereas only FATHMM predicts a benign outcome. The high‑accuracy subset confirms this trend: AlphaMissense‑Optimized is pathogenic; SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.098513Structured0.356594Uncertain0.9660.3380.000-11.576Likely Pathogenic0.988Likely PathogenicLikely Pathogenic2.66Destabilizing0.13.21Destabilizing2.94Destabilizing1.49Destabilizing0.595Likely Pathogenic-6.71Deleterious0.995Probably Damaging0.885Possibly Damaging3.05Benign0.00Affected0.16560.1783-1-11.4-48.04
c.2012A>G
D671G
2D
AIThe SynGAP1 D671G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. No evidence from these tools contradicts the pathogenic prediction. Overall, the balance of evidence favors a pathogenic classification for D671G, and this conclusion is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.194234Structured0.096749Uncertain0.6770.3700.000-10.346Likely Pathogenic0.857Likely PathogenicAmbiguous0.50Ambiguous0.51.53Ambiguous1.02Ambiguous0.00Likely Benign0.279Likely Benign-4.78Deleterious0.995Probably Damaging0.946Probably Damaging3.45Benign0.01Affected0.40320.58231-13.1-58.04
c.2020A>C
T674P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T674P missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The high‑accuracy AlphaMissense‑Optimized predicts benign, while Foldetta predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split. No other high‑accuracy tool provides a definitive call. Consequently, the evidence is evenly split between benign and pathogenic, leaving the variant’s clinical significance uncertain. This uncertainty does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.109297Uncertain0.5210.3490.000-8.661Likely Pathogenic0.109Likely BenignLikely Benign0.91Ambiguous0.64.12Destabilizing2.52Destabilizing0.12Likely Benign0.143Likely Benign-2.69Deleterious0.995Probably Damaging0.891Possibly Damaging3.50Benign0.16Tolerated0.20390.61030-1-0.9-3.99
c.2064G>C
E688D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E688D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. Tools that predict a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods specifically give AlphaMissense‑Optimized a pathogenic prediction, SGM‑Consensus a pathogenic prediction, and Foldetta an uncertain result. Overall, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.061840Structured0.211124Uncertain0.9470.2230.000-11.890Likely Pathogenic0.987Likely PathogenicLikely Pathogenic1.79Ambiguous0.50.53Ambiguous1.16Ambiguous0.91Ambiguous0.302Likely Benign-2.89Deleterious0.995Probably Damaging0.960Probably Damaging3.47Benign0.08Tolerated0.17220.3492320.0-14.03
c.2064G>T
E688D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E688D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. Tools that predict a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods specifically give: AlphaMissense‑Optimized – pathogenic; SGM‑Consensus – pathogenic; Foldetta – uncertain. Taken together, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.061840Structured0.211124Uncertain0.9470.2230.000-11.890Likely Pathogenic0.987Likely PathogenicLikely Pathogenic1.79Ambiguous0.50.53Ambiguous1.16Ambiguous0.91Ambiguous0.302Likely Benign-2.89Deleterious0.995Probably Damaging0.960Probably Damaging3.47Benign0.08Tolerated0.17220.3492320.0-14.03
c.2114A>C
K705T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K705T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain calls are made by FoldX and AlphaMissense‑Optimized. High‑accuracy assessments indicate that the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts a pathogenic effect, while Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign outcome. Overall, the balance of evidence leans toward a pathogenic interpretation, and this assessment does not conflict with ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000-8.617Likely Pathogenic0.826Likely PathogenicAmbiguous0.60Ambiguous0.00.04Likely Benign0.32Likely Benign0.17Likely Benign0.272Likely Benign-4.05Deleterious0.995Probably Damaging0.991Probably Damaging3.38Benign0.02Affected0.12990.26120-13.2-27.07
c.2140C>G
L714V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714V has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Overall, the majority of predictions (10 pathogenic vs. 4 benign) indicate a likely pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no record for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.314870Structured0.402311Uncertain0.9610.3690.000-4.966Likely Benign0.781Likely PathogenicLikely Benign3.91Destabilizing0.16.19Destabilizing5.05Destabilizing1.21Destabilizing0.259Likely Benign-2.76Deleterious0.995Probably Damaging0.970Probably Damaging3.16Benign0.00Affected0.14210.2689210.4-14.03
c.2149C>G
L717V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L717V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Two tools predict a damaging effect: polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Stability‑based methods (FoldX, Rosetta, Foldetta) return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta as inconclusive. Taken together, the majority of evidence points to a benign impact. This conclusion is consistent with the absence of a ClinVar assertion, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.239899Structured0.429342Uncertain0.9690.3970.000-6.164Likely Benign0.308Likely BenignLikely Benign1.53Ambiguous0.01.25Ambiguous1.39Ambiguous0.09Likely Benign0.119Likely Benign-0.25Neutral0.995Probably Damaging0.970Probably Damaging3.38Benign0.51Tolerated0.12260.2489210.4-14.03
c.2167A>C
T723P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T723P is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FATHMM, and AlphaMissense‑Optimized. Tools that predict pathogenicity are SGM Consensus, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. premPS is uncertain and does not influence the overall assessment. Overall, the majority of tools and the high‑accuracy methods support a pathogenic effect. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.476583Structured0.458243Uncertain0.9450.4470.375-9.231Likely Pathogenic0.741Likely PathogenicLikely Benign3.98Destabilizing0.16.10Destabilizing5.04Destabilizing0.54Ambiguous0.085Likely Benign-2.51Deleterious0.995Probably Damaging0.929Probably Damaging3.49Benign0.04Affected0.18260.44060-1-0.9-3.99
c.2189T>C
I730T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant I730T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are premPS and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign classification, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a benign effect. Overall, the consensus of both general and high‑accuracy predictors points to a benign impact, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-5.641Likely Benign0.404AmbiguousLikely Benign0.18Likely Benign0.20.12Likely Benign0.15Likely Benign0.54Ambiguous0.103Likely Benign-0.83Neutral0.995Probably Damaging0.934Probably Damaging3.49Benign0.08Tolerated0.10740.08850-1-5.2-12.05
c.2338T>C
S780P
2D
AIThe SynGAP1 missense variant S780P is reported in gnomAD (ID 6‑33442890‑T‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.599170Disordered0.812415Binding0.2830.8830.5006-33442890-T-C16.22e-7-6.055Likely Benign0.234Likely BenignLikely Benign0.088Likely Benign-1.11Neutral0.995Probably Damaging0.892Possibly Damaging2.64Benign0.30Tolerated3.6460.20860.6171-11-0.810.04
c.2339C>A
S780Y
2D
AIThe SynGAP1 missense variant S780Y is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default; ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.599170Disordered0.812415Binding0.2830.8830.500-7.682In-Between0.656Likely PathogenicLikely Benign0.091Likely Benign-1.71Neutral0.995Probably Damaging0.925Probably Damaging2.61Benign0.11Tolerated0.08100.6428-3-2-0.576.10
c.2339C>T
S780F
2D
AIThe SynGAP1 missense variant S780F is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign, two pathogenic) and therefore unavailable as evidence. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, is also unavailable for this variant. Overall, the majority of available predictions (five benign vs. four pathogenic) lean toward a benign impact. There is no ClinVar annotation to contradict this assessment, so the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.599170Disordered0.812415Binding0.2830.8830.500-8.055Likely Pathogenic0.677Likely PathogenicLikely Benign0.104Likely Benign-1.42Neutral0.995Probably Damaging0.925Probably Damaging2.61Benign0.10Tolerated0.07680.6706-3-23.660.10
c.2344G>A
D782N
2D
AIThe SynGAP1 missense variant D782N is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic vs four benign) lean toward a pathogenic impact. This conclusion does not contradict ClinVar status, as the variant has no existing ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.604312Disordered0.768342Binding0.2850.8830.625-6.857Likely Benign0.766Likely PathogenicLikely Benign0.131Likely Benign-2.26Neutral0.995Probably Damaging0.950Probably Damaging1.98Pathogenic0.02Affected0.11670.6884210.0-0.98
c.2345A>G
D782G
2D
AIThe SynGAP1 missense variant D782G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic effect: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Pathogenic” verdict (3 pathogenic vs. 1 benign). AlphaMissense‑Optimized is uncertain, and Foldetta results are unavailable. Based on the overall pattern of predictions, the variant is most likely pathogenic, and this assessment does not contradict any existing ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.604312Disordered0.768342Binding0.2850.8830.625-6.811Likely Benign0.858Likely PathogenicAmbiguous0.291Likely Benign-3.27Deleterious0.995Probably Damaging0.950Probably Damaging1.95Pathogenic0.02Affected0.38160.63181-13.1-58.04
c.2408A>T
K803I
2D
AIThe SynGAP1 K803I missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score. The high‑accuracy AlphaMissense‑Optimized assessment is uncertain, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently contains no classification for K803I.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.827927Disordered0.733908Binding0.3490.9000.625-5.207Likely Benign0.894Likely PathogenicAmbiguous0.196Likely Benign-4.06Deleterious0.995Probably Damaging0.913Probably Damaging2.31Pathogenic0.00Affected0.14250.3889-2-38.4-15.01
c.2503C>G
L835V
2D
AIThe SynGAP1 missense variant L835V is reported in gnomAD (variant ID 6‑33443055‑C‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely benign. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict the variant to be pathogenic. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence from multiple prediction algorithms and high‑accuracy tools indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.642742Binding0.3190.8630.1256-33443055-C-G16.19e-7-3.439Likely Benign0.115Likely BenignLikely Benign0.073Likely Benign-0.70Neutral0.995Probably Damaging0.926Probably Damaging2.72Benign0.17Tolerated3.7750.14920.2886120.4-14.03
c.251G>A
R84H
2D
AIThe SynGAP1 missense variant R84H is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD: not present). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. Two tools give uncertain results: ESM1b and AlphaMissense‑Optimized. High‑accuracy assessment shows that AlphaMissense‑Optimized remains uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves as benign, and Foldetta (combining FoldX‑MD and Rosetta) has no available output. Overall, the majority of standard predictors (four pathogenic vs. three benign) lean toward a pathogenic interpretation, and the high‑accuracy consensus does not overturn this trend. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.666105Disordered0.529205Binding0.2980.8880.500-7.333In-Between0.935Likely PathogenicAmbiguous0.147Likely Benign-1.77Neutral0.995Probably Damaging0.840Possibly Damaging3.68Benign0.00Affected0.27390.2426201.3-19.05
c.2524T>C
S842P
2D
AIThe SynGAP1 missense variant S842P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity largely agree: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict a deleterious effect. Only REVEL classifies the variant as benign. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus indicates “Likely Pathogenic.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the consensus of the majority of tools, including the high‑accuracy predictors, indicates that S842P is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.604312Disordered0.617281Binding0.2740.8610.250-13.890Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.309Likely Benign-3.43Deleterious0.995Probably Damaging0.892Possibly Damaging1.99Pathogenic0.00Affected0.14940.53421-1-0.810.04
c.2584A>G
N862D
2D
AIThe SynGAP1 missense variant N862D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.564559Binding0.2570.7910.250-5.255Likely Benign0.323Likely BenignLikely Benign0.144Likely Benign-1.22Neutral0.995Probably Damaging0.926Probably Damaging4.06Benign0.51Tolerated0.17860.4764210.00.98
c.2585A>C
N862T
2D
AIThe SynGAP1 missense variant at residue 862 (Asn→Thr) is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates “Likely Benign.” In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the majority of evidence supports a benign classification, and this is consistent with the lack of ClinVar annotation—there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.564559Binding0.2570.7910.250-5.623Likely Benign0.170Likely BenignLikely Benign0.122Likely Benign-1.60Neutral0.995Probably Damaging0.946Probably Damaging4.09Benign0.19Tolerated0.15420.7704002.8-13.00
c.2586C>A
N862K
2D
AIThe SynGAP1 missense variant N862K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools cluster into two groups: benign predictions from REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. ESM1b is uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.525368Disordered0.564559Binding0.2570.7910.250-7.000In-Between0.766Likely PathogenicLikely Benign0.084Likely Benign-1.87Neutral0.995Probably Damaging0.946Probably Damaging4.10Benign0.20Tolerated0.23130.546910-0.414.07
c.2586C>G
N862K
2D
AIThe SynGAP1 missense variant N862K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools cluster into two groups: benign predictions from REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. ESM1b is uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.525368Disordered0.564559Binding0.2570.7910.250-7.000In-Between0.766Likely PathogenicLikely Benign0.084Likely Benign-1.87Neutral0.995Probably Damaging0.946Probably Damaging4.10Benign0.20Tolerated0.23130.546910-0.414.07
c.2587C>G
L863V
2D
AIThe SynGAP1 missense variant L863V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign effect. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign impact for the L863V variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.594839Binding0.2670.7950.250-3.651Likely Benign0.107Likely BenignLikely Benign0.103Likely Benign-0.72Neutral0.995Probably Damaging0.926Probably Damaging4.09Benign0.21Tolerated0.16550.3544210.4-14.03
c.2650C>T
R884W
2D
AIThe SynGAP1 missense variant R884W is listed in ClinVar with an “Uncertain” status and is present in the gnomAD database (gnomAD ID 6‑33443202‑C‑T). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also benign. No Foldetta (protein‑folding stability) result is available for this variant. Overall, the majority of computational predictions, including the high‑accuracy tools, indicate that R884W is most likely benign, which is consistent with the ClinVar “Uncertain” status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.720929Disordered0.641526Binding0.3050.8980.250Uncertain 16-33443202-C-T53.10e-6-3.785Likely Benign0.332Likely BenignLikely Benign0.151Likely Benign0.26Neutral0.995Probably Damaging0.812Possibly Damaging2.56Benign0.05Affected4.3240.12230.3304-323.630.03
c.2704G>C
A902P
2D
AIThe SynGAP1 missense variant A902P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for A902P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.517703Binding0.3190.9190.375-4.509Likely Benign0.154Likely BenignLikely Benign0.146Likely Benign0.09Neutral0.995Probably Damaging0.846Possibly Damaging2.56Benign0.01Affected0.16940.53041-1-3.426.04
c.2810A>C
D937A
2D
AIThe SynGAP1 missense variant D937A is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. AlphaMissense‑Default is uncertain, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.819762Disordered0.963385Binding0.3480.8830.625-1.652Likely Benign0.385AmbiguousLikely Benign0.096Likely Benign-1.45Neutral0.995Probably Damaging0.895Possibly Damaging2.76Benign0.10Tolerated0.42960.72440-25.3-44.01
c.2835T>A
H945Q
2D
AIThe SynGAP1 missense variant H945Q is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33443387‑T‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The high‑accuracy consensus from AlphaMissense‑Optimized is benign, and the SGM consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—is also benign. Foldetta results are not available for this variant. Overall, the majority of computational evidence points to a benign impact, which is consistent with the ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.982235Disordered0.849210Binding0.3860.9230.750Conflicting 26-33443387-T-A31.86e-6-5.248Likely Benign0.091Likely BenignLikely Benign0.343Likely Benign-0.36Neutral0.995Probably Damaging0.939Probably Damaging5.03Benign0.06Tolerated4.3240.26710.312830-0.3-9.01
c.2835T>G
H945Q
2D
AIThe SynGAP1 missense variant H945Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. Only two tools, polyPhen‑2 HumDiv and polyPhen‑2 HumVar, predict a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact for H945Q, and this conclusion is not contradicted by any ClinVar classification (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.982235Disordered0.849210Binding0.3860.9230.750-5.248Likely Benign0.091Likely BenignLikely Benign0.343Likely Benign-0.36Neutral0.995Probably Damaging0.939Probably Damaging5.03Benign0.06Tolerated4.3240.26710.312830-0.3-9.01
c.2951A>T
K984M
2D
AIThe SynGAP1 missense variant K984M is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are not available. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.951648Binding0.2880.8950.750-4.761Likely Benign0.934Likely PathogenicAmbiguous0.141Likely Benign-1.82Neutral0.995Probably Damaging0.944Probably Damaging2.60Benign0.00Affected0.15760.41680-15.83.02
c.2999T>A
I1000N
2D
AIThe SynGAP1 missense variant I1000N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.745909Disordered0.957020Binding0.2930.9040.625-5.246Likely Benign0.677Likely PathogenicLikely Benign0.145Likely Benign-0.82Neutral0.995Probably Damaging0.913Probably Damaging2.72Benign0.16Tolerated0.10010.0900-2-3-8.00.94
c.3056G>A
R1019H
2D
AIThe SynGAP1 missense variant R1019H is listed in ClinVar (ID 1195115.0) with an “Uncertain” status and is present in gnomAD (variant ID 6‑33443608‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote) also benign; Foldetta stability analysis is unavailable. Overall, the preponderance of evidence points to a benign impact for R1019H, and this conclusion does not contradict the current ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.856457Disordered0.966400Binding0.3150.7940.500Conflicting 26-33443608-G-A674.15e-5-4.610Likely Benign0.258Likely BenignLikely Benign0.122Likely Benign-1.95Neutral0.995Probably Damaging0.845Possibly Damaging2.39Pathogenic0.01Affected3.7750.24000.1903201.3-19.05
c.3059G>A
R1020Q
2D
AIThe SynGAP1 missense variant R1020Q is catalogued in gnomAD (6‑33443611‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized scores the variant as benign, and the SGM‑Consensus also indicates “Likely Benign.” No Foldetta stability analysis is available, so it does not influence the overall assessment. Based on the collective predictions, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.852992Disordered0.972945Binding0.3400.7770.5006-33443611-G-A21.24e-6-3.753Likely Benign0.445AmbiguousLikely Benign0.137Likely Benign-2.19Neutral0.995Probably Damaging0.870Possibly Damaging2.52Benign0.00Affected3.7750.30500.2997111.0-28.06
c.3065T>C
L1022P
2D
AIThe SynGAP1 missense variant L1022P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic, two benign), and Foldetta data are unavailable. Overall, the balance of evidence favors a pathogenic interpretation, and this assessment does not conflict with ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.859585Disordered0.986981Binding0.3390.7520.500-2.532Likely Benign0.643Likely PathogenicLikely Benign0.177Likely Benign-2.22Neutral0.995Probably Damaging0.925Probably Damaging2.49Pathogenic0.01Affected0.33320.1589-3-3-5.4-16.04
c.307G>T
G103C
2D
AIThe SynGAP1 missense variant G103C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available. Overall, the majority of evidence points to a benign effect for G103C, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.795062Disordered0.687376Binding0.3810.8770.625-5.681Likely Benign0.136Likely BenignLikely Benign0.128Likely Benign-1.12Neutral0.995Probably Damaging0.829Possibly Damaging4.17Benign0.00Affected0.14940.3767-3-32.946.09
c.3094C>A
L1032M
2D
AIThe SynGAP1 missense variant L1032M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this is consistent with the lack of any ClinVar pathogenic annotation. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.995318Binding0.3650.7350.500-4.353Likely Benign0.219Likely BenignLikely Benign0.064Likely Benign-0.09Neutral0.995Probably Damaging0.892Possibly Damaging2.66Benign0.10Tolerated0.09350.471942-1.918.03
c.3095T>A
L1032Q
2D
AIThe SynGAP1 missense variant L1032Q is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar) and SIFT. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the aggregate evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.995318Binding0.3650.7350.500-2.992Likely Benign0.467AmbiguousLikely Benign0.134Likely Benign-0.78Neutral0.995Probably Damaging0.892Possibly Damaging2.66Benign0.03Affected0.12170.1677-2-2-7.314.97
c.3095T>G
L1032R
2D
AIThe SynGAP1 missense variant L1032R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.995318Binding0.3650.7350.500-2.658Likely Benign0.707Likely PathogenicLikely Benign0.099Likely Benign-1.03Neutral0.995Probably Damaging0.892Possibly Damaging2.66Benign0.02Affected0.13500.1919-3-2-8.343.03
c.3209G>T
R1070M
2D
AIThe SynGAP1 missense variant R1070M is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the balance of evidence, including the consensus benign call and the absence of pathogenic predictions from the most reliable tools, suggests the variant is most likely benign. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.930790Disordered0.982693Binding0.2970.9060.875-6.455Likely Benign0.917Likely PathogenicAmbiguous0.183Likely Benign-2.27Neutral0.995Probably Damaging0.907Possibly Damaging3.74Benign0.00Affected0.16610.43240-16.4-24.99
c.3226T>G
L1076V
2D
AIThe SynGAP1 missense variant L1076V is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign, while Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.989617Binding0.3010.8920.750-3.615Likely Benign0.344AmbiguousLikely Benign0.097Likely Benign-0.56Neutral0.995Probably Damaging0.982Probably Damaging2.53Benign0.11Tolerated0.16320.3781210.4-14.03
c.3448G>C
A1150P
2D
AIThe SynGAP1 missense variant A1150P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (SGM‑Consensus, REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and pathogenic predictions (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Benign. No Foldetta stability data are available, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign effect for A1150P, and this conclusion is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.762850Disordered0.795712Binding0.3710.8310.625-2.250Likely Benign0.180Likely BenignLikely Benign0.152Likely Benign-0.74Neutral0.995Probably Damaging0.940Probably Damaging2.48Pathogenic0.25Tolerated0.18960.52941-1-3.426.04
c.3449C>A
A1150D
2D
AIThe SynGAP1 missense variant A1150D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evaluated tools (five pathogenic vs. three benign) predict a pathogenic impact. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.762850Disordered0.795712Binding0.3710.8310.625-3.923Likely Benign0.859Likely PathogenicAmbiguous0.156Likely Benign-2.30Neutral0.995Probably Damaging0.940Probably Damaging2.30Pathogenic0.01Affected0.17540.21430-2-5.344.01
c.3451T>C
S1151P
2D
AIThe SynGAP1 missense variant S1151P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy methods further support this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus itself is benign; Foldetta results are not available. Overall, the consensus of the available predictions indicates that the variant is most likely benign, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.741537Disordered0.805072Binding0.3940.8390.625-3.031Likely Benign0.298Likely BenignLikely Benign0.123Likely Benign-1.47Neutral0.995Probably Damaging0.892Possibly Damaging2.67Benign0.11Tolerated0.19530.53201-1-0.810.04
c.3452C>A
S1151Y
2D
AIThe SynGAP1 missense variant S1151Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. AlphaMissense‑Optimized also predicts a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of high‑confidence tools and the consensus prediction favor a benign impact, and there is no ClinVar entry to contradict this assessment. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.741537Disordered0.805072Binding0.3940.8390.625-4.456Likely Benign0.642Likely PathogenicLikely Benign0.166Likely Benign-0.87Neutral0.995Probably Damaging0.925Probably Damaging2.68Benign0.05Affected0.07780.5287-3-2-0.576.10
c.3452C>T
S1151F
2D
AIThe SynGAP1 missense variant S1151F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. There is no ClinVar entry to contradict this assessment, so the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.741537Disordered0.805072Binding0.3940.8390.625-4.433Likely Benign0.661Likely PathogenicLikely Benign0.170Likely Benign-0.60Neutral0.995Probably Damaging0.925Probably Damaging2.70Benign0.19Tolerated0.07490.5370-3-23.660.10
c.3496G>A
A1166T
2D
AIThe SynGAP1 missense variant A1166T is not reported in ClinVar and has no gnomAD entry. Consensus and most in silico predictors classify it as benign: SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate a benign effect. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default predict a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Benign. No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by ClinVar data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.811691Binding0.3810.8030.375-3.615Likely Benign0.748Likely PathogenicLikely Benign0.343Likely Benign-1.13Neutral0.995Probably Damaging0.963Probably Damaging5.37Benign0.26Tolerated0.13280.641810-2.530.03
c.3496G>T
A1166S
2D
AIThe SynGAP1 missense variant A1166S is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster around a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports a likely benign outcome. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact. The AlphaMissense‑Default score is uncertain, and no Foldetta stability assessment is available. High‑accuracy methods that are available—AlphaMissense‑Optimized and the SGM‑Consensus—both support a benign classification. Consequently, the variant is most likely benign according to the majority of predictive evidence, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.811691Binding0.3810.8030.375-2.587Likely Benign0.396AmbiguousLikely Benign0.308Likely Benign-0.59Neutral0.995Probably Damaging0.949Probably Damaging5.41Benign0.35Tolerated0.25680.523911-2.616.00
c.3497C>T
A1166V
2D
AIThe SynGAP1 A1166V missense variant has no ClinVar record and is not listed in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and the Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect. The variant’s predicted benign status does not contradict any ClinVar annotation, as none exists. Thus, based on current computational predictions, the A1166V variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.811691Binding0.3810.8030.375-4.305Likely Benign0.843Likely PathogenicAmbiguous0.291Likely Benign-1.04Neutral0.995Probably Damaging0.963Probably Damaging5.43Benign0.40Tolerated0.09670.5384002.428.05
c.3499G>A
D1167N
2D
AIThe SynGAP1 missense variant D1167N is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evaluated predictors (five pathogenic vs. three benign) lean toward a pathogenic interpretation. This prediction does not contradict any ClinVar status, as the variant is not yet catalogued in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.599170Disordered0.783999Binding0.3360.7980.500-3.671Likely Benign0.924Likely PathogenicAmbiguous0.180Likely Benign-1.72Neutral0.995Probably Damaging0.963Probably Damaging2.33Pathogenic0.01Affected0.13150.7940210.0-0.98
c.3500A>G
D1167G
2D
AIThe SynGAP1 missense variant D1167G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that classify the variant as benign include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that D1167G is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.783999Binding0.3360.7980.500-2.967Likely Benign0.986Likely PathogenicLikely Pathogenic0.246Likely Benign-2.57Deleterious0.995Probably Damaging0.949Probably Damaging2.29Pathogenic0.01Affected0.41720.73051-13.1-58.04
c.3506A>C
E1169A
2D
AIThe SynGAP1 missense variant E1169A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on benign impact include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict pathogenicity are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, a majority‑vote method from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, and Foldetta results are unavailable. Considering the consensus of benign‑predicting tools and the SGM‑Consensus outcome, the variant is most likely benign. This assessment does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.699094Disordered0.732455Binding0.4000.7810.625-2.132Likely Benign0.901Likely PathogenicAmbiguous0.217Likely Benign-2.46Neutral0.995Probably Damaging0.949Probably Damaging2.50Benign0.00Affected0.37140.62930-15.3-58.04
c.3506A>G
E1169G
2D
AIThe SynGAP1 missense variant E1169G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evaluated predictors (five pathogenic vs. three benign) lean toward a pathogenic classification. This prediction is not contradicted by ClinVar status, as the variant is not yet catalogued there. Thus, based on current computational evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.699094Disordered0.732455Binding0.4000.7810.625-3.172Likely Benign0.940Likely PathogenicAmbiguous0.203Likely Benign-2.33Neutral0.995Probably Damaging0.963Probably Damaging2.45Pathogenic0.00Affected0.30050.60190-23.1-72.06
c.3526G>A
E1176K
2D
AIThe SynGAP1 E1176K missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves as Likely Benign. High‑accuracy assessments further show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta) is not available for this residue. Because the majority of evidence, including the consensus score, points to a benign effect and no ClinVar entry contradicts this, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.538167Disordered0.572075Binding0.5250.7150.250-4.240Likely Benign0.959Likely PathogenicLikely Pathogenic0.400Likely Benign-1.41Neutral0.995Probably Damaging0.949Probably Damaging5.54Benign0.18Tolerated0.16580.632101-0.4-0.94
c.3526G>C
E1176Q
2D
AIThe SynGAP1 missense variant E1176Q is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence favors a benign interpretation; this conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.538167Disordered0.572075Binding0.5250.7150.250-3.881Likely Benign0.860Likely PathogenicAmbiguous0.372Likely Benign-1.19Neutral0.995Probably Damaging0.963Probably Damaging5.45Benign0.18Tolerated0.07880.6068220.0-0.98
c.3527A>C
E1176A
2D
AIThe SynGAP1 E1176A missense change is not reported in ClinVar and has no gnomAD entry. Consensus from multiple in‑silico predictors shows a split: benign‑oriented tools (REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) all indicate a benign effect, whereas pathogenic‑oriented tools (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default) predict a deleterious impact. The high‑accuracy AlphaMissense‑Optimized score is uncertain, and the Foldetta stability assessment is unavailable. Taking the overall evidence together, the variant is most likely benign; this assessment does not conflict with ClinVar, which contains no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.538167Disordered0.572075Binding0.5250.7150.250-3.164Likely Benign0.909Likely PathogenicAmbiguous0.411Likely Benign-1.95Neutral0.995Probably Damaging0.924Probably Damaging5.55Benign0.19Tolerated0.31600.58890-15.3-58.04
c.3527A>G
E1176G
2D
AIThe SynGAP1 missense variant E1176G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM‑Consensus as “Likely Benign,” and Foldetta results are unavailable. Overall, the balance of evidence—five benign predictions versus three pathogenic, a consensus leaning benign, and no conflicting ClinVar annotation—suggests that E1176G is most likely benign. This conclusion does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.538167Disordered0.572075Binding0.5250.7150.250-4.531Likely Benign0.838Likely PathogenicAmbiguous0.459Likely Benign-2.14Neutral0.995Probably Damaging0.963Probably Damaging5.48Benign0.08Tolerated0.26680.54140-23.1-72.06
c.3530A>T
E1177V
2D
AIThe SynGAP1 E1177V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, while those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta results are unavailable. Overall, more tools predict pathogenicity (5) than benignity (3), and no ClinVar evidence contradicts this assessment. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.541878Disordered0.566503Binding0.5420.7050.250-3.091Likely Benign0.892Likely PathogenicAmbiguous0.481Likely Benign-2.90Deleterious0.995Probably Damaging0.892Possibly Damaging5.66Benign0.01Affected0.04630.4520-2-27.7-29.98
c.3532T>A
Y1178N
2D
AIThe SynGAP1 missense variant Y1178N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools are divided: benign predictions come from REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.541878Disordered0.568433Binding0.5540.6880.250-2.125Likely Benign0.619Likely PathogenicLikely Benign0.410Likely Benign-1.18Neutral0.995Probably Damaging0.892Possibly Damaging5.50Benign0.09Tolerated0.24560.0341-2-2-2.2-49.07
c.3532T>C
Y1178H
2D
AIThe SynGAP1 missense variant Y1178H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence points to a benign impact, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.541878Disordered0.568433Binding0.5540.6880.250-2.926Likely Benign0.775Likely PathogenicLikely Benign0.340Likely Benign-0.78Neutral0.995Probably Damaging0.892Possibly Damaging5.48Benign0.03Affected0.22720.034102-1.9-26.03
c.3532T>G
Y1178D
2D
AIThe SynGAP1 missense variant Y1178D is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. AlphaMissense‑Optimized yields an Uncertain result, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available prediction for this variant. Overall, the balance of evidence from high‑accuracy tools and consensus predictions leans toward a benign classification. This conclusion is not contradicted by ClinVar status, which currently contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.541878Disordered0.568433Binding0.5540.6880.250-1.250Likely Benign0.801Likely PathogenicAmbiguous0.434Likely Benign-1.33Neutral0.995Probably Damaging0.846Possibly Damaging5.55Benign0.07Tolerated0.45620.0173-4-3-2.2-48.09
c.3541A>G
K1181E
2D
AIThe SynGAP1 missense variant K1181E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense (Default and Optimized) predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM‑Consensus remains benign; Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.622677Disordered0.539278Binding0.6250.6600.375-3.244Likely Benign0.964Likely PathogenicLikely Pathogenic0.196Likely Benign-1.19Neutral0.995Probably Damaging0.949Probably Damaging2.86Benign0.55Tolerated0.28620.0877010.40.94
c.3698T>A
I1233N
2D
AIThe SynGAP1 I1233N missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM. All other evaluated tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic impact. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.525368Disordered0.564054Binding0.8810.5310.125-9.586Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.193Likely Benign-4.36Deleterious0.995Probably Damaging0.913Probably Damaging2.52Benign0.00Affected0.08790.0340-2-3-8.00.94
c.3788T>A
I1263N
2D
AIThe SynGAP1 missense variant I1263N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no classification for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.425610Structured0.740957Binding0.8670.5740.000-9.158Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.379Likely Benign-5.80Deleterious0.995Probably Damaging0.913Probably Damaging1.79Pathogenic0.00Affected0.10410.0340-2-3-8.00.94
c.3796C>G
L1266V
2D
AIThe SynGAP1 missense variant L1266V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: REVEL predicts a benign outcome, whereas all other evaluated algorithms (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.433034Structured0.802655Binding0.8680.6020.000-10.024Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.125Likely Benign-2.53Deleterious0.995Probably Damaging0.890Possibly Damaging2.16Pathogenic0.00Affected0.13010.3118210.4-14.03
c.3806T>G
V1269G
2D
AIThe SynGAP1 missense variant V1269G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include only REVEL, whereas all other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic outcome. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenicity. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus is pathogenic; Foldetta results are unavailable. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.433034Structured0.787464Binding0.8430.6470.125-9.927Likely Pathogenic0.969Likely PathogenicLikely Pathogenic0.420Likely Benign-5.91Deleterious0.995Probably Damaging0.999Probably Damaging2.10Pathogenic0.00Affected0.21800.2557-1-3-4.6-42.08
c.3812A>T
E1271V
2D
AISynGAP1 missense variant E1271V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and ESM1b, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. AlphaMissense‑Optimized yields an uncertain result, and no Foldetta stability assessment is available. Considering the majority of high‑confidence tools and the consensus score, the variant is most likely pathogenic. This assessment does not contradict any ClinVar annotation, as no ClinVar entry exists for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.483068Structured0.767529Binding0.8320.6660.375-6.961Likely Benign0.848Likely PathogenicAmbiguous0.303Likely Benign-5.64Deleterious0.995Probably Damaging0.846Possibly Damaging2.02Pathogenic0.00Affected0.06200.6106-2-27.7-29.98
c.3877G>T
D1293Y
2D
AIThe SynGAP1 missense variant D1293Y is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions (five pathogenic vs. three benign) and the SGM Consensus support a pathogenic classification, with no ClinVar entry to contradict this assessment. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.779859Disordered0.892346Binding0.5690.8010.625-5.452Likely Benign0.392AmbiguousLikely Benign0.310Likely Benign-6.15Deleterious0.995Probably Damaging0.897Possibly Damaging2.15Pathogenic0.00Affected0.06270.3577-4-32.248.09
c.3923G>C
R1308P
2D
AIThe SynGAP1 missense variant R1308P is not reported in ClinVar but is present in gnomAD (ID 6‑33451797‑G‑C). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is a 2‑vs‑2 split and therefore inconclusive. Foldetta, a protein‑folding stability method that combines FoldX‑MD and Rosetta outputs, has no available result for this variant. Because the available predictions are evenly divided between benign and pathogenic, the overall computational assessment is inconclusive; the variant is neither clearly benign nor clearly pathogenic. This lack of consensus does not contradict ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.741537Disordered0.930652Binding0.3780.9040.7506-33451797-G-C-1.320Likely Benign0.216Likely BenignLikely Benign0.158Likely Benign-4.62Deleterious0.995Probably Damaging0.992Probably Damaging2.32Pathogenic0.00Affected3.7750.20700.5020-202.9-59.07
c.418T>C
S140P
2D
AIThe SynGAP1 missense variant S140P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic vs. two benign votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy tools specifically show AlphaMissense‑Optimized as pathogenic, while SGM Consensus and Foldetta are unavailable. Overall, the majority of evidence points to a pathogenic impact for S140P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.476583Structured0.587898Binding0.3210.8960.625-4.089Likely Benign0.990Likely PathogenicLikely Pathogenic0.287Likely Benign-2.59Deleterious0.995Probably Damaging0.979Probably Damaging3.52Benign0.08Tolerated0.17260.51171-1-0.810.04
c.419C>A
S140Y
2D
AIThe SynGAP1 missense variant S140Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the S140Y variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.476583Structured0.587898Binding0.3210.8960.625-13.071Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.252Likely Benign-3.88Deleterious0.995Probably Damaging0.986Probably Damaging3.48Benign0.00Affected0.05970.5849-3-2-0.576.10
c.419C>T
S140F
2D
AIThe SynGAP1 missense variant S140F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic or likely pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote) also indicates likely pathogenic. Foldetta results are unavailable. Overall, the consensus of the available predictions points to a pathogenic effect for S140F, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.476583Structured0.587898Binding0.3210.8960.625-10.824Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.246Likely Benign-3.83Deleterious0.995Probably Damaging0.986Probably Damaging3.48Benign0.00Affected0.05650.5988-3-23.660.10
c.463A>C
S155R
2D
AIThe SynGAP1 missense variant S155R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the S155R variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.497853Structured0.515359Binding0.2920.7870.500-11.939Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.250Likely Benign-2.74Deleterious0.995Probably Damaging0.979Probably Damaging3.88Benign0.00Affected0.07120.35280-1-3.769.11
c.464G>T
S155I
2D
AIThe SynGAP1 missense variant S155I is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus indicates a likely pathogenic status, and the Foldetta stability analysis is unavailable. Taken together, the majority of evidence points to a pathogenic impact for S155I. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.497853Structured0.515359Binding0.2920.7870.500-11.298Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.264Likely Benign-2.70Deleterious0.995Probably Damaging0.986Probably Damaging3.81Benign0.00Affected0.07640.5711-1-25.326.08
c.465C>A
S155R
2D
AIThe SynGAP1 missense variant S155R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus indicates a likely pathogenic status, and a Foldetta stability analysis is not available. Taken together, the majority of evidence points to a pathogenic impact for S155R. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.497853Structured0.515359Binding0.2920.7870.500-11.939Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.160Likely Benign-2.74Deleterious0.995Probably Damaging0.979Probably Damaging3.88Benign0.00Affected0.07120.35280-1-3.769.11
c.465C>G
S155R
2D
AIThe SynGAP1 missense variant S155R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus indicates a likely pathogenic status, and a Foldetta stability analysis is not available. Taken together, the majority of evidence points to a pathogenic impact for S155R. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.497853Structured0.515359Binding0.2920.7870.500-11.939Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.160Likely Benign-2.74Deleterious0.995Probably Damaging0.979Probably Damaging3.88Benign0.00Affected0.07120.35280-1-3.769.11
c.467T>C
F156S
2D
AIThe SynGAP1 missense variant F156S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Pathogenic” based on a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (derived from the same set of high‑accuracy predictors) also indicates a likely pathogenic outcome. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.476583Structured0.521964Binding0.2840.7850.500-14.082Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.282Likely Benign-3.62Deleterious0.995Probably Damaging0.979Probably Damaging3.97Benign0.00Affected0.51830.0200Weaken-3-2-3.6-60.10
c.475A>T
I159F
2D
AIThe SynGAP1 missense variant I159F is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign (2 benign vs. 1 pathogenic, 1 uncertain). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the balance of evidence, particularly from the high‑accuracy tools, points to a benign impact. This conclusion is not contradicted by any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.454136Structured0.529953Binding0.2780.7310.125-9.530Likely Pathogenic0.447AmbiguousLikely Benign0.200Likely Benign-1.41Neutral0.995Probably Damaging0.979Probably Damaging3.87Benign0.00Affected0.04900.244610-1.734.02
c.476T>A
I159N
2D
AIThe SynGAP1 missense variant I159N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, whereas polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all predict a pathogenic impact. The high‑accuracy AlphaMissense‑Optimized result is uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑vs‑2 split. Foldetta, which would assess protein‑folding stability, has no available output for this variant. Overall, the majority of tools (five out of eight) predict pathogenicity, while three predict benign and one is uncertain. Thus, the variant is most likely pathogenic based on current computational predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.454136Structured0.529953Binding0.2780.7310.125-14.684Likely Pathogenic0.891Likely PathogenicAmbiguous0.218Likely Benign-1.93Neutral0.995Probably Damaging0.986Probably Damaging3.82Benign0.00Affected0.09190.0342-2-3-8.00.94
c.476T>G
I159S
2D
AIThe SynGAP1 missense variant I159S is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool rates the variant as uncertain, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the majority of available predictions (five pathogenic vs. three benign) lean toward pathogenicity. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.454136Structured0.529953Binding0.2780.7310.125-13.684Likely Pathogenic0.905Likely PathogenicAmbiguous0.241Likely Benign-1.70Neutral0.995Probably Damaging0.979Probably Damaging3.85Benign0.00Affected0.28540.0712-1-2-5.3-26.08
c.477C>G
I159M
2D
AIThe SynGAP1 missense variant I159M is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical databases.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.454136Structured0.529953Binding0.2780.7310.125-9.838Likely Pathogenic0.142Likely BenignLikely Benign0.071Likely Benign-0.48Neutral0.995Probably Damaging0.986Probably Damaging3.89Benign0.00Affected0.06780.250021-2.618.03
c.488T>C
F163S
2D
AIThe SynGAP1 missense variant F163S has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus reports it as Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence indicates that F163S is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.433034Structured0.513928Binding0.3250.6860.375-13.338Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.273Likely Benign-2.64Deleterious0.995Probably Damaging0.979Probably Damaging4.05Benign0.00Affected0.52400.0358Weaken-3-2-3.6-60.10
c.563G>T
S188I
2D
AIThe SynGAP1 missense variant S188I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and FATHMM, while the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic or likely pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus also pathogenic; Foldetta results are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for S188I, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.490133Structured0.428502Uncertain0.2980.6030.500-12.133Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.205Likely Benign-3.98Deleterious0.995Probably Damaging0.880Possibly Damaging3.90Benign0.00Affected0.08780.6335-1-25.326.08
c.604G>C
E202Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E202Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar) and SIFT. Two tools, ESM1b and AlphaMissense‑Default, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation and gnomAD presence, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.363090Structured0.429450Uncertain0.7120.4150.125-7.129In-Between0.456AmbiguousLikely Benign-0.16Likely Benign0.00.23Likely Benign0.04Likely Benign-0.13Likely Benign0.175Likely Benign-1.39Neutral0.995Probably Damaging0.747Possibly Damaging4.07Benign0.02Affected0.09490.6792220.0-0.98
c.605A>G
E202G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E202G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic impact are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Tools with uncertain or inconclusive results are Rosetta, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) leans toward pathogenic (2 pathogenic, 1 benign, 1 uncertain). Foldetta remains uncertain. Overall, the majority of standard prediction tools suggest a benign effect, and this conclusion does not contradict the lack of ClinVar reporting. Thus, the variant is most likely benign based on the current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.363090Structured0.429450Uncertain0.7120.4150.125-8.310Likely Pathogenic0.495AmbiguousLikely Benign0.37Likely Benign0.00.74Ambiguous0.56Ambiguous0.27Likely Benign0.259Likely Benign-4.70Deleterious0.995Probably Damaging0.829Possibly Damaging4.01Benign0.07Tolerated0.30610.54050-23.1-72.06
c.619A>C
K207Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K207Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments give a mixed picture: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; AlphaMissense‑Optimized is uncertain; Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign impact. Folding‑stability scores from FoldX and Rosetta are inconclusive, and premPS is unavailable. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-9.544Likely Pathogenic0.874Likely PathogenicAmbiguous0.57Ambiguous0.1-0.57Ambiguous0.00Likely Benign0.61Ambiguous0.250Likely Benign-2.95Deleterious0.995Probably Damaging0.829Possibly Damaging4.00Benign0.10Tolerated0.40100.1797110.4-0.04
c.621G>C
K207N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K207N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicating likely pathogenic, while Foldetta’s stability prediction is unavailable. Overall, the preponderance of evidence points to a pathogenic effect for K207N, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-12.881Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.72Ambiguous0.11.48Ambiguous1.10Ambiguous1.00Destabilizing0.123Likely Benign-3.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.98Benign0.07Tolerated0.31840.2335100.4-14.07
c.621G>T
K207N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K207N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions arise from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, and the SGM Consensus (majority vote) also predicts Pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the preponderance of evidence indicates that K207N is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-12.881Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.72Ambiguous0.11.48Ambiguous1.10Ambiguous1.00Destabilizing0.124Likely Benign-3.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.98Benign0.07Tolerated0.31840.2335100.4-14.07
c.625G>A
V209M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V209M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Five tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) give uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Overall, the majority of available predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.247041Structured0.397624Uncertain0.8740.3310.125-8.112Likely Pathogenic0.932Likely PathogenicAmbiguous0.70Ambiguous0.40.77Ambiguous0.74Ambiguous0.78Ambiguous0.115Likely Benign-1.48Neutral0.995Probably Damaging0.880Possibly Damaging3.68Benign0.02Affected0.06690.398221-2.332.06
c.626T>A
V209E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V209E is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining 13 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) all predict a pathogenic outcome. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming majority of pathogenic predictions, V209E is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.247041Structured0.397624Uncertain0.8740.3310.125-14.366Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.53Destabilizing1.32.35Destabilizing2.94Destabilizing1.52Destabilizing0.403Likely Benign-4.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.65Benign0.00Affected0.08260.1652-2-2-7.729.98
c.631A>C
S211R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, FoldX, Rosetta, and FATHMM, whereas a pathogenic signal is reported by SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign. Overall, the majority of tools predict a pathogenic effect, and the high‑accuracy predictions reinforce this conclusion. The variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.209395Structured0.389893Uncertain0.8460.3000.125-14.126Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.49Likely Benign1.00.20Likely Benign0.35Likely Benign0.97Ambiguous0.132Likely Benign-4.00Deleterious0.995Probably Damaging0.829Possibly Damaging3.95Benign0.02Affected0.10030.35920-1-3.769.11
c.632G>T
S211I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 S211I missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and FATHMM; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. No evidence from FoldX or Rosetta is available. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.209395Structured0.389893Uncertain0.8460.3000.125-17.090Likely Pathogenic0.973Likely PathogenicLikely Pathogenic1.06Ambiguous1.11.05Ambiguous1.06Ambiguous0.12Likely Benign0.251Likely Benign-4.94Deleterious0.995Probably Damaging0.767Possibly Damaging3.90Benign0.01Affected0.09090.5220-1-25.326.08
c.633C>A
S211R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, Rosetta, FATHMM, and Foldetta. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled “Likely Pathogenic.” The premPS score is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions and the two high‑accuracy pathogenic calls suggest that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.209395Structured0.389893Uncertain0.8460.3000.125-14.126Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.49Likely Benign1.00.20Likely Benign0.35Likely Benign0.97Ambiguous0.144Likely Benign-4.00Deleterious0.995Probably Damaging0.829Possibly Damaging3.95Benign0.02Affected0.10030.35920-1-3.769.11
c.633C>G
S211R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211R is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, FoldX, Rosetta, FATHMM, and the protein‑stability integrator Foldetta, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic, and premPS is uncertain. High‑accuracy assessments give conflicting signals: AlphaMissense‑Optimized predicts Pathogenic, SGM‑Consensus also predicts Likely Pathogenic, but Foldetta, which combines FoldX‑MD and Rosetta outputs, predicts Benign. Overall, the majority of tools and the consensus score point to a pathogenic effect, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.209395Structured0.389893Uncertain0.8460.3000.125-14.126Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.49Likely Benign1.00.20Likely Benign0.35Likely Benign0.97Ambiguous0.144Likely Benign-4.00Deleterious0.995Probably Damaging0.829Possibly Damaging3.95Benign0.02Affected0.10030.35920-1-3.769.11
c.634T>C
S212P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S212P is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX and FATHMM, whereas the remaining tools—REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict it to be pathogenic. High‑accuracy methods give consistent pathogenic results: AlphaMissense‑Optimized scores it as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a destabilizing, pathogenic effect. With the overwhelming majority of tools supporting pathogenicity and no ClinVar entry to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.381517Uncertain0.8460.2780.125-13.051Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.02Likely Benign0.96.30Destabilizing3.16Destabilizing0.90Ambiguous0.809Likely Pathogenic-4.13Deleterious0.995Probably Damaging0.979Probably Damaging5.75Benign0.01Affected0.18590.56791-1-0.810.04
c.635C>A
S212Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S212Y is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include FoldX, FATHMM, and premPS. In contrast, a majority of tools predict a pathogenic impact: REVEL, SGM‑Consensus, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, is inconclusive for this variant. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as likely pathogenic; Foldetta remains uncertain. Overall, the preponderance of evidence from multiple in silico predictors indicates that S212Y is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.381517Uncertain0.8460.2780.125-14.812Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.43Likely Benign0.52.32Destabilizing1.38Ambiguous0.22Likely Benign0.819Likely Pathogenic-5.15Deleterious0.995Probably Damaging0.986Probably Damaging5.76Benign0.00Affected0.05550.6120-3-2-0.576.10
c.635C>T
S212F
2D
AIThe SynGAP1 missense variant S212F is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include FoldX, FATHMM, and premPS, whereas the majority of other in‑silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus score (Likely Pathogenic) predict a pathogenic outcome. The remaining tools, Foldetta and Rosetta, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overall consensus of the majority of predictors and the high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.381517Uncertain0.8460.2780.125-14.029Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.11Likely Benign1.60.88Ambiguous0.50Ambiguous-0.02Likely Benign0.820Likely Pathogenic-5.15Deleterious0.995Probably Damaging0.986Probably Damaging5.76Benign0.00Affected0.05030.6259-3-23.660.10
c.637A>T
I213F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I213F missense variant is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, while the remaining evaluated algorithms (SGM‑Consensus, REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact; FoldX and premPS are uncertain and are treated as unavailable evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain and thus not considered. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.372201Uncertain0.8500.2950.125-12.212Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.96Ambiguous0.72.66Destabilizing1.81Ambiguous0.73Ambiguous0.815Likely Pathogenic-3.30Deleterious0.995Probably Damaging0.829Possibly Damaging5.79Benign0.01Affected0.04730.256010-1.734.02
c.638T>A
I213N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I213N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining evaluated algorithms—SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; FoldX is uncertain and is treated as unavailable. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.372201Uncertain0.8500.2950.125-15.069Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.71Ambiguous0.82.81Destabilizing2.26Destabilizing1.85Destabilizing0.862Likely Pathogenic-5.81Deleterious0.995Probably Damaging0.880Possibly Damaging5.83Benign0.00Affected0.07500.0412-2-3-8.00.94
c.638T>G
I213S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I213S missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the change as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.372201Uncertain0.8500.2950.125-12.858Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.00Destabilizing1.12.95Destabilizing2.48Destabilizing1.53Destabilizing0.879Likely Pathogenic-4.88Deleterious0.995Probably Damaging0.829Possibly Damaging5.83Benign0.00Affected0.22900.0800-1-2-5.3-26.08
c.639C>G
I213M
2D
AIThe SynGAP1 missense variant I213M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are PROVEAN and FATHMM, while a larger group—REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) return uncertain or inconclusive results and are therefore treated as unavailable. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie, and Foldetta is uncertain. Overall, the majority of available predictions lean toward pathogenicity, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.158265Structured0.372201Uncertain0.8500.2950.125-10.777Likely Pathogenic0.906Likely PathogenicAmbiguous0.66Ambiguous0.51.58Ambiguous1.12Ambiguous0.85Ambiguous0.680Likely Pathogenic-2.31Neutral0.995Probably Damaging0.880Possibly Damaging5.85Benign0.01Affected0.06110.252421-2.618.03
c.706G>C
A236P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A236P missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized, whereas those that predict a pathogenic outcome are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and AlphaMissense‑Default; the remaining tools (FoldX, Rosetta, premPS, ESM1b) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. No prediction or stability result is missing or inconclusive. Overall, the majority of individual tools lean toward pathogenicity, but the two most reliable high‑accuracy methods (AlphaMissense‑Optimized and Foldetta) suggest a benign effect, while the SGM Consensus indicates pathogenicity. Given the mixed evidence, the variant is most likely benign based on the strongest high‑accuracy predictions, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.185198Structured0.329926Uncertain0.7750.3300.000-7.932In-Between0.621Likely PathogenicLikely Benign-0.99Ambiguous0.11.44Ambiguous0.23Likely Benign0.67Ambiguous0.862Likely Pathogenic-4.31Deleterious0.995Probably Damaging0.880Possibly Damaging5.78Benign0.12Tolerated0.19800.48971-1-3.426.04
c.709G>C
A237P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A237P is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include FoldX and FATHMM, whereas the majority of tools predict a pathogenic impact: REVEL, SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, Rosetta, and Foldetta. High‑accuracy assessments further support pathogenicity: the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, Foldetta is pathogenic, and AlphaMissense‑Optimized is uncertain (treated as unavailable). Overall, the preponderance of evidence indicates that A237P is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar status is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.200174Structured0.334699Uncertain0.7190.3520.000-9.119Likely Pathogenic0.827Likely PathogenicAmbiguous0.10Likely Benign0.54.20Destabilizing2.15Destabilizing1.04Destabilizing0.752Likely Pathogenic-3.68Deleterious0.995Probably Damaging0.832Possibly Damaging5.77Benign0.03Affected0.15930.37241-1-3.426.04
c.712G>A
E238K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E238K missense change is not reported in ClinVar and is absent from gnomAD. In silico predictors cluster into two groups: a single benign call from FATHMM, and a consensus of pathogenic predictions from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Four tools (FoldX, Rosetta, Foldetta, premPS) returned uncertain results and are not considered evidence. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, while Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E238K. This conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.194234Structured0.332638Uncertain0.7960.3260.000-13.475Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.56Ambiguous0.41.83Ambiguous1.20Ambiguous0.83Ambiguous0.858Likely Pathogenic-3.63Deleterious0.995Probably Damaging0.695Possibly Damaging5.46Benign0.01Affected4.293910.28120.552401-0.4-0.94209.055.90.00.0-0.10.0XPotentially PathogenicThe negatively charged residue Glu238, located in an α helix (res. Ala236-Val250), is replaced by the positively charged residue Lys238. This charge reversal removes the periodically formed salt bridge between the carboxylate group of Glu238 and the guanidinium group of Arg234 observed in the WT simulations. In the variant simulations, both Lys238 and Arg234 form alternative salt bridges with the carboxylate group of Glu680 in the GAP domain loop. Although not visible in the simulations, the absence of the Glu238-Arg234 salt bridge could weaken the integrity of the α helix (residues Ala236-Val250) and potentially affect the tertiary assembly between the PH and GAP domains.
c.721A>C
K241Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K241Q missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, FATHMM, and Foldetta, whereas the majority of tools predict it to be pathogenic: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, nine tools predict pathogenicity versus four predicting benign, with no ClinVar evidence to contradict these findings. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.196879Structured0.349250Uncertain0.7970.3470.000-10.593Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.33Likely Benign0.00.46Likely Benign0.40Likely Benign0.63Ambiguous0.767Likely Pathogenic-3.33Deleterious0.995Probably Damaging0.914Probably Damaging5.83Benign0.04Affected0.42250.1527110.4-0.04
c.722A>C
K241T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K241T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions come from SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Benign predictions are reported by Rosetta and FATHMM. Two tools (Foldetta and premPS) give uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenic; Foldetta remains uncertain. Overall, the consensus of the majority of evidence points to a pathogenic effect for K241T, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.196879Structured0.349250Uncertain0.7970.3470.000-10.911Likely Pathogenic0.987Likely PathogenicLikely Pathogenic2.00Destabilizing0.40.06Likely Benign1.03Ambiguous0.60Ambiguous0.853Likely Pathogenic-5.14Deleterious0.995Probably Damaging0.747Possibly Damaging5.74Benign0.03Affected0.20210.39510-13.2-27.07
c.723A>C
K241N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K241N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.196879Structured0.349250Uncertain0.7970.3470.000-10.198Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.92Ambiguous0.11.13Ambiguous1.03Ambiguous0.89Ambiguous0.663Likely Pathogenic-4.23Deleterious0.995Probably Damaging0.829Possibly Damaging5.81Benign0.03Affected0.34260.1872100.4-14.07
c.723A>T
K241N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K241N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported for FoldX, Rosetta, Foldetta, and premPS and are not used as evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Based on the overall consensus of the available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.196879Structured0.349250Uncertain0.7970.3470.000-10.198Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.92Ambiguous0.11.13Ambiguous1.03Ambiguous0.89Ambiguous0.663Likely Pathogenic-4.23Deleterious0.995Probably Damaging0.829Possibly Damaging5.81Benign0.03Affected0.34260.1872100.4-14.07
c.724T>A
W242R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant W242R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that assess evolutionary conservation and protein function uniformly indicate a deleterious effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool predicts a benign outcome; the only inconclusive results come from FoldX, Rosetta, and Foldetta, which are treated as unavailable evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Consequently, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.000-11.948Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.85Ambiguous0.51.15Ambiguous1.00Ambiguous1.34Destabilizing0.859Likely Pathogenic-12.71Deleterious0.995Probably Damaging0.854Possibly Damaging1.52Pathogenic0.00Affected3.40140.42060.0771-32-3.6-30.03
c.724T>C
W242R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W242R is reported in gnomAD (ID 6‑33435575‑T‑C) but has no ClinVar entry. Across the evaluated predictors, every tool that provides a definitive call classifies the substitution as pathogenic: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No predictor reports a benign effect. FoldX, Rosetta, and Foldetta return uncertain results and are treated as unavailable evidence. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, while Foldetta remains inconclusive. Consequently, the variant is most likely pathogenic based on the consensus of pathogenic predictions, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.0006-33435575-T-C21.24e-6-11.948Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.85Ambiguous0.51.15Ambiguous1.00Ambiguous1.34Destabilizing0.858Likely Pathogenic-12.71Deleterious0.995Probably Damaging0.854Possibly Damaging1.52Pathogenic0.00Affected3.40140.42060.0771-32-3.6-30.03
c.728T>A
I243N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant I243N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into three groups: benign (FATHMM), pathogenic (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized), and uncertain (FoldX, Rosetta, Foldetta). High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.344471Uncertain0.8420.3470.000-14.784Likely Pathogenic0.988Likely PathogenicLikely Pathogenic1.90Ambiguous0.21.43Ambiguous1.67Ambiguous1.76Destabilizing0.811Likely Pathogenic-4.46Deleterious0.995Probably Damaging0.854Possibly Damaging5.49Benign0.00Affected0.08990.0212-2-3-8.00.94
c.728T>G
I243S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I243S is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity largely agree: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. Only FATHMM predicts a benign outcome. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No predictions are missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.344471Uncertain0.8420.3470.000-14.097Likely Pathogenic0.975Likely PathogenicLikely Pathogenic2.52Destabilizing0.22.22Destabilizing2.37Destabilizing1.71Destabilizing0.802Likely Pathogenic-3.55Deleterious0.995Probably Damaging0.795Possibly Damaging5.52Benign0.00Affected0.26580.0600-1-2-5.3-26.08
c.733A>C
N245H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N245H is not reported in ClinVar and is absent from gnomAD. Among in‑silico predictors, benign calls come from FoldX, Rosetta, and FATHMM, whereas pathogenic calls are made by SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. The overall pattern of predictions leans toward pathogenicity, with a majority of tools indicating a deleterious effect. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.454136Structured0.315864Uncertain0.8310.3510.000-11.536Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.23Likely Benign0.1-0.20Likely Benign0.02Likely Benign0.55Ambiguous0.825Likely Pathogenic-4.15Deleterious0.995Probably Damaging0.880Possibly Damaging5.84Benign0.01Affected0.14370.7271210.323.04
c.733A>T
N245Y
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N245Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Rosetta, Foldetta, and FATHMM, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus, SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a pathogenic majority (3/4). AlphaMissense‑Optimized independently predicts pathogenicity, while Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. premPS remains uncertain. Overall, the majority of evidence points toward a pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no entry for this variant. Thus, the variant is most likely pathogenic, with no ClinVar entry to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.454136Structured0.315864Uncertain0.8310.3510.000-12.476Likely Pathogenic0.982Likely PathogenicLikely Pathogenic-0.36Likely Benign0.10.11Likely Benign-0.13Likely Benign0.59Ambiguous0.855Likely Pathogenic-6.68Deleterious0.995Probably Damaging0.880Possibly Damaging5.86Benign0.00Affected0.07060.6771-2-22.249.07
c.734A>T
N245I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N245I is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include Rosetta, Foldetta, and FATHMM, while those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a pathogenic impact. This conclusion does not contradict ClinVar status, as the variant is currently unreported in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.454136Structured0.315864Uncertain0.8310.3510.000-14.527Likely Pathogenic0.996Likely PathogenicLikely Pathogenic-0.56Ambiguous0.10.04Likely Benign-0.26Likely Benign0.60Ambiguous0.831Likely Pathogenic-7.46Deleterious0.995Probably Damaging0.832Possibly Damaging5.88Benign0.00Affected0.06720.6999-2-38.0-0.94
c.740A>C
Q247P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q247P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are limited to FATHMM, while the remaining evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic or likely pathogenic impact; premPS is uncertain and therefore treated as unavailable. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.490133Structured0.283012Uncertain0.8220.3390.250-14.361Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.43Destabilizing0.27.83Destabilizing5.63Destabilizing0.81Ambiguous0.770Likely Pathogenic-3.56Deleterious0.995Probably Damaging0.795Possibly Damaging5.69Benign0.02Affected0.17680.36310-11.9-31.01
c.741G>C
Q247H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q247H is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include SGM‑Consensus, FoldX, Rosetta, Foldetta, ESM1b, FATHMM, AlphaMissense‑Optimized, and PROVEAN. Tools that predict a pathogenic outcome are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.490133Structured0.283012Uncertain0.8220.3390.250-6.239Likely Benign0.583Likely PathogenicLikely Benign0.37Likely Benign0.20.02Likely Benign0.20Likely Benign0.58Ambiguous0.579Likely Pathogenic-2.10Neutral0.995Probably Damaging0.854Possibly Damaging5.71Benign0.02Affected0.09320.2558300.39.01
c.741G>T
Q247H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q247H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, ESM1b, FATHMM, AlphaMissense‑Optimized, and PROVEAN. Those that predict a pathogenic impact are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default, while premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as benign. No prediction or folding stability result is missing or inconclusive. Based on the overall balance of evidence—seven benign versus five pathogenic predictions, and all high‑accuracy tools indicating benign—the variant is most likely benign. This conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.490133Structured0.283012Uncertain0.8220.3390.250-6.239Likely Benign0.583Likely PathogenicLikely Benign0.37Likely Benign0.20.02Likely Benign0.20Likely Benign0.58Ambiguous0.579Likely Pathogenic-2.10Neutral0.995Probably Damaging0.854Possibly Damaging5.71Benign0.02Affected0.09320.2558300.39.01
c.986G>A
R329H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R329H is listed in ClinVar with an uncertain significance (ClinVar ID 2074400.0) and is present in gnomAD (ID 6‑33437891‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—predicts pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result and is treated as unavailable evidence. Overall, the balance of predictions favors a pathogenic impact, which does not contradict the ClinVar uncertain status but suggests the variant is more likely deleterious.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250Uncertain 16-33437891-G-A21.24e-6-10.154Likely Pathogenic0.769Likely PathogenicLikely Benign2.53Destabilizing0.70.71Ambiguous1.62Ambiguous0.82Ambiguous0.155Likely Benign-3.17Deleterious0.995Probably Damaging0.778Possibly Damaging4.04Benign0.05Affected3.41150.29550.1961201.3-19.05220.481.40.10.10.20.3UncertainThe guanidinium group of Arg329, located at the end of an anti-parallel β sheet strand (res. Ala322-Asp330), faces the negatively charged lipid bilayer surface. While the residue swap does not cause any apparent negative effects on the protein structure in the variant simulations, it could adversely affect the SynGAP-membrane association in reality. The positively charged Arg329 side chain forms hydrogen bonds with other loop residues (e.g., Ser371, Asp338) that are expected to dynamically interact with the membrane head group region. However, this phenomenon is beyond the scope of the solvent-only simulations to unravel. Notably, histidine can also be double protonated and positively charged, but this alternative protonation state was not considered in the variant simulations.
c.1028T>A
V343D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343D is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, PROVEAN, ESM1b, FATHMM, premPS, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. Rosetta and Foldetta, which evaluate protein‑folding stability, also predict a pathogenic outcome, while FoldX remains uncertain. No tool in the dataset predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta is pathogenic. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.291804Structured0.383911Uncertain0.8820.4970.250-15.523Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.57Ambiguous0.23.40Destabilizing2.49Destabilizing1.73Destabilizing0.530Likely Pathogenic-5.62Deleterious0.996Probably Damaging0.930Probably Damaging1.59Pathogenic0.00Affected0.17810.2261-2-3-7.715.96
c.1082A>C
Q361P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q361P is listed in ClinVar as Pathogenic (ClinVar ID 3235087.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and premPS. All other evaluated algorithms—FoldX, Rosetta, Foldetta, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy methods specifically give a pathogenic verdict: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. Based on the overwhelming agreement of these predictions, the variant is most likely pathogenic, which is consistent with its ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.427593Uncertain0.9450.5340.250Likely Pathogenic 1-13.280Likely Pathogenic0.956Likely PathogenicLikely Pathogenic3.12Destabilizing0.03.45Destabilizing3.29Destabilizing0.38Likely Benign0.482Likely Benign-3.03Deleterious0.996Probably Damaging0.979Probably Damaging1.63Pathogenic0.05Affected3.37250.19860.5151-101.9-31.01
c.1083G>C
Q361H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q361H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The remaining tools—FoldX, Rosetta, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also unavailable. Overall, the majority of conventional predictors lean toward pathogenicity, while the single high‑accuracy tool suggests benign. No ClinVar annotation exists to contradict these findings. Thus, based on the collective evidence, the variant is most likely pathogenic, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.305330Structured0.427593Uncertain0.9450.5340.250-7.269In-Between0.410AmbiguousLikely Benign0.68Ambiguous0.10.52Ambiguous0.60Ambiguous0.32Likely Benign0.281Likely Benign-2.73Deleterious0.996Probably Damaging0.986Probably Damaging1.79Pathogenic0.04Affected0.13520.4151300.39.01
c.1083G>T
Q361H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q361H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The remaining tools—FoldX, Rosetta, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also unavailable. Overall, the majority of conventional predictors (five pathogenic vs. three benign) lean toward a pathogenic interpretation, while the single high‑accuracy tool suggests benign. No ClinVar entry exists, so there is no contradiction with clinical database status. Based on the collective evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.305330Structured0.427593Uncertain0.9450.5340.250-7.269In-Between0.410AmbiguousLikely Benign0.68Ambiguous0.10.52Ambiguous0.60Ambiguous0.32Likely Benign0.281Likely Benign-2.73Deleterious0.996Probably Damaging0.986Probably Damaging1.79Pathogenic0.04Affected0.13520.4151300.39.01
c.1141G>T
G381W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G381W is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438046‑G‑T). Prediction tools that agree on a benign effect include premPS, PROVEAN, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments give AlphaMissense‑Optimized a benign call, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) a pathogenic call, and Foldetta (combining FoldX‑MD and Rosetta outputs) a pathogenic call. No prediction or folding result is missing or inconclusive. Overall, the majority of tools and the high‑accuracy methods indicate a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.724957Disordered0.431692Uncertain0.3010.9510.7506-33438046-G-T16.24e-7-10.173Likely Pathogenic0.438AmbiguousLikely Benign8.81Destabilizing2.03.17Destabilizing5.99Destabilizing0.02Likely Benign0.576Likely Pathogenic-1.04Neutral0.996Probably Damaging0.920Probably Damaging1.31Pathogenic0.01Affected4.3290.09930.4000-2-7-0.5129.16
c.1156G>T
G386W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G386W is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Computational predictors that classify the change as benign include REVEL, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. High‑accuracy assessments give a benign verdict from AlphaMissense‑Optimized, a benign consensus from the SGM method (majority of the four contributing tools are benign), and a pathogenic result from Foldetta. Uncertain calls from AlphaMissense‑Default and Rosetta are treated as unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not conflict with the lack of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.733139Disordered0.424156Uncertain0.3340.8980.750-10.389Likely Pathogenic0.519AmbiguousLikely Benign6.07Destabilizing5.51.28Ambiguous3.68Destabilizing-0.23Likely Benign0.471Likely Benign-0.85Neutral0.996Probably Damaging0.920Probably Damaging3.90Benign0.00Affected0.10580.4676-7-2-0.5129.16
c.1193C>A
P398Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P398Q has no ClinVar record (ClinVar ID None) and is not reported in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, while the majority of tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default) predict a pathogenic impact. Two tools report uncertainty: ESM1b and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic based on the collective evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.436924Structured0.401041Uncertain0.8910.5250.250-7.402In-Between0.792Likely PathogenicAmbiguous2.13Destabilizing0.12.01Destabilizing2.07Destabilizing1.01Destabilizing0.719Likely Pathogenic-5.57Deleterious0.996Probably Damaging0.724Possibly Damaging5.48Benign0.00Affected0.15220.51760-1-1.931.01
c.1225A>G
M409V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M409V is not reported in ClinVar and is absent from gnomAD. Consensus from most in silico predictors indicates a benign effect: REVEL, Rosetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all score benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports likely benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict pathogenicity. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote) is likely benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, reports benign. No conflicting evidence is present. Therefore, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.150080Structured0.360643Uncertain0.8840.2190.000-4.109Likely Benign0.123Likely BenignLikely Benign1.13Ambiguous0.2-0.25Likely Benign0.44Likely Benign0.37Likely Benign0.163Likely Benign-0.76Neutral0.996Probably Damaging0.974Probably Damaging4.26Benign1.00Tolerated0.27060.4286212.3-32.06
c.1316T>G
L439R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L439R lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, while the remaining evaluated algorithms (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic or likely pathogenic impact; FoldX is uncertain and is treated as unavailable. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.222385Structured0.281542Uncertain0.9420.2650.000-12.870Likely Pathogenic0.985Likely PathogenicLikely Pathogenic1.90Ambiguous0.52.62Destabilizing2.26Destabilizing1.40Destabilizing0.554Likely Pathogenic-5.25Deleterious0.996Probably Damaging0.983Probably Damaging3.22Benign0.01Affected0.12170.0488-3-2-8.343.03
c.1342G>A
A448T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A448T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; premPS is uncertain and therefore not counted. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Taken together, the overwhelming majority of evidence indicates that A448T is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.225814Structured0.292774Uncertain0.9730.2570.000-9.192Likely Pathogenic0.987Likely PathogenicLikely Pathogenic3.06Destabilizing0.22.40Destabilizing2.73Destabilizing0.63Ambiguous0.558Likely Pathogenic-3.95Deleterious0.996Probably Damaging0.973Probably Damaging3.19Benign0.00Affected0.11870.505010-2.530.03
c.1348G>A
A450T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A450T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Because the majority of conventional tools lean toward benign and no ClinVar evidence contradicts this, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.321458Structured0.306281Uncertain0.9630.2340.000-9.149Likely Pathogenic0.380AmbiguousLikely Benign0.50Ambiguous0.20.98Ambiguous0.74Ambiguous0.81Ambiguous0.233Likely Benign-3.35Deleterious0.996Probably Damaging0.973Probably Damaging3.40Benign0.06Tolerated0.09430.590210-2.530.03
c.1368G>C
Q456H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q456H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Tools with uncertain or inconclusive results are FoldX, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of predictions lean toward a benign impact, and this does not contradict the lack of ClinVar annotation. Thus, based on the available computational evidence, the variant is most likely benign, though a high‑accuracy consensus suggests a possible pathogenic effect that warrants further investigation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.302348Uncertain0.9390.1640.000-7.993In-Between0.598Likely PathogenicLikely Benign0.74Ambiguous0.10.39Likely Benign0.57Ambiguous0.32Likely Benign0.214Likely Benign-4.07Deleterious0.996Probably Damaging0.974Probably Damaging3.37Benign0.19Tolerated0.09870.2358300.39.01
c.1368G>T
Q456H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q456H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Tools with uncertain or inconclusive results are FoldX, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of predictions lean toward a benign impact, and this does not contradict the lack of ClinVar annotation. Thus, based on the available computational evidence, the variant is most likely benign, though a high‑accuracy consensus suggests a possible pathogenic effect that warrants further investigation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.302348Uncertain0.9390.1640.000-7.993In-Between0.598Likely PathogenicLikely Benign0.74Ambiguous0.10.39Likely Benign0.57Ambiguous0.32Likely Benign0.214Likely Benign-4.07Deleterious0.996Probably Damaging0.974Probably Damaging3.37Benign0.19Tolerated0.09870.2358300.39.01
c.1387G>C
D463H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D463H is not reported in ClinVar and is absent from gnomAD. Consensus from standard prediction algorithms shows a split: benign predictions come from REVEL, FoldX, SIFT, and FATHMM, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, SGM Consensus confirms Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains Uncertain. No evidence from ClinVar contradicts these findings. Overall, the preponderance of computational evidence indicates that D463H is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-13.151Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.20Likely Benign0.10.85Ambiguous0.53Ambiguous0.57Ambiguous0.356Likely Benign-5.96Deleterious0.996Probably Damaging0.852Possibly Damaging3.35Benign0.11Tolerated0.13410.61561-10.322.05
c.1393C>G
L465V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465V is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL and SIFT, while the remaining tools—FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default—indicate pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports likely pathogenic; and Foldetta, which combines FoldX‑MD and Rosetta stability outputs, predicts pathogenic. Overall, the majority of evidence points to a pathogenic impact, which is consistent with the ClinVar uncertain status and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000Uncertain 1-9.893Likely Pathogenic0.838Likely PathogenicAmbiguous2.46Destabilizing0.12.66Destabilizing2.56Destabilizing1.21Destabilizing0.276Likely Benign-2.98Deleterious0.996Probably Damaging0.992Probably Damaging2.44Pathogenic0.10Tolerated3.37340.14930.3378210.4-14.03204.330.90.00.0-0.40.6XPotentially BenignThe iso-butyl side chain of Leu465, located in the middle of an α helix (res. Ala461–Phe476), packs with hydrophobic residues (e.g., Phe464, Met468, Tyr497, Ile494) in an inter-helix space formed with two other α helices (res. Ala461–Phe476 and res. Thr488-Gly502). In the variant simulations, the iso-propyl side chain of Val465 is equally sized and similarly hydrophobic as the original side chain of Leu465. Hence, the mutation does not exert any negative effects on the protein structure based on the variant simulations.
c.1409T>C
M470T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M470T is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas the remaining tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic impact. High‑accuracy methods further support this: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding‑stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, which is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000Uncertain 1-8.104Likely Pathogenic0.976Likely PathogenicLikely Pathogenic3.19Destabilizing0.12.68Destabilizing2.94Destabilizing1.49Destabilizing0.763Likely Pathogenic-5.30Deleterious0.996Probably Damaging0.985Probably Damaging-1.08Pathogenic0.24Tolerated3.37340.17820.1950-1-1-2.6-30.09213.846.50.00.0-0.20.2XXPotentially PathogenicThe thioether group of Met470, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues in the inter-helix space (e.g., Val473, Leu558, Cys576, Trp572) formed by two other α helices (res. Ser604–Arg581, res. Pro562–Arg579). In the WT simulations, the Met470 side chain also packs against the positively charged guanidinium groups of Arg575, Arg429, and Arg579, which form salt bridges with the negatively charged carboxylate groups of the Asp474 and Asp467 side chains at the protein surface. In the variant simulations, the hydroxyl group of the Thr470 side chain forms an H-bond with the backbone carbonyl group of Ser466 in the α helix, potentially lowering its structural integrity. Importantly, the hydroxyl group of Thr470 also forms an H-bond with the guanidinium group of Arg575, which helps it form a more permanent salt bridge with Asp467.
c.1414G>A
E472K
2D
AIThe SynGAP1 missense variant E472K is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect; the only inconclusive result is from premPS, which is listed as uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a destabilizing, pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-15.214Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.01Destabilizing1.23.23Destabilizing2.62Destabilizing0.78Ambiguous0.670Likely Pathogenic-3.95Deleterious0.996Probably Damaging0.987Probably Damaging2.33Pathogenic0.03Affected0.30770.565101-0.4-0.94
c.1415A>T
E472V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E472V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include Foldetta and premPS, whereas the remaining tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as benign. No prediction or folding‑stability result is missing or inconclusive; uncertain outputs from FoldX and Rosetta are treated as unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-14.957Likely Pathogenic0.991Likely PathogenicLikely Pathogenic1.05Ambiguous0.3-0.64Ambiguous0.21Likely Benign0.37Likely Benign0.733Likely Pathogenic-6.90Deleterious0.996Probably Damaging0.991Probably Damaging2.29Pathogenic0.00Affected0.08810.6347-2-27.7-29.98
c.1426T>G
F476V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F476V variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM. Those that agree on a pathogenic effect are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and Foldetta. Tools with uncertain or mixed outputs are Rosetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a pathogenic impact. Overall, the majority of evidence points toward a pathogenic effect. The variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.329Likely Pathogenic0.918Likely PathogenicAmbiguous3.01Destabilizing0.21.90Ambiguous2.46Destabilizing0.64Ambiguous0.353Likely Benign-1.63Neutral0.996Probably Damaging0.993Probably Damaging3.49Benign0.53Tolerated0.14780.2251-1-11.4-48.04
c.1438G>A
E480K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E480K is catalogued in gnomAD (ID 6‑33438470‑G‑A) but has no entry in ClinVar. Functional prediction tools cluster into two groups: benign predictions come from FoldX and SIFT, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results are reported by Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is labeled Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that E480K is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.426867Uncertain0.7980.2500.0006-33438470-G-A16.20e-7-14.059Likely Pathogenic0.961Likely PathogenicLikely Pathogenic0.40Likely Benign0.11.08Ambiguous0.74Ambiguous0.83Ambiguous0.768Likely Pathogenic-3.45Deleterious0.996Probably Damaging0.987Probably Damaging-1.26Pathogenic0.11Tolerated3.37340.18280.681310-0.4-0.94
c.1439A>T
E480V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E480V is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only premPS. All other evaluated algorithms—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—classify the variant as pathogenic or likely pathogenic. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results and are therefore not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Taken together, the overwhelming majority of predictions support a pathogenic effect for E480V. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.426867Uncertain0.7980.2500.000-12.347Likely Pathogenic0.983Likely PathogenicLikely Pathogenic0.94Ambiguous0.10.74Ambiguous0.84Ambiguous0.31Likely Benign0.797Likely Pathogenic-6.07Deleterious0.996Probably Damaging0.991Probably Damaging-1.24Pathogenic0.02Affected0.04960.7192-2-27.7-29.98
c.1462A>G
T488A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T488A is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL and FATHMM, while the majority of tools (FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) predict pathogenicity; Rosetta and premPS are uncertain. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Taken together, the preponderance of evidence indicates that T488A is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.332663Uncertain0.9280.2330.125-11.341Likely Pathogenic0.963Likely PathogenicLikely Pathogenic2.12Destabilizing0.21.99Ambiguous2.06Destabilizing0.57Ambiguous0.497Likely Benign-4.64Deleterious0.996Probably Damaging0.989Probably Damaging3.24Benign0.01Affected0.28710.2872102.5-30.03
c.1488G>C
E496D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E496D missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain predictions come from Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a unanimous majority of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion is consistent with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.000-10.552Likely Pathogenic0.922Likely PathogenicAmbiguous0.43Likely Benign0.21.78Ambiguous1.11Ambiguous1.18Destabilizing0.583Likely Pathogenic-2.78Deleterious0.996Probably Damaging0.989Probably Damaging-1.45Pathogenic0.04Affected3.37350.15760.1912230.0-14.03
c.1488G>T
E496D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E496D is reported in gnomAD (ID 6‑33438520‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions are provided only by FoldX, whereas the remaining tools—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—classify the change as pathogenic. Uncertain results come from Rosetta, Foldetta, and AlphaMissense‑Optimized and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.0006-33438520-G-T21.24e-6-10.552Likely Pathogenic0.922Likely PathogenicAmbiguous0.43Likely Benign0.21.78Ambiguous1.11Ambiguous1.18Destabilizing0.583Likely Pathogenic-2.78Deleterious0.996Probably Damaging0.989Probably Damaging-1.45Pathogenic0.04Affected3.37350.15760.1912230.0-14.03
c.1511A>T
K504I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K504I is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess the variant’s effect fall into two groups: benign predictions include REVEL, FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized; pathogenic predictions include PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus as pathogenic. Because the majority of tools (seven) predict pathogenicity while three high‑accuracy methods provide conflicting evidence, the overall prediction leans toward pathogenic. This assessment does not contradict ClinVar status, as no ClinVar entry exists for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.028107Structured0.304984Uncertain0.8500.1890.000-12.597Likely Pathogenic0.727Likely PathogenicLikely Benign-0.04Likely Benign0.3-0.36Likely Benign-0.20Likely Benign0.40Likely Benign0.491Likely Benign-7.35Deleterious0.996Probably Damaging0.993Probably Damaging-1.49Pathogenic0.02Affected0.07690.2713-2-38.4-15.01
c.1516C>G
L506V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L506V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and the SGM Consensus) all indicate a pathogenic impact. AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the preponderance of pathogenic predictions and the high‑accuracy tools’ results, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.034884Structured0.279180Uncertain0.9240.1960.000-10.220Likely Pathogenic0.512AmbiguousLikely Benign2.61Destabilizing0.23.27Destabilizing2.94Destabilizing1.36Destabilizing0.420Likely Benign-2.98Deleterious0.996Probably Damaging0.992Probably Damaging1.62Pathogenic0.04Affected0.11260.1660210.4-14.03
c.1555G>A
E519K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E519K missense variant is listed in gnomAD (ID 6‑33438798‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and FATHMM, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E519K, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.078022Structured0.104514Uncertain0.8990.3280.0006-33438798-G-A16.20e-7-13.532Likely Pathogenic0.970Likely PathogenicLikely Pathogenic-0.55Ambiguous0.0-0.60Ambiguous-0.58Ambiguous0.06Likely Benign0.328Likely Benign-3.48Deleterious0.996Probably Damaging0.987Probably Damaging3.28Benign0.03Affected3.37350.25450.337910-0.4-0.94
c.1556A>T
E519V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E519V missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign predictions come from REVEL, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight the discord: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates benign stability. Overall, the preponderance of evidence points to a pathogenic effect for E519V. This conclusion does not conflict with ClinVar status, as the variant is currently unreported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.078022Structured0.104514Uncertain0.8990.3280.000-10.513Likely Pathogenic0.957Likely PathogenicLikely Pathogenic0.59Ambiguous0.0-0.40Likely Benign0.10Likely Benign0.16Likely Benign0.400Likely Benign-6.33Deleterious0.996Probably Damaging0.991Probably Damaging3.20Benign0.00Affected0.08250.4369-2-27.7-29.98
c.1567A>C
N523H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N523H is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect are Rosetta and Foldetta, while the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Uncertain results come from FoldX, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta as Benign. Overall, the preponderance of evidence points to a pathogenic effect for this variant, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.069024Structured0.033426Uncertain0.8830.3830.125-9.755Likely Pathogenic0.815Likely PathogenicAmbiguous0.56Ambiguous0.20.09Likely Benign0.33Likely Benign0.64Ambiguous0.694Likely Pathogenic-4.52Deleterious0.996Probably Damaging0.941Probably Damaging-1.40Pathogenic0.02Affected0.11320.3461210.323.04
c.1574A>T
E525V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E525V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include Foldetta, premPS, and FATHMM, whereas the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic outcome; FoldX and Rosetta are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of evidence points to a pathogenic effect for E525V, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.023618Uncertain0.9370.3820.125-13.622Likely Pathogenic0.989Likely PathogenicLikely Pathogenic1.10Ambiguous0.7-0.69Ambiguous0.21Likely Benign0.00Likely Benign0.683Likely Pathogenic-6.96Deleterious0.996Probably Damaging0.991Probably Damaging2.66Benign0.00Affected0.07210.4946-2-27.7-29.98
c.1658A>G
K553R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K553R has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FoldX, premPS, SIFT, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Rosetta’s output is uncertain and is treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicating likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability calculations) predicting a benign outcome. Overall, the majority of tools (nine pathogenic vs. five benign) lean toward a pathogenic interpretation, while the high‑accuracy consensus is split. Because ClinVar has no classification, there is no contradiction with existing clinical data. Based on the preponderance of predictions, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.012270Structured0.006539Uncertain0.9490.2460.000-8.182Likely Pathogenic0.644Likely PathogenicLikely Benign-0.14Likely Benign0.20.63Ambiguous0.25Likely Benign0.38Likely Benign0.641Likely Pathogenic-2.58Deleterious0.996Probably Damaging0.990Probably Damaging-1.31Pathogenic0.13Tolerated0.37620.083532-0.628.01
c.1667A>C
N556T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N556T is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SIFT, premPS, AlphaMissense‑Optimized, and Rosetta. Tools that predict a pathogenic effect are REVEL, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta reporting an uncertain stability change. FoldX‑MD and Foldetta results are inconclusive and are treated as unavailable. Overall, the majority of evidence points to a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.015078Structured0.008655Uncertain0.9250.2250.000-8.636Likely Pathogenic0.642Likely PathogenicLikely Benign1.03Ambiguous0.10.08Likely Benign0.56Ambiguous0.06Likely Benign0.695Likely Pathogenic-4.73Deleterious0.996Probably Damaging0.990Probably Damaging-1.36Pathogenic0.09Tolerated0.11890.3171002.8-13.00
c.1690G>C
E564Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E564Q is not reported in ClinVar and has no gnomAD entry. Consensus from standard predictors shows a split: benign calls come from FoldX, Rosetta, Foldetta, premPS, and SIFT, while pathogenic calls come from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta predicts benign stability. Overall, the majority of tools lean toward pathogenicity, and the high‑accuracy consensus supports this view. The variant is therefore most likely pathogenic, with no ClinVar annotation to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.023534Structured0.038418Uncertain0.8910.2080.000-12.077Likely Pathogenic0.927Likely PathogenicAmbiguous0.33Likely Benign0.00.27Likely Benign0.30Likely Benign-0.03Likely Benign0.598Likely Pathogenic-2.95Deleterious0.996Probably Damaging0.986Probably Damaging-1.26Pathogenic0.12Tolerated0.09820.5119220.0-0.98
c.1693C>G
L565V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L565V has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two consensus groups: benign predictions come from REVEL and FATHMM, while pathogenic predictions are made by SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and Foldetta. Two tools (AlphaMissense‑Optimized and Rosetta) give uncertain results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic,” and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a pathogenic impact on protein stability. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.034884Structured0.045819Uncertain0.9220.2050.000-11.118Likely Pathogenic0.833Likely PathogenicAmbiguous2.69Destabilizing0.01.37Ambiguous2.03Destabilizing1.40Destabilizing0.303Likely Benign-2.99Deleterious0.996Probably Damaging0.992Probably Damaging2.87Benign0.03Affected0.15580.2488210.4-14.03
c.1697A>G
K566R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K566R missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. FoldX, Rosetta, and Foldetta give uncertain or inconclusive results. High‑accuracy methods show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is unavailable. Overall, predictions are split evenly between benign and pathogenic, with no clear consensus. The variant is therefore most likely of uncertain significance; this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.027463Structured0.047887Uncertain0.9240.2190.000-8.493Likely Pathogenic0.279Likely BenignLikely Benign1.26Ambiguous0.51.04Ambiguous1.15Ambiguous0.29Likely Benign0.555Likely Pathogenic-2.39Neutral0.996Probably Damaging0.990Probably Damaging-0.79Pathogenic0.43Tolerated0.40930.109932-0.628.01
c.1701G>C
E567D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E567D missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain or unavailable results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta’s stability prediction is uncertain. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-8.276Likely Pathogenic0.575Likely PathogenicLikely Benign0.87Ambiguous0.11.94Ambiguous1.41Ambiguous0.70Ambiguous0.184Likely Benign-2.72Deleterious0.996Probably Damaging0.989Probably Damaging3.41Benign0.21Tolerated0.16020.3426320.0-14.03
c.1701G>T
E567D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E567D missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Uncertain or unavailable results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta’s stability prediction is inconclusive. Overall, the majority of pathogenic predictions outweigh the benign ones, suggesting the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-8.276Likely Pathogenic0.575Likely PathogenicLikely Benign0.87Ambiguous0.11.94Ambiguous1.41Ambiguous0.70Ambiguous0.184Likely Benign-2.72Deleterious0.996Probably Damaging0.989Probably Damaging3.41Benign0.21Tolerated0.16020.3426320.0-14.03
c.1732G>A
E578K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E578K is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, and SIFT, whereas polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default predict a pathogenic outcome. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show that the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Pathogenic, AlphaMissense‑Optimized remains Uncertain, and Foldetta predicts a benign effect. Overall, the majority of tools (seven benign vs. five pathogenic) suggest a benign impact, and this assessment does not contradict the absence of ClinVar evidence. Thus, the variant is most likely benign based on the current predictions, with no conflicting ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.059222Structured0.020971Uncertain0.9020.2400.000-13.391Likely Pathogenic0.870Likely PathogenicAmbiguous0.07Likely Benign0.1-0.19Likely Benign-0.06Likely Benign-0.27Likely Benign0.450Likely Benign-1.65Neutral0.996Probably Damaging0.987Probably Damaging-1.30Pathogenic0.49Tolerated0.19540.548001-0.4-0.94
c.1733A>T
E578V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E578V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. In silico predictors cluster into two groups: benign predictions come from Rosetta, Foldetta, premPS, and SIFT, while pathogenic predictions arise from SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: FoldX and AlphaMissense‑Optimized. High‑accuracy assessments further show that the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic, AlphaMissense‑Optimized is uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the balance of evidence favors a pathogenic effect, and this conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.059222Structured0.020971Uncertain0.9020.2400.000-11.393Likely Pathogenic0.881Likely PathogenicAmbiguous0.72Ambiguous0.10.02Likely Benign0.37Likely Benign0.12Likely Benign0.607Likely Pathogenic-3.74Deleterious0.996Probably Damaging0.991Probably Damaging-1.43Pathogenic0.13Tolerated0.05750.5703-2-27.7-29.98
c.1747G>A
D583N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D583N is reported in gnomAD (ID 6‑33440799‑G‑A) but has no ClinVar entry. Functional prediction tools show mixed results: benign calls come from FoldX, Rosetta, Foldetta, premPS, and SIFT, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. The high‑accuracy assessment indicates AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the predictions are split, with a slight tilt toward pathogenicity from the consensus and high‑accuracy tools, while stability‑based methods suggest benign. Therefore, the variant is most likely pathogenic based on the aggregate predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.038478Uncertain0.8050.2470.0006-33440799-G-A31.86e-6-8.048Likely Pathogenic0.856Likely PathogenicAmbiguous0.13Likely Benign0.10.00Likely Benign0.07Likely Benign0.21Likely Benign0.632Likely Pathogenic-4.78Deleterious0.996Probably Damaging0.995Probably Damaging-1.40Pathogenic0.09Tolerated3.37350.10240.3884120.0-0.98
c.1808T>C
M603T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M603T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that provide a clear verdict all classify the substitution as pathogenic: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool in the dataset reports a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus indicates likely pathogenic, while the Foldetta stability analysis is inconclusive and therefore not considered evidence. No contradictory evidence is present in ClinVar. Consequently, the variant is most likely pathogenic based on the available predictions, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.011342Structured0.197847Uncertain0.9420.1760.000-13.152Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.71Ambiguous0.21.71Ambiguous1.71Ambiguous0.66Ambiguous0.903Likely Pathogenic-5.48Deleterious0.996Probably Damaging0.985Probably Damaging-1.29Pathogenic0.00Affected0.18830.1495-1-1-2.6-30.09
c.1837G>A
E613K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E613K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Foldetta, and premPS, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also pathogenic. High‑accuracy assessments give AlphaMissense‑Optimized as pathogenic, SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction is inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-11.892Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.34Likely Benign0.6-0.54Ambiguous-0.10Likely Benign-0.08Likely Benign0.567Likely Pathogenic-3.72Deleterious0.996Probably Damaging0.987Probably Damaging-1.15Pathogenic0.04Affected0.29790.594201-0.4-0.94
c.1838A>T
E613V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E613V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are Foldetta and premPS, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—consistently predict a pathogenic impact. FoldX and Rosetta give uncertain results and are not included in the agreement groups. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as benign. Because the majority of evidence points to a deleterious effect, the variant is most likely pathogenic, which is consistent with the lack of ClinVar annotation and gnomAD observation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-12.799Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.72Ambiguous0.5-0.76Ambiguous-0.02Likely Benign0.31Likely Benign0.767Likely Pathogenic-6.57Deleterious0.996Probably Damaging0.991Probably Damaging-1.25Pathogenic0.03Affected0.09350.6565-2-27.7-29.98
c.1849G>C
E617Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E617Q missense variant is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Foldetta and Rosetta give uncertain results, which are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (derived from a majority of high‑confidence predictors) indicates a likely pathogenic outcome. Foldetta’s stability prediction is inconclusive. Overall, the balance of evidence leans toward a pathogenic impact for E617Q, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.155123Uncertain0.8770.2400.000-8.650Likely Pathogenic0.747Likely PathogenicLikely Benign0.20Likely Benign0.21.01Ambiguous0.61Ambiguous0.21Likely Benign0.481Likely Benign-2.39Neutral0.996Probably Damaging0.986Probably Damaging-1.39Pathogenic0.29Tolerated0.10500.5951220.0-0.98
c.1855A>G
T619A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T619A missense variant is not reported in ClinVar and has no gnomAD entry. Consensus prediction tools cluster into two groups: benign predictions come from SIFT, ESM1b, and AlphaMissense‑Optimized, whereas pathogenic predictions arise from SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the change as benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels it as likely pathogenic; Foldetta’s stability analysis is inconclusive. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.219301Structured0.119723Uncertain0.9290.2370.000-6.341Likely Benign0.672Likely PathogenicLikely Benign0.59Ambiguous0.10.62Ambiguous0.61Ambiguous0.53Ambiguous0.613Likely Pathogenic-4.21Deleterious0.996Probably Damaging0.989Probably Damaging-1.27Pathogenic0.17Tolerated0.39150.3109102.5-30.03
c.1883A>G
K628R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K628R is reported in gnomAD (variant ID 6‑33440935‑A‑G) but has no ClinVar entry. Functional prediction tools show a split assessment: benign calls come from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Two tools remain inconclusive (premPS and AlphaMissense‑Default). The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a likely pathogenic verdict, while the high‑accuracy AlphaMissense‑Optimized predicts benign. Foldetta, a protein‑folding stability method that combines FoldX‑MD and Rosetta outputs, also predicts benign. Overall, the majority of evidence leans toward pathogenicity, and this conclusion does not conflict with ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.035486Uncertain0.9570.2290.0006-33440935-A-G16.20e-7-11.324Likely Pathogenic0.476AmbiguousLikely Benign0.22Likely Benign0.1-0.11Likely Benign0.06Likely Benign0.94Ambiguous0.592Likely Pathogenic-2.99Deleterious0.996Probably Damaging0.990Probably Damaging2.49Pathogenic0.00Affected3.37340.38730.087323-0.628.01
c.1897C>G
L633V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L633V is not reported in ClinVar and is present in the gnomAD database (ID 6‑33440949‑C‑G). Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, SGM‑Consensus, and Foldetta; the Rosetta score is uncertain and therefore not considered. High‑accuracy methods give a pathogenic consensus: AlphaMissense‑Optimized predicts benign, but the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta both predict pathogenic. Overall, the majority of evidence supports a pathogenic impact for L633V, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.045407Uncertain0.9520.2520.0006-33440949-C-G16.20e-7-9.992Likely Pathogenic0.760Likely PathogenicLikely Benign2.32Destabilizing0.21.71Ambiguous2.02Destabilizing1.32Destabilizing0.327Likely Benign-2.99Deleterious0.996Probably Damaging0.992Probably Damaging2.86Benign0.03Affected3.37340.15170.2766120.4-14.03
c.1949A>G
N650S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N650S lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain or inconclusive results come from AlphaMissense‑Optimized, FoldX, Rosetta, Foldetta, and premPS. For high‑accuracy methods, AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta is uncertain. Overall, the majority of available predictions support a pathogenic effect. The variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.086953Structured0.361944Uncertain0.9610.3570.000-11.291Likely Pathogenic0.916Likely PathogenicAmbiguous0.79Ambiguous0.21.43Ambiguous1.11Ambiguous0.77Ambiguous0.395Likely Benign-4.98Deleterious0.996Probably Damaging0.606Possibly Damaging3.06Benign0.02Affected0.37910.5090112.7-27.03
c.1954T>A
F652I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F652I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. No prediction or stability assessment is missing or inconclusive. Based on the consensus of the available tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.098513Structured0.356594Uncertain0.9660.3380.000-12.085Likely Pathogenic0.991Likely PathogenicLikely Pathogenic2.15Destabilizing0.13.40Destabilizing2.78Destabilizing1.40Destabilizing0.574Likely Pathogenic-5.71Deleterious0.996Probably Damaging0.776Possibly Damaging3.06Benign0.00Affected0.15530.1955101.7-34.02
c.2083C>A
L695I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L695I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and ESM1b predict a pathogenic outcome. The remaining tools—AlphaMissense‑Default, Foldetta, premPS, and Rosetta—return uncertain results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, whereas Foldetta remains uncertain. Overall, the majority of reliable predictions support a benign classification, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.118441Structured0.373419Uncertain0.9420.2580.000-12.096Likely Pathogenic0.395AmbiguousLikely Benign0.47Likely Benign0.10.63Ambiguous0.55Ambiguous0.93Ambiguous0.251Likely Benign-2.00Neutral0.996Probably Damaging0.905Possibly Damaging3.24Benign0.08Tolerated0.08150.2759220.70.00
c.2086C>A
L696I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L696I missense change is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. FoldX, Rosetta, Foldetta, and premPS give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is unavailable. Overall, the majority of conventional tools lean toward pathogenicity, and the high‑accuracy prediction that is available (AlphaMissense‑Optimized) indicates benign, leaving the evidence mixed. Thus, the variant is most likely pathogenic based on the preponderance of predictions, and this does not contradict the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.200174Structured0.390093Uncertain0.9620.2670.000-10.652Likely Pathogenic0.698Likely PathogenicLikely Benign1.01Ambiguous0.10.58Ambiguous0.80Ambiguous0.85Ambiguous0.250Likely Benign-1.86Neutral0.996Probably Damaging0.989Probably Damaging3.15Benign0.00Affected0.09210.2542220.70.00
c.2115G>C
K705N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K705N is listed in ClinVar (ID 872011.0) as Pathogenic and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, Rosetta, premPS, FATHMM) and pathogenic predictions (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default). Uncertain results come from FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as Likely Pathogenic, and Foldetta also yields an uncertain stability change. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, which aligns with its ClinVar classification and does not contradict the reported status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000Likely Pathogenic 1-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign0.183Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.47100.24800.1124100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2115G>T
K705N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K705N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Three tools (FoldX, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments further support a pathogenic interpretation: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic”; AlphaMissense‑Optimized remains uncertain, and Foldetta is also uncertain. Overall, the balance of evidence favors a pathogenic effect for K705N, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign0.183Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.47100.24800.1124100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2119G>C
A707P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A707P is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, SIFT, and FATHMM, whereas pathogenic predictions come from Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as Pathogenic. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.371229Uncertain0.9270.3650.000-8.082Likely Pathogenic0.885Likely PathogenicAmbiguous0.28Likely Benign0.15.75Destabilizing3.02Destabilizing0.76Ambiguous0.228Likely Benign-2.92Deleterious0.996Probably Damaging0.983Probably Damaging3.41Benign0.09Tolerated0.13750.30951-1-3.426.04
c.2120C>A
A707D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A707D is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Two tools give uncertain results: premPS and Rosetta. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta predicts benign. Overall, the majority of evidence points to a pathogenic impact, and this assessment does not contradict any ClinVar classification because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.371229Uncertain0.9270.3650.000-9.160Likely Pathogenic0.772Likely PathogenicLikely Benign0.29Likely Benign0.0-0.61Ambiguous-0.16Likely Benign0.89Ambiguous0.225Likely Benign-3.16Deleterious0.996Probably Damaging0.983Probably Damaging3.39Benign0.02Affected0.13760.17410-2-5.344.01
c.2211G>C
Q737H
2D
AIThe SynGAP1 missense variant Q737H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the majority of computational evidence points to a benign effect for Q737H, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.889439Disordered0.425743Uncertain0.3230.8030.875-4.517Likely Benign0.109Likely BenignLikely Benign0.139Likely Benign-1.55Neutral0.996Probably Damaging0.930Probably Damaging2.72Benign0.04Affected0.16830.3707300.39.01
c.2211G>T
Q737H
2D
AIThe SynGAP1 missense variant Q737H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for Q737H, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.889439Disordered0.425743Uncertain0.3230.8030.875-4.517Likely Benign0.109Likely BenignLikely Benign0.132Likely Benign-1.55Neutral0.996Probably Damaging0.930Probably Damaging2.72Benign0.04Affected0.16830.3707300.39.01
c.2249G>C
G750A
2D
AIThe SynGAP1 missense variant G750A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.618285Disordered0.646832Binding0.3480.8660.625-3.263Likely Benign0.124Likely BenignLikely Benign0.106Likely Benign-1.65Neutral0.996Probably Damaging0.887Possibly Damaging2.52Benign0.04Affected0.36830.4792102.214.03
c.2282G>A
R761Q
2D
AIThe SynGAP1 missense variant R761Q is listed in ClinVar (ID 2882770.0) with an “Uncertain” status and is present in gnomAD (6‑33441747‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.538167Disordered0.900613Binding0.3530.8650.250Uncertain 16-33441747-G-A116.81e-6-4.187Likely Benign0.202Likely BenignLikely Benign0.191Likely Benign-0.63Neutral0.996Probably Damaging0.878Possibly Damaging2.75Benign0.40Tolerated3.9950.26400.2329111.0-28.06
c.2293A>C
S765R
2D
AIThe SynGAP1 missense variant S765R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus (majority vote) as Benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. There is no ClinVar entry to contradict this conclusion, so the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-5.422Likely Benign0.791Likely PathogenicAmbiguous0.157Likely Benign-1.57Neutral0.996Probably Damaging0.985Probably Damaging4.16Benign0.07Tolerated3.6460.07410.3859-10-3.769.11
c.2294G>T
S765I
2D
AIThe SynGAP1 missense variant S765I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also resolves to benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-6.891Likely Benign0.699Likely PathogenicLikely Benign0.187Likely Benign-1.24Neutral0.996Probably Damaging0.985Probably Damaging4.09Benign0.69Tolerated0.07680.5577-1-25.326.08
c.2295C>A
S765R
2D
AIThe SynGAP1 missense variant S765R is reported in gnomAD (ID 6‑33442453‑C‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM. Those that predict a pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Taken together, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status because none is assigned. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.2506-33442453-C-A-5.422Likely Benign0.791Likely PathogenicAmbiguous0.155Likely Benign-1.57Neutral0.996Probably Damaging0.985Probably Damaging4.16Benign0.07Tolerated3.6460.07410.3859-10-3.769.11
c.2295C>G
S765R
2D
AIThe SynGAP1 missense variant S765R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence points to a benign impact for S765R, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-5.422Likely Benign0.791Likely PathogenicAmbiguous0.155Likely Benign-1.57Neutral0.996Probably Damaging0.985Probably Damaging4.16Benign0.07Tolerated3.6460.07410.3859-10-3.769.11
c.2428C>A
R810S
2D
AIThe SynGAP1 R810S missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score. AlphaMissense‑Optimized is uncertain, and no Foldetta stability assessment is available. The high‑accuracy consensus from SGM (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors pathogenicity, while the lack of a Foldetta result leaves that evidence inconclusive. Overall, the preponderance of pathogenic predictions suggests that R810S is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant has not yet been classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.486429Structured0.851848Binding0.2630.9070.375-5.996Likely Benign0.950Likely PathogenicAmbiguous0.204Likely Benign-3.20Deleterious0.996Probably Damaging0.900Possibly Damaging2.44Pathogenic0.01Affected0.31520.45560-13.7-69.11
c.2428C>G
R810G
2D
AISynGAP1 missense variant R810G is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: a single benign call from REVEL, and six pathogenic calls from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Two tools (ESM1b and AlphaMissense‑Optimized) give uncertain results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized remains uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as Likely Pathogenic, and Foldetta stability analysis is unavailable. Overall, the preponderance of evidence points to a pathogenic impact for R810G, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.486429Structured0.851848Binding0.2630.9070.375-7.190In-Between0.828Likely PathogenicAmbiguous0.202Likely Benign-3.57Deleterious0.996Probably Damaging0.925Probably Damaging2.35Pathogenic0.01Affected0.36860.4207-3-24.1-99.14
c.2429G>T
R810L
2D
AIThe SynGAP1 R810L missense change is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to REVEL, while the majority of algorithms (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) predict a pathogenic outcome. Uncertain calls come from ESM1b and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta results are unavailable. Overall, the preponderance of evidence from multiple in‑silico predictors points to a pathogenic impact for R810L. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.486429Structured0.851848Binding0.2630.9070.375-7.172In-Between0.834Likely PathogenicAmbiguous0.338Likely Benign-4.57Deleterious0.996Probably Damaging0.925Probably Damaging2.35Pathogenic0.01Affected0.20190.5271-3-28.3-43.03
c.2504T>A
L835Q
2D
AIThe SynGAP1 missense variant L835Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign effect. Foldetta results are not available, so they do not influence the overall assessment. Based on the majority of predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.642742Binding0.3190.8630.125-4.788Likely Benign0.162Likely BenignLikely Benign0.093Likely Benign-0.84Neutral0.996Probably Damaging0.967Probably Damaging2.70Benign0.02Affected0.10330.1162-2-2-7.314.97
c.2504T>G
L835R
2D
AIThe SynGAP1 missense variant L835R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic outcome. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized independently predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.642742Binding0.3190.8630.125-4.749Likely Benign0.381AmbiguousLikely Benign0.126Likely Benign-1.05Neutral0.996Probably Damaging0.955Probably Damaging2.70Benign0.02Affected0.12390.0804-3-2-8.343.03
c.2517G>C
K839N
2D
AIThe SynGAP1 missense variant K839N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated predictors—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus also indicates Likely Pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence from multiple in silico tools indicates that K839N is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.642678Disordered0.611185Binding0.2820.8650.375-10.939Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.093Likely Benign-2.94Deleterious0.996Probably Damaging0.951Probably Damaging2.44Pathogenic0.01Affected0.36290.1876100.4-14.07
c.2517G>T
K839N
2D
AIThe SynGAP1 missense variant K839N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized returns a pathogenic score, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence indicates that K839N is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.642678Disordered0.611185Binding0.2820.8650.375-10.939Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.093Likely Benign-2.94Deleterious0.996Probably Damaging0.951Probably Damaging2.44Pathogenic0.01Affected0.36290.1876100.4-14.07
c.2548G>T
G850W
2D
AIThe SynGAP1 missense variant G850W is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Two tools—ESM1b and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two benign, two uncertain), and Foldetta data are unavailable. Overall, the balance of evidence (four benign vs. three pathogenic predictions, with a benign high‑accuracy result and no contradictory ClinVar annotation) indicates that the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.648219Disordered0.540897Binding0.3120.8200.500-7.826In-Between0.351AmbiguousLikely Benign0.170Likely Benign-1.94Neutral0.996Probably Damaging0.933Probably Damaging4.16Benign0.00Affected0.07340.4002-7-2-0.5129.16
c.2621A>C
Q874P
2D
AIThe SynGAP1 missense variant Q874P is reported in gnomAD (ID 6‑33443173‑A‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar classification (none exists). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.490133Structured0.635258Binding0.2890.8730.2506-33443173-A-C95.58e-6-4.622Likely Benign0.125Likely BenignLikely Benign0.219Likely Benign-2.89Deleterious0.996Probably Damaging0.992Probably Damaging2.77Benign0.00Affected3.7750.23730.5911-101.9-31.01
c.2622G>C
Q874H
2D
AIThe SynGAP1 missense variant Q874H is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default is uncertain. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign, while Foldetta results are unavailable. Overall, the balance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.490133Structured0.635258Binding0.2890.8730.250-4.658Likely Benign0.543AmbiguousLikely Benign0.236Likely Benign-2.90Deleterious0.996Probably Damaging0.995Probably Damaging2.65Benign0.00Affected0.15880.5088300.39.01
c.2622G>T
Q874H
2D
AIThe SynGAP1 missense variant Q874H has no ClinVar record and is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized, while PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT all predict a pathogenic outcome; AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a benign majority, and Foldetta data are unavailable. Overall, the balance of evidence leans toward a benign impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.490133Structured0.635258Binding0.2890.8730.250-4.658Likely Benign0.543AmbiguousLikely Benign0.236Likely Benign-2.90Deleterious0.996Probably Damaging0.995Probably Damaging2.65Benign0.00Affected0.15880.5088300.39.01
c.2723A>C
Q908P
2D
AIThe SynGAP1 missense variant Q908P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect for Q908P, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.678728Binding0.2750.9170.250-4.446Likely Benign0.151Likely BenignLikely Benign0.196Likely Benign-0.59Neutral0.996Probably Damaging0.992Probably Damaging2.51Benign0.11Tolerated0.23790.51210-11.9-31.01
c.2724G>C
Q908H
2D
AIThe SynGAP1 missense variant Q908H is listed in ClinVar (ID 436926.0) with an “Uncertain” status and is present in gnomAD (variant ID 6‑33443276‑G‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This consensus does not contradict the ClinVar “Uncertain” classification, which remains inconclusive.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.678728Binding0.2750.9170.250Conflicting 46-33443276-G-C16.20e-7-4.658Likely Benign0.311Likely BenignLikely Benign0.112Likely Benign-0.74Neutral0.996Probably Damaging0.995Probably Damaging2.58Benign0.05Affected3.7750.12930.3597300.39.01
c.2724G>T
Q908H
2D
AIThe SynGAP1 missense variant Q908H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all classify the change as benign or likely benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized reports benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely benign. Foldetta results are not available. Overall, the majority of evidence points to a benign effect for Q908H, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.678728Binding0.2750.9170.250-4.658Likely Benign0.311Likely BenignLikely Benign0.110Likely Benign-0.74Neutral0.996Probably Damaging0.995Probably Damaging2.58Benign0.05Affected3.7750.12930.3597300.39.01
c.2741A>C
D914A
2D
AIThe SynGAP1 missense variant D914A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default remains uncertain, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for D914A, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.699094Disordered0.785987Binding0.3200.8920.250-1.690Likely Benign0.387AmbiguousLikely Benign0.128Likely Benign-1.48Neutral0.996Probably Damaging0.953Probably Damaging2.69Benign0.05Affected0.44130.70860-25.3-44.01
c.275G>C
G92A
2D
AIThe SynGAP1 missense variant G92A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized returns “Benign” and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates “Likely Benign.” No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for G92A, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.537848Binding0.3370.8740.625-4.044Likely Benign0.219Likely BenignLikely Benign0.080Likely Benign-1.53Neutral0.996Probably Damaging0.910Probably Damaging4.08Benign0.00Affected0.39220.4930102.214.03
c.2818G>T
G940C
2D
AIThe SynGAP1 missense variant G940C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. There is no ClinVar entry to contradict this conclusion, so the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.889439Disordered0.920635Binding0.3830.9020.625-8.158Likely Pathogenic0.097Likely BenignLikely Benign0.089Likely Benign-0.40Neutral0.996Probably Damaging0.905Possibly Damaging2.70Benign0.11Tolerated0.13070.4354-3-32.946.09
c.2900G>C
R967P
2D
AIThe SynGAP1 missense variant R967P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign effect for R967P, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.974374Disordered0.969686Binding0.3400.8880.750-2.506Likely Benign0.132Likely BenignLikely Benign0.175Likely Benign-0.76Neutral0.996Probably Damaging0.828Possibly Damaging4.14Benign0.17Tolerated0.21450.55330-22.9-59.07
c.2966C>G
S989C
2D
AIThe SynGAP1 missense variant S989C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Benign, while Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.795062Disordered0.908835Binding0.2960.9110.750-5.889Likely Benign0.160Likely BenignLikely Benign0.080Likely Benign-2.88Deleterious0.996Probably Damaging0.905Possibly Damaging2.59Benign0.00Affected0.08280.52020-13.316.06
c.305T>G
L102W
2D
AIThe SynGAP1 missense variant L102W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign effect for L102W, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.795062Disordered0.696014Binding0.3570.8850.625-5.833Likely Benign0.202Likely BenignLikely Benign0.125Likely Benign-1.42Neutral0.996Probably Damaging0.984Probably Damaging4.09Benign0.00Affected0.08210.3078-2-2-4.773.05
c.3062A>C
Q1021P
2D
AIThe SynGAP1 missense variant Q1021P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus also indicates Likely Benign. No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for Q1021P, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.899122Disordered0.979641Binding0.3260.7630.500-3.522Likely Benign0.267Likely BenignLikely Benign0.235Likely Benign-2.11Neutral0.996Probably Damaging0.992Probably Damaging2.56Benign0.02Affected0.20220.47890-11.9-31.01
c.3063G>C
Q1021H
2D
AIThe SynGAP1 missense variant Q1021H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, as no ClinVar status is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.899122Disordered0.979641Binding0.3260.7630.500-4.694Likely Benign0.664Likely PathogenicLikely Benign0.184Likely Benign-1.72Neutral0.996Probably Damaging0.995Probably Damaging2.61Benign0.01Affected0.12110.3601300.39.01
c.3063G>T
Q1021H
2D
AIThe SynGAP1 missense variant Q1021H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.899122Disordered0.979641Binding0.3260.7630.500-4.694Likely Benign0.664Likely PathogenicLikely Benign0.184Likely Benign-1.72Neutral0.996Probably Damaging0.995Probably Damaging2.61Benign0.01Affected0.12110.3601300.39.01
c.3142G>T
G1048W
2D
AIThe SynGAP1 missense variant G1048W is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.977651Disordered0.923876Binding0.3460.9160.750-8.803Likely Pathogenic0.340Likely BenignLikely Benign0.498Likely Benign-1.52Neutral0.996Probably Damaging0.961Probably Damaging2.54Benign0.02Affected0.08520.4046-7-2-0.5129.16
c.3196C>A
P1066T
2D
AIThe SynGAP1 missense variant P1066T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (majority vote) also indicates Likely Benign. Foldetta results are unavailable. Overall, the majority of computational evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.967676Disordered0.968838Binding0.4030.9130.875-5.973Likely Benign0.082Likely BenignLikely Benign0.167Likely Benign-2.61Deleterious0.996Probably Damaging0.928Probably Damaging2.66Benign0.00Affected0.16520.72400-10.93.99
c.3197C>T
P1066L
2D
AIThe SynGAP1 missense variant P1066L is listed in ClinVar as a benign variant (ClinVar ID 951518.0) and is present in gnomAD (ID 6‑33443749‑C‑T). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, which is consistent with the ClinVar classification and does not contradict the reported status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.967676Disordered0.968838Binding0.4030.9130.875Likely Benign 16-33443749-C-T148.71e-6-5.478Likely Benign0.092Likely BenignLikely Benign0.173Likely Benign-3.68Deleterious0.996Probably Damaging0.903Possibly Damaging2.72Benign0.00Affected4.3220.22690.6780-3-35.416.04
c.3224A>C
Q1075P
2D
AIThe SynGAP1 missense variant Q1075P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy methods corroborate this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the consensus of the majority of evidence points to a benign effect, and this is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.988305Binding0.3540.8940.750-1.854Likely Benign0.086Likely BenignLikely Benign0.175Likely Benign0.78Neutral0.996Probably Damaging0.988Probably Damaging2.68Benign0.28Tolerated0.22880.57410-11.9-31.01
c.3225G>C
Q1075H
2D
AIThe SynGAP1 missense variant Q1075H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar. AlphaMissense‑Default is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM‑Consensus also indicates likely benign, while Foldetta data is missing. Overall, the majority of reliable predictors classify the variant as benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.988305Binding0.3540.8940.750-4.616Likely Benign0.486AmbiguousLikely Benign0.072Likely Benign-1.06Neutral0.996Probably Damaging0.992Probably Damaging2.68Benign0.13Tolerated0.14570.4214300.39.01
c.3225G>T
Q1075H
2D
AIThe SynGAP1 missense variant Q1075H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar. AlphaMissense‑Default is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM‑Consensus also indicates likely benign, while Foldetta data is missing. Overall, the majority of reliable predictors classify the variant as benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.988305Binding0.3540.8940.750-4.616Likely Benign0.486AmbiguousLikely Benign0.072Likely Benign-1.06Neutral0.996Probably Damaging0.992Probably Damaging2.68Benign0.13Tolerated0.14570.4214300.39.01
c.3238G>C
A1080P
2D
AIThe SynGAP1 missense variant A1080P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for A1080P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.912647Disordered0.981457Binding0.3030.9000.750-2.429Likely Benign0.254Likely BenignLikely Benign0.170Likely Benign-1.15Neutral0.996Probably Damaging0.833Possibly Damaging3.96Benign0.02Affected0.18840.53241-1-3.426.04
c.3302C>A
P1101H
2D
AIThe SynGAP1 missense variant P1101H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available. Overall, the majority of evidence points to a benign effect for P1101H, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.968967Binding0.4570.8610.875-5.370Likely Benign0.149Likely BenignLikely Benign0.167Likely Benign-1.87Neutral0.996Probably Damaging0.864Possibly Damaging4.18Benign0.02Affected0.20460.45970-2-1.640.02
c.3307C>T
R1103C
2D
AISynGAP1 missense variant R1103C is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33443859‑C‑T). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign, two pathogenic). AlphaMissense‑Optimized reports a benign outcome, while Foldetta results are unavailable. Overall, the balance of evidence favors a pathogenic interpretation, which is in contrast to the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.945666Disordered0.957363Binding0.3280.8620.875Uncertain 16-33443859-C-T63.92e-6-2.440Likely Benign0.246Likely BenignLikely Benign0.140Likely Benign-3.01Deleterious0.996Probably Damaging0.787Possibly Damaging2.41Pathogenic0.01Affected3.7750.33760.4121-3-47.0-53.05
c.3308G>A
R1103H
2D
AIThe SynGAP1 missense variant R1103H is listed in ClinVar (ID 577408.0) as benign and is present in gnomAD (variant ID 6‑33443860‑G‑A). Prediction tools that classify the variant as benign include REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as benign, while Foldetta results are unavailable. Overall, the majority of predictions support a benign impact, and this conclusion aligns with the ClinVar benign classification, indicating no contradiction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.945666Disordered0.957363Binding0.3280.8620.875Benign/Likely benign 36-33443860-G-A312.03e-5-3.622Likely Benign0.156Likely BenignLikely Benign0.116Likely Benign-1.97Neutral0.996Probably Damaging0.733Possibly Damaging2.49Pathogenic0.01Affected3.7750.29770.2380201.3-19.05
c.3317A>C
Q1106P
2D
AIThe SynGAP1 missense variant Q1106P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta results are unavailable. Overall, the balance of evidence (5 benign vs 4 pathogenic predictions, with a benign high‑accuracy score and no contradictory ClinVar annotation) indicates that the variant is most likely benign. This conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.885302Disordered0.952043Binding0.3820.8700.875-3.807Likely Benign0.077Likely BenignLikely Benign0.162Likely Benign-3.14Deleterious0.996Probably Damaging0.988Probably Damaging1.75Pathogenic0.31Tolerated0.20290.57810-11.9-31.01
c.3318A>C
Q1106H
2D
AIThe SynGAP1 missense variant Q1106H is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.885302Disordered0.952043Binding0.3820.8700.875-4.893Likely Benign0.370AmbiguousLikely Benign0.174Likely Benign-3.03Deleterious0.996Probably Damaging0.992Probably Damaging1.75Pathogenic0.03Affected0.14530.4214300.39.01
c.3318A>T
Q1106H
2D
AIThe SynGAP1 missense variant Q1106H is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.885302Disordered0.952043Binding0.3820.8700.875-4.893Likely Benign0.370AmbiguousLikely Benign0.174Likely Benign-3.03Deleterious0.996Probably Damaging0.992Probably Damaging1.75Pathogenic0.03Affected0.14530.4214300.39.01
c.3346G>T
G1116W
2D
AIThe SynGAP1 missense variant G1116W is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33443898‑G‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized, whereas polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b all predict a pathogenic outcome. AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields benign, and Foldetta’s protein‑folding stability result is unavailable. Taken together, the majority of reliable predictors and the consensus high‑accuracy tools indicate a benign effect. This conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.889439Disordered0.873279Binding0.3200.9090.7506-33443898-G-T-9.448Likely Pathogenic0.356AmbiguousLikely Benign0.405Likely Benign-1.27Neutral0.996Probably Damaging0.946Probably Damaging4.04Benign0.01Affected4.3220.07760.4046-2-7-0.5129.16
c.3428C>G
T1143R
2D
AIThe SynGAP1 missense variant T1143R is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency data. Functional prediction tools cluster into two groups: benign predictions include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from AlphaMissense‑Default, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.919029Disordered0.722918Binding0.2750.8371.000-2.882Likely Benign0.782Likely PathogenicLikely Benign0.175Likely Benign-2.31Neutral0.996Probably Damaging0.951Probably Damaging2.73Benign0.09Tolerated0.10870.3060-1-1-3.855.08
c.3437C>G
P1146R
2D
AIThe SynGAP1 missense variant P1146R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. Tools that agree on a benign effect are ESM1b, FATHMM, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the majority of available predictions (seven pathogenic versus three benign) indicate that the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, as the variant has no existing ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.919029Disordered0.732173Binding0.4150.8371.000-3.826Likely Benign0.729Likely PathogenicLikely Benign0.603Likely Pathogenic-4.81Deleterious0.996Probably Damaging0.967Probably Damaging5.50Benign0.00Affected0.13150.31930-2-2.959.07
c.3638A>T
N1213I
2D
AIThe SynGAP1 missense variant N1213I is not reported in ClinVar and is absent from gnomAD. Prediction tools show a split opinion: benign calls come from REVEL, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further highlight this discordance: AlphaMissense‑Optimized predicts a benign effect, whereas the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic outcome. No Foldetta stability analysis is available for this residue. Overall, the preponderance of evidence points to a pathogenic effect for N1213I, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.580690Disordered0.521638Binding0.8880.5610.500-10.798Likely Pathogenic0.743Likely PathogenicLikely Benign0.093Likely Benign-3.10Deleterious0.996Probably Damaging0.930Probably Damaging2.71Benign0.03Affected0.04370.4407-2-38.0-0.94
c.365C>A
P122H
2D
AIThe SynGAP1 missense variant P122H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. Foldetta results are unavailable. Overall, the majority of evidence, including the high‑accuracy tools, points to a benign effect for P122H. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.618285Disordered0.672358Binding0.4000.8870.750-4.993Likely Benign0.321Likely BenignLikely Benign0.096Likely Benign-1.82Neutral0.996Probably Damaging0.750Possibly Damaging4.14Benign0.03Affected0.23060.42130-2-1.640.02
c.374C>A
P125H
2D
AIThe SynGAP1 missense variant P125H is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2). Foldetta results are unavailable. Overall, the majority of conventional predictors (five pathogenic vs four benign) lean toward a pathogenic interpretation, but the single high‑accuracy benign prediction and the inconclusive SGM Consensus temper this view. No ClinVar annotation is present, so there is no reported status to contradict the computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.505461Disordered0.704227Binding0.3730.8780.625-5.177Likely Benign0.583Likely PathogenicLikely Benign0.235Likely Benign-4.18Deleterious0.996Probably Damaging0.750Possibly Damaging2.82Benign0.01Affected0.15980.42630-2-1.640.02
c.3781A>C
S1261R
2D
AIThe SynGAP1 missense variant S1261R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect for S1261R, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.501700Disordered0.671500Binding0.8890.5740.250-4.363Likely Benign0.967Likely PathogenicLikely Pathogenic0.152Likely Benign-2.97Deleterious0.996Probably Damaging0.898Possibly Damaging2.21Pathogenic0.04Affected0.06610.26420-1-3.769.11
c.3782G>T
S1261I
2D
AIThe SynGAP1 missense variant S1261I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and AlphaMissense‑Optimized, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score indicates a benign effect, whereas the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely pathogenic. No Foldetta stability assessment is available for this residue. Overall, the preponderance of evidence from standard and high‑accuracy predictors points to a pathogenic impact for S1261I. This conclusion is not contradicted by ClinVar status, which currently contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.501700Disordered0.671500Binding0.8890.5740.250-8.835Likely Pathogenic0.761Likely PathogenicLikely Benign0.244Likely Benign-4.20Deleterious0.996Probably Damaging0.898Possibly Damaging2.21Pathogenic0.02Affected0.06310.4410-1-25.326.08
c.3783C>A
S1261R
2D
AIThe SynGAP1 missense variant S1261R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from multiple in silico tools points to a pathogenic classification, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.501700Disordered0.671500Binding0.8890.5740.250-4.363Likely Benign0.967Likely PathogenicLikely Pathogenic0.190Likely Benign-2.97Deleterious0.996Probably Damaging0.898Possibly Damaging2.21Pathogenic0.04Affected0.06610.26420-1-3.769.11
c.3783C>G
S1261R
2D
AIThe SynGAP1 missense variant S1261R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence indicates that S1261R is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.501700Disordered0.671500Binding0.8890.5740.250-4.363Likely Benign0.967Likely PathogenicLikely Pathogenic0.190Likely Benign-2.97Deleterious0.996Probably Damaging0.898Possibly Damaging2.21Pathogenic0.04Affected0.06610.26420-1-3.769.11
c.3797T>G
L1266R
2D
AISynGAP1 missense variant L1266R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic, and the SGM‑Consensus confirms a likely pathogenic classification. Foldetta results are unavailable for this variant. Overall, the preponderance of evidence from multiple in silico predictors and high‑accuracy tools points to a pathogenic effect, with no conflict from ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.433034Structured0.802655Binding0.8680.6020.000-16.676Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.391Likely Benign-5.04Deleterious0.996Probably Damaging0.951Probably Damaging2.13Pathogenic0.00Affected0.10630.0891-3-2-8.343.03
c.3826G>C
D1276H
2D
AIThe SynGAP1 missense variant D1276H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates majority votes from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further highlight discordance: AlphaMissense‑Optimized predicts a benign effect, whereas the SGM‑Consensus (a high‑accuracy consensus) indicates Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions support a pathogenic effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.666105Disordered0.802156Binding0.6360.7050.6250.715Likely Benign0.778Likely PathogenicLikely Benign0.321Likely Benign-5.08Deleterious0.996Probably Damaging0.898Possibly Damaging1.19Pathogenic0.00Affected0.10770.56971-10.322.05
c.383C>A
P128H
2D
AIThe SynGAP1 missense variant P128H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic outcome. AlphaMissense‑Default remains uncertain, and the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.497853Structured0.713069Binding0.3760.8780.625-4.806Likely Benign0.564AmbiguousLikely Benign0.169Likely Benign-1.90Neutral0.996Probably Damaging0.750Possibly Damaging4.14Benign0.03Affected0.22070.34140-2-1.640.02
c.3905T>G
L1302W
2D
AIThe SynGAP1 missense variant L1302W is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM; ESM1b is uncertain and not counted. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic. Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic vs. three benign) lean toward pathogenicity, and this is consistent with the SGM Consensus result. Therefore, the variant is most likely pathogenic based on current computational evidence, and this does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.784345Disordered0.889642Binding0.4290.8420.875-7.133In-Between0.297Likely BenignLikely Benign0.290Likely Benign-4.20Deleterious0.996Probably Damaging0.946Probably Damaging1.49Pathogenic0.00Affected0.06710.2530-2-2-4.773.05
c.3976C>G
P1326A
2D
AIThe SynGAP1 missense variant P1326A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.948786Disordered0.887377Binding0.3930.7820.875-4.450Likely Benign0.068Likely BenignLikely Benign0.097Likely Benign-0.76Neutral0.996Probably Damaging0.986Probably Damaging3.73Benign0.00Affected0.37280.43331-13.4-26.04
c.4004G>C
G1335A
2D
AIThe SynGAP1 missense variant G1335A is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also likely pathogenic. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect for G1335A, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.891961Disordered0.967705Binding0.3230.7240.750-4.942Likely Benign0.993Likely PathogenicLikely Pathogenic0.357Likely Benign-3.69Deleterious0.996Probably Damaging0.992Probably Damaging2.05Pathogenic0.00Affected0.33830.4953102.214.03
c.4010T>G
F1337C
2D
AIThe SynGAP1 missense variant F1337C is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 vs 2). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence (six pathogenic vs. three benign predictions) indicates that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.823549Disordered0.979265Binding0.3880.7120.625-4.628Likely Benign0.998Likely PathogenicLikely Pathogenic0.357Likely Benign-4.57Deleterious0.996Probably Damaging0.984Probably Damaging2.73Benign0.00Affected0.26190.1905-4-2-0.3-44.04
c.557T>G
L186W
2D
AIThe SynGAP1 missense variant L186W has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from both general and high‑accuracy tools indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.458154Structured0.428613Uncertain0.3970.6170.500-16.177Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.274Likely Benign-4.78Deleterious0.996Probably Damaging0.819Possibly Damaging3.46Benign0.00Affected0.05390.3138-2-2-4.773.05
c.575C>T
A192V
2D
AIThe SynGAP1 missense variant A192V is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. ESM1b remains uncertain. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic majority (2 pathogenic vs. 1 benign, 1 uncertain). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence indicates that A192V is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.422041Structured0.428195Uncertain0.3210.5890.125-7.464In-Between0.964Likely PathogenicLikely Pathogenic0.172Likely Benign-2.66Deleterious0.996Probably Damaging0.877Possibly Damaging4.01Benign0.11Tolerated0.09040.5066002.428.05
c.601G>A
D201N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The remaining tools—Rosetta, Foldetta, ESM1b, and AlphaMissense‑Default—return uncertain results and are treated as unavailable for pathogenicity inference. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is unavailable because two of the four inputs are uncertain. Foldetta also yields an uncertain result and is unavailable. Overall, the preponderance of evidence points to a benign impact for D201N, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428570Uncertain0.6980.4470.125-7.686In-Between0.525AmbiguousLikely Benign0.31Likely Benign0.01.21Ambiguous0.76Ambiguous-0.10Likely Benign0.160Likely Benign-2.36Neutral0.996Probably Damaging0.877Possibly Damaging4.08Benign0.13Tolerated0.09110.5413210.0-0.98
c.602A>G
D201G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201G missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence favors a pathogenic interpretation, with no ClinVar annotation to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428570Uncertain0.6980.4470.125-7.744In-Between0.603Likely PathogenicLikely Benign0.71Ambiguous0.02.64Destabilizing1.68Ambiguous0.24Likely Benign0.289Likely Benign-3.03Deleterious0.996Probably Damaging0.877Possibly Damaging4.09Benign0.39Tolerated0.32680.50471-13.1-58.04
c.712G>C
E238Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E238Q missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two consensus groups: benign predictions come from SIFT and FATHMM, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Stability‑based methods (FoldX, Rosetta, premPS) and Foldetta give uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.194234Structured0.332638Uncertain0.7960.3260.000-11.476Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.63Ambiguous0.50.59Ambiguous0.61Ambiguous0.52Ambiguous0.723Likely Pathogenic-2.72Deleterious0.996Probably Damaging0.891Possibly Damaging5.44Benign0.06Tolerated0.13720.5412220.0-0.98
c.1009A>G
K337E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K337E missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and Foldetta. Those that predict a pathogenic impact comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The premPS score is uncertain and does not influence the overall assessment. High‑accuracy analyses show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as benign. Based on the majority of predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.348540Uncertain0.4490.4380.500-13.673Likely Pathogenic0.992Likely PathogenicLikely Pathogenic-0.05Likely Benign0.10.49Likely Benign0.22Likely Benign0.52Ambiguous0.316Likely Benign-3.48Deleterious0.997Probably Damaging0.992Probably Damaging1.76Pathogenic0.02Affected0.31020.1039010.40.94
c.1010A>G
K337R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K337R has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into benign and pathogenic groups: benign predictions come from REVEL, FoldX, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta; pathogenic predictions come from polyPhen2_HumDiv, polyPhen2_HumVar, and FATHMM, while Rosetta remains uncertain. High‑accuracy methods reinforce the benign assessment: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts benign. Consequently, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.321458Structured0.348540Uncertain0.4490.4380.500-6.302Likely Benign0.249Likely BenignLikely Benign-0.30Likely Benign0.21.07Ambiguous0.39Likely Benign0.12Likely Benign0.142Likely Benign-2.36Neutral0.997Probably Damaging0.992Probably Damaging1.70Pathogenic0.07Tolerated0.39130.113432-0.628.01
c.1021G>T
G341C
2D
AIThe SynGAP1 missense variant G341C has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FoldX, Foldetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (likely benign). Tools that predict a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; Rosetta remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.431164Uncertain0.7450.4790.250-6.156Likely Benign0.190Likely BenignLikely Benign0.42Likely Benign1.2-0.92Ambiguous-0.25Likely Benign0.24Likely Benign0.501Likely Pathogenic-2.40Neutral0.997Probably Damaging0.870Possibly Damaging0.34Pathogenic0.01Affected0.12850.3650-3-32.946.09
c.1078G>A
E360K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E360K is reported in gnomAD (variant ID 6-33437983‑G‑A) but has no ClinVar entry. Prediction tools that agree on a benign effect are limited to FoldX, which scores the variant as benign. In contrast, the majority of algorithms predict a pathogenic impact: REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Tools with inconclusive results (Foldetta and premPS) are noted as unavailable. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus indicates likely pathogenic, while Foldetta remains uncertain. Overall, the consensus of high‑confidence predictors points to a pathogenic effect for E360K. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.421183Uncertain0.9550.4980.2506-33437983-G-A-16.006Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.27Likely Benign0.02.21Destabilizing1.24Ambiguous0.55Ambiguous0.526Likely Pathogenic-3.68Deleterious0.997Probably Damaging0.980Probably Damaging1.68Pathogenic0.04Affected3.37250.31060.859410-0.4-0.94
c.1078G>C
E360Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E360Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and premPS, while a majority of tools predict a pathogenic outcome: SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from the unanimous pathogenic vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E360Q, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.421183Uncertain0.9550.4980.250-11.012Likely Pathogenic0.925Likely PathogenicAmbiguous0.55Ambiguous0.11.38Ambiguous0.97Ambiguous-0.02Likely Benign0.343Likely Benign-2.76Deleterious0.997Probably Damaging0.986Probably Damaging1.61Pathogenic0.03Affected0.18240.8282220.0-0.98
c.1079A>C
E360A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E360A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only premPS. All other evaluated tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic effect, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Because the majority of consensus tools predict pathogenicity and no ClinVar entry contradicts this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.421183Uncertain0.9550.4980.250-13.229Likely Pathogenic0.939Likely PathogenicAmbiguous1.37Ambiguous0.11.72Ambiguous1.55Ambiguous0.39Likely Benign0.545Likely Pathogenic-5.52Deleterious0.997Probably Damaging0.980Probably Damaging1.63Pathogenic0.01Affected0.42950.82430-15.3-58.04
c.1084T>G
W362G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD, so no population frequency data are available. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the single uncertain call (premPS) does not alter the overall consensus. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. Thus, based on the collective predictions, the variant is most likely pathogenic, and this conclusion is consistent with the absence of any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125-14.242Likely Pathogenic0.985Likely PathogenicLikely Pathogenic4.22Destabilizing0.15.28Destabilizing4.75Destabilizing0.95Ambiguous0.707Likely Pathogenic-11.95Deleterious0.997Probably Damaging0.986Probably Damaging1.25Pathogenic0.00Affected0.47510.1281-7-20.5-129.16
c.1085G>T
W362L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362L is not reported in ClinVar and is absent from gnomAD. All tools except premPS predict pathogenic, leaving no benign predictions. Functional prediction tools uniformly indicate a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while premPS remains uncertain. High‑accuracy methods corroborate this assessment: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Consequently, the variant is most likely pathogenic, and this prediction is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125-12.748Likely Pathogenic0.977Likely PathogenicLikely Pathogenic2.16Destabilizing0.12.60Destabilizing2.38Destabilizing0.71Ambiguous0.523Likely Pathogenic-11.95Deleterious0.997Probably Damaging0.986Probably Damaging1.32Pathogenic0.01Affected0.27010.2452-2-24.7-73.05
c.1088A>T
Y363F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y363F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, seven tools predict benign while four predict pathogenic, with no evidence of pathogenicity from the most accurate methods. Therefore, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.321458Structured0.435392Uncertain0.9540.5860.125-6.621Likely Benign0.114Likely BenignLikely Benign-0.23Likely Benign0.00.42Likely Benign0.10Likely Benign0.58Ambiguous0.293Likely Benign-3.42Deleterious0.997Probably Damaging0.970Probably Damaging1.74Pathogenic0.18Tolerated0.27810.3583734.1-16.00
c.1201C>G
R401G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R401G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.314870Structured0.424277Uncertain0.9610.4190.000-13.353Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.06Destabilizing0.24.31Destabilizing3.69Destabilizing1.01Destabilizing0.741Likely Pathogenic-6.45Deleterious0.997Probably Damaging0.987Probably Damaging5.45Benign0.00Affected0.35490.2866-3-24.1-99.14
c.1202G>T
R401L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R401L is not reported in ClinVar and is present in gnomAD (ID 6‑33438107‑G‑T). Prediction tools that classify the variant as benign include Rosetta, FATHMM, and premPS, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) indicate a pathogenic effect. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No evidence from FoldX alone is available. Based on the preponderance of pathogenic predictions and the corroborating high‑accuracy tools, R401L is most likely pathogenic; this assessment does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.314870Structured0.424277Uncertain0.9610.4190.0006-33438107-G-T16.20e-7-12.280Likely Pathogenic0.972Likely PathogenicLikely Pathogenic-1.52Ambiguous0.1-0.23Likely Benign-0.88Ambiguous0.22Likely Benign0.858Likely Pathogenic-6.42Deleterious0.997Probably Damaging0.987Probably Damaging5.44Benign0.02Affected3.38270.19720.4263-2-38.3-43.03
c.1216T>C
Y406H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y406H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors—FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently classify the substitution as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic outcome, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic effect. Taken together, the preponderance of evidence indicates that Y406H is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.393707Uncertain0.9460.2910.000-9.015Likely Pathogenic0.858Likely PathogenicAmbiguous2.13Destabilizing0.12.15Destabilizing2.14Destabilizing1.03Destabilizing0.239Likely Benign-4.21Deleterious0.997Probably Damaging0.966Probably Damaging3.80Benign0.03Affected0.26660.081102-1.9-26.03
c.1241T>C
M414T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M414T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta; Rosetta remains uncertain. High‑accuracy methods all support a deleterious effect: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta predicts a destabilizing, pathogenic outcome. Consequently, the consensus of the most reliable predictors classifies M414T as pathogenic, with no conflict with the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.329108Uncertain0.9140.2170.000-8.698Likely Pathogenic0.975Likely PathogenicLikely Pathogenic2.04Destabilizing0.11.96Ambiguous2.00Destabilizing1.27Destabilizing0.406Likely Benign-5.00Deleterious0.997Probably Damaging0.972Probably Damaging3.41Benign0.08Tolerated0.17710.1976-1-1-2.6-30.09
c.1243G>C
E415Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E415Q missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, seven tools predict pathogenicity versus six predicting benignity, and the two most reliable predictors (AlphaMissense‑Optimized and SGM‑Consensus) both favor pathogenicity. Therefore, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.100716Structured0.330366Uncertain0.9150.2360.000-9.085Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.29Likely Benign0.20.22Likely Benign0.26Likely Benign0.01Likely Benign0.236Likely Benign-2.63Deleterious0.997Probably Damaging0.973Probably Damaging3.26Benign0.08Tolerated0.10840.3474220.0-0.98
c.1246C>A
L416I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L416I missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, and FATHMM. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Predictions that remain inconclusive are FoldX, Rosetta, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a benign prediction. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Overall, the preponderance of evidence points to a benign effect. This conclusion is not contradicted by any ClinVar annotation, as the variant has no existing ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.104810Structured0.336105Uncertain0.9350.2270.000-8.613Likely Pathogenic0.396AmbiguousLikely Benign0.57Ambiguous0.00.69Ambiguous0.63Ambiguous0.50Likely Benign0.127Likely Benign-1.28Neutral0.997Probably Damaging0.989Probably Damaging3.38Benign0.37Tolerated0.10730.3480220.70.00
c.1255G>C
E419Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419Q missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the predictions are split, with a slight majority leaning toward pathogenicity. The variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.371949Uncertain0.9610.2610.000-9.268Likely Pathogenic0.923Likely PathogenicAmbiguous0.01Likely Benign0.10.36Likely Benign0.19Likely Benign0.02Likely Benign0.280Likely Benign-2.80Deleterious0.997Probably Damaging0.973Probably Damaging3.41Benign0.04Affected0.14990.6938220.0-0.98
c.1264G>C
E422Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E422Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, and FATHMM, while those that predict a pathogenic effect are SIFT, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool rates the variant as uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.067594Structured0.426709Uncertain0.9650.2550.000-9.460Likely Pathogenic0.926Likely PathogenicAmbiguous0.32Likely Benign0.00.21Likely Benign0.27Likely Benign-0.15Likely Benign0.208Likely Benign-2.26Neutral0.997Probably Damaging0.973Probably Damaging3.38Benign0.03Affected0.10450.4913220.0-0.98
c.1271T>C
V424A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 V424A is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on benign impact are REVEL and FATHMM, whereas the remaining tools—SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as unavailable, SGM‑Consensus as likely pathogenic, and Foldetta as pathogenic. Based on the collective evidence, the variant is most likely pathogenic; this conclusion is not contradicted by the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-9.665Likely Pathogenic0.904Likely PathogenicAmbiguous2.31Destabilizing0.12.54Destabilizing2.43Destabilizing2.10Destabilizing0.245Likely Benign-3.45Deleterious0.997Probably Damaging0.961Probably Damaging3.39Benign0.01Affected0.21050.135500-2.4-28.05
c.1292T>G
L431R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L431R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.094817Structured0.374755Uncertain0.9590.3000.000-14.777Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.45Destabilizing0.04.76Destabilizing4.11Destabilizing1.93Destabilizing0.654Likely Pathogenic-5.47Deleterious0.997Probably Damaging0.833Possibly Damaging2.93Benign0.00Affected0.11910.0730-3-2-8.343.03
c.1324A>G
K442E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K442E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split consensus: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments give mixed results: AlphaMissense‑Optimized remains uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. No single evidence decisively outweighs the others. Therefore, the variant’s pathogenicity remains uncertain; the predictions do not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.255766Uncertain0.9120.2250.000-12.813Likely Pathogenic0.939Likely PathogenicAmbiguous-0.05Likely Benign0.1-0.21Likely Benign-0.13Likely Benign0.24Likely Benign0.324Likely Benign-3.34Deleterious0.997Probably Damaging0.966Probably Damaging3.47Benign0.16Tolerated0.29430.0789010.40.94
c.1330A>G
K444E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K444E missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated predictors—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-15.571Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.99Destabilizing0.13.75Destabilizing3.37Destabilizing1.10Destabilizing0.437Likely Benign-3.82Deleterious0.997Probably Damaging0.981Probably Damaging3.40Benign0.01Affected0.34860.0793010.40.94
c.1334A>C
E445A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E445A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and FATHMM. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as Benign. Overall, the majority of predictions lean toward pathogenicity, and the high‑accuracy consensus supports a likely pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.270205Uncertain0.9470.2280.000-12.659Likely Pathogenic0.849Likely PathogenicAmbiguous0.09Likely Benign0.0-0.34Likely Benign-0.13Likely Benign0.56Ambiguous0.476Likely Benign-5.73Deleterious0.997Probably Damaging0.991Probably Damaging3.34Benign0.01Affected0.28460.48760-15.3-58.04
c.1351C>A
L451I
2D
AIThe SynGAP1 L451I missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results come from FoldX, Rosetta, premPS, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta is also inconclusive. Overall, the majority of available predictions (five pathogenic versus four benign) indicate that the variant is most likely pathogenic, and this assessment does not contradict the absence of a ClinVar record.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.281712Structured0.314017Uncertain0.9780.2320.000-11.046Likely Pathogenic0.658Likely PathogenicLikely Benign1.43Ambiguous0.80.70Ambiguous1.07Ambiguous0.94Ambiguous0.284Likely Benign-1.94Neutral0.997Probably Damaging0.989Probably Damaging2.75Benign0.02Affected0.06810.2958220.70.00
c.1382C>A
A461D
2D
AIThe SynGAP1 missense variant A461D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM. The majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta are inconclusive, providing no definitive evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that A461D is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.179055Structured0.292531Uncertain0.9360.1510.125-14.918Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.89Ambiguous1.12.18Destabilizing1.54Ambiguous1.09Destabilizing0.477Likely Benign-5.47Deleterious0.997Probably Damaging0.792Possibly Damaging3.32Benign0.01Affected0.15330.20160-2-5.344.01
c.1400A>T
D467V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D467V missense variant is not reported in ClinVar or gnomAD. Prediction tools cluster into two groups: benign predictions come from Rosetta and premPS, while the majority—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—label the change as pathogenic. Two tools, FoldX and Foldetta, give uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus indicates likely pathogenic, and Foldetta remains uncertain. Overall, the consensus of high‑confidence predictors points to a pathogenic effect, and this conclusion is consistent with the absence of any ClinVar annotation or gnomAD observation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.000-15.041Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.24Ambiguous0.10.08Likely Benign0.66Ambiguous0.02Likely Benign0.893Likely Pathogenic-8.70Deleterious0.997Probably Damaging0.997Probably Damaging-1.28Pathogenic0.02Affected0.06440.5274-2-37.7-15.96
c.1406C>G
A469G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A469G is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD. Prediction tools that agree on a benign effect include PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise REVEL, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default; FoldX is uncertain. High‑accuracy methods give mixed results: AlphaMissense‑Optimized indicates benign, Foldetta indicates pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of tools (12 vs. 4) predict pathogenicity, and there is no ClinVar entry to contradict this assessment. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.343926Uncertain0.9100.2760.000-4.438Likely Benign0.733Likely PathogenicLikely Benign1.99Ambiguous0.12.22Destabilizing2.11Destabilizing1.01Destabilizing0.569Likely Pathogenic-2.42Neutral0.997Probably Damaging0.990Probably Damaging-1.32Pathogenic0.37Tolerated0.17970.307810-2.2-14.03
c.1406C>T
A469V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A469V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect comprise FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and Foldetta; premPS and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts pathogenic. With seven tools supporting pathogenicity versus four supporting benignity, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.343926Uncertain0.9100.2760.000-8.858Likely Pathogenic0.459AmbiguousLikely Benign2.30Destabilizing0.42.66Destabilizing2.48Destabilizing-0.77Ambiguous0.426Likely Benign0.26Neutral0.997Probably Damaging0.976Probably Damaging-1.20Pathogenic0.60Tolerated0.08270.5421002.428.05
c.1426T>A
F476I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F476I has no ClinVar entry and is not reported in gnomAD. Functional prediction tools fall into two groups: benign predictions come from REVEL, premPS, PROVEAN, SIFT, and FATHMM; pathogenic predictions come from FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—remains inconclusive and is treated as unavailable. With seven tools indicating pathogenicity versus five indicating benign, and two high‑accuracy tools supporting pathogenicity, the evidence points to a likely pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no record for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.617Likely Pathogenic0.962Likely PathogenicLikely Pathogenic3.90Destabilizing0.13.09Destabilizing3.50Destabilizing0.39Likely Benign0.239Likely Benign-1.23Neutral0.997Probably Damaging0.989Probably Damaging3.50Benign0.37Tolerated0.13830.2202101.7-34.02
c.1426T>C
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. No other tools provide definitive evidence. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous0.196Likely Benign-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.40220.16530.2916201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1428C>A
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. No other tools provide definitive evidence. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous0.180Likely Benign-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.40220.16530.2916201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1428C>G
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33438460‑C‑G). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, SIFT, and FATHMM, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that returned uncertain results—FoldX, Rosetta, Foldetta, and premPS—do not contribute to the assessment. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, with two pathogenic and two benign calls; Foldetta also reports an uncertain stability change. Overall, the balance of evidence favors a pathogenic effect for F476L, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000Uncertain 26-33438460-C-G42.48e-6-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous0.180Likely Benign-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.40220.16530.2916201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1448T>G
I483R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.000-17.066Likely Pathogenic0.995Likely PathogenicLikely Pathogenic5.14Destabilizing0.44.09Destabilizing4.62Destabilizing1.97Destabilizing0.595Likely Pathogenic-6.50Deleterious0.997Probably Damaging0.991Probably Damaging3.14Benign0.00Affected0.11200.0870-2-3-9.043.03
c.1475A>G
K492R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K492R is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts benign. No prediction or folding stability result is missing or inconclusive. Overall, the majority of tools (seven pathogenic vs. six benign) lean toward a pathogenic interpretation, and this does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.061840Structured0.327121Uncertain0.9470.1920.000-11.290Likely Pathogenic0.599Likely PathogenicLikely Benign-0.20Likely Benign0.10.45Likely Benign0.13Likely Benign0.84Ambiguous0.487Likely Benign-2.98Deleterious0.997Probably Damaging0.990Probably Damaging3.25Benign0.05Affected0.39110.083532-0.628.01
c.1523A>G
D508G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D508G missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls are made by Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta. FoldX‑MD is inconclusive and is treated as unavailable. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a likely pathogenic verdict from the SGM Consensus, and a pathogenic prediction from Foldetta. Overall, the majority of evidence, including the high‑accuracy tools, supports a pathogenic effect. This conclusion does not contradict ClinVar, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.019401Structured0.255890Uncertain0.8900.2280.000-8.478Likely Pathogenic0.622Likely PathogenicLikely Benign0.87Ambiguous0.23.20Destabilizing2.04Destabilizing0.13Likely Benign0.368Likely Benign-6.61Deleterious0.997Probably Damaging0.933Probably Damaging3.30Benign0.07Tolerated0.38210.45281-13.1-58.04
c.1535A>G
E512G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E512G is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. The remaining tools—FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized—return uncertain or inconclusive results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E512G, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.247079Uncertain0.9230.2730.000-11.996Likely Pathogenic0.817Likely PathogenicAmbiguous0.86Ambiguous0.11.84Ambiguous1.35Ambiguous0.17Likely Benign0.381Likely Benign-6.46Deleterious0.997Probably Damaging0.915Probably Damaging3.30Benign0.02Affected0.32620.41850-23.1-72.06
c.1540A>T
I514F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I514F is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS (uncertain), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—report it as pathogenic or likely pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, classifies the variant as pathogenic. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, which is consistent with its ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.049374Structured0.221408Uncertain0.9480.2660.000Uncertain 1-13.383Likely Pathogenic0.962Likely PathogenicLikely Pathogenic2.35Destabilizing0.33.74Destabilizing3.05Destabilizing0.93Ambiguous0.601Likely Pathogenic-3.98Deleterious0.997Probably Damaging0.993Probably Damaging2.89Benign0.00Affected3.37350.05740.162901-1.734.02
c.1546G>A
A516T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A516T is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include SIFT, Rosetta, and Foldetta, whereas a majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) as benign. With the pathogenic predictions outweighing the benign ones, the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.167423Uncertain0.9380.2840.000-9.716Likely Pathogenic0.941Likely PathogenicAmbiguous0.57Ambiguous0.2-0.14Likely Benign0.22Likely Benign0.63Ambiguous0.520Likely Pathogenic-3.21Deleterious0.997Probably Damaging0.993Probably Damaging-1.29Pathogenic0.17Tolerated0.15860.573910-2.530.03
c.1558T>C
S520P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S520P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report a pathogenic outcome, while premPS remains inconclusive. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. Overall, the evidence strongly supports a pathogenic impact for S520P, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.094817Structured0.084894Uncertain0.8870.3370.000Uncertain 1-12.707Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.72Destabilizing0.88.86Destabilizing6.29Destabilizing0.83Ambiguous0.855Likely Pathogenic-4.57Deleterious0.997Probably Damaging0.986Probably Damaging-1.32Pathogenic0.01Affected0.21540.47761-1-0.810.04
c.1586T>A
I529N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign) all predict a neutral impact. In contrast, polyPhen‑2 (HumDiv and HumVar) and FATHMM predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign effect. Taken together, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.000-4.478Likely Benign0.283Likely BenignLikely Benign0.12Likely Benign0.2-0.05Likely Benign0.04Likely Benign0.46Likely Benign0.378Likely Benign-0.31Neutral0.997Probably Damaging0.952Probably Damaging-1.24Pathogenic0.20Tolerated0.07220.0700-2-3-8.00.94
c.1616A>G
H539R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H539R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from SIFT and the protein‑folding stability method Foldetta, whereas the remaining tools (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) suggests a benign impact. Overall, the preponderance of evidence points to a pathogenic effect for H539R, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.031398Uncertain0.9480.3600.000-14.979Likely Pathogenic0.982Likely PathogenicLikely Pathogenic-0.83Ambiguous0.10.66Ambiguous-0.09Likely Benign1.02Destabilizing0.832Likely Pathogenic-7.19Deleterious0.997Probably Damaging0.989Probably Damaging-1.16Pathogenic0.07Tolerated0.14970.111220-1.319.05
c.1625A>C
N542T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N542T is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are SIFT and Rosetta. Tools that predict a pathogenic effect include SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results come from FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.053060Structured0.026143Uncertain0.9530.3310.000-9.918Likely Pathogenic0.974Likely PathogenicLikely Pathogenic1.13Ambiguous0.10.20Likely Benign0.67Ambiguous0.75Ambiguous0.784Likely Pathogenic-5.37Deleterious0.997Probably Damaging0.990Probably Damaging-1.41Pathogenic0.12Tolerated0.11200.5872002.8-13.00
c.1661T>G
V554G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V554G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, while the remaining eleven tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as pathogenic. No predictions are missing or inconclusive. Overall, the variant is most likely pathogenic based on the collective evidence, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.020522Structured0.007349Uncertain0.9550.2260.000-13.879Likely Pathogenic0.942Likely PathogenicAmbiguous3.31Destabilizing0.14.13Destabilizing3.72Destabilizing2.40Destabilizing0.594Likely Pathogenic-6.96Deleterious0.997Probably Damaging1.000Probably Damaging3.21Benign0.00Affected0.16190.1548-1-3-4.6-42.08
c.1669T>C
S557P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S557P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic or likely pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also labels it pathogenic. Based on the uniform predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.028107Structured0.010261Uncertain0.9240.2150.000-15.383Likely Pathogenic0.997Likely PathogenicLikely Pathogenic6.91Destabilizing0.48.79Destabilizing7.85Destabilizing1.09Destabilizing0.934Likely Pathogenic-4.60Deleterious0.997Probably Damaging0.986Probably Damaging-1.76Pathogenic0.01Affected0.22220.62391-1-0.810.04
c.1690G>A
E564K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E564K is not reported in ClinVar and is present in the gnomAD database (variant ID 6‑33440742‑G‑A). Functional prediction tools largely agree on a deleterious effect: pathogenic calls are made by REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, while only SIFT predicts a benign outcome. Uncertain results are reported by FoldX, Foldetta, and premPS. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence supports a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.023534Structured0.038418Uncertain0.8910.2080.0006-33440742-G-A-15.834Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.76Ambiguous0.12.06Destabilizing1.41Ambiguous0.89Ambiguous0.854Likely Pathogenic-3.95Deleterious0.997Probably Damaging0.987Probably Damaging-1.35Pathogenic0.10Tolerated3.37350.19880.528010-0.4-0.94
c.1702G>A
V568M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V568M is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include FoldX, whereas the remaining tools—REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus—predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With the majority of evidence pointing to pathogenicity and no ClinVar annotation to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.024826Structured0.053503Uncertain0.9370.2570.000-10.361Likely Pathogenic0.913Likely PathogenicAmbiguous0.06Likely Benign0.32.71Destabilizing1.39Ambiguous0.66Ambiguous0.811Likely Pathogenic-2.79Deleterious0.997Probably Damaging0.924Probably Damaging-1.42Pathogenic0.00Affected0.06970.312421-2.332.06
c.1730C>G
A577G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A577G is listed in ClinVar as Benign (ClinVar ID 1010280.0) and is present in gnomAD (ID 6‑33440782‑C‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions that are inconclusive (FoldX, Rosetta, Foldetta, premPS) are treated as unavailable. High‑accuracy methods give a benign verdict: AlphaMissense‑Optimized is benign, the SGM‑Consensus is Likely Benign, and Foldetta is uncertain. Overall, the majority of reliable predictions support a benign impact, which is consistent with the ClinVar status and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.113710Structured0.019074Uncertain0.9130.2390.000Benign/Likely benign 26-33440782-C-G16.20e-7-5.717Likely Benign0.268Likely BenignLikely Benign0.83Ambiguous0.01.02Ambiguous0.93Ambiguous0.86Ambiguous0.443Likely Benign-1.84Neutral0.997Probably Damaging0.990Probably Damaging-1.31Pathogenic0.31Tolerated3.37340.21200.378010-2.2-14.03158.723.60.00.00.00.0XPotentially BenignAla577 is located near the end and outer surface of an α-helix (res. Arg563-Glu578), where its methyl group does not form any particular interactions in the WT simulations. The introduced residue, glycine, is known as an “α-helix breaker.” However, the residue swap caused only minor helix shortening in one of the replica simulations for the variant system. Regardless, the residue swap seems to be well tolerated based on the variant simulations.
c.1730C>T
A577V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A577V is catalogued in gnomAD (ID 6‑33440782‑C‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores benign; the SGM consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also reports benign. No prediction or stability result is missing or inconclusive in these key analyses. Consequently, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.113710Structured0.019074Uncertain0.9130.2390.0006-33440782-C-T21.24e-6-4.265Likely Benign0.432AmbiguousLikely Benign0.69Ambiguous0.10.00Likely Benign0.35Likely Benign0.16Likely Benign0.417Likely Benign-2.11Neutral0.997Probably Damaging0.976Probably Damaging-1.32Pathogenic0.26Tolerated3.37340.12780.4790002.428.05
c.1810T>C
S604P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S604P is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include premPS and FATHMM, whereas the remaining tools—REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy methods give consistent results: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also labels the variant as likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a destabilizing, pathogenic effect. Taken together, the overwhelming majority of computational evidence supports a pathogenic classification for S604P, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.010926Structured0.192527Uncertain0.9110.1950.000-10.953Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.76Destabilizing0.38.40Destabilizing6.08Destabilizing0.04Likely Benign0.512Likely Pathogenic-4.98Deleterious0.997Probably Damaging0.986Probably Damaging3.10Benign0.01Affected0.25240.48291-1-0.810.04
c.1849G>A
E617K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E617K is not reported in ClinVar but is present in gnomAD (6‑33440901‑G‑A). Functional prediction tools cluster into two groups: benign predictions come from FoldX, premPS, and SIFT, while pathogenic predictions arise from SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. A third set of methods (Foldetta, AlphaMissense‑Optimized, Rosetta) yield uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect for E617K, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.155123Uncertain0.8770.2400.0006-33440901-G-A16.20e-7-10.702Likely Pathogenic0.910Likely PathogenicAmbiguous0.37Likely Benign0.11.19Ambiguous0.78Ambiguous0.17Likely Benign0.534Likely Pathogenic-3.32Deleterious0.997Probably Damaging0.987Probably Damaging-1.34Pathogenic0.48Tolerated3.37350.19810.628210-0.4-0.94
c.1880C>G
A627G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A627G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect comprise SGM‑Consensus, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. FoldX and Foldetta are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.100716Structured0.037862Uncertain0.9700.2100.000-11.716Likely Pathogenic0.640Likely PathogenicLikely Benign1.38Ambiguous0.12.07Destabilizing1.73Ambiguous1.25Destabilizing0.458Likely Benign-3.96Deleterious0.997Probably Damaging0.876Possibly Damaging2.51Benign0.01Affected0.19210.299010-2.2-14.03
c.1889T>C
I630T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I630T has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default; ESM1b remains uncertain. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized indicates benign, whereas the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic majority, and Foldetta also predicts pathogenic. No prediction is missing or inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for I630T, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.040537Structured0.036106Uncertain0.9660.2360.000-7.780In-Between0.754Likely PathogenicLikely Benign2.77Destabilizing0.12.27Destabilizing2.52Destabilizing1.94Destabilizing0.734Likely Pathogenic-2.15Neutral0.997Probably Damaging0.961Probably Damaging-1.46Pathogenic0.35Tolerated0.09850.06400-1-5.2-12.05
c.1891C>G
Q631E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q631E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that indicate a benign effect include FoldX, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifying it as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yielding an uncertain result. Overall, the majority of evidence (eight pathogenic predictions versus three benign) points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which is currently unavailable.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.038963Uncertain0.9480.2300.000-15.628Likely Pathogenic0.782Likely PathogenicLikely Benign0.04Likely Benign0.11.55Ambiguous0.80Ambiguous0.95Ambiguous0.532Likely Pathogenic-2.99Deleterious0.997Probably Damaging0.981Probably Damaging2.78Benign0.01Affected0.10680.1264220.00.98
c.1901C>G
A634G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A634G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized, while pathogenic calls are made by Rosetta, premPS, PROVEAN, both polyPhen‑2 versions, ESM1b, and AlphaMissense‑Default. FoldX and Foldetta give uncertain results. High‑accuracy assessments indicate AlphaMissense‑Optimized predicts benign, whereas the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta remains uncertain. Overall, the majority of tools lean toward pathogenicity, and the high‑accuracy consensus also supports a pathogenic interpretation. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.085092Structured0.052058Uncertain0.9320.2420.000-10.685Likely Pathogenic0.613Likely PathogenicLikely Benign1.63Ambiguous0.12.27Destabilizing1.95Ambiguous1.09Destabilizing0.418Likely Benign-3.98Deleterious0.997Probably Damaging0.990Probably Damaging2.69Benign0.15Tolerated0.21820.318710-2.2-14.03
c.1901C>T
A634V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A634V is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools largely converge on a deleterious effect: pathogenic calls are made by REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score, while only FATHMM predicts a benign outcome; Rosetta remains inconclusive. High‑accuracy assessments reinforce the pathogenic trend: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. Taken together, the overwhelming majority of evidence supports a pathogenic effect for A634V, which is in contrast to its current ClinVar classification of uncertain significance. Therefore, the variant is most likely pathogenic, contradicting its ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.085092Structured0.052058Uncertain0.9320.2420.000Uncertain 1-12.612Likely Pathogenic0.971Likely PathogenicLikely Pathogenic2.67Destabilizing0.21.44Ambiguous2.06Destabilizing1.14Destabilizing0.631Likely Pathogenic-3.98Deleterious0.997Probably Damaging0.976Probably Damaging2.55Benign0.01Affected0.12150.4371002.428.05
c.1912A>C
K638Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K638Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.045352Structured0.098064Uncertain0.9370.2600.000-9.561Likely Pathogenic0.556AmbiguousLikely Benign0.45Likely Benign0.00.37Likely Benign0.41Likely Benign0.22Likely Benign0.421Likely Benign-3.60Deleterious0.997Probably Damaging0.991Probably Damaging3.42Benign0.12Tolerated0.36230.0920110.4-0.04
c.1945A>G
M649V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M649V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. With 8 pathogenic versus 3 benign predictions, the overall evidence favors a deleterious effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-9.907Likely Pathogenic0.887Likely PathogenicAmbiguous2.84Destabilizing0.32.55Destabilizing2.70Destabilizing1.05Destabilizing0.370Likely Benign-3.99Deleterious0.997Probably Damaging0.735Possibly Damaging3.40Benign0.06Tolerated0.23890.3121212.3-32.06
c.1954T>C
F652L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F652L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are made by REVEL and FATHMM, whereas the remaining evaluated algorithms (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) all indicate pathogenicity. Stability‑based assessments from FoldX and Rosetta are inconclusive, and Foldetta likewise yields an uncertain result. High‑accuracy methods give a clearer picture: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels the variant as likely pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for F652L. This conclusion is consistent with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.098513Structured0.356594Uncertain0.9660.3380.000-9.026Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.31Ambiguous0.11.88Ambiguous1.60Ambiguous1.35Destabilizing0.467Likely Benign-5.65Deleterious0.997Probably Damaging0.619Possibly Damaging3.09Benign0.00Affected0.17500.2926201.0-34.02
c.1956T>A
F652L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F652L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are made by REVEL and FATHMM, whereas the remaining evaluated algorithms (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) all indicate pathogenicity. Stability‑based assessments from FoldX and Rosetta are inconclusive, and Foldetta likewise yields an uncertain result. High‑accuracy methods give a clearer picture: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels the variant as likely pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for F652L. This conclusion is consistent with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.098513Structured0.356594Uncertain0.9660.3380.000-9.026Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.31Ambiguous0.11.88Ambiguous1.60Ambiguous1.35Destabilizing0.306Likely Benign-5.65Deleterious0.997Probably Damaging0.619Possibly Damaging3.09Benign0.00Affected0.17500.2926201.0-34.02
c.1956T>G
F652L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F652L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) indicate a pathogenic impact. FoldX and Rosetta give uncertain results, and Foldetta likewise reports an uncertain stability change. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it Likely Pathogenic, and Foldetta remaining uncertain. Overall, the preponderance of evidence from multiple pathogenic‑predicting tools and the high‑accuracy methods points to a likely pathogenic effect for F652L, with no conflict from ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.098513Structured0.356594Uncertain0.9660.3380.000-9.026Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.31Ambiguous0.11.88Ambiguous1.60Ambiguous1.35Destabilizing0.305Likely Benign-5.65Deleterious0.997Probably Damaging0.619Possibly Damaging3.09Benign0.00Affected0.17500.2926201.0-34.02
c.1958T>G
L653R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L653R lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.049374Structured0.335213Uncertain0.9630.3320.000-16.078Likely Pathogenic0.995Likely PathogenicLikely Pathogenic6.92Destabilizing1.15.84Destabilizing6.38Destabilizing2.55Destabilizing0.649Likely Pathogenic-5.75Deleterious0.997Probably Damaging0.806Possibly Damaging3.09Benign0.00Affected0.15010.0805-3-2-8.343.03
c.1996G>C
E666Q
2D
AIThe SynGAP1 E666Q missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split and is treated as unavailable. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of reliable predictions indicate a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.155435Structured0.086870Uncertain0.9250.3870.000-10.963Likely Pathogenic0.737Likely PathogenicLikely Benign0.54Ambiguous0.50.20Likely Benign0.37Likely Benign0.46Likely Benign0.268Likely Benign-2.29Neutral0.997Probably Damaging0.696Possibly Damaging3.46Benign0.13Tolerated0.14370.4788220.0-0.98
c.2023A>G
N675D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N675D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments give AlphaMissense‑Optimized a benign call, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) a pathogenic call, and Foldetta an uncertain result. With an equal split of general predictions but a pathogenic majority in the high‑accuracy consensus, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.111024Uncertain0.5130.3330.000-12.829Likely Pathogenic0.497AmbiguousLikely Benign1.41Ambiguous0.4-0.26Likely Benign0.58Ambiguous1.05Destabilizing0.246Likely Benign-3.87Deleterious0.997Probably Damaging0.865Possibly Damaging3.53Benign0.17Tolerated0.19140.4901210.00.98
c.2041G>A
G681S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM, while those that predict a pathogenic outcome are SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yielding an uncertain result. Overall, the majority of tools lean toward pathogenicity, but the presence of a benign prediction from AlphaMissense‑Optimized and an uncertain Foldetta score leaves the assessment inconclusive. No ClinVar entry exists, so there is no contradiction with clinical database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-9.913Likely Pathogenic0.716Likely PathogenicLikely Benign2.11Destabilizing1.3-0.23Likely Benign0.94Ambiguous0.41Likely Benign0.483Likely Benign-5.99Deleterious0.997Probably Damaging0.780Possibly Damaging3.45Benign0.08Tolerated0.25910.458410-0.430.03
c.2045A>T
Y682F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y682F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. The SGM Consensus, which is a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign vs. two pathogenic votes) and is treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta (combining FoldX‑MD and Rosetta outputs) as benign, and the SGM Consensus remains unavailable. Overall, the balance of evidence—both from general predictors and from the high‑accuracy tools—leans toward a benign classification. This conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.206376Structured0.141467Uncertain0.7580.3280.000-9.740Likely Pathogenic0.225Likely BenignLikely Benign0.21Likely Benign0.1-0.09Likely Benign0.06Likely Benign0.42Likely Benign0.278Likely Benign-3.72Deleterious0.997Probably Damaging0.947Probably Damaging3.40Benign0.04Affected0.24520.3662734.1-16.00
c.2062G>C
E688Q
2D
AIThe SynGAP1 missense variant E688Q is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic outcome: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools (premPS and AlphaMissense‑Optimized) give uncertain results and are treated as unavailable. High‑accuracy assessments further show SGM‑Consensus as Likely Pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign, and AlphaMissense‑Optimized as uncertain. Overall, the balance of evidence leans toward pathogenicity, with no ClinVar annotation to contradict this assessment. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.061840Structured0.211124Uncertain0.9470.2230.000-9.419Likely Pathogenic0.943Likely PathogenicAmbiguous0.17Likely Benign0.90.15Likely Benign0.16Likely Benign0.59Ambiguous0.302Likely Benign-2.53Deleterious0.997Probably Damaging0.973Probably Damaging3.27Benign0.15Tolerated0.11540.5387220.0-0.98
c.2093A>C
E698A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E698A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM, while those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. No prediction or folding result is missing. Overall, the majority of tools (seven versus six) favor a pathogenic interpretation, and this does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-10.962Likely Pathogenic0.822Likely PathogenicAmbiguous0.31Likely Benign0.00.26Likely Benign0.29Likely Benign0.25Likely Benign0.476Likely Benign-5.57Deleterious0.997Probably Damaging0.991Probably Damaging3.35Benign0.01Affected0.31470.41600-15.3-58.04
c.2110A>C
S704R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704R is not reported in gnomAD and has no ClinVar entry. Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM, whereas the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely pathogenic. FoldX, Rosetta, and Foldetta provide uncertain stability results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the evidence points to the variant being most likely pathogenic, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-9.417Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.81Ambiguous0.10.92Ambiguous0.87Ambiguous0.31Likely Benign0.178Likely Benign-2.65Deleterious0.997Probably Damaging0.822Possibly Damaging3.53Benign0.05Affected0.07140.30380-1-3.769.11
c.2110A>T
S704C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Other stability‑based tools such as FoldX, Rosetta, and premPS also return uncertain results. Overall, the majority of individual predictors lean toward pathogenicity, and the high‑accuracy consensus also supports a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.096677Structured0.383620Uncertain0.9280.3630.000-10.438Likely Pathogenic0.423AmbiguousLikely Benign1.56Ambiguous0.10.98Ambiguous1.27Ambiguous0.52Ambiguous0.251Likely Benign-3.52Deleterious0.997Probably Damaging0.789Possibly Damaging3.40Benign0.01Affected0.07890.46120-13.316.06
c.2111G>T
S704I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704I lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM, whereas the majority of other in silico predictors (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) report a pathogenic or likely pathogenic outcome. FoldX, Rosetta, and Foldetta provide uncertain results. High‑accuracy methods specifically give AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overall consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-14.222Likely Pathogenic0.978Likely PathogenicLikely Pathogenic1.63Ambiguous0.11.32Ambiguous1.48Ambiguous0.29Likely Benign0.232Likely Benign-4.05Deleterious0.997Probably Damaging0.758Possibly Damaging3.49Benign0.02Affected0.07270.4798-1-25.326.08
c.2112C>A
S704R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, the SGM Consensus confirms Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result, providing no additional evidence. Overall, the preponderance of evidence from multiple independent predictors indicates that S704R is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-9.417Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.81Ambiguous0.10.92Ambiguous0.87Ambiguous0.31Likely Benign0.200Likely Benign-2.65Deleterious0.997Probably Damaging0.822Possibly Damaging3.53Benign0.05Affected0.07140.30380-1-3.769.11
c.2112C>G
S704R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). FoldX and Rosetta give uncertain results, and Foldetta (a combined FoldX‑MD/Rosetta stability assessment) is also uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic; this conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-9.417Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.81Ambiguous0.10.92Ambiguous0.87Ambiguous0.31Likely Benign0.200Likely Benign-2.65Deleterious0.997Probably Damaging0.822Possibly Damaging3.53Benign0.05Affected0.07140.30380-1-3.769.11
c.2113A>C
K705Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K705Q missense variant (ClinVar ID 3699560.0) is listed as “Uncertain” in ClinVar and is present in gnomAD (variant ID 6‑33441372‑A‑C). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (benign), FATHMM (benign), and PROVEAN (benign)—also yields a benign classification; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the preponderance of evidence supports a benign impact for K705Q, and this conclusion does not contradict the ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.134866Structured0.379324Uncertain0.9220.3640.000Uncertain 16-33441372-A-C16.20e-7-5.787Likely Benign0.436AmbiguousLikely Benign-0.10Likely Benign0.00.33Likely Benign0.12Likely Benign-0.02Likely Benign0.142Likely Benign-0.24Neutral0.997Probably Damaging0.969Probably Damaging3.42Benign0.78Tolerated3.47100.30630.1014110.4-0.04
c.2149C>A
L717I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L717I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only two tools—polyPhen‑2 HumDiv and HumVar—predict a pathogenic outcome, while premPS is inconclusive. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts Benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.239899Structured0.429342Uncertain0.9690.3970.000-4.836Likely Benign0.168Likely BenignLikely Benign0.27Likely Benign0.00.33Likely Benign0.30Likely Benign-0.73Ambiguous0.182Likely Benign0.60Neutral0.997Probably Damaging0.989Probably Damaging3.43Benign1.00Tolerated0.07120.2570220.70.00
c.2203A>C
S735R
2D
AIThe SynGAP1 missense variant S735R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, while the SGM‑Consensus (majority vote) remains Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. The variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-6.318Likely Benign0.784Likely PathogenicAmbiguous0.126Likely Benign-1.25Neutral0.997Probably Damaging0.933Probably Damaging2.66Benign0.72Tolerated0.09130.28610-1-3.769.11
c.2205C>A
S735R
2D
AIThe SynGAP1 missense variant S735R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, whereas the SGM‑Consensus (majority vote) supports a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-6.318Likely Benign0.784Likely PathogenicAmbiguous0.108Likely Benign-1.25Neutral0.997Probably Damaging0.933Probably Damaging2.66Benign0.72Tolerated0.09130.28610-1-3.769.11
c.2205C>G
S735R
2D
AIThe SynGAP1 missense variant S735R has no ClinVar record and is not listed in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, whereas the SGM‑Consensus (majority vote) remains Benign; Foldetta results are unavailable. Overall, the balance of evidence—five benign versus three pathogenic predictions, a benign SGM‑Consensus, and no contradictory ClinVar annotation—indicates that the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-6.318Likely Benign0.784Likely PathogenicAmbiguous0.108Likely Benign-1.25Neutral0.997Probably Damaging0.933Probably Damaging2.66Benign0.72Tolerated0.09130.28610-1-3.769.11
c.2269G>T
G757C
2D
AIThe SynGAP1 missense variant G757C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.436924Structured0.830995Binding0.3100.8690.375-6.652Likely Benign0.139Likely BenignLikely Benign0.179Likely Benign-1.74Neutral0.997Probably Damaging0.870Possibly Damaging2.65Benign0.04Affected0.13020.3630-3-32.946.09
c.2297C>G
S766C
2D
AIThe SynGAP1 missense variant S766C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. ESM1b is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for S766C, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.405110Structured0.923125Binding0.3380.8740.250-7.681In-Between0.326Likely BenignLikely Benign0.192Likely Benign-2.02Neutral0.997Probably Damaging0.889Possibly Damaging4.07Benign0.00Affected0.10490.61100-13.316.06
c.2326G>A
G776S
2D
AIThe SynGAP1 missense variant G776S is reported in ClinVar as “Not submitted” and is present in gnomAD (variant ID 6-33442484-G-A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus likewise indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of predictive evidence points to a benign effect, and this conclusion does not contradict the ClinVar status, which currently contains no pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.377384Structured0.886983Binding0.2960.8880.2506-33442484-G-A11.28e-6-3.334Likely Benign0.147Likely BenignLikely Benign0.163Likely Benign-1.21Neutral0.997Probably Damaging0.992Probably Damaging4.28Benign0.13Tolerated3.6460.25390.578501-0.430.03
c.2330T>A
L777H
2D
AIThe SynGAP1 missense variant L777H has no ClinVar record and is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors a benign outcome. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the balance of evidence—including the consensus of high‑accuracy tools—suggests that the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.408655Structured0.876129Binding0.3360.8820.250-6.719Likely Benign0.492AmbiguousLikely Benign0.230Likely Benign-2.51Deleterious0.997Probably Damaging0.993Probably Damaging3.95Benign0.00Affected0.10520.0972-2-3-7.023.98
c.2356C>A
L786I
2D
AIThe SynGAP1 missense variant L786I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of evidence, especially from the high‑accuracy methods, points to a benign impact. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.882776Disordered0.655253Binding0.3410.8950.750-5.464Likely Benign0.215Likely BenignLikely Benign0.087Likely Benign-1.12Neutral0.997Probably Damaging0.992Probably Damaging1.93Pathogenic0.00Affected0.10560.4199220.70.00
c.2356C>G
L786V
2D
AIThe SynGAP1 missense variant L786V is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict the ClinVar status, which currently has no classification for L786V.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.882776Disordered0.655253Binding0.3410.8950.750-4.607Likely Benign0.310Likely BenignLikely Benign0.099Likely Benign-1.66Neutral0.997Probably Damaging0.992Probably Damaging2.00Pathogenic0.00Affected0.16830.4049210.4-14.03
c.2362T>C
S788P
2D
AIThe SynGAP1 missense variant S788P is catalogued in gnomAD (ID 6‑33442914‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, and AlphaMissense‑Optimized, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The AlphaMissense‑Default score is uncertain. A consensus derived from the SGM framework (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is unavailable for this residue. Taken together, the preponderance of evidence from standard predictors and the SGM consensus points to a likely pathogenic effect, which does not contradict any existing ClinVar annotation because none is present.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.956248Disordered0.573557Binding0.3490.8950.7506-33442914-T-C-1.857Likely Benign0.435AmbiguousLikely Benign0.236Likely Benign-3.91Deleterious0.997Probably Damaging0.995Probably Damaging1.51Pathogenic0.01Affected3.6460.23380.5537-11-0.810.04
c.2363C>A
S788Y
2D
AIThe SynGAP1 missense variant S788Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score—consistently predict a pathogenic or likely pathogenic impact. High‑accuracy assessments show that the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic effect, AlphaMissense‑Optimized is uncertain (treated as unavailable), and Foldetta results are not provided. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.956248Disordered0.573557Binding0.3490.8950.750-8.745Likely Pathogenic0.795Likely PathogenicAmbiguous0.251Likely Benign-4.56Deleterious0.997Probably Damaging0.996Probably Damaging1.50Pathogenic0.00Affected0.08440.5551-3-2-0.576.10
c.2363C>T
S788F
2D
AIThe SynGAP1 missense variant S788F is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; Foldetta stability analysis is unavailable. Overall, the preponderance of predictions points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.956248Disordered0.573557Binding0.3490.8950.750-7.870In-Between0.749Likely PathogenicLikely Benign0.275Likely Benign-4.73Deleterious0.997Probably Damaging0.996Probably Damaging1.50Pathogenic0.00Affected0.07810.5824-3-23.660.10
c.2368A>T
T790S
2D
AIThe SynGAP1 missense variant T790S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability data are available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for T790S, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.964893Disordered0.509280Binding0.3850.8960.875-3.914Likely Benign0.123Likely BenignLikely Benign0.125Likely Benign-1.83Neutral0.997Probably Damaging0.989Probably Damaging2.39Pathogenic0.33Tolerated3.6460.34160.444911-0.1-14.03
c.2369C>G
T790S
2D
AIThe SynGAP1 missense variant T790S (ClinVar ID 1020340) is listed as Uncertain in ClinVar and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus, which is derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN. Pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar status of Uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.964893Disordered0.509280Binding0.3850.8960.875Uncertain 2-3.914Likely Benign0.123Likely BenignLikely Benign0.134Likely Benign-1.83Neutral0.997Probably Damaging0.989Probably Damaging2.39Pathogenic0.33Tolerated3.6460.34160.444911-0.1-14.03
c.2411A>T
D804V
2D
AIThe SynGAP1 missense variant D804V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—predict a pathogenic impact. The AlphaMissense‑Optimized score is uncertain, providing no definitive evidence. High‑accuracy assessments show that the SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic outcome; AlphaMissense‑Optimized remains inconclusive, and Foldetta results are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for D804V, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.801317Disordered0.786762Binding0.2940.9000.625-8.143Likely Pathogenic0.832Likely PathogenicAmbiguous0.402Likely Benign-4.77Deleterious0.997Probably Damaging0.951Probably Damaging1.19Pathogenic0.01Affected0.11960.6981-2-37.7-15.96
c.2416T>A
F806I
2D
AIThe SynGAP1 missense variant F806I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized, whereas the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic effect; Foldetta results are unavailable. Overall, the balance of evidence from the consensus of prediction algorithms points to a pathogenic impact for F806I. This conclusion is not contradicted by ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.736850Disordered0.847454Binding0.2760.9040.500-5.040Likely Benign0.744Likely PathogenicLikely Benign0.182Likely Benign-3.19Deleterious0.997Probably Damaging0.994Probably Damaging2.15Pathogenic0.03Affected0.25830.1357101.7-34.02
c.2416T>G
F806V
2D
AIThe SynGAP1 missense variant F806V is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, ESM1b, and AlphaMissense‑Optimized, whereas the majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) predict it to be pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus remains pathogenic; a Foldetta stability analysis is unavailable. Overall, the balance of evidence from the majority of prediction algorithms points to a pathogenic impact, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.736850Disordered0.847454Binding0.2760.9040.500-4.548Likely Benign0.676Likely PathogenicLikely Benign0.192Likely Benign-3.79Deleterious0.997Probably Damaging0.992Probably Damaging2.16Pathogenic0.02Affected0.24640.1325-1-11.4-48.04
c.2417T>A
F806Y
2D
AIThe SynGAP1 missense variant F806Y is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized, whereas polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM all predict a pathogenic outcome; AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also classifies it as benign, and Foldetta results are unavailable. Taken together, the majority of evidence points to a benign effect, and this conclusion does not contradict the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.736850Disordered0.847454Binding0.2760.9040.500-5.229Likely Benign0.404AmbiguousLikely Benign0.162Likely Benign-1.51Neutral0.997Probably Damaging0.987Probably Damaging2.32Pathogenic0.03Affected0.17460.143773-4.116.00
c.2420A>G
Y807C
2D
AIThe SynGAP1 missense variant Y807C is listed in ClinVar with an “Uncertain” status (ClinVar ID 2119812.0) and is present in gnomAD (ID 6‑33442972‑A‑G). Prediction tools that agree on a benign effect include REVEL, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions (five pathogenic vs. three benign) and the SGM Consensus support a pathogenic interpretation, whereas AlphaMissense‑Optimized alone suggests benign. The variant is most likely pathogenic based on the collective evidence, and this conclusion is not contradicted by the ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.699094Disordered0.853760Binding0.3360.9010.500Uncertain 16-33442972-A-G16.20e-7-7.228In-Between0.204Likely BenignLikely Benign0.243Likely Benign-3.89Deleterious0.997Probably Damaging0.934Probably Damaging2.42Pathogenic0.01Affected3.7750.31010.19070-23.8-60.04
c.2450C>T
S817L
2D
AIThe SynGAP1 missense variant S817L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas a majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) predict a pathogenic impact; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports the variant as Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.490133Structured0.727082Binding0.3140.9010.625-7.612In-Between0.659Likely PathogenicLikely Benign0.226Likely Benign-3.90Deleterious0.997Probably Damaging0.945Probably Damaging2.41Pathogenic0.00Affected0.12260.5662-3-24.626.08
c.2453C>T
P818L
2D
AIThe SynGAP1 missense variant P818L is catalogued in gnomAD (ID 6‑33443005‑C‑T) but has no ClinVar entry. Functional prediction tools fall into two consensus groups: benign predictions come from REVEL and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). AlphaMissense‑Optimized returns an uncertain result. High‑accuracy assessments are limited: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates “Likely Pathogenic,” and Foldetta data are unavailable. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification. Thus, the variant is most likely pathogenic based on current predictive tools.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.715889Binding0.3710.8930.6256-33443005-C-T16.20e-7-6.064Likely Benign0.938Likely PathogenicAmbiguous0.285Likely Benign-5.81Deleterious0.997Probably Damaging0.954Probably Damaging1.98Pathogenic0.02Affected3.7750.23510.6951-3-35.416.04
c.2461T>A
C821S
2D
AIThe SynGAP1 missense variant C821S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, whereas the SGM‑Consensus (majority vote) supports a benign outcome. Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for C821S, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.745909Disordered0.672821Binding0.3510.8830.750-0.425Likely Benign0.898Likely PathogenicAmbiguous0.190Likely Benign-0.47Neutral0.997Probably Damaging0.994Probably Damaging2.91Benign1.00Tolerated0.52840.2012Weaken0-1-3.3-16.06
c.2462G>C
C821S
2D
AIThe SynGAP1 missense variant C821S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, whereas the SGM‑Consensus (majority vote) supports a benign outcome. Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for C821S, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.745909Disordered0.672821Binding0.3510.8830.750-0.425Likely Benign0.898Likely PathogenicAmbiguous0.314Likely Benign-0.47Neutral0.997Probably Damaging0.994Probably Damaging2.91Benign1.00Tolerated0.52840.2012Weaken0-1-3.3-16.06
c.2468G>A
S823N
2D
AIThe SynGAP1 missense variant S823N is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b. Tools that agree on a pathogenic effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic, two benign votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.685117Disordered0.627336Binding0.3580.8840.750-6.880Likely Benign0.974Likely PathogenicLikely Pathogenic0.170Likely Benign-1.76Neutral0.997Probably Damaging0.992Probably Damaging1.93Pathogenic0.00Affected0.13700.517211-2.727.03
c.2471G>A
S824N
2D
AIThe SynGAP1 missense variant S824N is reported in gnomAD (6‑33443023‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM. Those that predict a pathogenic impact are PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, and this conclusion is not contradicted by any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.728858Disordered0.611272Binding0.3140.8840.7506-33443023-G-A21.24e-6-4.473Likely Benign0.909Likely PathogenicAmbiguous0.091Likely Benign-1.08Neutral0.997Probably Damaging0.992Probably Damaging2.67Benign0.61Tolerated3.7750.17130.532711-2.727.03
c.2478C>A
D826E
2D
AIThe SynGAP1 missense variant D826E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.666105Disordered0.627309Binding0.3270.8860.625-4.172Likely Benign0.859Likely PathogenicAmbiguous0.164Likely Benign-0.66Neutral0.997Probably Damaging0.994Probably Damaging2.92Benign0.56Tolerated0.17950.7687320.014.03
c.2478C>G
D826E
2D
AIThe SynGAP1 missense variant D826E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.666105Disordered0.627309Binding0.3270.8860.625-4.172Likely Benign0.859Likely PathogenicAmbiguous0.164Likely Benign-0.66Neutral0.997Probably Damaging0.994Probably Damaging2.92Benign0.56Tolerated0.17950.7687320.014.03
c.2480T>C
I827T
2D
AIThe SynGAP1 missense variant I827T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.590140Disordered0.636272Binding0.3830.8840.625-4.586Likely Benign0.874Likely PathogenicAmbiguous0.147Likely Benign-0.47Neutral0.997Probably Damaging0.994Probably Damaging2.74Benign0.40Tolerated0.10020.06850-1-5.2-12.05
c.2482A>G
T828A
2D
AIThe SynGAP1 missense variant T828A is reported in gnomAD (variant ID 6‑33443034‑A‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also likely benign. No Foldetta stability analysis is available, so it does not influence the overall assessment. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar classification (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.604312Disordered0.631236Binding0.3210.8790.5006-33443034-A-G16.20e-7-2.974Likely Benign0.340Likely BenignLikely Benign0.197Likely Benign-2.13Neutral0.997Probably Damaging0.992Probably Damaging2.67Benign0.24Tolerated3.7750.40390.3861012.5-30.03
c.2497A>G
K833E
2D
AIThe SynGAP1 missense variant K833E is evaluated by multiple in silico tools. Benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions are reported by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The AlphaMissense‑Default score is uncertain. The consensus predictor SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, SGM‑Consensus confirms Likely Benign, and Foldetta data are not available. ClinVar contains no entry for this variant, and it is absent from gnomAD, so no external evidence contradicts the computational assessment. Based on the collective predictions, the variant is most likely benign, with no conflict from ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.671169Disordered0.625797Binding0.3150.8630.375-2.495Likely Benign0.506AmbiguousLikely Benign0.108Likely Benign-0.69Neutral0.997Probably Damaging0.925Probably Damaging2.72Benign0.04Affected0.31620.1039010.40.94
c.2498A>G
K833R
2D
AIThe SynGAP1 missense variant K833R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also likely benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence indicates that K833R is most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.671169Disordered0.625797Binding0.3150.8630.375-2.158Likely Benign0.114Likely BenignLikely Benign0.094Likely Benign-0.83Neutral0.997Probably Damaging0.925Probably Damaging2.61Benign0.11Tolerated0.38640.094532-0.628.01
c.2498A>T
K833M
2D
AIThe SynGAP1 missense variant K833M is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evaluated predictors (six benign vs. four pathogenic) support a benign classification. Thus, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.671169Disordered0.625797Binding0.3150.8630.375-3.234Likely Benign0.685Likely PathogenicLikely Benign0.181Likely Benign-2.05Neutral0.997Probably Damaging0.954Probably Damaging2.55Benign0.01Affected0.08670.36520-15.83.02
c.2506A>T
S836C
2D
AIThe SynGAP1 missense variant S836C is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, while pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT; ESM1b remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields benign, and Foldetta results are unavailable. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.525368Disordered0.634582Binding0.2690.8590.250-7.859In-Between0.208Likely BenignLikely Benign0.184Likely Benign-2.66Deleterious0.997Probably Damaging0.923Probably Damaging2.50Benign0.04Affected0.08340.54680-13.316.06
c.2510T>G
V837G
2D
AIThe SynGAP1 missense variant V837G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta results are not available, so they do not influence the overall assessment. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.626284Binding0.3180.8710.125-2.599Likely Benign0.315Likely BenignLikely Benign0.187Likely Benign0.93Neutral0.997Probably Damaging0.999Probably Damaging3.18Benign1.00Tolerated0.22600.2422-1-3-4.6-42.08
c.2512A>G
N838D
2D
AIThe SynGAP1 missense variant N838D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. AlphaMissense‑Default remains uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.622677Disordered0.613320Binding0.2760.8610.250-6.035Likely Benign0.529AmbiguousLikely Benign0.119Likely Benign-2.08Neutral0.997Probably Damaging0.992Probably Damaging2.69Benign0.44Tolerated0.18040.2954210.00.98
c.2513A>C
N838T
2D
AIThe SynGAP1 missense variant N838T is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, favors a benign outcome (2 benign vs. 1 pathogenic, with one uncertain). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy predictions therefore point to a benign classification: AlphaMissense‑Optimized is benign, and the SGM Consensus is benign. Consequently, the variant is most likely benign based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.622677Disordered0.613320Binding0.2760.8610.250-4.847Likely Benign0.373AmbiguousLikely Benign0.091Likely Benign-2.59Deleterious0.997Probably Damaging0.992Probably Damaging2.69Benign0.12Tolerated0.12790.5586002.8-13.00
c.2513A>G
N838S
2D
AIThe SynGAP1 missense variant at residue N838S is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. Only the two polyPhen‑2 classifiers (HumDiv and HumVar) predict pathogenicity. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the majority of evidence supports a benign classification, and this is not in conflict with ClinVar, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.622677Disordered0.613320Binding0.2760.8610.250-3.748Likely Benign0.104Likely BenignLikely Benign0.082Likely Benign-1.24Neutral0.997Probably Damaging0.989Probably Damaging2.83Benign0.50Tolerated0.35520.5485112.7-27.03
c.2514C>A
N838K
2D
AIThe SynGAP1 missense variant N838K is listed in ClinVar with an “Uncertain” status (ClinVar ID 1377909.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM‑Consensus as “Likely Pathogenic,” and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Overall, the balance of evidence leans toward a pathogenic interpretation, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.622677Disordered0.613320Binding0.2760.8610.250Uncertain 2-8.470Likely Pathogenic0.862Likely PathogenicAmbiguous0.097Likely Benign-2.78Deleterious0.997Probably Damaging0.995Probably Damaging2.69Benign0.16Tolerated3.7750.21870.386610-0.414.07
c.2514C>G
N838K
2D
AIThe SynGAP1 missense variant N838K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, SIFT, and FATHMM, whereas pathogenic calls arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Pathogenic, while AlphaMissense‑Optimized yields an Uncertain result and Foldetta data are unavailable. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with ClinVar, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.622677Disordered0.613320Binding0.2760.8610.250-8.470Likely Pathogenic0.862Likely PathogenicAmbiguous0.097Likely Benign-2.78Deleterious0.997Probably Damaging0.995Probably Damaging2.69Benign0.16Tolerated3.7750.21870.386610-0.414.07
c.2522T>G
V841G
2D
AIThe SynGAP1 missense variant V841G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect are REVEL and FATHMM, while the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, whereas the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect for V841G, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.622677Disordered0.616495Binding0.2610.8730.125-10.054Likely Pathogenic0.913Likely PathogenicAmbiguous0.288Likely Benign-4.11Deleterious0.997Probably Damaging0.999Probably Damaging2.51Benign0.00Affected0.23510.2422-1-3-4.6-42.08
c.2533G>A
D845N
2D
AIThe SynGAP1 missense variant D845N is not reported in ClinVar and has no entries in gnomAD, indicating it is not catalogued in these databases. Functional prediction tools show a split: benign predictions come from REVEL and ESM1b, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. When the high‑accuracy consensus is considered, AlphaMissense‑Optimized remains pathogenic, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also indicates pathogenicity. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.553315Disordered0.599971Binding0.2970.8270.500-6.586Likely Benign0.961Likely PathogenicLikely Pathogenic0.264Likely Benign-3.42Deleterious0.997Probably Damaging0.996Probably Damaging1.96Pathogenic0.00Affected0.12160.7112210.0-0.98
c.2534A>G
D845G
2D
AIThe SynGAP1 missense variant D845G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: REVEL classifies it as benign, whereas the remaining 11 predictors (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict pathogenicity. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports the variant as Likely Pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus confirms a Likely Pathogenic status; Foldetta results are not available. Taken together, the preponderance of evidence indicates that D845G is most likely pathogenic, and this assessment does not conflict with the current ClinVar record, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.553315Disordered0.599971Binding0.2970.8270.500-8.209Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.399Likely Benign-4.96Deleterious0.997Probably Damaging0.996Probably Damaging2.06Pathogenic0.00Affected0.39530.67401-13.1-58.04
c.2536T>A
L846I
2D
AIThe SynGAP1 missense variant L846I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Two tools, ESM1b and AlphaMissense‑Default, return uncertain results. For high‑accuracy assessment, AlphaMissense‑Optimized classifies the variant as benign. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive because the votes are split (one pathogenic, one benign, two uncertain). Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, has no available output for this variant. Overall, the balance of evidence from the majority of prediction tools suggests the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.653063Disordered0.589606Binding0.3490.8250.500-7.882In-Between0.474AmbiguousLikely Benign0.151Likely Benign-1.38Neutral0.997Probably Damaging0.992Probably Damaging2.18Pathogenic0.00Affected0.09730.3475220.70.00
c.2536T>G
L846V
2D
AIThe SynGAP1 missense variant L846V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Pathogenic, while AlphaMissense‑Optimized remains benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a pathogenic impact, and this assessment does not conflict with any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.653063Disordered0.589606Binding0.3490.8250.500-8.326Likely Pathogenic0.569Likely PathogenicLikely Benign0.165Likely Benign-2.07Neutral0.997Probably Damaging0.992Probably Damaging2.20Pathogenic0.00Affected0.15400.3126210.4-14.03
c.2551C>G
P851A
2D
AIThe SynGAP1 missense variant P851A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy methods confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence supports a benign impact for P851A, and this conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.648219Disordered0.526893Binding0.3470.8190.625-3.699Likely Benign0.055Likely BenignLikely Benign0.108Likely Benign-0.73Neutral0.997Probably Damaging0.989Probably Damaging4.27Benign0.18Tolerated0.36050.57581-13.4-26.04
c.2551C>T
P851S
2D
AIThe SynGAP1 missense variant P851S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic effect. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. Foldetta results are not available for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.648219Disordered0.526893Binding0.3470.8190.625-3.696Likely Benign0.061Likely BenignLikely Benign0.103Likely Benign-0.29Neutral0.997Probably Damaging0.992Probably Damaging4.27Benign0.12Tolerated0.34980.61581-10.8-10.04
c.2561G>A
R854H
2D
AIThe SynGAP1 missense variant R854H is listed in ClinVar with an “Uncertain” status and is present in gnomAD (variant ID 6‑33443113‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also as likely benign; the Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.671169Disordered0.488780Uncertain0.2770.8150.750Uncertain 16-33443113-G-A42.48e-6-3.686Likely Benign0.094Likely BenignLikely Benign0.183Likely Benign-1.38Neutral0.997Probably Damaging0.899Possibly Damaging4.07Benign0.04Affected3.8830.31030.2202201.3-19.05
c.2569A>C
S857R
2D
AIThe SynGAP1 missense variant S857R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates a likely benign outcome. Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for S857R, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.728858Disordered0.475747Uncertain0.2880.8260.375-4.490Likely Benign0.718Likely PathogenicLikely Benign0.138Likely Benign-1.09Neutral0.997Probably Damaging0.992Probably Damaging4.07Benign0.18Tolerated0.10300.41120-1-3.769.11
c.2570G>T
S857I
2D
AIThe SynGAP1 missense variant S857I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. ESM1b is uncertain, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for S857I, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.728858Disordered0.475747Uncertain0.2880.8260.375-7.092In-Between0.192Likely BenignLikely Benign0.198Likely Benign-0.44Neutral0.997Probably Damaging0.995Probably Damaging4.04Benign0.05Affected0.10700.6208-1-25.326.08
c.2571C>A
S857R
2D
AIThe SynGAP1 missense variant S857R is not reported in ClinVar and has no entry in gnomAD, indicating it is not catalogued in these databases. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.728858Disordered0.475747Uncertain0.2880.8260.375-4.490Likely Benign0.718Likely PathogenicLikely Benign0.132Likely Benign-1.09Neutral0.997Probably Damaging0.992Probably Damaging4.07Benign0.18Tolerated0.10300.41120-1-3.769.11
c.2571C>G
S857R
2D
AIThe SynGAP1 missense variant S857R is not reported in ClinVar and has no entry in gnomAD, indicating it is not catalogued in these databases. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.728858Disordered0.475747Uncertain0.2880.8260.375-4.490Likely Benign0.718Likely PathogenicLikely Benign0.132Likely Benign-1.09Neutral0.997Probably Damaging0.992Probably Damaging4.07Benign0.18Tolerated0.10300.41120-1-3.769.11
c.2575A>C
S859R
2D
AIThe SynGAP1 missense variant S859R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain predictions come from ESM1b and AlphaMissense‑Optimized. High‑accuracy assessment shows that AlphaMissense‑Optimized is uncertain, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans toward benign (two benign versus one pathogenic vote). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.648219Disordered0.497075Uncertain0.2880.8190.375-7.810In-Between0.844Likely PathogenicAmbiguous0.127Likely Benign-1.42Neutral0.997Probably Damaging0.995Probably Damaging4.00Benign0.06Tolerated0.09450.40610-1-3.769.11
c.2576G>T
S859I
2D
AIThe SynGAP1 missense variant S859I is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors a benign outcome. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of computational evidence indicates a benign impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar record exists for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.648219Disordered0.497075Uncertain0.2880.8190.375-8.342Likely Pathogenic0.351AmbiguousLikely Benign0.256Likely Benign-1.94Neutral0.997Probably Damaging0.996Probably Damaging3.99Benign0.02Affected0.10940.5867-1-25.326.08
c.2577T>A
S859R
2D
AIThe SynGAP1 missense variant S859R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain predictions come from ESM1b and AlphaMissense‑Optimized. High‑accuracy assessment shows that the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans benign (2 benign vs. 1 pathogenic, 1 uncertain). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact; this conclusion does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.648219Disordered0.497075Uncertain0.2880.8190.375-7.810In-Between0.844Likely PathogenicAmbiguous0.120Likely Benign-1.42Neutral0.997Probably Damaging0.995Probably Damaging4.00Benign0.06Tolerated0.09450.40610-1-3.769.11
c.2577T>G
S859R
2D
AIThe SynGAP1 missense variant S859R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain predictions come from ESM1b and AlphaMissense‑Optimized. High‑accuracy assessment shows that AlphaMissense‑Optimized remains uncertain, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans toward benign (two benign versus one pathogenic vote). Foldetta, which would provide a protein‑folding stability estimate, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.648219Disordered0.497075Uncertain0.2880.8190.375-7.810In-Between0.844Likely PathogenicAmbiguous0.120Likely Benign-1.42Neutral0.997Probably Damaging0.995Probably Damaging4.00Benign0.06Tolerated0.09450.40610-1-3.769.11
c.2599G>A
G867R
2D
AIThe SynGAP1 missense variant G867R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.657954Binding0.2850.8010.250-3.569Likely Benign0.755Likely PathogenicLikely Benign0.131Likely Benign-1.76Neutral0.997Probably Damaging0.943Probably Damaging2.70Benign0.05Affected3.8240.08860.4494-2-3-4.199.14
c.2599G>C
G867R
2D
AIThe SynGAP1 missense variant G867R is catalogued in gnomAD (6‑33443151‑G‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus score, whereas pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized reports a benign effect, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign status. No Foldetta stability analysis is available for this residue. Overall, the majority of evidence points to a benign effect for G867R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.657954Binding0.2850.8010.2506-33443151-G-C16.20e-7-3.569Likely Benign0.755Likely PathogenicLikely Benign0.131Likely Benign-1.76Neutral0.997Probably Damaging0.943Probably Damaging2.70Benign0.05Affected3.8240.08860.4494-2-3-4.199.14
c.2608C>G
L870V
2D
AIThe SynGAP1 missense variant L870V is listed in ClinVar (ID 946946.0) with an “Uncertain” status and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). In contrast, PolyPhen‑2 (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not conflict with the ClinVar designation of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.483068Structured0.688079Binding0.2740.8500.125Uncertain 1-4.123Likely Benign0.300Likely BenignLikely Benign0.111Likely Benign-1.19Neutral0.997Probably Damaging0.992Probably Damaging2.64Benign0.12Tolerated3.8830.15490.3977210.4-14.03
c.2614T>C
S872P
2D
AIThe SynGAP1 missense variant S872P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The only tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (majority vote) also predicts Likely Benign. Foldetta results are not available for this variant. Overall, the majority of evidence indicates that S872P is most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.662664Binding0.2620.8650.125-4.291Likely Benign0.273Likely BenignLikely Benign0.187Likely Benign-1.91Neutral0.997Probably Damaging0.995Probably Damaging2.59Benign0.13Tolerated0.23210.55811-1-0.810.04
c.2617A>C
S873R
2D
AIThe SynGAP1 missense variant S873R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the balance of evidence (five pathogenic vs four benign predictions) suggests the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.414856Structured0.649816Binding0.2830.8660.125-5.856Likely Benign0.976Likely PathogenicLikely Pathogenic0.218Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging2.67Benign0.06Tolerated3.7750.09700.36670-1-3.769.11
c.2618G>T
S873I
2D
AIThe SynGAP1 missense variant S873I has no ClinVar record and is not reported in gnomAD. Functional prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the majority of other in‑silico predictors (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) indicate a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. AlphaMissense‑Optimized returns an uncertain result, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available prediction for this residue. High‑accuracy assessment therefore points to a Likely Pathogenic status from SGM‑Consensus, with AlphaMissense‑Optimized inconclusive and Foldetta missing. Overall, the preponderance of evidence suggests the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.414856Structured0.649816Binding0.2830.8660.125-9.412Likely Pathogenic0.945Likely PathogenicAmbiguous0.305Likely Benign-3.44Deleterious0.997Probably Damaging0.996Probably Damaging2.66Benign0.02Affected0.10120.5560-1-25.326.08
c.2619C>A
S873R
2D
AIThe SynGAP1 missense variant S873R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the balance of evidence (five pathogenic vs. four benign predictions, with a pathogenic high‑accuracy tool) suggests the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as the variant has not yet been classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.414856Structured0.649816Binding0.2830.8660.125-5.856Likely Benign0.976Likely PathogenicLikely Pathogenic0.192Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging2.67Benign0.06Tolerated3.7750.09700.36670-1-3.769.11
c.2619C>G
S873R
2D
AIThe SynGAP1 missense variant S873R is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33443171‑C‑G). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic versus two benign votes), and Foldetta stability analysis is unavailable. Overall, the balance of evidence favors a pathogenic effect, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.414856Structured0.649816Binding0.2830.8660.125Uncertain 16-33443171-C-G16.20e-7-5.856Likely Benign0.976Likely PathogenicLikely Pathogenic0.192Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging2.67Benign0.06Tolerated3.7750.09700.36670-1-3.769.11
c.2623G>C
A875P
2D
AIThe SynGAP1 missense variant A875P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). In contrast, PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar all predict a pathogenic impact. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the overall assessment. Overall, the majority of evidence points to a benign effect for A875P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.632173Binding0.2730.8720.250-3.799Likely Benign0.237Likely BenignLikely Benign0.154Likely Benign-2.53Deleterious0.997Probably Damaging0.959Probably Damaging2.66Benign0.09Tolerated0.17500.56881-1-3.426.04
c.2626T>C
S876P
2D
AIThe SynGAP1 missense variant S876P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the consensus of the available predictions indicates that S876P is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.549308Disordered0.631130Binding0.2800.8720.250-5.002Likely Benign0.229Likely BenignLikely Benign0.171Likely Benign-2.04Neutral0.997Probably Damaging0.995Probably Damaging2.56Benign0.35Tolerated0.19790.69281-1-0.810.04
c.2683A>C
S895R
2D
AIThe SynGAP1 missense variant S895R is reported in ClinVar as not yet classified and is present in gnomAD (ID 6‑33443235‑A‑C). Consensus from multiple in silico predictors shows a split: benign calls come from REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic calls arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. When grouping by agreement, the benign group contains five tools, whereas the pathogenic group contains four. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts pathogenicity, whereas the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points toward a benign effect, and this conclusion does not conflict with the current ClinVar status, which remains unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.7506-33443235-A-C16.20e-7-4.746Likely Benign0.973Likely PathogenicLikely Pathogenic0.167Likely Benign-1.72Neutral0.997Probably Damaging0.995Probably Damaging2.64Benign0.10Tolerated4.3240.09490.4046-10-3.769.11
c.2684G>T
S895I
2D
AIThe SynGAP1 missense variant S895I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors a benign outcome; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for S895I, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750-6.315Likely Benign0.697Likely PathogenicLikely Benign0.144Likely Benign-2.34Neutral0.997Probably Damaging0.996Probably Damaging2.65Benign0.04Affected0.10100.6248-1-25.326.08
c.2685T>A
S895R
2D
AIThe SynGAP1 missense variant S895R is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign effect, and this is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750-4.746Likely Benign0.973Likely PathogenicLikely Pathogenic0.123Likely Benign-1.72Neutral0.997Probably Damaging0.995Probably Damaging2.64Benign0.10Tolerated4.3240.09490.4046-10-3.769.11
c.2685T>G
S895R
2D
AIThe SynGAP1 missense variant S895R is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign impact, and this is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750-4.746Likely Benign0.973Likely PathogenicLikely Pathogenic0.123Likely Benign-1.72Neutral0.997Probably Damaging0.995Probably Damaging2.64Benign0.10Tolerated4.3240.09490.4046-10-3.769.11
c.2687G>A
G896D
2D
AIThe SynGAP1 missense variant G896D is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and ESM1b, whereas polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. The high‑accuracy AlphaMissense‑Optimized score is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive, and Foldetta stability analysis is unavailable. Consequently, the evidence is evenly split between benign and pathogenic predictions, with no decisive support from the most reliable methods. The variant is therefore classified as of uncertain significance; it does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.675549Disordered0.412816Uncertain0.3140.9230.625-4.500Likely Benign0.905Likely PathogenicAmbiguous0.159Likely Benign-2.39Neutral0.997Probably Damaging0.934Probably Damaging2.44Pathogenic0.16Tolerated0.17070.18421-1-3.158.04
c.2687G>T
G896V
2D
AIThe SynGAP1 missense variant G896V is reported in gnomAD (6-33443239-G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign outcome. Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect for G896V, and this conclusion is not contradicted by any ClinVar classification (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.412816Uncertain0.3140.9230.6256-33443239-G-T16.20e-7-2.936Likely Benign0.285Likely BenignLikely Benign0.165Likely Benign-1.96Neutral0.997Probably Damaging0.912Probably Damaging2.46Pathogenic0.30Tolerated4.3240.12640.4026-3-14.642.08
c.2708G>A
G903D
2D
AIThe SynGAP1 missense variant G903D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of available predictions (five pathogenic vs. three benign) lean toward a pathogenic interpretation. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.680603Disordered0.549818Binding0.2910.9170.375-4.481Likely Benign0.849Likely PathogenicAmbiguous0.137Likely Benign-1.85Neutral0.997Probably Damaging0.939Probably Damaging2.33Pathogenic0.01Affected0.15350.13211-1-3.158.04
c.2708G>T
G903V
2D
AIThe SynGAP1 missense variant G903V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, while Foldetta results are unavailable. Overall, the balance of evidence (five benign predictions versus three pathogenic predictions, with no conflicting ClinVar annotation) indicates that the variant is most likely benign. This conclusion does not contradict any ClinVar status, as the variant is not currently catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.680603Disordered0.549818Binding0.2910.9170.375-4.750Likely Benign0.491AmbiguousLikely Benign0.168Likely Benign-1.93Neutral0.997Probably Damaging0.959Probably Damaging2.44Pathogenic0.95Tolerated0.12690.4266-1-34.642.08
c.2737A>G
T913A
2D
AIThe SynGAP1 missense variant T913A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus likewise indicates Likely Benign. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the collective predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.661982Disordered0.763517Binding0.3390.8990.375-2.386Likely Benign0.083Likely BenignLikely Benign0.098Likely Benign-1.41Neutral0.997Probably Damaging0.992Probably Damaging2.79Benign0.15Tolerated0.42400.4905102.5-30.03
c.2744G>T
G915V
2D
AIThe SynGAP1 missense variant G915V is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (6‑33443296‑G‑T). Functional prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also as benign; the Foldetta stability analysis is unavailable. Overall, the majority of predictions, including the most reliable tools, indicate a benign impact. This consensus does not contradict ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.657645Disordered0.808641Binding0.3020.8800.3756-33443296-G-T-4.586Likely Benign0.189Likely BenignLikely Benign0.149Likely Benign-2.52Deleterious0.997Probably Damaging0.918Probably Damaging2.68Benign0.01Affected3.7750.09270.4291-3-14.642.08
c.2779T>A
F927I
2D
AIThe SynGAP1 missense variant F927I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from multiple in silico tools indicates that F927I is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.529623Disordered0.985043Binding0.3240.8540.250-4.793Likely Benign0.997Likely PathogenicLikely Pathogenic0.370Likely Benign-4.50Deleterious0.997Probably Damaging0.994Probably Damaging1.34Pathogenic0.00Affected0.22550.1238101.7-34.02
c.2779T>G
F927V
2D
AIThe SynGAP1 missense variant F927V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus also indicates Likely Pathogenic. Foldetta results are unavailable and therefore not considered. Overall, the preponderance of evidence from multiple in silico predictors and high‑accuracy tools indicates that the variant is most likely pathogenic, with no ClinVar annotation to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.529623Disordered0.985043Binding0.3240.8540.250-4.919Likely Benign0.996Likely PathogenicLikely Pathogenic0.470Likely Benign-5.21Deleterious0.997Probably Damaging0.992Probably Damaging1.34Pathogenic0.00Affected0.22070.1206-1-11.4-48.04
c.2780T>A
F927Y
2D
AIThe SynGAP1 missense variant F927Y is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas tools that agree on a pathogenic effect include polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of available predictions (5 pathogenic vs. 3 benign) lean toward a pathogenic interpretation. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.529623Disordered0.985043Binding0.3240.8540.250-5.244Likely Benign0.954Likely PathogenicAmbiguous0.291Likely Benign-2.29Neutral0.997Probably Damaging0.987Probably Damaging1.40Pathogenic0.00Affected0.15510.151873-4.116.00
c.2794T>A
F932I
2D
AIThe SynGAP1 missense variant F932I is not reported in ClinVar and has no entries in gnomAD, indicating it is not catalogued in these databases. Functional prediction tools cluster into two groups: benign predictions come from REVEL and ESM1b, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves as Likely Pathogenic because three of the four constituent tools predict pathogenicity. High‑accuracy assessments further support this: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (majority vote) is also pathogenic; Foldetta results are unavailable. Consequently, the collective evidence points to a pathogenic effect for F932I. This conclusion is consistent with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.675549Disordered0.989197Binding0.2930.8580.500-4.963Likely Benign0.982Likely PathogenicLikely Pathogenic0.348Likely Benign-3.45Deleterious0.997Probably Damaging0.994Probably Damaging2.32Pathogenic0.01Affected0.22020.2914101.7-34.02
c.2794T>G
F932V
2D
AIThe SynGAP1 missense variant F932V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic outcome. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic status. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.675549Disordered0.989197Binding0.2930.8580.500-5.728Likely Benign0.976Likely PathogenicLikely Pathogenic0.392Likely Benign-3.68Deleterious0.997Probably Damaging0.992Probably Damaging2.32Pathogenic0.01Affected0.21370.3082-1-11.4-48.04
c.2795T>A
F932Y
2D
AIThe SynGAP1 missense variant F932Y is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster around a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign, while the majority of other predictors (polyPhen‑2 HumDiv and HumVar) suggest pathogenic. When predictions are grouped by agreement, the benign‑predicating tools outnumber the pathogenic ones, and the single uncertain call from AlphaMissense‑Default does not alter this balance. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as Likely Benign. Foldetta data are unavailable. Overall, the computational evidence overwhelmingly supports a benign classification, and this is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.989197Binding0.2930.8580.500-5.248Likely Benign0.540AmbiguousLikely Benign0.180Likely Benign1.58Neutral0.997Probably Damaging0.987Probably Damaging3.13Benign0.74Tolerated0.14730.200373-4.116.00
c.2797C>A
H933N
2D
AIThe SynGAP1 missense variant H933N is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 benign vs 2 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy predictions show AlphaMissense‑Optimized as benign, while SGM Consensus and Foldetta are unavailable. Overall, five tools predict pathogenicity versus four predicting benignity, suggesting the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as the variant has not yet been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.666105Disordered0.987531Binding0.3050.8620.625-4.333Likely Benign0.226Likely BenignLikely Benign0.261Likely Benign-3.65Deleterious0.997Probably Damaging0.992Probably Damaging2.39Pathogenic0.04Affected0.18970.343921-0.3-23.04
c.2797C>G
H933D
2D
AIThe SynGAP1 missense variant H933D is not reported in ClinVar and has no entries in gnomAD, indicating it is not catalogued in these databases. Functional prediction tools cluster into two groups: benign predictions come from REVEL and ESM1b, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves as Likely Pathogenic, matching the majority of individual scores. AlphaMissense‑Optimized returns an Uncertain result, and no Foldetta stability assessment is available. Overall, the preponderance of evidence points to a pathogenic effect for H933D. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with existing database annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.666105Disordered0.987531Binding0.3050.8620.625-2.888Likely Benign0.798Likely PathogenicAmbiguous0.320Likely Benign-4.70Deleterious0.997Probably Damaging0.994Probably Damaging2.40Pathogenic0.04Affected0.24810.27171-1-0.3-22.05
c.2797C>T
H933Y
2D
AIThe SynGAP1 H933Y variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic prediction. Foldetta results are unavailable. Overall, the majority of evidence (five pathogenic vs. three benign predictions) points to a pathogenic impact for H933Y. This conclusion does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.666105Disordered0.987531Binding0.3050.8620.625-3.952Likely Benign0.525AmbiguousLikely Benign0.314Likely Benign-3.49Deleterious0.997Probably Damaging0.992Probably Damaging2.36Pathogenic0.01Affected0.09680.4815021.926.03
c.2798A>G
H933R
2D
AIThe SynGAP1 missense variant H933R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and AlphaMissense‑Optimized, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Overall, the majority of tools (five pathogenic vs. four benign) predict a pathogenic impact. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.666105Disordered0.987531Binding0.3050.8620.625-4.410Likely Benign0.650Likely PathogenicLikely Benign0.393Likely Benign-3.84Deleterious0.997Probably Damaging0.994Probably Damaging2.43Pathogenic0.06Tolerated0.20740.292220-1.319.05
c.2813G>A
G938E
2D
AIThe SynGAP1 missense variant G938E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. The variant’s predicted benign status does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.905695Disordered0.949795Binding0.3180.8830.625-5.394Likely Benign0.577Likely PathogenicLikely Benign0.112Likely Benign-1.40Neutral0.997Probably Damaging0.979Probably Damaging2.75Benign0.28Tolerated0.13700.37200-2-3.172.06
c.2842G>T
G948C
2D
AIThe SynGAP1 missense variant G948C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. The high‑accuracy consensus (SGM‑Consensus) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, did not provide a result for this variant. Overall, the majority of evidence points to a benign impact. The predictions do not contradict ClinVar status, as no ClinVar assertion exists for this variant. Thus, based on the available computational predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.988505Disordered0.862121Binding0.3650.9190.750-10.254Likely Pathogenic0.102Likely BenignLikely Benign0.247Likely Benign-0.77Neutral0.997Probably Damaging0.840Possibly Damaging4.50Benign0.04Affected0.14220.4439-3-32.946.09
c.2845G>C
G949R
2D
AIThe SynGAP1 missense variant G949R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Consensus from standard in silico predictors shows a split: benign calls come from REVEL, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized, while pathogenic calls come from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; ESM1b is uncertain. High‑accuracy assessment further supports a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign outcome, and Foldetta data are unavailable. Overall, the preponderance of evidence indicates the variant is most likely benign, and this conclusion does not conflict with any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.988861Disordered0.874971Binding0.3650.9230.750-7.650In-Between0.301Likely BenignLikely Benign0.317Likely Benign-0.14Neutral0.997Probably Damaging0.934Probably Damaging2.21Pathogenic0.01Affected0.10950.4569-3-2-4.199.14
c.2942G>T
G981V
2D
AIThe SynGAP1 missense variant G981V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of evidence points to a benign impact for G981V, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.798249Disordered0.970320Binding0.2750.8970.625-3.873Likely Benign0.714Likely PathogenicLikely Benign0.156Likely Benign-2.10Neutral0.997Probably Damaging0.958Probably Damaging3.75Benign0.00Affected0.13220.3861-1-34.642.08
c.2945A>G
Y982C
2D
AIThe SynGAP1 missense variant Y982C is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33443497‑A‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.966717Binding0.2720.8950.625Conflicting 26-33443497-A-G21.24e-6-6.256Likely Benign0.746Likely PathogenicLikely Benign0.195Likely Benign-1.67Neutral0.997Probably Damaging0.923Probably Damaging3.87Benign0.00Affected4.3210.29880.23450-23.8-60.04
c.2947A>C
S983R
2D
AIThe SynGAP1 missense variant S983R is reported in ClinVar as “Not submitted” and is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus, SGM‑Consensus, is derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN and also indicates a likely pathogenic outcome. AlphaMissense‑Optimized independently predicts pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple in silico predictors points to a pathogenic effect for S983R, and this conclusion does not contradict any ClinVar annotation, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.707965Disordered0.960212Binding0.2770.8890.625-4.733Likely Benign0.992Likely PathogenicLikely Pathogenic0.156Likely Benign-2.66Deleterious0.997Probably Damaging0.995Probably Damaging2.03Pathogenic0.00Affected0.11630.37400-1-3.769.11
c.2948G>T
S983I
2D
AIThe SynGAP1 missense variant S983I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). In silico predictors that agree on a benign effect are REVEL and ESM1b, whereas the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (3 pathogenic vs. 1 benign) is likely pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence indicates that S983I is most likely pathogenic, and this conclusion is not contradicted by the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.707965Disordered0.960212Binding0.2770.8890.625-6.259Likely Benign0.968Likely PathogenicLikely Pathogenic0.190Likely Benign-2.67Deleterious0.997Probably Damaging0.996Probably Damaging2.02Pathogenic0.00Affected0.13800.4625-1-25.326.08
c.2949C>A
S983R
2D
AIThe SynGAP1 missense variant S983R is reported in ClinVar as “Not submitted” and is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (3 pathogenic vs. 1 benign) is likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that S983R is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently lacks a classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.707965Disordered0.960212Binding0.2770.8890.625-4.733Likely Benign0.992Likely PathogenicLikely Pathogenic0.190Likely Benign-2.66Deleterious0.997Probably Damaging0.995Probably Damaging2.03Pathogenic0.00Affected0.11630.37400-1-3.769.11
c.2949C>G
S983R
2D
AIThe SynGAP1 missense variant S983R is reported in ClinVar as “Not submitted” and is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (3 pathogenic vs. 1 benign) is likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that S983R is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently lacks a pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.707965Disordered0.960212Binding0.2770.8890.625-4.733Likely Benign0.992Likely PathogenicLikely Pathogenic0.190Likely Benign-2.66Deleterious0.997Probably Damaging0.995Probably Damaging2.03Pathogenic0.00Affected0.11630.37400-1-3.769.11
c.2953A>C
S985R
2D
AIThe SynGAP1 missense variant S985R has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Those that predict pathogenicity are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains benign; Foldetta, a protein‑folding stability method, has no available result for this variant. Consequently, the evidence is split evenly between benign and pathogenic predictions, with no contradiction to ClinVar status. The variant’s impact remains uncertain, and no definitive benign or pathogenic classification can be assigned based solely on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.720929Disordered0.941547Binding0.3020.8960.750-6.148Likely Benign0.991Likely PathogenicLikely Pathogenic0.174Likely Benign-2.40Neutral0.997Probably Damaging0.995Probably Damaging2.52Benign0.00Affected0.12130.39050-1-3.769.11
c.2954G>T
S985I
2D
AIThe SynGAP1 missense variant S985I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. ESM1b remains uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict (2 pathogenic vs. 1 benign). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence indicates that S985I is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.720929Disordered0.941547Binding0.3020.8960.750-7.858In-Between0.971Likely PathogenicLikely Pathogenic0.131Likely Benign-2.78Deleterious0.997Probably Damaging0.996Probably Damaging2.50Benign0.00Affected0.13670.5206-1-25.326.08
c.2955T>A
S985R
2D
AIThe SynGAP1 missense variant S985R has no ClinVar entry and is not reported in gnomAD. Consensus predictions from multiple in‑silico tools are split: benign calls come from REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) which reports a likely benign outcome. Pathogenic calls arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments are mixed: AlphaMissense‑Optimized predicts pathogenic, whereas the SGM‑Consensus (a majority‑vote aggregator) predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the predictions are evenly divided, leaving the variant’s clinical significance uncertain; it does not contradict any ClinVar status because none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.720929Disordered0.941547Binding0.3020.8960.750-6.148Likely Benign0.991Likely PathogenicLikely Pathogenic0.203Likely Benign-2.40Neutral0.997Probably Damaging0.995Probably Damaging2.52Benign0.00Affected0.12130.39050-1-3.769.11
c.2955T>G
S985R
2D
AISynGAP1 missense variant S985R has no ClinVar record and is not present in gnomAD. Computational predictions are mixed: benign calls come from REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Pathogenic calls come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy tools give a split result: AlphaMissense‑Optimized predicts pathogenic, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely benign; Foldetta data are unavailable. Consequently, the variant’s predicted impact is ambiguous, with an equal number of benign and pathogenic scores. No ClinVar evidence contradicts these predictions. Thus, the variant is best classified as of uncertain significance, with no clear bias toward benign or pathogenic status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.720929Disordered0.941547Binding0.3020.8960.750-6.148Likely Benign0.991Likely PathogenicLikely Pathogenic0.203Likely Benign-2.40Neutral0.997Probably Damaging0.995Probably Damaging2.52Benign0.00Affected0.12130.39050-1-3.769.11
c.2971G>T
G991W
2D
AIThe SynGAP1 missense variant G991W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the overall assessment. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.745909Disordered0.911393Binding0.2860.9200.750-6.281Likely Benign0.336Likely BenignLikely Benign0.124Likely Benign-2.32Neutral0.997Probably Damaging0.975Probably Damaging4.07Benign0.00Affected0.07450.3654-7-2-0.5129.16
c.3002T>A
L1001H
2D
AIThe SynGAP1 missense variant L1001H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.754692Disordered0.958507Binding0.2690.9020.375-3.119Likely Benign0.258Likely BenignLikely Benign0.109Likely Benign-1.02Neutral0.997Probably Damaging0.870Possibly Damaging2.64Benign0.00Affected0.11410.0958-2-3-7.023.98
c.3008G>A
S1003N
2D
AIThe SynGAP1 missense variant S1003N is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, more tools (five) predict pathogenicity than benign (three), and the high‑accuracy methods do not overturn this trend. Therefore, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because the variant has not been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.834292Disordered0.947349Binding0.2720.9010.625-5.175Likely Benign0.889Likely PathogenicAmbiguous0.122Likely Benign-1.37Neutral0.997Probably Damaging0.992Probably Damaging2.48Pathogenic0.00Affected0.17980.502911-2.727.03
c.3010C>A
H1004N
2D
AIThe SynGAP1 missense variant H1004N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. There is no ClinVar entry to contradict this assessment, so the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.808535Disordered0.943707Binding0.2710.9010.750-4.265Likely Benign0.601Likely PathogenicLikely Benign0.072Likely Benign-1.18Neutral0.997Probably Damaging0.992Probably Damaging2.88Benign0.35Tolerated0.20560.358021-0.3-23.04
c.3010C>G
H1004D
2D
AIThe SynGAP1 missense variant H1004D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for H1004D. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.808535Disordered0.943707Binding0.2710.9010.750-5.275Likely Benign0.913Likely PathogenicAmbiguous0.148Likely Benign-2.16Neutral0.997Probably Damaging0.994Probably Damaging2.78Benign0.29Tolerated0.26950.25301-1-0.3-22.05
c.3010C>T
H1004Y
2D
AIThe SynGAP1 missense variant H1004Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.808535Disordered0.943707Binding0.2710.9010.750-5.196Likely Benign0.676Likely PathogenicLikely Benign0.131Likely Benign-1.67Neutral0.997Probably Damaging0.992Probably Damaging2.72Benign0.49Tolerated0.11750.5143021.926.03
c.3011A>G
H1004R
2D
AIThe SynGAP1 missense variant H1004R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and no Foldetta stability data is available. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.808535Disordered0.943707Binding0.2710.9010.750-3.316Likely Benign0.813Likely PathogenicAmbiguous0.198Likely Benign-1.88Neutral0.997Probably Damaging0.994Probably Damaging2.77Benign0.50Tolerated0.20970.313220-1.319.05
c.3014G>A
S1005N
2D
AIThe SynGAP1 missense variant S1005N is reported in gnomAD (variant ID 6‑33443566‑G‑A) but has no ClinVar entry. Prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, and FATHMM, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the majority of evidence, including the consensus score, points to a benign effect. This conclusion does not contradict ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.812494Disordered0.936602Binding0.2610.8970.7506-33443566-G-A16.20e-7-6.577Likely Benign0.890Likely PathogenicAmbiguous0.110Likely Benign-1.50Neutral0.997Probably Damaging0.992Probably Damaging2.65Benign0.00Affected3.7750.15200.376111-2.727.03
c.3020G>A
S1007N
2D
AIThe SynGAP1 missense variant S1007N is listed in ClinVar (ID 2759915.0) as Benign and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Overall, the majority of high‑accuracy predictors (including the SGM‑Consensus) indicate a benign impact, and the single uncertain AlphaMissense‑Optimized result does not overturn this consensus. Therefore, the variant is most likely benign, and this conclusion is consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.671169Disordered0.925648Binding0.2950.8990.750Benign 1-5.113Likely Benign0.803Likely PathogenicAmbiguous0.075Likely Benign-1.54Neutral0.997Probably Damaging0.992Probably Damaging2.65Benign0.01Affected3.7750.17430.434211-2.727.03
c.3024T>A
D1008E
2D
AIThe SynGAP1 D1008E missense variant is catalogued in gnomAD (6‑33443576‑T‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). In contrast, polyPhen‑2 HumDiv and HumVar both predict a pathogenic outcome. AlphaMissense‑Default remains uncertain, providing no definitive signal. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, and the SGM‑Consensus also reports it as likely benign. No Foldetta stability analysis is available, so it does not influence the overall assessment. Based on the preponderance of evidence from both general and high‑accuracy predictors, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.694846Disordered0.919416Binding0.2800.8990.6256-33443576-T-A16.20e-7-2.809Likely Benign0.428AmbiguousLikely Benign0.151Likely Benign-0.53Neutral0.997Probably Damaging0.994Probably Damaging2.93Benign1.00Tolerated3.7750.23150.6303230.014.03
c.3024T>G
D1008E
2D
AIThe SynGAP1 missense variant D1008E is listed in gnomAD (ID 6‑33443576‑T‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar. AlphaMissense‑Default is uncertain, and Foldetta results are unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta provides no data. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the absence of a ClinVar pathogenic classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.694846Disordered0.919416Binding0.2800.8990.6256-33443576-T-G-2.809Likely Benign0.428AmbiguousLikely Benign0.151Likely Benign-0.53Neutral0.997Probably Damaging0.994Probably Damaging2.93Benign1.00Tolerated3.7750.23150.6303230.014.03
c.3040G>T
G1014C
2D
AIThe SynGAP1 G1014C missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. ESM1b is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.771762Disordered0.914808Binding0.2930.8350.625-7.424In-Between0.151Likely BenignLikely Benign0.089Likely Benign-2.49Neutral0.997Probably Damaging0.889Possibly Damaging2.68Benign0.06Tolerated0.14010.4126-3-32.946.09
c.3067T>C
S1023P
2D
AIThe SynGAP1 missense variant S1023P is reported in gnomAD (ID 6‑33443619‑T‑C) but has no ClinVar entry (ClinVar status: not reported). Functional prediction tools are split: benign calls come from REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized, while pathogenic calls come from polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign, two pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, SGM Consensus remains inconclusive, and Foldetta (combining FoldX‑MD and Rosetta) has no available result. Overall, the majority of standard predictors lean toward pathogenicity, whereas the few high‑accuracy tools do not support a pathogenic verdict. Thus, the variant is most likely pathogenic based on the aggregate predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.831250Disordered0.990262Binding0.3220.7500.5006-33443619-T-C21.24e-6-5.634Likely Benign0.679Likely PathogenicLikely Benign0.146Likely Benign-2.11Neutral0.997Probably Damaging0.995Probably Damaging2.43Pathogenic0.02Affected3.7750.18180.4616-11-0.810.04
c.3071T>G
L1024R
2D
AIThe SynGAP1 missense variant L1024R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of available predictions (5 pathogenic vs. 3 benign) lean toward a pathogenic interpretation. This assessment does not contradict ClinVar status, as the variant is not yet catalogued there. Thus, based on current computational evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.862302Disordered0.992699Binding0.3270.7530.500-3.434Likely Benign0.841Likely PathogenicAmbiguous0.148Likely Benign-2.41Neutral0.997Probably Damaging0.962Probably Damaging2.40Pathogenic0.02Affected0.13350.1557-3-2-8.343.03
c.3104C>A
P1035H
2D
AIThe SynGAP1 missense variant P1035H is not reported in ClinVar and has no entries in gnomAD. Consensus predictions from multiple in‑silico tools are mixed: benign calls come from SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls are made by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign effect, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates a likely benign outcome. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.945666Disordered0.989572Binding0.3000.7560.625-5.333Likely Benign0.608Likely PathogenicLikely Benign0.058Likely Benign-0.76Neutral0.997Probably Damaging0.889Possibly Damaging2.68Benign0.15Tolerated0.18930.56690-2-1.640.02
c.3154G>T
G1052W
2D
AIThe SynGAP1 missense variant G1052W is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.984420Disordered0.892068Binding0.3670.9380.875-11.322Likely Pathogenic0.309Likely BenignLikely Benign0.457Likely Benign-0.90Neutral0.997Probably Damaging0.946Probably Damaging3.90Benign0.02Affected0.08720.4046-7-2-0.5129.16
c.3163G>T
G1055W
2D
AIThe SynGAP1 missense variant G1055W is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.982235Disordered0.872113Binding0.3790.9350.875-11.436Likely Pathogenic0.317Likely BenignLikely Benign0.367Likely Benign-0.77Neutral0.997Probably Damaging0.946Probably Damaging3.28Benign0.01Affected0.08990.4246-7-2-0.5129.16
c.3211G>T
G1071C
2D
AIThe SynGAP1 missense variant G1071C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also as likely benign; the Foldetta stability analysis is unavailable. Overall, the majority of evidence—including the consensus and high‑accuracy predictions—supports a benign classification, and this is consistent with the lack of ClinVar annotation. Thus, the variant is most likely benign, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.919029Disordered0.983740Binding0.3130.9050.875-5.364Likely Benign0.305Likely BenignLikely Benign0.182Likely Benign-2.16Neutral0.997Probably Damaging0.889Possibly Damaging4.01Benign0.00Affected0.13230.4227-3-32.946.09
c.3214A>G
K1072E
2D
AIThe SynGAP1 missense variant K1072E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions are returned by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments indicate that AlphaMissense‑Optimized classifies the variant as pathogenic, whereas the SGM‑Consensus (derived from the same set of predictors) labels it as likely benign. No Foldetta stability analysis is available for this residue. Overall, the majority of tools lean toward a benign effect, but the presence of pathogenic calls from several high‑confidence predictors suggests uncertainty. The variant is most likely benign based on the preponderance of evidence, and this conclusion does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.984675Binding0.3070.9070.750-3.889Likely Benign0.961Likely PathogenicLikely Pathogenic0.105Likely Benign-0.90Neutral0.997Probably Damaging0.989Probably Damaging3.96Benign0.08Tolerated0.36360.1874010.40.94
c.3215A>G
K1072R
2D
AIThe SynGAP1 missense variant K1072R is reported in gnomAD (ID 6‑33443767‑A‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 (HumDiv and HumVar) predict it to be pathogenic. When predictions are grouped by consensus, the benign group contains seven tools, whereas the pathogenic group contains two. High‑accuracy assessments reinforce the benign view: AlphaMissense‑Optimized reports a benign outcome, and the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign effect. No Foldetta stability data are available, so folding‑stability evidence is unavailable. Overall, the majority of evidence points to a benign impact, and this is not in conflict with ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.984675Binding0.3070.9070.7506-33443767-A-G16.23e-7-2.458Likely Benign0.100Likely BenignLikely Benign0.116Likely Benign-0.15Neutral0.997Probably Damaging0.989Probably Damaging4.16Benign0.88Tolerated3.7750.46550.206123-0.628.01
c.3218C>G
S1073C
2D
AISynGAP1 missense variant S1073C is recorded in gnomAD (ID 6‑33443770‑C‑G) but has no ClinVar submission. Functional prediction tools show mixed results: benign calls come from REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls are made by polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The AlphaMissense‑Default score is uncertain. A consensus from the SGM framework (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because the votes are split. High‑accuracy methods give a benign prediction from AlphaMissense‑Optimized; the SGM Consensus remains ambiguous, and Foldetta stability analysis is unavailable. Consequently, the evidence does not strongly favor either outcome. The variant is most likely of uncertain significance, with no contradiction to ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.916840Disordered0.985818Binding0.3130.9050.7506-33443770-C-G16.23e-7-8.862Likely Pathogenic0.461AmbiguousLikely Benign0.137Likely Benign-1.52Neutral0.997Probably Damaging0.840Possibly Damaging3.81Benign0.00Affected3.7750.13430.6088-103.316.06
c.3247A>G
K1083E
2D
AIThe SynGAP1 missense variant K1083E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is not available for this variant. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.837511Disordered0.978906Binding0.3020.8931.000-3.538Likely Benign0.864Likely PathogenicAmbiguous0.133Likely Benign-0.78Neutral0.997Probably Damaging0.989Probably Damaging4.09Benign0.27Tolerated0.41350.1717010.40.94
c.3248A>G
K1083R
2D
AIThe SynGAP1 missense variant K1083R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. The variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.837511Disordered0.978906Binding0.3020.8931.000-2.212Likely Benign0.132Likely BenignLikely Benign0.119Likely Benign-0.53Neutral0.997Probably Damaging0.989Probably Damaging4.06Benign0.84Tolerated0.50530.1903Weaken32-0.628.01
c.3251C>A
P1084H
2D
AIThe SynGAP1 missense variant P1084H is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33443803‑C‑A). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which reports “Likely Benign”). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this is consistent with the ClinVar designation of uncertainty rather than a definitive pathogenic claim. Thus, the variant is most likely benign, and its prediction profile does not contradict the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.842060Disordered0.979020Binding0.3480.8891.000Uncertain 16-33443803-C-A16.31e-7-4.125Likely Benign0.323Likely BenignLikely Benign0.134Likely Benign-3.16Deleterious0.997Probably Damaging0.840Possibly Damaging3.96Benign0.00Affected3.7750.17510.5523-20-1.640.02
c.3253C>G
R1085G
2D
AIThe SynGAP1 missense variant R1085G is reported in gnomAD (ID 6‑33443805‑C‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from REVEL, ESM1b, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. A high‑accuracy consensus (SGM) that aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN yields a 2‑to‑2 split, leaving the consensus inconclusive. No Foldetta stability assessment is available. Overall, the majority of evidence (five pathogenic versus three benign) points to a pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.852992Disordered0.978838Binding0.2700.8881.0006-33443805-C-G-4.225Likely Benign0.846Likely PathogenicAmbiguous0.179Likely Benign-2.79Deleterious0.997Probably Damaging0.993Probably Damaging2.72Benign0.01Affected3.7750.33100.3693-2-34.1-99.14
c.3254G>T
R1085L
2D
AIThe SynGAP1 missense variant R1085L is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for R1085L, and this conclusion does not contradict the ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.852992Disordered0.978838Binding0.2700.8881.000-3.674Likely Benign0.734Likely PathogenicLikely Benign0.243Likely Benign-2.38Neutral0.997Probably Damaging0.993Probably Damaging2.72Benign0.01Affected0.19090.4568-3-28.3-43.03
c.3260C>G
S1087C
2D
AIThe SynGAP1 missense variant S1087C is catalogued in gnomAD (ID 6‑33443812‑C‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact, while ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also as likely benign; the Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.912647Disordered0.974805Binding0.3570.8911.0006-33443812-C-G16.34e-7-7.369In-Between0.194Likely BenignLikely Benign0.083Likely Benign-2.22Neutral0.997Probably Damaging0.840Possibly Damaging2.55Benign0.05Affected3.7750.09790.6118-103.316.06
c.3263G>T
S1088I
2D
AIThe SynGAP1 missense variant S1088I is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33443815‑G‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. AlphaMissense‑Optimized is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Based on the balance of evidence, the variant is most likely benign; this assessment does not contradict ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.910643Disordered0.975261Binding0.3360.8891.0006-33443815-G-T-4.893Likely Benign0.891Likely PathogenicAmbiguous0.288Likely Benign-2.05Neutral0.997Probably Damaging0.995Probably Damaging2.62Benign0.01Affected3.7750.13220.5712-2-15.326.08
c.3268A>G
N1090D
2D
AIThe SynGAP1 missense variant N1090D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely benign, and no Foldetta stability data is available. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.896620Disordered0.979886Binding0.3410.8871.000-3.354Likely Benign0.827Likely PathogenicAmbiguous0.066Likely Benign-1.39Neutral0.997Probably Damaging0.989Probably Damaging2.70Benign0.47Tolerated0.19940.4375210.00.98
c.3269A>C
N1090T
2D
AIThe SynGAP1 missense variant N1090T is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools cluster around a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign, while the majority of high‑accuracy predictors (AlphaMissense‑Optimized and the SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also support a benign classification. In contrast, polyPhen‑2 (both HumDiv and HumVar tracks) predict a pathogenic impact, but these are the only tools in disagreement. The AlphaMissense‑Default score is uncertain, and no Foldetta stability assessment is available. Overall, the preponderance of evidence points to a benign effect for the variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.896620Disordered0.979886Binding0.3410.8871.000-3.478Likely Benign0.542AmbiguousLikely Benign0.129Likely Benign-0.78Neutral0.997Probably Damaging0.989Probably Damaging2.77Benign0.58Tolerated0.14510.7930002.8-13.00
c.3269A>G
N1090S
2D
AIThe SynGAP1 missense variant N1090S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.896620Disordered0.979886Binding0.3410.8871.000-2.451Likely Benign0.228Likely BenignLikely Benign0.135Likely Benign-0.49Neutral0.997Probably Damaging0.983Probably Damaging2.97Benign0.38Tolerated0.39800.7620112.7-27.03
c.3270T>A
N1090K
2D
AIThe SynGAP1 missense variant N1090K is reported in ClinVar as “None” and is present in gnomAD (ID 6‑33443822‑T‑A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains likely benign; a Foldetta stability analysis is unavailable. Overall, the majority of predictions (six benign vs. four pathogenic) and the consensus result lean toward a benign interpretation. This conclusion does not contradict ClinVar, which currently has no pathogenic classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.896620Disordered0.979886Binding0.3410.8871.0006-33443822-T-A21.28e-6-3.423Likely Benign0.963Likely PathogenicLikely Pathogenic0.053Likely Benign-1.52Neutral0.997Probably Damaging0.992Probably Damaging2.73Benign0.18Tolerated3.7750.21470.612101-0.414.07
c.3270T>G
N1090K
2D
AIThe SynGAP1 missense variant N1090K has no ClinVar entry and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains Likely Benign; Foldetta results are unavailable. The overall balance of evidence leans toward a benign interpretation, and this is consistent with the lack of a ClinVar classification. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.896620Disordered0.979886Binding0.3410.8871.000-3.423Likely Benign0.963Likely PathogenicLikely Pathogenic0.053Likely Benign-1.52Neutral0.997Probably Damaging0.992Probably Damaging2.73Benign0.18Tolerated3.7750.21470.612101-0.414.07
c.3272T>A
L1091Q
2D
AIThe SynGAP1 missense variant L1091Q is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments are less definitive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs 2 benign), and Foldetta results are unavailable. Overall, the majority of available predictions (five pathogenic vs three benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because the variant has not yet been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.924947Disordered0.984454Binding0.3760.8891.000-4.381Likely Benign0.854Likely PathogenicAmbiguous0.155Likely Benign-1.32Neutral0.997Probably Damaging0.939Probably Damaging2.47Pathogenic0.02Affected0.11920.1514-2-2-7.314.97
c.3272T>C
L1091P
2D
AIThe SynGAP1 missense variant L1091P is listed in gnomAD (ID 6‑33443824‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, and ESM1b, while pathogenic predictions are reported by polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized returns an uncertain result, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, leaving it inconclusive. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of tools (five pathogenic vs three benign) predict a deleterious effect, and the high‑accuracy AlphaMissense‑Optimized score is uncertain. Consequently, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status, as none is reported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.924947Disordered0.984454Binding0.3760.8891.0006-33443824-T-C-4.139Likely Benign0.871Likely PathogenicAmbiguous0.180Likely Benign-1.25Neutral0.997Probably Damaging0.939Probably Damaging2.45Pathogenic0.04Affected3.7750.31990.1918-3-3-5.4-16.04
c.3272T>G
L1091R
2D
AIThe SynGAP1 missense variant L1091R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of consensus tools (five pathogenic vs. three benign) suggest a pathogenic impact. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.924947Disordered0.984454Binding0.3760.8891.000-3.662Likely Benign0.896Likely PathogenicAmbiguous0.191Likely Benign-1.51Neutral0.997Probably Damaging0.939Probably Damaging2.47Pathogenic0.02Affected0.12740.1357-3-2-8.343.03
c.3281C>G
S1094C
2D
AIThe SynGAP1 missense variant S1094C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Two tools—AlphaMissense‑Default and ESM1b—return uncertain results. High‑accuracy assessments are limited: AlphaMissense‑Optimized indicates a benign effect; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields no clear consensus and is treated as unavailable; Foldetta data are not provided, so its stability prediction is also unavailable. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.938133Disordered0.981352Binding0.3580.8771.000-7.143In-Between0.425AmbiguousLikely Benign0.131Likely Benign-1.81Neutral0.997Probably Damaging0.946Probably Damaging2.45Pathogenic0.05Affected0.14030.63090-13.316.06
c.3296A>G
Y1099C
2D
AIThe SynGAP1 missense variant Y1099C is reported in gnomAD (variant ID 6‑33443848‑A‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict pathogenicity. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.885302Disordered0.974267Binding0.4000.8621.0006-33443848-A-G31.95e-6-5.670Likely Benign0.109Likely BenignLikely Benign0.122Likely Benign-1.13Neutral0.997Probably Damaging0.840Possibly Damaging2.73Benign0.14Tolerated3.7750.30080.2382-203.8-60.04
c.3352A>T
S1118C
2D
AIThe SynGAP1 missense variant S1118C is listed in gnomAD (ID 6‑33443904‑A‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT, while ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.876521Disordered0.828802Binding0.3100.9190.7506-33443904-A-T-7.402In-Between0.096Likely BenignLikely Benign0.311Likely Benign-1.05Neutral0.997Probably Damaging0.889Possibly Damaging5.15Benign0.01Affected4.3220.16480.5695-103.316.06
c.3355G>T
G1119W
2D
AIThe SynGAP1 missense variant G1119W is reported in gnomAD (ID 6‑33443907‑G‑T) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign (three benign votes versus one pathogenic). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. Foldetta results are unavailable. Overall, the majority of computational evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.827927Disordered0.818538Binding0.3390.9280.8756-33443907-G-T-10.904Likely Pathogenic0.336Likely BenignLikely Benign0.386Likely Benign-1.19Neutral0.997Probably Damaging0.949Probably Damaging3.90Benign0.02Affected4.3220.09480.4059-2-7-0.5129.16
c.3412T>C
S1138P
2D
AIThe SynGAP1 missense variant S1138P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.891961Disordered0.738250Binding0.3460.8691.000-5.023Likely Benign0.187Likely BenignLikely Benign0.456Likely Benign-1.21Neutral0.997Probably Damaging0.995Probably Damaging5.41Benign0.10Tolerated0.22970.58561-1-0.810.04
c.3413C>A
S1138Y
2D
AIThe SynGAP1 missense variant S1138Y is listed in ClinVar with an “Uncertain” significance and is present in gnomAD (ID 6‑33444448‑C‑A). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. High‑accuracy predictions from AlphaMissense‑Optimized and the SGM Consensus both indicate a benign outcome, while Foldetta data are missing. Overall, the balance of evidence—especially from the high‑accuracy tools—suggests that the variant is most likely benign. This benign prediction does not contradict the ClinVar status, which remains uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.891961Disordered0.738250Binding0.3460.8691.000Uncertain 16-33444448-C-A31.86e-6-6.610Likely Benign0.449AmbiguousLikely Benign0.391Likely Benign-2.51Deleterious0.997Probably Damaging0.996Probably Damaging5.41Benign0.05Affected4.3240.10340.5449-2-3-0.576.10
c.3413C>T
S1138F
2D
AIThe SynGAP1 missense variant S1138F is not reported in ClinVar and is present in gnomAD (ID 6‑33444448‑C‑T). Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. The high‑accuracy AlphaMissense‑Optimized score is benign. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (benign), FATHMM (benign), and PROVEAN (pathogenic), resolves to benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of available predictions indicates a benign effect. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.891961Disordered0.738250Binding0.3460.8691.0006-33444448-C-T16.20e-7-6.298Likely Benign0.379AmbiguousLikely Benign0.407Likely Benign-2.88Deleterious0.997Probably Damaging0.996Probably Damaging5.42Benign0.03Affected4.3240.09910.5623-2-33.660.10
c.3433A>G
N1145D
2D
AIThe SynGAP1 missense variant N1145D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational evidence points to a benign effect, and this conclusion does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.722723Binding0.2840.8501.000-3.053Likely Benign0.682Likely PathogenicLikely Benign0.332Likely Benign-2.04Neutral0.997Probably Damaging0.992Probably Damaging5.57Benign0.08Tolerated0.20820.3956210.00.98
c.3434A>C
N1145T
2D
AIThe SynGAP1 missense variant N1145T is reported in gnomAD (ID 6‑33444469‑A‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. In contrast, polyPhen‑2 (HumDiv and HumVar) predict the variant to be pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta’s protein‑folding stability analysis is unavailable. Overall, the preponderance of evidence points to a benign impact for N1145T, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.722723Binding0.2840.8501.0006-33444469-A-C16.20e-7-1.915Likely Benign0.217Likely BenignLikely Benign0.403Likely Benign-2.17Neutral0.997Probably Damaging0.992Probably Damaging5.45Benign0.07Tolerated4.3240.14180.7209002.8-13.00
c.3434A>G
N1145S
2D
AIThe SynGAP1 missense variant N1145S is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33444469‑A‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). In contrast, PolyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.722723Binding0.2840.8501.000Uncertain 16-33444469-A-G21.24e-6-0.989Likely Benign0.126Likely BenignLikely Benign0.308Likely Benign-1.15Neutral0.997Probably Damaging0.989Probably Damaging5.55Benign0.89Tolerated4.3240.40780.6708112.7-27.03
c.3435C>A
N1145K
2D
AIThe SynGAP1 missense variant N1145K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.722723Binding0.2840.8501.000-2.545Likely Benign0.814Likely PathogenicAmbiguous0.440Likely Benign-2.40Neutral0.997Probably Damaging0.995Probably Damaging5.50Benign0.03Affected0.19590.601810-0.414.07
c.3435C>G
N1145K
2D
AIThe SynGAP1 missense variant N1145K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), which collectively suggest a likely benign impact. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized result is uncertain, and Foldetta stability analysis is unavailable. Overall, the balance of evidence leans toward a benign interpretation, with no conflict with ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.922952Disordered0.722723Binding0.2840.8501.000-2.545Likely Benign0.814Likely PathogenicAmbiguous0.440Likely Benign-2.40Neutral0.997Probably Damaging0.995Probably Damaging5.50Benign0.03Affected0.19590.601810-0.414.07
c.3454G>A
E1152K
2D
AIThe SynGAP1 missense variant E1152K is reported in gnomAD (ID 6‑33444489‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL and ESM1b, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a deleterious effect, and the SGM‑Consensus confirms a likely pathogenic outcome. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the collective evidence points to a pathogenic effect, and this conclusion is not contradicted by ClinVar, which contains no classification for E1152K.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.741537Disordered0.811118Binding0.3950.8460.5006-33444489-G-A16.20e-7-3.612Likely Benign0.966Likely PathogenicLikely Pathogenic0.300Likely Benign-2.64Deleterious0.997Probably Damaging0.992Probably Damaging2.38Pathogenic0.02Affected3.7750.29420.639710-0.4-0.94
c.3454G>C
E1152Q
2D
AIThe SynGAP1 missense variant E1152Q is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of available predictions (five pathogenic vs. three benign) lean toward a pathogenic interpretation. This conclusion is not contradicted by ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.741537Disordered0.811118Binding0.3950.8460.500-2.798Likely Benign0.830Likely PathogenicAmbiguous0.291Likely Benign-1.98Neutral0.997Probably Damaging0.995Probably Damaging2.37Pathogenic0.03Affected0.17470.6395220.0-0.98
c.3455A>C
E1152A
2D
AIThe SynGAP1 missense variant E1152A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Overall, the balance of evidence points to a pathogenic effect for E1152A. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.741537Disordered0.811118Binding0.3950.8460.500-2.482Likely Benign0.927Likely PathogenicAmbiguous0.349Likely Benign-3.82Deleterious0.997Probably Damaging0.992Probably Damaging2.37Pathogenic0.02Affected0.44340.65570-15.3-58.04
c.3457C>G
R1153G
2D
AIThe SynGAP1 missense variant R1153G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the majority of computational evidence indicates that R1153G is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.762850Disordered0.820118Binding0.3610.8480.625-3.010Likely Benign0.990Likely PathogenicLikely Pathogenic0.309Likely Benign-5.05Deleterious0.997Probably Damaging0.995Probably Damaging1.48Pathogenic0.00Affected0.34080.3475-3-24.1-99.14
c.3458G>T
R1153L
2D
AIThe SynGAP1 missense variant R1153L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL and ESM1b, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. When predictions are grouped by consensus, the majority of algorithms (seven of nine) favor a deleterious effect, while only two suggest a benign outcome. High‑accuracy assessments further support a damaging interpretation: AlphaMissense‑Optimized predicts pathogenicity, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels the variant as Likely Pathogenic. Foldetta results are not available. Overall, the evidence points to a pathogenic impact for R1153L, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.762850Disordered0.820118Binding0.3610.8480.625-3.595Likely Benign0.985Likely PathogenicLikely Pathogenic0.470Likely Benign-5.05Deleterious0.997Probably Damaging0.995Probably Damaging1.48Pathogenic0.00Affected0.19130.4400-3-28.3-43.03
c.3460A>T
T1154S
2D
AIThe SynGAP1 missense variant T1154S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also reports it as likely pathogenic. Foldetta results are unavailable. Overall, the consensus of the available predictions indicates that T1154S is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.685117Disordered0.838654Binding0.3820.8510.625-3.253Likely Benign0.992Likely PathogenicLikely Pathogenic0.192Likely Benign-2.92Deleterious0.997Probably Damaging0.989Probably Damaging1.78Pathogenic0.00Affected0.28170.320611-0.1-14.03
c.3464T>G
V1155G
2D
AIThe SynGAP1 missense variant V1155G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give mixed results: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (benign), FATHMM (benign), and PROVEAN (benign), reports a benign outcome; Foldetta’s stability assessment is unavailable. Overall, the majority of conventional tools lean toward pathogenicity, whereas the high‑accuracy consensus leans benign, leaving the functional impact uncertain. The variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.750527Disordered0.855718Binding0.3350.8570.500-3.018Likely Benign0.987Likely PathogenicLikely Pathogenic0.209Likely Benign-1.91Neutral0.997Probably Damaging0.999Probably Damaging2.59Benign0.05Affected0.22110.2374-1-3-4.6-42.08
c.3466G>A
A1156T
2D
AIThe SynGAP1 missense variant A1156T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from multiple in silico tools points to a pathogenic effect for A1156T, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.720929Disordered0.871395Binding0.2940.8610.500-3.732Likely Benign0.988Likely PathogenicLikely Pathogenic0.285Likely Benign-2.99Deleterious0.997Probably Damaging0.996Probably Damaging1.63Pathogenic0.00Affected0.13660.744210-2.530.03
c.3466G>T
A1156S
2D
AIThe SynGAP1 missense variant A1156S is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33444501‑G‑T). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of available predictions (five pathogenic vs. three benign) lean toward pathogenicity. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.720929Disordered0.871395Binding0.2940.8610.5006-33444501-G-T16.20e-7-2.052Likely Benign0.798Likely PathogenicAmbiguous0.197Likely Benign-2.23Neutral0.997Probably Damaging0.994Probably Damaging1.65Pathogenic0.00Affected3.7750.25940.615411-2.616.00
c.3467C>G
A1156G
2D
AIThe SynGAP1 missense variant A1156G is not reported in ClinVar and has no allele in gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the change as pathogenic, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also reports a likely pathogenic outcome. Foldetta results are unavailable for this variant. Overall, the consensus of the available predictions indicates that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.720929Disordered0.871395Binding0.2940.8610.500-3.728Likely Benign0.964Likely PathogenicLikely Pathogenic0.230Likely Benign-3.02Deleterious0.997Probably Damaging0.994Probably Damaging1.62Pathogenic0.00Affected0.22140.446110-2.2-14.03
c.3467C>T
A1156V
2D
AIThe SynGAP1 missense variant A1156V has no ClinVar entry and is not reported in gnomAD. Prediction tools that indicate a benign effect are REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labeling it “Likely Pathogenic”; Foldetta results are unavailable. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.720929Disordered0.871395Binding0.2940.8610.500-5.087Likely Benign0.994Likely PathogenicLikely Pathogenic0.270Likely Benign-2.99Deleterious0.997Probably Damaging0.994Probably Damaging1.62Pathogenic0.00Affected0.10620.6202002.428.05
c.3469T>G
W1157G
2D
AIThe SynGAP1 missense variant W1157G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate pathogenicity. Only ESM1b predicts a benign outcome, representing the sole disagreement. High‑accuracy assessments further support a harmful impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus labels it as Likely Pathogenic. No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the consensus of the majority of tools and the high‑accuracy predictions point to a pathogenic effect, and this conclusion is consistent with the absence of ClinVar annotation, so there is no contradiction with ClinVar status. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.694846Disordered0.877471Binding0.3640.8610.375-2.328Likely Benign0.999Likely PathogenicLikely Pathogenic0.558Likely Pathogenic-9.50Deleterious0.997Probably Damaging0.995Probably Damaging1.06Pathogenic0.00Affected0.46310.2065-7-20.5-129.16
c.3470G>T
W1157L
2D
AIThe SynGAP1 missense variant W1157L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—classify the change as pathogenic or likely pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic. Foldetta results are not available. Overall, the majority of evidence points to a pathogenic impact for W1157L, and this conclusion is consistent with the absence of a ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.694846Disordered0.877471Binding0.3640.8610.375-1.336Likely Benign0.995Likely PathogenicLikely Pathogenic0.306Likely Benign-9.46Deleterious0.997Probably Damaging0.995Probably Damaging1.08Pathogenic0.00Affected0.24000.2719-2-24.7-73.05
c.3473T>G
V1158G
2D
AIThe SynGAP1 missense variant V1158G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect are REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic outcome. High‑accuracy assessments reinforce this pattern: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that V1158G is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.599170Disordered0.877504Binding0.3690.8470.250-3.058Likely Benign0.986Likely PathogenicLikely Pathogenic0.433Likely Benign-4.62Deleterious0.997Probably Damaging0.999Probably Damaging2.30Pathogenic0.00Affected0.18700.3289-1-3-4.6-42.08
c.3475T>C
S1159P
2D
AIThe SynGAP1 missense variant S1159P is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus score, which is derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (majority vote) is benign. No Foldetta stability prediction is available for this residue. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.626927Disordered0.867068Binding0.3430.8460.375-3.656Likely Benign0.997Likely PathogenicLikely Pathogenic0.188Likely Benign-2.06Neutral0.997Probably Damaging0.995Probably Damaging2.64Benign0.14Tolerated0.18070.51111-1-0.810.04
c.3476C>A
S1159Y
2D
AIThe SynGAP1 missense variant S1159Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome; Foldetta results are unavailable. Overall, the majority of evidence (six benign predictions versus five pathogenic, plus a benign consensus) points to a likely benign impact for S1159Y. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.626927Disordered0.867068Binding0.3430.8460.375-5.665Likely Benign0.957Likely PathogenicLikely Pathogenic0.195Likely Benign-1.57Neutral0.997Probably Damaging0.996Probably Damaging2.65Benign0.07Tolerated0.05670.4923-3-2-0.576.10
c.3476C>T
S1159F
2D
AIThe SynGAP1 missense variant S1159F is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) remains benign; Foldetta stability analysis is unavailable. Overall, the balance of evidence leans toward a benign interpretation, and this conclusion does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.626927Disordered0.867068Binding0.3430.8460.375-5.627Likely Benign0.976Likely PathogenicLikely Pathogenic0.181Likely Benign-1.11Neutral0.997Probably Damaging0.996Probably Damaging2.66Benign0.20Tolerated0.05270.5211-3-23.660.10
c.3478A>G
N1160D
2D
AIThe SynGAP1 missense variant at position N1160D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and ESM1b, whereas a majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.585406Disordered0.861611Binding0.3610.8360.375-3.222Likely Benign0.978Likely PathogenicLikely Pathogenic0.225Likely Benign-3.22Deleterious0.997Probably Damaging0.992Probably Damaging1.84Pathogenic0.08Tolerated0.16180.3920210.00.98
c.3479A>C
N1160T
2D
AIThe SynGAP1 missense variant N1160T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, SIFT, and ESM1b, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) is unavailable for this variant. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.585406Disordered0.861611Binding0.3610.8360.375-3.017Likely Benign0.889Likely PathogenicAmbiguous0.229Likely Benign-3.61Deleterious0.997Probably Damaging0.992Probably Damaging1.81Pathogenic0.63Tolerated0.11470.6759002.8-13.00
c.3479A>G
N1160S
2D
AIThe SynGAP1 missense variant N1160S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the variant is most likely pathogenic based on the high‑accuracy consensus, and this assessment does not contradict ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.585406Disordered0.861611Binding0.3610.8360.375-1.880Likely Benign0.550AmbiguousLikely Benign0.228Likely Benign-3.26Deleterious0.997Probably Damaging0.989Probably Damaging1.83Pathogenic0.15Tolerated0.34590.6304112.7-27.03
c.3480C>A
N1160K
2D
AIThe SynGAP1 missense variant N1160K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL and ESM1b, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic. No Foldetta stability analysis is available for this residue. Overall, the majority of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.585406Disordered0.861611Binding0.3610.8360.375-3.768Likely Benign0.997Likely PathogenicLikely Pathogenic0.188Likely Benign-3.92Deleterious0.997Probably Damaging0.995Probably Damaging1.83Pathogenic0.04Affected0.19190.501710-0.414.07
c.3480C>G
N1160K
2D
AIThe SynGAP1 missense variant N1160K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL and ESM1b, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic. No Foldetta stability analysis is available for this residue. Overall, the majority of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.585406Disordered0.861611Binding0.3610.8360.375-3.768Likely Benign0.997Likely PathogenicLikely Pathogenic0.189Likely Benign-3.92Deleterious0.997Probably Damaging0.995Probably Damaging1.83Pathogenic0.04Affected0.19190.501710-0.414.07
c.3488A>C
H1163P
2D
AIThe SynGAP1 missense variant H1163P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are SIFT, ESM1b, and FATHMM, while those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie (2 pathogenic vs. 2 benign), and Foldetta results are unavailable. Overall, more tools predict pathogenicity than benignity (5 vs. 3), and there is no ClinVar record to contradict this assessment. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.509769Disordered0.858469Binding0.3280.8250.375-2.023Likely Benign0.815Likely PathogenicAmbiguous0.578Likely Pathogenic-3.19Deleterious0.997Probably Damaging0.996Probably Damaging5.39Benign0.10Tolerated0.20150.39000-21.6-40.02
c.3488A>T
H1163L
2D
AIThe SynGAP1 missense variant H1163L is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign) and Foldetta results are unavailable. Overall, the majority of predictions (5 pathogenic vs. 4 benign) lean toward a pathogenic impact. There is no ClinVar entry to contradict this assessment, so the variant is most likely pathogenic based on the available computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.509769Disordered0.858469Binding0.3280.8250.375-2.401Likely Benign0.707Likely PathogenicLikely Benign0.568Likely Pathogenic-3.15Deleterious0.997Probably Damaging0.995Probably Damaging5.55Benign0.10Tolerated0.09380.5356-2-37.0-23.98
c.3489C>A
H1163Q
2D
AIThe SynGAP1 missense variant H1163Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for H1163Q. This conclusion is consistent with the lack of a ClinVar entry, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.509769Disordered0.858469Binding0.3280.8250.375-2.970Likely Benign0.899Likely PathogenicAmbiguous0.414Likely Benign-1.41Neutral0.997Probably Damaging0.995Probably Damaging5.43Benign0.58Tolerated0.14450.342430-0.3-9.01
c.3489C>G
H1163Q
2D
AIThe SynGAP1 missense variant H1163Q is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign outcome. AlphaMissense‑Optimized is uncertain, and no Foldetta (FoldX‑MD/Rosetta stability) result is available. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar reporting and gnomAD presence, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.509769Disordered0.858469Binding0.3280.8250.375-2.970Likely Benign0.899Likely PathogenicAmbiguous0.414Likely Benign-1.41Neutral0.997Probably Damaging0.995Probably Damaging5.43Benign0.58Tolerated0.14450.342430-0.3-9.01
c.3490C>G
L1164V
2D
AIThe SynGAP1 missense variant L1164V has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and no Foldetta stability data are available. Overall, the balance of evidence leans toward a benign interpretation, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.853935Binding0.3250.8150.375-4.911Likely Benign0.797Likely PathogenicAmbiguous0.330Likely Benign-0.88Neutral0.997Probably Damaging0.992Probably Damaging5.54Benign0.14Tolerated0.14560.2617210.4-14.03
c.3493T>C
S1165P
2D
AIThe SynGAP1 missense variant S1165P is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, whereas the SGM‑Consensus remains Likely Benign; Foldetta results are unavailable. Overall, the majority of tools (six benign vs. four pathogenic) indicate that the variant is most likely benign. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.509769Disordered0.835017Binding0.3080.8070.375-3.476Likely Benign0.975Likely PathogenicLikely Pathogenic0.147Likely Benign-1.87Neutral0.997Probably Damaging0.995Probably Damaging2.55Benign0.23Tolerated0.22950.49301-1-0.810.04
c.3505G>A
E1169K
2D
AISynGAP1 missense variant E1169K is listed in gnomAD (ID 6‑33444540‑G‑A) but has no ClinVar record. Functional prediction tools fall into two groups: benign predictions come from SGM‑Consensus, REVEL, PROVEAN, ESM1b, and FATHMM; pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign. Foldetta stability analysis is unavailable. Overall, the evidence is split evenly, with one high‑accuracy tool supporting pathogenicity and the consensus tool supporting benignity. Therefore, the variant’s impact remains uncertain; it is not contradicted by ClinVar status, which has no entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.699094Disordered0.732455Binding0.4000.7810.6256-33444540-G-A16.20e-7-3.335Likely Benign0.973Likely PathogenicLikely Pathogenic0.185Likely Benign-1.81Neutral0.997Probably Damaging0.898Possibly Damaging2.51Benign0.00Affected3.8830.19690.642210-0.4-0.94
c.3523C>G
R1175G
2D
AIThe SynGAP1 missense variant R1175G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, and Foldetta results are unavailable. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.538167Disordered0.589347Binding0.5450.7320.375-4.888Likely Benign0.865Likely PathogenicAmbiguous0.477Likely Benign-1.64Neutral0.997Probably Damaging0.995Probably Damaging5.35Benign0.00Affected0.30060.2350-3-24.1-99.14
c.3524G>T
R1175L
2D
AISynGAP1 missense variant R1175L is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign predictions come from PROVEAN, ESM1b, and FATHMM, while pathogenic predictions arise from REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized is Uncertain, SGM‑Consensus remains Likely Benign, and Foldetta data are unavailable. Overall, the majority of individual predictors lean toward pathogenicity, yet the consensus of the most reliable tools suggests a benign outcome, leaving the variant’s clinical significance ambiguous. Consequently, the variant is most likely pathogenic based on the bulk of predictions, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.538167Disordered0.589347Binding0.5450.7320.375-2.560Likely Benign0.876Likely PathogenicAmbiguous0.535Likely Pathogenic-2.37Neutral0.997Probably Damaging0.995Probably Damaging5.38Benign0.00Affected0.12400.2849-3-28.3-43.03
c.3544G>A
E1182K
2D
AIThe SynGAP1 missense variant E1182K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM‑Consensus remains benign; a Foldetta stability analysis is unavailable. Overall, the majority of evidence points toward a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.566480Disordered0.530232Binding0.5970.6510.375-4.874Likely Benign0.986Likely PathogenicLikely Pathogenic0.162Likely Benign-2.04Neutral0.997Probably Damaging0.989Probably Damaging2.70Benign0.02Affected0.16890.615201-0.4-0.94
c.3544G>C
E1182Q
2D
AIThe SynGAP1 missense variant E1182Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, ESM1b, and FATHMM, while pathogenic calls arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain, SGM‑Consensus remains likely benign, and Foldetta data are unavailable. Overall, the majority of evidence leans toward a benign effect, and this is consistent with the lack of ClinVar annotation. Therefore, the variant is most likely benign, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.566480Disordered0.530232Binding0.5970.6510.375-4.004Likely Benign0.897Likely PathogenicAmbiguous0.104Likely Benign-1.43Neutral0.997Probably Damaging0.992Probably Damaging2.68Benign0.02Affected0.08240.6009220.0-0.98
c.3545A>C
E1182A
2D
AIThe SynGAP1 E1182A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score is uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2). Foldetta, which would assess protein‑folding stability, has no available result for this variant. Overall, more tools predict pathogenicity (5) than benign (3), and the high‑accuracy methods do not overturn this trend. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.566480Disordered0.530232Binding0.5970.6510.375-4.400Likely Benign0.888Likely PathogenicAmbiguous0.143Likely Benign-2.73Deleterious0.997Probably Damaging0.989Probably Damaging2.64Benign0.02Affected0.34830.60250-15.3-58.04
c.3550T>C
S1184P
2D
AIThe SynGAP1 missense variant S1184P is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains likely benign; Foldetta results are unavailable. Overall, the majority of tools and the consensus prediction lean toward a benign interpretation, and this assessment does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.648219Disordered0.514669Binding0.6240.6420.500-4.829Likely Benign0.995Likely PathogenicLikely Pathogenic0.110Likely Benign-1.38Neutral0.997Probably Damaging0.992Probably Damaging2.66Benign0.16Tolerated0.17720.45691-1-0.810.04
c.3553A>G
K1185E
2D
AISynGAP1 K1185E is not reported in ClinVar and has no gnomAD allele. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic calls come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome. High‑accuracy assessments further highlight this divergence: AlphaMissense‑Optimized predicts pathogenic, whereas the SGM‑Consensus (a majority‑vote method) indicates benign; Foldetta results are unavailable. Overall, the balance of evidence, including the consensus from multiple predictors, points to a benign effect. Thus, the variant is most likely benign, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.566480Disordered0.510264Binding0.6420.6380.625-4.465Likely Benign0.980Likely PathogenicLikely Pathogenic0.148Likely Benign-1.34Neutral0.997Probably Damaging0.989Probably Damaging2.89Benign0.19Tolerated0.37150.0720010.40.94
c.3554A>G
K1185R
2D
AIThe SynGAP1 missense variant K1185R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict pathogenicity. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence points to a benign impact for K1185R, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.566480Disordered0.510264Binding0.6420.6380.625-2.898Likely Benign0.224Likely BenignLikely Benign0.130Likely Benign-0.48Neutral0.997Probably Damaging0.989Probably Damaging2.67Benign0.66Tolerated0.44760.090932-0.628.01
c.3556T>C
S1186P
2D
AIThe SynGAP1 missense variant S1186P lies in a coiled‑coil domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 pathogenic vs. 2 benign), and Foldetta results are unavailable. Overall, the balance of evidence leans toward pathogenicity, with no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.562014Disordered0.506433Binding0.6340.6360.625-6.365Likely Benign0.994Likely PathogenicLikely Pathogenic0.198Likely Benign-2.51Deleterious0.997Probably Damaging0.995Probably Damaging2.64Benign0.09Tolerated0.17840.40061-1-0.810.04
c.3562G>A
D1188N
2D
AIThe SynGAP1 D1188N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the balance of evidence favors a pathogenic classification for D1188N, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.476583Structured0.484322Uncertain0.6870.6260.625-5.621Likely Benign0.962Likely PathogenicLikely Pathogenic0.340Likely Benign-2.50Deleterious0.997Probably Damaging0.996Probably Damaging5.47Benign0.00Affected0.07670.4663210.0-0.98
c.3563A>G
D1188G
2D
AIThe SynGAP1 D1188G missense change is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus method SGM, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a tie and is therefore inconclusive. Foldetta, a protein‑folding stability predictor, has no available result for this variant. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not conflict with any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.476583Structured0.484322Uncertain0.6870.6260.625-5.286Likely Benign0.981Likely PathogenicLikely Pathogenic0.440Likely Benign-3.69Deleterious0.997Probably Damaging0.996Probably Damaging5.47Benign0.00Affected0.27710.48801-13.1-58.04
c.3565G>A
E1189K
2D
AIThe SynGAP1 missense variant E1189K is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM‑Consensus as “Likely Benign,” and Foldetta results are unavailable. Overall, the balance of evidence—five benign predictions versus three pathogenic ones, a consensus benign rating, and no conflicting ClinVar annotation—suggests that E1189K is most likely benign. This conclusion does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.562014Disordered0.466885Uncertain0.7040.6230.625-5.565Likely Benign0.947Likely PathogenicAmbiguous0.423Likely Benign-1.64Neutral0.997Probably Damaging0.992Probably Damaging5.37Benign0.08Tolerated0.15970.404601-0.4-0.94
c.3565G>C
E1189Q
2D
AIThe SynGAP1 missense variant E1189Q has no ClinVar record and is not listed in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM‑Consensus as “Likely Benign,” and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, with no conflict with ClinVar status (which is absent). Thus, the variant is most likely benign based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.562014Disordered0.466885Uncertain0.7040.6230.625-4.977Likely Benign0.842Likely PathogenicAmbiguous0.338Likely Benign-1.45Neutral0.997Probably Damaging0.995Probably Damaging5.30Benign0.10Tolerated0.07380.3797220.0-0.98
c.3566A>C
E1189A
2D
AIThe SynGAP1 missense variant E1189A is not listed in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score is uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑vs‑2 split. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the predictions are evenly divided between benign and pathogenic, with no high‑confidence consensus. Thus, the variant is most likely of uncertain significance; there is no ClinVar annotation to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.562014Disordered0.466885Uncertain0.7040.6230.625-4.989Likely Benign0.860Likely PathogenicAmbiguous0.427Likely Benign-3.06Deleterious0.997Probably Damaging0.992Probably Damaging5.34Benign0.09Tolerated0.28270.41050-15.3-58.04
c.3568A>C
S1190R
2D
AIThe SynGAP1 missense variant S1190R is not reported in ClinVar and is absent from gnomAD. Prediction tools show a split assessment: benign calls come from REVEL, PROVEAN, ESM1b, and FATHMM, while pathogenic calls arise from polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Grouping by consensus, four tools predict benign and five predict pathogenic. High‑accuracy methods give further contrast: AlphaMissense‑Optimized labels the variant as pathogenic, whereas the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as likely benign; Foldetta results are unavailable. Overall, the balance of evidence leans toward a pathogenic interpretation, but the presence of strong benign predictions and the lack of a ClinVar classification mean the variant remains uncertain. No contradiction exists with ClinVar status, as no ClinVar entry is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.575842Disordered0.455760Uncertain0.7420.6240.625-5.258Likely Benign0.991Likely PathogenicLikely Pathogenic0.441Likely Benign-1.66Neutral0.997Probably Damaging0.995Probably Damaging5.26Benign0.05Affected0.09390.29970-1-3.769.11
c.3569G>T
S1190I
2D
AIThe SynGAP1 missense change S1190I is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM. Those that predict a pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized model classifies the variant as pathogenic, whereas the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Benign. Foldetta stability analysis is unavailable. Overall, the balance of evidence favors a pathogenic interpretation, and this assessment does not contradict any ClinVar annotation because no ClinVar record exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.575842Disordered0.455760Uncertain0.7420.6240.625-4.842Likely Benign0.958Likely PathogenicLikely Pathogenic0.371Likely Benign-1.89Neutral0.997Probably Damaging0.996Probably Damaging5.26Benign0.04Affected0.08810.4175-1-25.326.08
c.3570C>A
S1190R
2D
AIThe SynGAP1 missense variant S1190R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as Likely Benign, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result. Overall, the majority of individual predictors lean toward pathogenicity, but the SGM‑Consensus and several benign predictions introduce uncertainty. Based on the current predictions, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status because ClinVar has not classified the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.575842Disordered0.455760Uncertain0.7420.6240.625-5.258Likely Benign0.991Likely PathogenicLikely Pathogenic0.377Likely Benign-1.66Neutral0.997Probably Damaging0.995Probably Damaging5.26Benign0.05Affected0.09390.29970-1-3.769.11
c.3570C>G
S1190R
2D
AISynGAP1 missense variant S1190R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, PROVEAN, ESM1b, and FATHMM. Those that predict pathogenicity are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the majority of tools and the AlphaMissense‑Optimized score point toward pathogenicity, while the SGM‑Consensus suggests benign. Thus, the variant is most likely pathogenic based on the current predictions, and this assessment does not contradict ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.575842Disordered0.455760Uncertain0.7420.6240.625-5.258Likely Benign0.991Likely PathogenicLikely Pathogenic0.377Likely Benign-1.66Neutral0.997Probably Damaging0.995Probably Damaging5.26Benign0.05Affected0.09390.29970-1-3.769.11
c.3571C>G
R1191G
2D
AIThe SynGAP1 missense variant R1191G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evaluated tools (seven pathogenic vs. three benign) indicate that R1191G is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.661982Disordered0.439584Uncertain0.7650.6220.625-3.142Likely Benign0.994Likely PathogenicLikely Pathogenic0.304Likely Benign-2.52Deleterious0.997Probably Damaging0.995Probably Damaging2.64Benign0.02Affected0.37280.3013-3-24.1-99.14
c.3572G>T
R1191L
2D
AIThe SynGAP1 missense variant R1191L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for R1191L. This prediction does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.661982Disordered0.439584Uncertain0.7650.6220.6250.014Likely Benign0.981Likely PathogenicLikely Pathogenic0.352Likely Benign-2.82Deleterious0.997Probably Damaging0.995Probably Damaging2.64Benign0.03Affected0.17920.4178-3-28.3-43.03
c.3575T>C
L1192P
2D
AIThe SynGAP1 missense variant L1192P is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM‑Consensus remains benign; Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.575842Disordered0.441757Uncertain0.7620.6090.625-4.610Likely Benign0.989Likely PathogenicLikely Pathogenic0.181Likely Benign-1.94Neutral0.997Probably Damaging0.959Probably Damaging2.65Benign0.05Affected0.35150.1053-3-3-5.4-16.04
c.3583G>C
V1195L
2D
AIThe SynGAP1 missense variant V1195L has no ClinVar record and is not listed in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. AlphaMissense‑Optimized is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Considering the high‑accuracy tools, the consensus leans toward benign (SGM‑Consensus) with no definitive pathogenic signal from AlphaMissense‑Optimized or Foldetta. Overall, the majority of evidence supports a benign impact, and this assessment does not contradict any ClinVar status, as none exists for V1195L.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.604312Disordered0.434133Uncertain0.8420.6030.250-2.603Likely Benign0.928Likely PathogenicAmbiguous0.323Likely Benign-0.84Neutral0.997Probably Damaging0.992Probably Damaging5.46Benign0.70Tolerated0.06950.382721-0.414.03
c.3583G>T
V1195L
2D
AIThe SynGAP1 missense variant V1195L has no ClinVar record and is not listed in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” status. AlphaMissense‑Optimized is uncertain, and no Foldetta stability assessment is available. Overall, the majority of high‑confidence predictors (six benign vs. three pathogenic) lean toward a benign interpretation. Thus, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.604312Disordered0.434133Uncertain0.8420.6030.250-2.603Likely Benign0.928Likely PathogenicAmbiguous0.305Likely Benign-0.84Neutral0.997Probably Damaging0.992Probably Damaging5.46Benign0.70Tolerated0.06950.382721-0.414.03
c.3584T>C
V1195A
2D
AIThe SynGAP1 missense variant V1195A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default both predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM‑Consensus remains likely benign; Foldetta results are not available. Overall, the balance of evidence leans toward a benign impact, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.604312Disordered0.434133Uncertain0.8420.6030.250-4.291Likely Benign0.960Likely PathogenicLikely Pathogenic0.421Likely Benign-0.84Neutral0.997Probably Damaging0.992Probably Damaging5.60Benign0.44Tolerated0.26020.185400-2.4-28.05
c.3591G>C
E1197D
2D
AIThe SynGAP1 missense variant E1197D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to a likely benign verdict. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote) also indicates benign. Foldetta stability analysis is unavailable for this residue. Overall, the balance of evidence favors a benign effect for E1197D, and this conclusion does not conflict with any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.613573Disordered0.437361Uncertain0.8270.5990.250-5.158Likely Benign0.776Likely PathogenicLikely Benign0.348Likely Benign-1.78Neutral0.997Probably Damaging0.992Probably Damaging5.41Benign0.16Tolerated0.13270.3535320.0-14.03
c.3591G>T
E1197D
2D
AIThe SynGAP1 missense variant E1197D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome (3 benign vs. 1 pathogenic). High‑accuracy tools give the following results: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote) predicts benign; Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta) has no available result for this variant. Overall, the preponderance of evidence points to a benign impact, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.613573Disordered0.437361Uncertain0.8270.5990.250-5.158Likely Benign0.776Likely PathogenicLikely Benign0.348Likely Benign-1.78Neutral0.997Probably Damaging0.992Probably Damaging5.41Benign0.16Tolerated0.13270.3535320.0-14.03
c.3597G>C
E1199D
2D
AIThe SynGAP1 missense variant E1199D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, and FATHMM, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the majority of evidence points toward a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.538167Disordered0.444533Uncertain0.8780.5980.250-10.917Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.234Likely Benign-2.08Neutral0.997Probably Damaging0.992Probably Damaging2.52Benign0.00Affected0.17280.2146320.0-14.03
c.3597G>T
E1199D
2D
AIThe SynGAP1 missense variant E1199D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, and FATHMM, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the majority of evidence points toward a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.538167Disordered0.444533Uncertain0.8780.5980.250-10.917Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.236Likely Benign-2.08Neutral0.997Probably Damaging0.992Probably Damaging2.52Benign0.00Affected0.17280.2146320.0-14.03
c.3603G>C
E1201D
2D
AIThe SynGAP1 missense variant E1201D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, and SIFT, whereas pathogenic calls are made by polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy consensus methods reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic classification. Foldetta, a protein‑folding stability predictor, has no available result for this residue. Overall, the preponderance of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.525368Disordered0.481868Uncertain0.8700.5960.250-8.727Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.150Likely Benign-1.55Neutral0.997Probably Damaging0.992Probably Damaging1.66Pathogenic0.51Tolerated0.13410.3335320.0-14.03
c.3603G>T
E1201D
2D
AIThe SynGAP1 missense variant E1201D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, and SIFT, whereas pathogenic calls are made by polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy consensus methods reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic classification. Foldetta, a protein‑folding stability predictor, has no available result for this residue. Overall, the preponderance of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.525368Disordered0.481868Uncertain0.8700.5960.250-8.727Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.150Likely Benign-1.55Neutral0.997Probably Damaging0.992Probably Damaging1.66Pathogenic0.51Tolerated0.13410.3335320.0-14.03
c.3605T>C
I1202T
2D
AIThe SynGAP1 missense variant I1202T is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, and the SGM‑Consensus likewise indicates Likely Pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence points to the variant being most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.529623Disordered0.510422Binding0.8740.5930.250-9.433Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.407Likely Benign-3.96Deleterious0.997Probably Damaging0.994Probably Damaging1.81Pathogenic0.01Affected0.11180.08460-1-5.2-12.05
c.3651A>C
E1217D
2D
AIThe SynGAP1 missense variant E1217D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign effect. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also leans benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Taken together, the preponderance of evidence points to a benign impact for E1217D, and this conclusion is consistent with the absence of any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.599170Disordered0.493043Uncertain0.8770.5630.250-5.983Likely Benign0.705Likely PathogenicLikely Benign0.114Likely Benign-2.19Neutral0.997Probably Damaging0.992Probably Damaging2.51Benign0.00Affected0.17450.3146320.0-14.03
c.3651A>T
E1217D
2D
AIThe SynGAP1 missense variant E1217D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign effect. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also leans benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Taken together, the preponderance of evidence points to a benign impact for E1217D, and this conclusion is consistent with the absence of any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.599170Disordered0.493043Uncertain0.8770.5630.250-5.983Likely Benign0.705Likely PathogenicLikely Benign0.114Likely Benign-2.19Neutral0.997Probably Damaging0.992Probably Damaging2.51Benign0.00Affected0.17450.3146320.0-14.03
c.3654G>C
E1218D
2D
AIThe SynGAP1 missense variant E1218D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, and no Foldetta stability data are available. Overall, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.595080Disordered0.483050Uncertain0.8980.5650.375-3.574Likely Benign0.517AmbiguousLikely Benign0.138Likely Benign-2.42Neutral0.997Probably Damaging0.992Probably Damaging2.30Pathogenic0.00Affected0.14850.2475320.0-14.03
c.3654G>T
E1218D
2D
AIThe SynGAP1 missense variant E1218D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, and no Foldetta stability data are available. Overall, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.595080Disordered0.483050Uncertain0.8980.5650.375-3.574Likely Benign0.517AmbiguousLikely Benign0.138Likely Benign-2.42Neutral0.997Probably Damaging0.992Probably Damaging2.30Pathogenic0.00Affected0.14850.2475320.0-14.03
c.3660G>C
E1220D
2D
AIThe missense change E1220D occurs in the coiled‑coil domain of SynGAP1. ClinVar contains no entry for this variant and it is absent from gnomAD. Functional prediction tools cluster into two groups: a single benign call from REVEL, and a consensus of pathogenic predictions from the remaining methods (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized). The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM and PROVEAN, also reports a likely pathogenic outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus likewise indicates pathogenic. Foldetta stability analysis is not available for this variant. Taken together, the preponderance of evidence points to a pathogenic effect, and this assessment does not conflict with the absence of a ClinVar classification. The variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.703578Disordered0.444845Uncertain0.8810.5510.375-8.820Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.178Likely Benign-2.59Deleterious0.997Probably Damaging0.992Probably Damaging1.66Pathogenic0.00Affected0.15970.2810320.0-14.03
c.3660G>T
E1220D
2D
AIThe SynGAP1 missense variant E1220D is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this view: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus also reports it as likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.703578Disordered0.444845Uncertain0.8810.5510.375-8.820Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.179Likely Benign-2.59Deleterious0.997Probably Damaging0.992Probably Damaging1.66Pathogenic0.00Affected0.15970.2810320.0-14.03
c.3664A>G
R1222G
2D
AIThe SynGAP1 missense change R1222G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools split into two groups: benign predictions come from REVEL and SIFT, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Pathogenic.” High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote) also indicates likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.703578Disordered0.423869Uncertain0.8950.5410.250-11.498Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.226Likely Benign-5.41Deleterious0.997Probably Damaging0.994Probably Damaging1.48Pathogenic0.10Tolerated0.30120.2305-3-24.1-99.14
c.3665G>C
R1222T
2D
AIThe SynGAP1 missense variant R1222T is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and SIFT, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—consistently predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence indicates that R1222T is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no classification for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.703578Disordered0.423869Uncertain0.8950.5410.250-11.164Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.407Likely Benign-4.39Deleterious0.997Probably Damaging0.994Probably Damaging1.48Pathogenic0.13Tolerated0.15500.2851-1-13.8-55.08
c.3666G>C
R1222S
2D
AIThe SynGAP1 missense variant R1222S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and SIFT, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic. No Foldetta stability analysis is available for this variant. Overall, the preponderance of evidence from multiple in silico tools points to a pathogenic impact, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.703578Disordered0.423869Uncertain0.8950.5410.250-9.310Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.282Likely Benign-4.40Deleterious0.997Probably Damaging0.994Probably Damaging1.49Pathogenic0.10Tolerated0.29510.24260-13.7-69.11
c.3666G>T
R1222S
2D
AIThe SynGAP1 missense variant R1222S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and SIFT, whereas the majority of other in‑silico predictors (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus confirms a likely pathogenic status. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from both general and high‑accuracy prediction tools points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.703578Disordered0.423869Uncertain0.8950.5410.250-9.310Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.280Likely Benign-4.40Deleterious0.997Probably Damaging0.994Probably Damaging1.49Pathogenic0.10Tolerated0.29510.24260-13.7-69.11
c.3681A>C
E1227D
2D
AIThe SynGAP1 missense variant E1227D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority of the high‑accuracy tools) also indicates benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence, including the high‑accuracy tools, points to the variant being most likely benign, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.513880Disordered0.433399Uncertain0.8600.5440.500-5.675Likely Benign0.777Likely PathogenicLikely Benign0.172Likely Benign-1.67Neutral0.997Probably Damaging0.992Probably Damaging2.60Benign0.00Affected0.13630.4161320.0-14.03
c.3681A>T
E1227D
2D
AIThe SynGAP1 missense variant E1227D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority of the high‑accuracy tools) also indicates benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence, including the high‑accuracy tools, points to the variant being most likely benign, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.513880Disordered0.433399Uncertain0.8600.5440.500-5.675Likely Benign0.777Likely PathogenicLikely Benign0.170Likely Benign-1.67Neutral0.997Probably Damaging0.992Probably Damaging2.60Benign0.00Affected0.13630.4161320.0-14.03
c.3688A>G
T1230A
2D
AIThe SynGAP1 T1230A missense change is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that classify the variant as benign include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default predict it to be pathogenic. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, and the Foldetta stability analysis is unavailable. Overall, the majority of evidence—including the consensus and high‑accuracy tools—indicates that the variant is most likely benign, and this conclusion is consistent with the lack of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.570702Disordered0.486342Uncertain0.8450.5430.250-5.236Likely Benign0.644Likely PathogenicLikely Benign0.395Likely Benign-2.10Neutral0.997Probably Damaging0.992Probably Damaging5.58Benign0.03Affected0.29450.3231102.5-30.03
c.3691A>T
S1231C
2D
AIThe SynGAP1 missense variant S1231C has no ClinVar entry (ClinVar status: not reported) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 benign vs. 2 pathogenic votes) and Foldetta results are unavailable. Overall, the majority of standard predictors (5 pathogenic vs. 4 benign) lean toward a pathogenic interpretation, and the high‑accuracy tools do not overturn this trend. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.490133Structured0.519419Binding0.8760.5440.250-8.559Likely Pathogenic0.190Likely BenignLikely Benign0.132Likely Benign-3.04Deleterious0.997Probably Damaging0.870Possibly Damaging2.62Benign0.04Affected0.07570.45920-13.316.06
c.3701T>A
L1234Q
2D
AIThe SynGAP1 missense variant L1234Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—classify the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta results are unavailable. Based on the predominance of pathogenic predictions and the lack of supporting benign evidence, the variant is most likely pathogenic; this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.599170Disordered0.575096Binding0.8440.5270.125-12.969Likely Pathogenic0.858Likely PathogenicAmbiguous0.272Likely Benign-4.34Deleterious0.997Probably Damaging0.955Probably Damaging1.46Pathogenic0.01Affected0.09620.1049-2-2-7.314.97
c.3701T>G
L1234R
2D
AIThe SynGAP1 missense change L1234R occurs in a coiled‑coil domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to REVEL, which scores the variant as benign. All other evaluated predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—classify the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.599170Disordered0.575096Binding0.8440.5270.125-15.015Likely Pathogenic0.912Likely PathogenicAmbiguous0.211Likely Benign-4.52Deleterious0.997Probably Damaging0.939Probably Damaging1.46Pathogenic0.00Affected0.10610.0849-3-2-8.343.03
c.3731G>A
S1244N
2D
AIThe SynGAP1 missense variant S1244N is listed in ClinVar with an “Uncertain” status (ClinVar ID 931075.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and AlphaMissense‑Optimized, whereas PolyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—indicates pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence leans toward a pathogenic effect, which does not contradict the ClinVar designation of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500Uncertain 1-9.008Likely Pathogenic0.751Likely PathogenicLikely Benign0.154Likely Benign-1.87Neutral0.997Probably Damaging0.992Probably Damaging2.10Pathogenic0.15Tolerated3.7750.10330.346411-2.727.03
c.3735G>C
E1245D
2D
AIThe SynGAP1 missense variant E1245D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and no consensus could be drawn from the SGM Consensus (a tie between pathogenic and benign votes from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the balance of evidence from the available predictors leans toward a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation, as there is no reported ClinVar status to contradict the prediction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-6.075Likely Benign0.928Likely PathogenicAmbiguous0.157Likely Benign-2.46Neutral0.997Probably Damaging0.992Probably Damaging2.30Pathogenic0.00Affected0.15850.3097320.0-14.03
c.3735G>T
E1245D
2D
AIThe SynGAP1 missense variant E1245D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and no consensus could be drawn from the SGM Consensus (a tie between pathogenic and benign votes from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the balance of evidence from the available predictors leans toward a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-6.075Likely Benign0.928Likely PathogenicAmbiguous0.157Likely Benign-2.46Neutral0.997Probably Damaging0.992Probably Damaging2.30Pathogenic0.00Affected0.15850.3097320.0-14.03
c.3762G>C
E1254D
2D
AIThe SynGAP1 missense change E1254D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as “Likely Benign.” In contrast, only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is “Likely Benign.” Foldetta results are not available, so they do not influence the overall assessment. Overall, the majority of evidence indicates that E1254D is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-4.648Likely Benign0.274Likely BenignLikely Benign0.112Likely Benign-0.44Neutral0.997Probably Damaging0.992Probably Damaging2.62Benign0.51Tolerated0.14020.3471320.0-14.03
c.3762G>T
E1254D
2D
AIThe SynGAP1 missense change E1254D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence indicates that E1254D is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-4.648Likely Benign0.274Likely BenignLikely Benign0.112Likely Benign-0.44Neutral0.997Probably Damaging0.992Probably Damaging2.62Benign0.51Tolerated0.14020.3471320.0-14.03
c.3768T>A
D1256E
2D
AIThe SynGAP1 D1256E missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default all indicate pathogenicity. The SGM‑Consensus, which is a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as likely pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta results are unavailable. Taken together, the consensus of most evidence points to a pathogenic effect, and this conclusion does not contradict any existing ClinVar annotation (none is present). Thus, the variant is most likely pathogenic based on current predictive tools.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.549308Disordered0.445789Uncertain0.8760.5710.625-5.806Likely Benign0.842Likely PathogenicAmbiguous0.149Likely Benign-2.71Deleterious0.997Probably Damaging0.994Probably Damaging1.72Pathogenic0.00Affected0.10220.4172320.014.03
c.3768T>G
D1256E
2D
AIThe SynGAP1 D1256E missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools cluster into two groups: benign predictions come from REVEL and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, is derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN and therefore reports the variant as likely pathogenic. AlphaMissense‑Optimized is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Taken together, the majority of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.549308Disordered0.445789Uncertain0.8760.5710.625-5.806Likely Benign0.842Likely PathogenicAmbiguous0.149Likely Benign-2.71Deleterious0.997Probably Damaging0.994Probably Damaging1.72Pathogenic0.00Affected0.10220.4172320.014.03
c.3776T>C
I1259T
2D
AIThe SynGAP1 missense variant I1259T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two pathogenic, two benign) and Foldetta results are unavailable. Overall, the majority of evidence (six pathogenic vs. three benign predictions) points to a pathogenic impact. The variant is most likely pathogenic based on current predictions, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.494003Structured0.576405Binding0.8850.5740.250-10.057Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.399Likely Benign-2.47Neutral0.997Probably Damaging0.994Probably Damaging2.54Benign0.01Affected0.09910.10510-1-5.2-12.05
c.3785T>C
I1262T
2D
AIThe SynGAP1 missense variant I1262T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic status. The Foldetta stability analysis is not available for this variant. Overall, the consensus of all available predictions points to a pathogenic effect, and this conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.497853Structured0.707863Binding0.8860.5760.125-11.985Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.514Likely Pathogenic-4.14Deleterious0.997Probably Damaging0.994Probably Damaging1.81Pathogenic0.00Affected0.11090.14190-1-5.2-12.05
c.3790G>T
G1264C
2D
AIThe SynGAP1 missense variant G1264C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict pathogenicity. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence supports a benign classification for G1264C, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.429200Structured0.762385Binding0.8970.5790.000-5.666Likely Benign0.280Likely BenignLikely Benign0.122Likely Benign-1.03Neutral0.997Probably Damaging0.870Possibly Damaging2.74Benign0.09Tolerated0.10870.3691-3-32.946.09
c.3793A>G
R1265G
2D
AIThe SynGAP1 missense variant R1265G is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all label the change as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, while a Foldetta stability analysis is unavailable. Based on the unanimous pathogenic predictions and the lack of any benign calls, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.414856Structured0.782497Binding0.8870.5920.000-12.732Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.523Likely Pathogenic-5.80Deleterious0.997Probably Damaging0.994Probably Damaging2.27Pathogenic0.00Affected0.35200.3759-3-24.1-99.14
c.3794G>C
R1265T
2D
AIThe SynGAP1 missense variant R1265T is reported in ClinVar as Pathogenic (ClinVar ID 522047.0) and is not found in gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool in the dataset predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a Likely Pathogenic verdict. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of all available predictions supports a pathogenic classification, which is consistent with the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.414856Structured0.782497Binding0.8870.5920.000Likely Pathogenic 1-10.129Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.529Likely Pathogenic-4.97Deleterious0.997Probably Damaging0.994Probably Damaging2.29Pathogenic0.00Affected3.7750.19470.4618-1-13.8-55.08
c.3795G>C
R1265S
2D
AIThe SynGAP1 missense variant R1265S is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus also reports it as likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.414856Structured0.782497Binding0.8870.5920.000-9.874Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.289Likely Benign-4.96Deleterious0.997Probably Damaging0.994Probably Damaging2.40Pathogenic0.00Affected0.35250.39930-13.7-69.11
c.3795G>T
R1265S
2D
AIThe SynGAP1 missense variant R1265S is not reported in ClinVar and has no entry in gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus also reports it as likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.414856Structured0.782497Binding0.8870.5920.000-9.874Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.289Likely Benign-4.96Deleterious0.997Probably Damaging0.994Probably Damaging2.40Pathogenic0.00Affected0.35250.39930-13.7-69.11
c.3808G>A
E1270K
2D
AIThe SynGAP1 missense variant E1270K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: REVEL predicts a benign outcome, whereas all other evaluated algorithms (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence indicates that E1270K is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.490133Structured0.771865Binding0.8050.6590.250-12.549Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.413Likely Benign-3.37Deleterious0.997Probably Damaging0.989Probably Damaging2.07Pathogenic0.00Affected0.17800.627601-0.4-0.94
c.3808G>C
E1270Q
2D
AIThe SynGAP1 missense variant E1270Q is not reported in ClinVar and has no entries in gnomAD, indicating it is not catalogued in these databases. Prediction tools that agree on a benign effect include only REVEL, which scores the substitution as benign. In contrast, the majority of in silico predictors—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—classify the change as pathogenic. The high‑accuracy AlphaMissense‑Optimized assessment is uncertain, while the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic outcome. Foldetta predictions are unavailable for this variant. Overall, the preponderance of pathogenic predictions, together with the SGM Consensus result, indicates that E1270Q is most likely pathogenic; this conclusion does not contradict ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.490133Structured0.771865Binding0.8050.6590.250-8.645Likely Pathogenic0.935Likely PathogenicAmbiguous0.330Likely Benign-2.53Deleterious0.997Probably Damaging0.992Probably Damaging2.06Pathogenic0.00Affected0.09190.5858220.0-0.98
c.3809A>C
E1270A
2D
AIThe SynGAP1 missense change E1270A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: REVEL is the only score that flags the variant as benign, whereas PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) all predict pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized reports a pathogenic effect, and the SGM‑Consensus also indicates a likely pathogenic outcome. No Foldetta (FoldX‑MD/Rosetta stability) result is available, so it does not influence the assessment. Overall, the preponderance of evidence points to a pathogenic impact for E1270A, and this conclusion is consistent with the absence of a ClinVar entry (i.e., no contradictory clinical classification).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.490133Structured0.771865Binding0.8050.6590.250-12.081Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.388Likely Benign-5.04Deleterious0.997Probably Damaging0.989Probably Damaging2.06Pathogenic0.00Affected0.30240.51260-15.3-58.04
c.3814G>A
E1272K
2D
AIThe SynGAP1 E1272K missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions are made by REVEL and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic, and Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.483068Structured0.766082Binding0.7990.6770.500-4.227Likely Benign0.956Likely PathogenicLikely Pathogenic0.312Likely Benign-3.37Deleterious0.997Probably Damaging0.989Probably Damaging2.28Pathogenic0.00Affected0.15440.548801-0.4-0.94
c.3814G>C
E1272Q
2D
AIThe SynGAP1 E1272Q missense variant is catalogued in gnomAD (variant ID 6‑33447862‑G‑C) but has no ClinVar entry. Prediction tools cluster into two groups: benign calls come from REVEL, ESM1b, and AlphaMissense‑Optimized, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, a majority‑vote aggregator of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Pathogenic, and Foldetta (a protein‑folding stability predictor combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Overall, the preponderance of evidence (seven pathogenic versus three benign predictions) indicates that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.483068Structured0.766082Binding0.7990.6770.5006-33447862-G-C16.45e-7-3.000Likely Benign0.651Likely PathogenicLikely Benign0.207Likely Benign-2.53Deleterious0.997Probably Damaging0.992Probably Damaging2.25Pathogenic0.00Affected3.7750.07460.5258220.0-0.98
c.3815A>C
E1272A
2D
AIThe SynGAP1 missense variant E1272A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus indicates a likely pathogenic outcome; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of evidence points toward a pathogenic impact for E1272A. This prediction is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.483068Structured0.766082Binding0.7990.6770.500-0.783Likely Benign0.779Likely PathogenicLikely Benign0.261Likely Benign-5.05Deleterious0.997Probably Damaging0.989Probably Damaging2.26Pathogenic0.00Affected0.32430.55470-15.3-58.04
c.3818T>A
L1273Q
2D
AIThe SynGAP1 missense variant L1273Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic and the SGM‑Consensus is labeled Likely Pathogenic; Foldetta results are unavailable. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.773625Binding0.7470.6770.500-6.813Likely Benign0.957Likely PathogenicLikely Pathogenic0.423Likely Benign-5.05Deleterious0.997Probably Damaging0.950Probably Damaging2.13Pathogenic0.00Affected0.11390.1119-2-2-7.314.97
c.3818T>C
L1273P
2D
AIThe SynGAP1 missense variant L1273P is not reported in ClinVar (ClinVar status: not listed) but is present in the gnomAD database (gnomAD ID: 6‑33447866‑T‑C). Functional prediction tools uniformly indicate a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool in the dataset predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as likely pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the consensus of predictive algorithms strongly supports a pathogenic classification, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.773625Binding0.7470.6770.5006-33447866-T-C-9.443Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.523Likely Pathogenic-5.87Deleterious0.997Probably Damaging0.950Probably Damaging2.12Pathogenic0.00Affected3.7750.38360.1343-3-3-5.4-16.04
c.3818T>G
L1273R
2D
AIThe SynGAP1 missense variant L1273R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default all classify the variant as damaging. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the SGM‑Consensus outcome, the variant is most likely pathogenic; this assessment is not contradicted by any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.773625Binding0.7470.6770.500-6.252Likely Benign0.946Likely PathogenicAmbiguous0.431Likely Benign-5.05Deleterious0.997Probably Damaging0.934Probably Damaging2.13Pathogenic0.00Affected0.13690.0761-3-2-8.343.03
c.3820C>A
R1274S
2D
AIThe SynGAP1 missense variant R1274S is not reported in ClinVar (status: “None”) but is present in gnomAD (ID 6‑33447868‑C‑A). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are limited: AlphaMissense‑Optimized remains uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the majority of available predictions (five pathogenic vs. three benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.613573Disordered0.779985Binding0.7460.6880.6256-33447868-C-A-3.149Likely Benign0.830Likely PathogenicAmbiguous0.139Likely Benign-3.19Deleterious0.997Probably Damaging0.993Probably Damaging2.52Benign0.01Affected3.7750.30560.1830-103.7-69.11
c.3820C>G
R1274G
2D
AIThe SynGAP1 R1274G missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, is derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN and therefore predicts a pathogenic outcome. AlphaMissense‑Optimized alone predicts benign, while Foldetta results are unavailable. Overall, the majority of evidence (seven pathogenic versus three benign predictions) indicates that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.613573Disordered0.779985Binding0.7460.6880.625-3.288Likely Benign0.579Likely PathogenicLikely Benign0.145Likely Benign-4.36Deleterious0.997Probably Damaging0.993Probably Damaging2.49Pathogenic0.01Affected0.33160.2310-3-24.1-99.14
c.3821G>T
R1274L
2D
AIThe SynGAP1 missense variant R1274L is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign, while Foldetta results are unavailable. Overall, the majority of reliable predictors and the high‑accuracy consensus favor a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.613573Disordered0.779985Binding0.7460.6880.625-5.318Likely Benign0.457AmbiguousLikely Benign0.165Likely Benign-4.48Deleterious0.997Probably Damaging0.993Probably Damaging2.50Benign0.01Affected0.16570.3006-3-28.3-43.03
c.3880G>T
A1294S
2D
AIThe SynGAP1 missense variant A1294S is reported in ClinVar as not yet classified (no ClinVar ID) and is present in gnomAD (variant ID 6-33447928‑G‑T). Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates benign. No Foldetta stability analysis is available. Overall, the majority of evidence points to a benign effect for A1294S, and this conclusion does not contradict the current ClinVar status, which remains unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.784345Disordered0.895011Binding0.5650.8060.6256-33447928-G-T-3.229Likely Benign0.089Likely BenignLikely Benign0.276Likely Benign-2.21Neutral0.997Probably Damaging0.991Probably Damaging2.19Pathogenic0.00Affected3.7750.23020.399011-2.616.00
c.3881C>T
A1294V
2D
AIThe SynGAP1 missense variant A1294V is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33447929‑C‑T). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive because it yields a 2‑benign/2‑pathogenic split. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy tools specifically show AlphaMissense‑Optimized as benign, SGM Consensus as inconclusive, and Foldetta as unavailable. Overall, the predictions are mixed, with one more pathogenic than benign calls. Thus, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.784345Disordered0.895011Binding0.5650.8060.6256-33447929-C-T16.45e-7-3.842Likely Benign0.105Likely BenignLikely Benign0.164Likely Benign-3.16Deleterious0.997Probably Damaging0.983Probably Damaging2.22Pathogenic0.00Affected3.7750.10330.4413002.428.05
c.3907G>T
G1303C
2D
AIThe SynGAP1 missense variant G1303C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.871313Disordered0.886612Binding0.4290.8540.875-5.286Likely Benign0.257Likely BenignLikely Benign0.377Likely Benign-2.49Neutral0.997Probably Damaging0.961Probably Damaging2.76Benign0.02Affected0.13190.3681-3-32.946.09
c.3934G>C
A1312P
2D
AIThe SynGAP1 missense variant A1312P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.767246Disordered0.971112Binding0.3920.9020.750-2.488Likely Benign0.076Likely BenignLikely Benign0.222Likely Benign-1.64Neutral0.997Probably Damaging0.995Probably Damaging3.12Benign0.00Affected0.22080.58201-1-3.426.04
c.3935C>A
A1312D
2D
AIThe SynGAP1 missense variant A1312D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors a benign outcome (2 benign vs. 1 pathogenic, with one uncertain). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the balance of evidence, particularly from the high‑accuracy tools, indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.767246Disordered0.971112Binding0.3920.9020.750-4.419Likely Benign0.398AmbiguousLikely Benign0.272Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging3.11Benign0.00Affected0.22890.29930-2-5.344.01
c.3982C>T
R1328W
2D
AIThe SynGAP1 missense variant R1328W is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33451856‑C‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized, whereas polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default predict a pathogenic outcome. ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign, while Foldetta results are unavailable. Taken together, the majority of high‑confidence predictions favor a benign impact, and there is no conflict with ClinVar status. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.887230Disordered0.911775Binding0.3600.7620.8756-33451856-C-T42.56e-6-7.022In-Between0.779Likely PathogenicLikely Benign0.125Likely Benign-2.40Neutral0.997Probably Damaging0.756Possibly Damaging4.04Benign0.00Affected3.7750.13490.2906-323.630.03
c.455G>A
R152Q
2D
AIThe SynGAP1 missense variant R152Q is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33432752‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic, two benign). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus remains unavailable, and Foldetta (combining FoldX‑MD and Rosetta outputs) has no reported result for this variant. Overall, the preponderance of evidence (seven pathogenic versus three benign predictions) indicates that the variant is most likely pathogenic, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.618285Disordered0.500158Binding0.3190.8420.625Uncertain 16-33432752-G-A53.14e-6-10.336Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.181Likely Benign-2.34Neutral0.997Probably Damaging0.968Probably Damaging3.89Benign0.00Affected3.6150.36180.2996111.0-28.06
c.460A>T
S154C
2D
AIThe SynGAP1 missense variant S154C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. ESM1b is uncertain, and Foldetta results are unavailable. The high‑accuracy consensus (SGM‑Consensus) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. With the majority of evidence pointing to a benign outcome and no conflicting ClinVar annotation, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.505461Disordered0.508330Binding0.2840.7950.500-7.728In-Between0.244Likely BenignLikely Benign0.100Likely Benign-1.83Neutral0.997Probably Damaging0.841Possibly Damaging4.01Benign0.04Affected0.12880.50420-13.316.06
c.514C>T
R172W
2D
AIThe SynGAP1 missense variant R172W is listed in ClinVar (ID 996892.0) with an “Uncertain” status and is present in gnomAD (variant ID 6‑33435156‑C‑T). Prediction tools that agree on a benign effect include REVEL and FATHMM. Those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic.” AlphaMissense‑Optimized is uncertain, and Foldetta results are unavailable. High‑accuracy assessments therefore indicate a likely pathogenic outcome (SGM‑Consensus) with no definitive stabilizing‑folding evidence. Overall, the majority of computational predictions support a pathogenic classification, which does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.525368Disordered0.491688Uncertain0.4110.6510.375Uncertain 26-33435156-C-T95.58e-6-10.258Likely Pathogenic0.878Likely PathogenicAmbiguous0.228Likely Benign-3.61Deleterious0.997Probably Damaging0.803Possibly Damaging3.95Benign0.00Affected3.6150.10710.40652-33.630.03
c.551A>T
E184V
2D
AIThe SynGAP1 missense variant E184V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic calls come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, while benign calls are made only by REVEL and FATHMM. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized scores the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability analysis is available for this variant. Overall, the preponderance of evidence indicates that E184V is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.431514Uncertain0.3480.6220.625-13.119Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.371Likely Benign-5.72Deleterious0.997Probably Damaging0.879Possibly Damaging3.44Benign0.00Affected0.09950.8511-2-27.7-29.98
c.566C>G
P189R
2D
AIThe SynGAP1 missense variant P189R has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL and FATHMM, whereas the remaining eight tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—indicate pathogenicity. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus confirms a likely pathogenic status. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect for P189R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.497853Structured0.428590Uncertain0.3310.6020.250-13.503Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.331Likely Benign-6.45Deleterious0.997Probably Damaging0.916Probably Damaging4.05Benign0.01Affected0.13630.38940-2-2.959.07
c.575C>A
A192E
2D
AIThe SynGAP1 missense variant A192E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled Likely Pathogenic. The protein‑folding stability method Foldetta has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.422041Structured0.428195Uncertain0.3210.5890.125-12.188Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.268Likely Benign-3.52Deleterious0.997Probably Damaging0.888Possibly Damaging3.93Benign0.01Affected0.09390.16280-1-5.358.04
c.577G>C
A193P
2D
AIThe SynGAP1 missense variant A193P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect are REVEL and FATHMM, while the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The high‑accuracy AlphaMissense‑Optimized model classifies the variant as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic), also yields a pathogenic consensus. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple independent predictors indicates that A193P is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.429200Structured0.428386Uncertain0.3100.5770.125-7.293In-Between0.986Likely PathogenicLikely Pathogenic0.267Likely Benign-2.70Deleterious0.997Probably Damaging0.916Probably Damaging3.99Benign0.05Affected0.18550.56011-1-3.426.04
c.578C>A
A193D
2D
AIThe SynGAP1 missense variant A193D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect are REVEL and FATHMM, while the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The high‑accuracy AlphaMissense‑Optimized model classifies the variant as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic), also yields a pathogenic consensus. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that A193D is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.429200Structured0.428386Uncertain0.3100.5770.125-7.488In-Between0.998Likely PathogenicLikely Pathogenic0.217Likely Benign-3.46Deleterious0.997Probably Damaging0.916Probably Damaging3.99Benign0.01Affected0.16880.18350-2-5.344.01
c.583G>C
A195P
2D
AIThe SynGAP1 missense variant A195P is listed in ClinVar as Pathogenic (ClinVar ID 375527.0) and is not reported in gnomAD. Prediction tools that indicate a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as likely pathogenic; Foldetta results are unavailable. Overall, the preponderance of evidence supports a pathogenic classification, which aligns with the ClinVar status and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.346032Structured0.430388Uncertain0.3630.5330.125Likely Pathogenic 1-9.715Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.152Likely Benign-3.03Deleterious0.997Probably Damaging0.916Probably Damaging4.00Benign0.04Affected3.5460.14030.44021-1-3.426.04
c.584C>A
A195E
2D
AIThe SynGAP1 missense variant A195E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.346032Structured0.430388Uncertain0.3630.5330.125-10.909Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.237Likely Benign-3.20Deleterious0.997Probably Damaging0.879Possibly Damaging4.12Benign0.02Affected0.08550.18770-1-5.358.04
c.592C>T
L198F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198F has no ClinVar entry and is absent from gnomAD. Functional prediction tools split into two consensus groups: benign predictions come from REVEL, Rosetta, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments are mixed: AlphaMissense‑Optimized and Foldetta report uncertain results, whereas the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic effect. No evidence from ClinVar contradicts these findings. Overall, the preponderance of pathogenic predictions and the SGM‑Consensus designation suggest that the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-10.602Likely Pathogenic0.930Likely PathogenicAmbiguous1.03Ambiguous0.20.27Likely Benign0.65Ambiguous0.00Likely Benign0.282Likely Benign-3.33Deleterious0.997Probably Damaging0.916Probably Damaging3.39Benign0.00Affected0.05860.311220-1.034.02
c.593T>C
L198P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198P has no ClinVar entry and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a deleterious effect. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-12.250Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.55Ambiguous0.30.40Likely Benign0.98Ambiguous0.65Ambiguous0.491Likely Benign-5.87Deleterious0.997Probably Damaging0.916Probably Damaging3.33Benign0.00Affected0.38820.1582-3-3-5.4-16.04
c.598T>A
L200M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L200M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign outcome. Only two tools, polyPhen‑2 HumDiv and HumVar, predict pathogenicity. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM‑Consensus, derived from the four high‑confidence predictors, is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign effect. Taken together, the overwhelming majority of evidence supports a benign classification for L200M, and this conclusion is consistent with the absence of a ClinVar entry. Thus, the variant is most likely benign, and this assessment does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.366687Structured0.428168Uncertain0.6870.4530.125-4.107Likely Benign0.215Likely BenignLikely Benign0.08Likely Benign0.10.41Likely Benign0.25Likely Benign-0.25Likely Benign0.139Likely Benign0.47Neutral0.997Probably Damaging0.960Probably Damaging4.11Benign0.31Tolerated0.07510.351142-1.918.03
c.600G>C
L200F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L200F is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33435242‑G‑C). Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Predictions that are inconclusive are FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428168Uncertain0.6870.4530.125Uncertain 16-33435242-G-C21.24e-6-7.606In-Between0.592Likely PathogenicLikely Benign1.00Ambiguous0.51.45Ambiguous1.23Ambiguous0.43Likely Benign0.094Likely Benign-1.97Neutral0.997Probably Damaging0.916Probably Damaging4.02Benign0.17Tolerated3.4690.06400.312020-1.034.02250.4-15.10.60.20.50.0XUncertainLeu200, a hydrophobic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another hydrophobic residue, phenylalanine. Both the phenyl group of Phe200 and the branched iso-butyl hydrocarbon sidechain of Leu200 occupy an inward hydrophobic niche (e.g., Leu246, Val222, Phe231) during the simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.600G>T
L200F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L200F missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, ESM1b, Foldetta) returned uncertain results and are not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (benign)—is benign; Foldetta remains uncertain and is treated as unavailable. Overall, the balance of evidence (six benign vs. three pathogenic predictions, with a benign consensus from high‑accuracy methods) indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428168Uncertain0.6870.4530.125-7.606In-Between0.592Likely PathogenicLikely Benign1.00Ambiguous0.51.45Ambiguous1.23Ambiguous0.43Likely Benign0.094Likely Benign-1.97Neutral0.997Probably Damaging0.916Probably Damaging4.02Benign0.17Tolerated3.4690.06400.312020-1.034.02250.4-15.10.60.20.50.0XUncertainLeu200, a hydrophobic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another hydrophobic residue, phenylalanine. Both the phenyl group of Phe200 and the branched iso-butyl hydrocarbon sidechain of Leu200 occupy an inward hydrophobic niche (e.g., Leu246, Val222, Phe231) during the simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.640C>A
L214M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L214M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are PROVEAN and FATHMM, whereas the majority of tools (REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; the remaining tools (FoldX, Rosetta, Foldetta, premPS) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two pathogenic vs two benign) and Foldetta is uncertain. Thus, the available evidence points to a pathogenic effect. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.155435Structured0.372604Uncertain0.8180.3020.125-9.347Likely Pathogenic0.958Likely PathogenicLikely Pathogenic0.74Ambiguous0.31.43Ambiguous1.09Ambiguous0.80Ambiguous0.646Likely Pathogenic-1.72Neutral0.997Probably Damaging0.916Probably Damaging5.73Benign0.01Affected0.08050.405442-1.918.03
c.641T>A
L214Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change at residue 214 (Leu→Gln) is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, the majority (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic effect, while only FATHMM predicts a benign outcome. Three tools (FoldX, Rosetta, Foldetta) return uncertain results. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta is uncertain. Taken together, the overwhelming consensus of pathogenic predictions indicates that the variant is most likely pathogenic, with no ClinVar evidence contradicting this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.372604Uncertain0.8180.3020.125-10.119Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.60Ambiguous0.61.71Ambiguous1.66Ambiguous1.73Destabilizing0.912Likely Pathogenic-5.12Deleterious0.997Probably Damaging0.936Probably Damaging5.74Benign0.00Affected0.11400.0930-2-2-7.314.97
c.641T>C
L214P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L214P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, while the remaining 15 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus, and the consensus of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the overwhelming agreement among predictive algorithms, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.372604Uncertain0.8180.3020.125-11.348Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.38Destabilizing1.37.51Destabilizing5.45Destabilizing1.30Destabilizing0.930Likely Pathogenic-5.98Deleterious0.997Probably Damaging0.916Probably Damaging5.76Benign0.00Affected0.34480.1553-3-3-5.4-16.04
c.641T>G
L214R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L214R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the majority of tools (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; FoldX, Rosetta, and Foldetta are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the evidence strongly favors a pathogenic effect for this variant, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.372604Uncertain0.8180.3020.125-11.458Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.35Ambiguous0.60.92Ambiguous1.14Ambiguous1.68Destabilizing0.927Likely Pathogenic-4.98Deleterious0.997Probably Damaging0.916Probably Damaging5.75Benign0.00Affected0.13350.0772-3-2-8.343.03
c.657T>G
C219W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C219W is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only FATHMM, whereas the majority of tools (SGM‑Consensus, REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; Rosetta and premPS are inconclusive. High‑accuracy methods give consistent pathogenic results: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Taken together, the overwhelming evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this assessment does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.254060Structured0.426845Uncertain0.9030.2790.000-16.565Likely Pathogenic1.000Likely PathogenicLikely Pathogenic10.10Destabilizing3.61.20Ambiguous5.65Destabilizing0.52Ambiguous0.706Likely Pathogenic-9.23Deleterious0.997Probably Damaging0.808Possibly Damaging5.77Benign0.00Affected0.11310.3285-8-2-3.483.07
c.700C>T
R234W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R234W missense variant is listed in ClinVar (ID 856396.0) with an “Uncertain” clinical significance and is present in gnomAD (variant ID 6‑33435551‑C‑T). Prediction tools that agree on a benign effect include premPS and FATHMM, whereas the majority of other in‑silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) indicate a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain”; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is “Uncertain.” Overall, the preponderance of evidence points to a pathogenic effect, which is consistent with the ClinVar designation of uncertainty rather than a benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.239899Structured0.311558Uncertain0.8040.3220.000Uncertain 16-33435551-C-T31.86e-6-12.625Likely Pathogenic0.947Likely PathogenicAmbiguous0.96Ambiguous0.30.69Ambiguous0.83Ambiguous0.13Likely Benign0.805Likely Pathogenic-5.52Deleterious0.997Probably Damaging0.803Possibly Damaging5.76Benign0.01Affected3.40140.13020.40352-33.630.03262.839.6-0.10.0-0.20.2XPotentially PathogenicThe guanidinium group of Arg234, located in a β-α loop between an anti-parallel β sheet strand (residues Gly227-Phe231) and an α helix (res. Ala236-Val250), forms a salt bridge with the carboxylate group of Glu238 in the α helix. Occasionally, it also bonds with the GAP domain residues Ser678 and Glu680. Thus, the positively charged Arg234 could contribute to the tertiary structure assembly between the PH and GAP domains. In contrast, the indole side chain of Trp234 in the variant is located on the protein surface in the variant simulations and is unable to form any interactions.
c.713A>T
E238V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E238V is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include premPS and FATHMM, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta give uncertain results. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic; Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E238V. This conclusion is not contradicted by ClinVar, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.194234Structured0.332638Uncertain0.7960.3260.000-14.329Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.88Ambiguous0.40.75Ambiguous0.82Ambiguous0.45Likely Benign0.890Likely Pathogenic-6.35Deleterious0.997Probably Damaging0.879Possibly Damaging5.42Benign0.00Affected0.08480.6093-2-27.7-29.98
c.731A>T
E244V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E244V missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. Four tools (FoldX, Rosetta, Foldetta, premPS) returned uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also predicts pathogenicity; Foldetta remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.450668Structured0.329406Uncertain0.7780.3600.000-12.118Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.04Ambiguous0.11.02Ambiguous1.03Ambiguous0.56Ambiguous0.925Likely Pathogenic-5.90Deleterious0.997Probably Damaging0.879Possibly Damaging5.68Benign0.00Affected0.06360.6073-2-27.7-29.98
c.736C>A
L246M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L246M has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include PROVEAN and FATHMM, while a majority (REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) are uncertain. High‑accuracy methods are inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Thus no high‑accuracy tool provides a definitive verdict. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict any ClinVar status because no ClinVar record exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.472492Structured0.302312Uncertain0.8590.3640.000-11.386Likely Pathogenic0.922Likely PathogenicAmbiguous0.65Ambiguous0.20.76Ambiguous0.71Ambiguous0.87Ambiguous0.661Likely Pathogenic-1.79Neutral0.997Probably Damaging0.916Probably Damaging4.72Benign0.01Affected0.07100.351142-1.918.03
c.737T>A
L246Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L246Q missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; Rosetta is uncertain and is not grouped. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Taken together, the overwhelming majority of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.472492Structured0.302312Uncertain0.8590.3640.000-15.420Likely Pathogenic1.000Likely PathogenicLikely Pathogenic2.82Destabilizing0.31.79Ambiguous2.31Destabilizing1.69Destabilizing0.921Likely Pathogenic-5.43Deleterious0.997Probably Damaging0.916Probably Damaging4.67Benign0.00Affected0.10920.0758-2-2-7.314.97
c.737T>C
L246P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L246P is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: the single benign prediction comes from FATHMM, while all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.472492Structured0.302312Uncertain0.8590.3640.000-16.581Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.42Destabilizing0.38.72Destabilizing7.57Destabilizing1.79Destabilizing0.944Likely Pathogenic-6.30Deleterious0.997Probably Damaging0.916Probably Damaging4.67Benign0.00Affected0.37310.1582-3-3-5.4-16.04
c.737T>G
L246R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L246R missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.472492Structured0.302312Uncertain0.8590.3640.000-13.849Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.94Destabilizing0.82.77Destabilizing3.36Destabilizing1.72Destabilizing0.925Likely Pathogenic-5.43Deleterious0.997Probably Damaging0.916Probably Damaging4.67Benign0.00Affected0.12660.0600-3-2-8.343.03
c.746C>A
A249E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A249E has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are SIFT and FATHMM. The majority of other in‑silico predictors (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the variant as pathogenic; FoldX is uncertain and is not counted as evidence for either side. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.505461Disordered0.255452Uncertain0.8100.3360.125-13.519Likely Pathogenic0.991Likely PathogenicLikely Pathogenic1.60Ambiguous1.22.59Destabilizing2.10Destabilizing1.02Destabilizing0.818Likely Pathogenic-3.29Deleterious0.997Probably Damaging0.879Possibly Damaging5.64Benign0.09Tolerated0.07990.15090-1-5.358.04
c.749T>A
V250E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V250E is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign predictions are limited to FATHMM, whereas the remaining 12 tools (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify the change as pathogenic. The high‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. No prediction or stability result is inconclusive. Consequently, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.447574Structured0.244075Uncertain0.7780.3240.125-15.723Likely Pathogenic0.983Likely PathogenicLikely Pathogenic1.85Ambiguous0.13.34Destabilizing2.60Destabilizing2.01Destabilizing0.906Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.916Probably Damaging5.74Benign0.00Affected0.07870.1564-2-2-7.729.98
c.751A>C
K251Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K251Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and polyPhen‑2 HumVar, while premPS and AlphaMissense‑Default are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Taken together, the majority of evidence supports a benign classification for K251Q, and this conclusion does not contradict the absence of a ClinVar entry. Based on the aggregate predictions, K251Q is most likely benign, and this is consistent with its absence from ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.447574Structured0.226632Uncertain0.7580.3120.125-5.869Likely Benign0.362AmbiguousLikely Benign0.36Likely Benign0.10.42Likely Benign0.39Likely Benign-0.62Ambiguous0.465Likely Benign0.55Neutral0.997Probably Damaging0.879Possibly Damaging5.86Benign0.63Tolerated0.44660.1085110.4-0.04
c.755C>G
P252R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P252R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Computational predictors that classify the variant as benign are FoldX and FATHMM, whereas the majority of tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. Predictions that are inconclusive are Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; Foldetta remains uncertain. Overall, the preponderance of evidence indicates that P252R is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.461924Structured0.211606Uncertain0.7530.3040.250-14.648Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.40Likely Benign0.11.23Ambiguous0.82Ambiguous0.81Ambiguous0.890Likely Pathogenic-8.27Deleterious0.997Probably Damaging0.916Probably Damaging5.80Benign0.00Affected0.14130.28480-2-2.959.07
c.760A>C
K254Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K254Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Foldetta, SIFT, and FATHMM. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools, Rosetta and premPS, give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. No prediction or folding stability result is missing or inconclusive. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.207751Uncertain0.7990.2850.375-12.332Likely Pathogenic0.979Likely PathogenicLikely Pathogenic0.13Likely Benign0.1-0.61Ambiguous-0.24Likely Benign0.90Ambiguous0.737Likely Pathogenic-3.04Deleterious0.997Probably Damaging0.879Possibly Damaging5.91Benign0.11Tolerated0.37490.1483110.4-0.04
c.763G>A
D255N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D255N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS and FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. FoldX, Rosetta, and Foldetta provide uncertain results. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta remains inconclusive. Overall, the consensus of the available predictions points to a pathogenic effect for D255N, and this conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.501700Disordered0.219132Uncertain0.8010.2730.250-12.251Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.86Ambiguous0.11.48Ambiguous1.17Ambiguous0.38Likely Benign0.682Likely Pathogenic-4.30Deleterious0.997Probably Damaging0.989Probably Damaging5.84Benign0.01Affected0.11170.4774210.0-0.98
c.764A>G
D255G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D255G missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include premPS and FATHMM, while the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive results and are therefore not used as evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.501700Disordered0.219132Uncertain0.8010.2730.250-12.652Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.72Ambiguous0.11.34Ambiguous1.53Ambiguous0.31Likely Benign0.885Likely Pathogenic-6.13Deleterious0.997Probably Damaging0.989Probably Damaging5.86Benign0.01Affected0.32110.51851-13.1-58.04
c.766A>G
N256D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N256D is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include Rosetta, Foldetta, premPS, and FATHMM, while the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. FoldX is uncertain and therefore not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as benign. Taken together, the overall consensus leans toward a pathogenic effect, with 10 tools supporting pathogenicity versus 4 supporting benignity. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-12.478Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.69Ambiguous0.30.21Likely Benign0.45Likely Benign0.44Likely Benign0.701Likely Pathogenic-4.36Deleterious0.997Probably Damaging0.980Probably Damaging5.81Benign0.03Affected0.18900.3514210.00.98
c.767A>C
N256T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign predictions come from Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The high‑accuracy AlphaMissense‑Optimized model classifies the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, while the Foldetta stability assessment reports a benign effect. No prediction or stability result is missing or inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-12.212Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.88Ambiguous0.1-0.18Likely Benign0.35Likely Benign0.49Likely Benign0.819Likely Pathogenic-5.25Deleterious0.997Probably Damaging0.980Probably Damaging5.85Benign0.01Affected0.12490.5848002.8-13.00
c.767A>G
N256S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256S is listed in ClinVar as Pathogenic (ClinVar ID 2584352.0) and is not reported in gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Rosetta, Foldetta, premPS, and FATHMM, while pathogenic calls come from SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy subset gives AlphaMissense‑Optimized as Uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of predictions support a pathogenic effect, aligning with the ClinVar classification. Therefore, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250Likely Pathogenic 1-10.640Likely Pathogenic0.950Likely PathogenicAmbiguous0.31Likely Benign0.20.36Likely Benign0.34Likely Benign0.48Likely Benign0.707Likely Pathogenic-4.33Deleterious0.997Probably Damaging0.970Probably Damaging5.87Benign0.02Affected3.39150.30240.5864112.7-27.03
c.768C>A
N256K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256K is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, and FATHMM. Those that predict pathogenicity comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools favor a pathogenic effect, whereas a minority suggest benign. Thus, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-13.814Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.22Likely Benign0.3-0.10Likely Benign0.06Likely Benign0.55Ambiguous0.569Likely Pathogenic-5.02Deleterious0.997Probably Damaging0.986Probably Damaging5.90Benign0.01Affected0.17020.524010-0.414.07
c.768C>G
N256K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256K is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, and FATHMM. Those that predict pathogenicity comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools support a pathogenic effect, whereas a minority suggest benign. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-13.814Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.22Likely Benign0.3-0.10Likely Benign0.06Likely Benign0.55Ambiguous0.569Likely Pathogenic-5.02Deleterious0.997Probably Damaging0.986Probably Damaging5.90Benign0.01Affected0.17020.524010-0.414.07
c.772C>A
R258S
2D
AIThe SynGAP1 missense variant R258S is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect are limited to FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the preponderance of evidence points to a pathogenic effect for R258S, and this conclusion is consistent with the absence of ClinVar annotation or gnomAD frequency data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250-14.336Likely Pathogenic0.990Likely PathogenicLikely Pathogenic2.11Destabilizing0.81.29Ambiguous1.70Ambiguous1.14Destabilizing0.796Likely Pathogenic-4.92Deleterious0.997Probably Damaging0.987Probably Damaging5.89Benign0.01Affected0.30570.38810-13.7-69.11
c.772C>G
R258G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R258G is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while the remaining twelve tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify the variant as pathogenic; premPS remains uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. No prediction is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250-14.239Likely Pathogenic0.980Likely PathogenicLikely Pathogenic2.42Destabilizing0.52.33Destabilizing2.38Destabilizing0.94Ambiguous0.788Likely Pathogenic-5.83Deleterious0.997Probably Damaging0.987Probably Damaging5.78Benign0.04Affected0.31660.3447-3-24.1-99.14
c.773G>T
R258L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R258L is not reported in ClinVar and is present in gnomAD (ID 6‑33437678‑G‑T). Prediction tools that agree on a benign effect include FoldX, Rosetta, FATHMM, and the combined Foldetta stability method. Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Two tools give inconclusive results: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.2506-33437678-G-T16.20e-7-13.302Likely Pathogenic0.905Likely PathogenicAmbiguous0.14Likely Benign0.20.10Likely Benign0.12Likely Benign0.52Ambiguous0.908Likely Pathogenic-5.90Deleterious0.997Probably Damaging0.987Probably Damaging5.84Benign0.01Affected3.39150.16060.4602-2-38.3-43.03
c.775C>G
R259G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R259G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, whereas the remaining 13 tools—including SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. The high‑accuracy subset reinforces this assessment: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. Rosetta alone is uncertain and is treated as unavailable. Overall, the consensus of available predictions indicates that R259G is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.338208Uncertain0.8850.2550.250-15.389Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.17Destabilizing0.61.53Ambiguous2.35Destabilizing1.14Destabilizing0.762Likely Pathogenic-6.43Deleterious0.997Probably Damaging0.987Probably Damaging5.78Benign0.00Affected0.33420.4139-3-24.1-99.14
c.776G>T
R259L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R259L is not reported in ClinVar and is absent from gnomAD. Among the available in‑silico predictors, the benign‑predicted tools are Rosetta and FATHMM, while the pathogenic‑predicted tools include SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; Foldetta and premPS are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the majority of predictions support a pathogenic effect, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.338208Uncertain0.8850.2550.250-14.185Likely Pathogenic0.991Likely PathogenicLikely Pathogenic2.84Destabilizing1.10.16Likely Benign1.50Ambiguous0.64Ambiguous0.894Likely Pathogenic-6.43Deleterious0.997Probably Damaging0.987Probably Damaging5.87Benign0.00Affected0.19340.5499-3-28.3-43.03
c.781G>A
D261N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261N is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include premPS, FATHMM, and AlphaMissense‑Optimized, while the majority of tools predict a pathogenic outcome: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-11.804Likely Pathogenic0.746Likely PathogenicLikely Benign1.58Ambiguous0.71.28Ambiguous1.43Ambiguous0.23Likely Benign0.579Likely Pathogenic-2.94Deleterious0.997Probably Damaging0.989Probably Damaging5.82Benign0.02Affected0.07670.4745210.0-0.98
c.782A>G
D261G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261G is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include premPS and FATHMM, while the remaining tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-10.847Likely Pathogenic0.945Likely PathogenicAmbiguous2.81Destabilizing0.52.96Destabilizing2.89Destabilizing0.21Likely Benign0.850Likely Pathogenic-4.77Deleterious0.997Probably Damaging0.989Probably Damaging5.81Benign0.02Affected0.29240.45621-13.1-58.04
c.784A>G
N262D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N262D is reported in gnomAD (ID 6‑33437689‑A‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from FoldX, Rosetta, Foldetta, and FATHMM; pathogenic predictions from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is Uncertain, SGM‑Consensus remains Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar classification because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.0006-33437689-A-G16.20e-7-13.363Likely Pathogenic0.848Likely PathogenicAmbiguous0.27Likely Benign0.10.36Likely Benign0.32Likely Benign1.16Destabilizing0.820Likely Pathogenic-4.31Deleterious0.997Probably Damaging0.980Probably Damaging5.85Benign0.05Affected3.40140.16960.2586120.00.98
c.785A>C
N262T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262T has no ClinVar record and is not reported in gnomAD. Functional prediction tools cluster into three groups: benign predictions come from SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b; the remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta’s stability analysis is uncertain. Overall, the balance of evidence leans toward pathogenicity, with no conflict with ClinVar status (which is absent). Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-11.478Likely Pathogenic0.544AmbiguousLikely Benign1.40Ambiguous0.31.44Ambiguous1.42Ambiguous0.74Ambiguous0.723Likely Pathogenic-5.23Deleterious0.997Probably Damaging0.980Probably Damaging5.88Benign0.19Tolerated0.10550.5164002.8-13.00
c.785A>G
N262S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N262S is not listed in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools cluster into two groups: benign predictions come from SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is uncertain. Consequently, the overall evidence is mixed, with a slight tilt toward pathogenicity because five tools predict pathogenic while four predict benign. The variant is most likely pathogenic based on the current predictions, and this assessment does not contradict ClinVar status, as the variant is not yet reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-8.841Likely Pathogenic0.182Likely BenignLikely Benign0.91Ambiguous0.20.90Ambiguous0.91Ambiguous0.69Ambiguous0.638Likely Pathogenic-4.31Deleterious0.997Probably Damaging0.970Probably Damaging5.84Benign0.16Tolerated0.31010.5158112.7-27.03
c.786T>A
N262K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262K has no ClinVar entry and is not present in gnomAD. Prediction tools that indicate a benign effect include FoldX, premPS, and FATHMM. Those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are reported by Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as inconclusive. Overall, the majority of evidence points to a pathogenic impact for N262K. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-12.512Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.47Likely Benign0.21.00Ambiguous0.74Ambiguous0.33Likely Benign0.531Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.986Probably Damaging5.84Benign0.02Affected0.17990.341310-0.414.07
c.786T>G
N262K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262K has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely disagree: benign predictions come from FoldX, premPS, and FATHMM, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Rosetta and Foldetta. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as inconclusive. Taken together, the majority of evidence points to a pathogenic effect for N262K. This conclusion is consistent with the absence of a ClinVar classification, as there is no existing report to contradict the prediction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-12.512Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.47Likely Benign0.21.00Ambiguous0.74Ambiguous0.33Likely Benign0.532Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.986Probably Damaging5.84Benign0.02Affected0.17990.341310-0.414.07
c.803T>C
I268T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268T is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on pathogenicity include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; no tool predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenicity, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a destabilizing, pathogenic effect. All available predictions are concordant and point to a deleterious impact. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.314336Uncertain0.9510.2640.000-10.753Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.44Destabilizing0.13.19Destabilizing3.32Destabilizing1.93Destabilizing0.828Likely Pathogenic-4.24Deleterious0.997Probably Damaging0.994Probably Damaging1.53Pathogenic0.00Affected0.08820.06380-1-5.2-12.05
c.806T>C
I269T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I269T is not reported in ClinVar (no ClinVar entry) but is present in gnomAD (variant ID 6‑33437711‑T‑C). Among general in‑silico predictors, only SIFT classifies the change as benign, whereas the remaining tools that provide a definitive call (REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic effect. High‑accuracy assessments give a more nuanced view: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also reports a pathogenic effect. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.343787Uncertain0.9370.2440.1256-33437711-T-C21.24e-6-9.376Likely Pathogenic0.887Likely PathogenicAmbiguous1.97Ambiguous0.12.10Destabilizing2.04Destabilizing1.38Destabilizing0.727Likely Pathogenic-3.70Deleterious0.997Probably Damaging0.994Probably Damaging1.72Pathogenic0.09Tolerated3.38190.08330.0808-10-5.2-12.05
c.810G>C
E270D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. The majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Rosetta. Tools with inconclusive results—FoldX, Foldetta, and premPS—are listed as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-11.954Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.52Ambiguous0.12.15Destabilizing1.84Ambiguous0.91Ambiguous0.379Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.60Pathogenic0.02Affected0.19080.2540320.0-14.03
c.810G>T
E270D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. The majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, and the SGM‑Consensus (which is “Likely Pathogenic”). Predictions that are inconclusive or uncertain are FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus also indicating a likely pathogenic outcome, while Foldetta’s stability analysis is uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E270D, and this conclusion is consistent with the lack of ClinVar annotation (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-11.954Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.52Ambiguous0.12.15Destabilizing1.84Ambiguous0.91Ambiguous0.383Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.60Pathogenic0.02Affected0.19080.2540320.0-14.03
c.844T>A
C282S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282S is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, whereas the majority of other in‑silico predictors (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all classify the variant as pathogenic. Stability‑based methods (FoldX, Rosetta, and Foldetta) return uncertain results and are therefore not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000Uncertain 1-11.846Likely Pathogenic0.958Likely PathogenicLikely Pathogenic1.55Ambiguous0.11.23Ambiguous1.39Ambiguous1.62Destabilizing0.460Likely Benign-9.19Deleterious0.997Probably Damaging0.994Probably Damaging1.64Pathogenic0.03Affected3.39180.50090.1286Weaken0-1-3.3-16.06233.214.8-0.10.0-0.20.3XPotentially BenignThe thiol-containing side chain of Cys282, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), packs against multiple hydrophobic residues (e.g., Ile268, Leu284, Trp308, Leu327). In the variant simulations, the hydroxyl-containing side chain of Ser282 is more hydrophilic and, hence, not as favorable as Cys282 for this hydrophobic niche. Due to this polarity difference, the residue swap could potentially weaken the hydrophobic packing of the C2 domain during the folding process.Moreover, because the C2 domain interacts with the membrane, there could also be a negative effect on the stability of the SynGAP-membrane association. However, no large-scale structural changes were observed during the variant simulations. The hydroxyl group of Ser282 forms a hydrogen bond with the backbone carbonyl group of His326 in another β strand (res. Ala322-Arg329), which competes directly with the backbone amide group of Glu283 within the secondary structure element.
c.845G>C
C282S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Predictions from FoldX, Rosetta, and Foldetta are inconclusive and are treated as unavailable. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, while Foldetta remains uncertain. Based on the preponderance of pathogenic predictions and the lack of benign evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000-11.846Likely Pathogenic0.958Likely PathogenicLikely Pathogenic1.55Ambiguous0.11.23Ambiguous1.39Ambiguous1.62Destabilizing0.436Likely Benign-9.19Deleterious0.997Probably Damaging0.994Probably Damaging1.64Pathogenic0.03Affected3.39180.50090.1286Weaken0-1-3.3-16.06233.214.8-0.10.0-0.20.3XPotentially BenignThe thiol-containing side chain of Cys282, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), packs against multiple hydrophobic residues (e.g., Ile268, Leu284, Trp308, Leu327). In the variant simulations, the hydroxyl-containing side chain of Ser282 is more hydrophilic and, hence, not as favorable as Cys282 for this hydrophobic niche. Due to this polarity difference, the residue swap could potentially weaken the hydrophobic packing of the C2 domain during the folding process.Moreover, because the C2 domain interacts with the membrane, there could also be a negative effect on the stability of the SynGAP-membrane association. However, no large-scale structural changes were observed during the variant simulations. The hydroxyl group of Ser282 forms a hydrogen bond with the backbone carbonyl group of His326 in another β strand (res. Ala322-Arg329), which competes directly with the backbone amide group of Glu283 within the secondary structure element.
c.849G>C
E283D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E283D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and SIFT, whereas pathogenic predictions are made by AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and FoldX. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a pathogenic change, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic. The Foldetta stability analysis is inconclusive and therefore treated as unavailable. Overall, the majority of evidence points to a pathogenic effect for E283D, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.358602Uncertain0.9500.2490.000-10.190Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.25Destabilizing0.20.94Ambiguous1.60Ambiguous0.60Ambiguous0.280Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.63Pathogenic0.06Tolerated0.20080.3480320.0-14.03
c.849G>T
E283D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E283D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and SIFT, whereas a majority of tools predict a pathogenic impact: AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and FoldX. Predictions that remain inconclusive are Foldetta, Rosetta, and premPS. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta’s stability analysis is uncertain. Overall, the preponderance of evidence indicates that E283D is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.358602Uncertain0.9500.2490.000-10.190Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.25Destabilizing0.20.94Ambiguous1.60Ambiguous0.60Ambiguous0.280Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.63Pathogenic0.06Tolerated0.20080.3480320.0-14.03
c.853T>A
C285S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285S has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas a majority of the remaining predictors (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default) indicate a pathogenic impact. The remaining tools (FoldX, Rosetta, Foldetta, ESM1b, AlphaMissense‑Optimized) return uncertain results, which are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-7.149In-Between0.868Likely PathogenicAmbiguous0.73Ambiguous0.10.75Ambiguous0.74Ambiguous1.20Destabilizing0.507Likely Pathogenic-8.09Deleterious0.997Probably Damaging0.994Probably Damaging1.90Pathogenic0.08Tolerated0.52100.2038Weaken0-1-3.3-16.06
c.854G>C
C285S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285S is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and SIFT, whereas premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. Predictions from FoldX, Rosetta, ESM1b, AlphaMissense‑Optimized, and Foldetta are inconclusive. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic classification; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. Overall, the preponderance of evidence points to a pathogenic effect for C285S, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-7.149In-Between0.868Likely PathogenicAmbiguous0.73Ambiguous0.10.75Ambiguous0.74Ambiguous1.20Destabilizing0.499Likely Benign-8.09Deleterious0.997Probably Damaging0.994Probably Damaging1.90Pathogenic0.08Tolerated0.52100.2038Weaken0-1-3.3-16.06
c.861T>A
D287E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D287E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, ESM1b, and the protein‑folding stability method Foldetta; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy AlphaMissense‑Optimized tool classifies the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (benign), FATHMM (pathogenic), and PROVEAN (pathogenic), also reports it as pathogenic. In contrast, Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect on protein stability. No evidence is available from Rosetta alone. Overall, the majority of predictions, including the high‑accuracy methods, indicate a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-5.250Likely Benign0.990Likely PathogenicLikely Pathogenic0.35Likely Benign0.20.54Ambiguous0.45Likely Benign0.50Likely Benign0.416Likely Benign-3.68Deleterious0.997Probably Damaging0.994Probably Damaging1.54Pathogenic0.01Affected0.15410.7833320.014.03
c.861T>G
D287E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D287E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, ESM1b, and the protein‑folding stability method Foldetta; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy AlphaMissense‑Optimized tool classifies the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (benign), FATHMM (pathogenic), and PROVEAN (pathogenic), also reports it as pathogenic. In contrast, Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect on protein stability. No evidence is available from Rosetta alone. Overall, the majority of predictions, including the high‑accuracy methods, indicate a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-5.250Likely Benign0.990Likely PathogenicLikely Pathogenic0.35Likely Benign0.20.54Ambiguous0.45Likely Benign0.50Likely Benign0.416Likely Benign-3.68Deleterious0.997Probably Damaging0.994Probably Damaging1.54Pathogenic0.01Affected0.15410.7833320.014.03
c.864C>A
D288E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Two tools give uncertain results: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.125101Structured0.395525Uncertain0.8730.2610.000-6.685Likely Benign0.350AmbiguousLikely Benign0.10Likely Benign0.00.74Ambiguous0.42Likely Benign-0.10Likely Benign0.203Likely Benign-2.84Deleterious0.997Probably Damaging0.994Probably Damaging1.74Pathogenic0.13Tolerated0.15590.5476320.014.03
c.864C>G
D288E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Two tools give uncertain results: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.125101Structured0.395525Uncertain0.8730.2610.000-6.685Likely Benign0.350AmbiguousLikely Benign0.10Likely Benign0.00.74Ambiguous0.42Likely Benign-0.10Likely Benign0.203Likely Benign-2.84Deleterious0.997Probably Damaging0.994Probably Damaging1.74Pathogenic0.13Tolerated0.15590.5476320.014.03
c.880A>G
T294A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T294A missense variant is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tool with an uncertain call is FoldX. High‑accuracy methods give consistent results: AlphaMissense‑Optimized predicts Pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts Likely Pathogenic, and Foldetta predicts Pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-12.371Likely Pathogenic0.971Likely PathogenicLikely Pathogenic1.87Ambiguous0.12.27Destabilizing2.07Destabilizing1.05Destabilizing0.719Likely Pathogenic-4.60Deleterious0.997Probably Damaging0.992Probably Damaging-0.18Pathogenic0.03Affected0.36870.3494102.5-30.03
c.883A>G
T295A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T295A missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into benign (REVEL, FoldX, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized) and pathogenic (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM). Four tools are uncertain (Rosetta, Foldetta, premPS, ESM1b). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as inconclusive. Overall, the majority of conventional predictors lean toward a benign effect, whereas the SGM Consensus indicates a pathogenic signal. Thus, the variant is most likely benign based on the bulk of evidence, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.401658Structured0.295548Uncertain0.8810.2880.125-7.276In-Between0.336Likely BenignLikely Benign0.22Likely Benign0.11.17Ambiguous0.70Ambiguous0.56Ambiguous0.340Likely Benign-3.51Deleterious0.997Probably Damaging0.992Probably Damaging1.96Pathogenic0.11Tolerated0.46230.4190102.5-30.03
c.893C>G
P298R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P298R has no ClinVar entry and is not reported in gnomAD. Computational predictors fall into two consensus groups: benign predictions come from REVEL, FoldX, PROVEAN, SIFT, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain results are reported only by Foldetta and premPS. High‑accuracy tools give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta reports an uncertain stability change. Overall, the majority of evidence points toward a pathogenic effect, and this assessment is not contradicted by ClinVar, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.268765Uncertain0.8600.2830.500-11.427Likely Pathogenic0.733Likely PathogenicLikely Benign0.45Likely Benign0.02.08Destabilizing1.27Ambiguous0.61Ambiguous0.280Likely Benign-1.83Neutral0.997Probably Damaging0.952Probably Damaging2.03Pathogenic0.09Tolerated0.12990.38720-2-2.959.07
c.901G>A
A301T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A301T is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33437806‑G‑A). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is benign. Overall, the majority of evidence points to a benign effect, and this is not in conflict with the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.258424Uncertain0.6470.2720.375Uncertain 56-33437806-G-A21.24e-6-3.448Likely Benign0.070Likely BenignLikely Benign0.36Likely Benign0.2-0.33Likely Benign0.02Likely Benign0.03Likely Benign0.150Likely Benign-0.25Neutral0.997Probably Damaging0.989Probably Damaging4.15Benign0.22Tolerated4.32140.13620.720110-2.530.03219.8-42.8-0.10.0-0.50.2UncertainThe methyl group of Ala301, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), points outward from the β hairpin loop, and its backbone atoms do not participate in the loop formation in the WT simulations. In the variant simulations, the hydroxyl group of the Thr301 side chain also mostly points outward; however, the guanidinium group of Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.902C>T
A301V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A301V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict pathogenicity. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Thus, the overall evidence supports a benign classification for A301V, and this conclusion is consistent with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.258424Uncertain0.6470.2720.375-2.476Likely Benign0.095Likely BenignLikely Benign0.25Likely Benign0.10.48Likely Benign0.37Likely Benign0.06Likely Benign0.116Likely Benign-0.49Neutral0.997Probably Damaging0.983Probably Damaging4.14Benign0.26Tolerated0.10960.6264002.428.05
c.912C>A
D304E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304E missense variant has no ClinVar entry and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign effect, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250-2.715Likely Benign0.233Likely BenignLikely Benign0.34Likely Benign0.10.21Likely Benign0.28Likely Benign0.48Likely Benign0.186Likely Benign-3.29Deleterious0.997Probably Damaging0.994Probably Damaging1.77Pathogenic0.04Affected0.15040.6998320.014.03
c.912C>G
D304E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304E missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—yields a tie and is therefore inconclusive. Overall, the balance of evidence favors a benign classification, and this conclusion does not conflict with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250-2.715Likely Benign0.233Likely BenignLikely Benign0.34Likely Benign0.10.21Likely Benign0.28Likely Benign0.48Likely Benign0.186Likely Benign-3.29Deleterious0.997Probably Damaging0.994Probably Damaging1.77Pathogenic0.04Affected0.15040.6998320.014.03
c.913A>C
T305P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T305P missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of tools (7 pathogenic vs. 5 benign) lean toward a pathogenic impact, and this assessment does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic based on current predictive evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.359901Structured0.299706Uncertain0.8720.2740.125-5.203Likely Benign0.177Likely BenignLikely Benign3.64Destabilizing1.16.02Destabilizing4.83Destabilizing0.71Ambiguous0.293Likely Benign-2.83Deleterious0.997Probably Damaging0.929Probably Damaging1.72Pathogenic0.06Tolerated0.22060.53330-1-0.9-3.99
c.914C>T
T305I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T305I is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33437819‑C‑T). Functional prediction tools that agree on a benign effect include REVEL, FoldX, premPS, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. The high‑accuracy AlphaMissense‑Optimized score is benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign effect. Overall, the balance of evidence from high‑confidence predictors leans toward a benign impact, and this assessment does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.359901Structured0.299706Uncertain0.8720.2740.125Uncertain 16-33437819-C-T16.20e-7-5.222Likely Benign0.305Likely BenignLikely Benign0.37Likely Benign0.20.58Ambiguous0.48Likely Benign0.25Likely Benign0.224Likely Benign-2.90Deleterious0.997Probably Damaging0.929Probably Damaging1.70Pathogenic0.04Affected3.40200.09390.5693-105.212.05
c.917T>C
V306A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas the remaining tools (SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) all predict a pathogenic outcome; ESM1b is uncertain and therefore not counted. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a likely pathogenic verdict from the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and a pathogenic prediction from Foldetta. Taken together, the preponderance of evidence indicates that V306A is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.315026Uncertain0.8960.2870.125-7.924In-Between0.599Likely PathogenicLikely Benign2.76Destabilizing0.13.00Destabilizing2.88Destabilizing2.25Destabilizing0.300Likely Benign-2.94Deleterious0.997Probably Damaging0.992Probably Damaging1.77Pathogenic0.05Affected0.26870.198900-2.4-28.05
c.919T>A
F307I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307I is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign are FoldX, Rosetta, and Foldetta. Tools that predict it as pathogenic include SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments give AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Benign. Overall, the majority of predictions (10/13) indicate pathogenicity, while only three tools suggest benign. Therefore, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-13.114Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.49Likely Benign0.20.19Likely Benign0.34Likely Benign0.61Ambiguous0.632Likely Pathogenic-5.52Deleterious0.997Probably Damaging0.994Probably Damaging2.06Pathogenic0.01Affected0.25310.3036101.7-34.02
c.919T>G
F307V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307V is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include Rosetta and premPS, whereas the majority of other in silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) and the consensus score SGM‑Consensus all classify the change as pathogenic or likely pathogenic. High‑accuracy methods give a pathogenic call from AlphaMissense‑Optimized, a likely pathogenic result from the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and an inconclusive result from Foldetta (combining FoldX‑MD and Rosetta). No prediction is missing or inconclusive enough to alter the overall assessment. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-12.262Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.91Ambiguous0.10.10Likely Benign0.51Ambiguous0.36Likely Benign0.605Likely Pathogenic-6.43Deleterious0.997Probably Damaging0.992Probably Damaging2.29Pathogenic0.05Affected0.25230.3393-1-11.4-48.04
c.920T>A
F307Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307Y is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently contains no assertion for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-9.870Likely Pathogenic0.889Likely PathogenicAmbiguous0.36Likely Benign0.1-0.21Likely Benign0.08Likely Benign0.11Likely Benign0.596Likely Pathogenic-2.76Deleterious0.997Probably Damaging0.987Probably Damaging1.96Pathogenic0.05Affected0.15700.232573-4.116.00
c.930G>C
E310D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E310D is reported in ClinVar (ID 975473.0) as Pathogenic and is not found in gnomAD. Prediction tools that assess the variant’s effect all converge on a deleterious outcome: REVEL, FoldX (uncertain), Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, leaving no tool in the benign category. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also reports Pathogenic. The single uncertain result from FoldX is treated as unavailable. Overall, the variant is most likely pathogenic, and this assessment is consistent with its ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125Likely Pathogenic1-11.218Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.87Ambiguous0.52.39Destabilizing2.13Destabilizing1.04Destabilizing0.666Likely Pathogenic-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.19Pathogenic0.02Affected3.38190.19810.5222320.0-14.03232.627.20.10.00.10.1XPotentially BenignThe carboxylate group of Glu310, located in an anti-parallel β sheet strand (res. Thr305-Asn315), is ideally positioned to interact with the hydroxyl and backbone amide groups of Thr295 on a twisted anti-parallel β strand. Because the carboxylate group can also interact with the GAP domain residues (e.g., Gln612, Tyr614), Glu310 potentially plays a key role in maintaining the tertiary assembly between the C2 and GAP domains. In the variant simulations, the carboxylate group of Asp310 can form the same interactions as glutamate; however, due to its one hydrocarbon shorter length, the connections are less stable or less optimal.
c.930G>T
E310D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E310D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity uniformly favor a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL (Pathogenic), Rosetta (Pathogenic), Foldetta (Pathogenic), premPS (Pathogenic), PROVEAN (Pathogenic), polyPhen‑2 HumDiv (Pathogenic), polyPhen‑2 HumVar (Pathogenic), SIFT (Pathogenic), ESM1b (Pathogenic), FATHMM (Pathogenic), AlphaMissense‑Default (Pathogenic), and AlphaMissense‑Optimized (Pathogenic). No tool predicts a benign outcome; the only inconclusive result is FoldX (Uncertain). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently has no entry for E310D.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125-11.218Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.87Ambiguous0.52.39Destabilizing2.13Destabilizing1.04Destabilizing0.666Likely Pathogenic-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.19Pathogenic0.02Affected3.38190.19810.5222320.0-14.03232.627.20.10.00.10.1XPotentially BenignThe carboxylate group of Glu310, located in an anti-parallel β sheet strand (res. Thr305-Asn315), is ideally positioned to interact with the hydroxyl and backbone amide groups of Thr295 on a twisted anti-parallel β strand. Because the carboxylate group can also interact with the GAP domain residues (e.g., Gln612, Tyr614), Glu310 potentially plays a key role in maintaining the tertiary assembly between the C2 and GAP domains. In the variant simulations, the carboxylate group of Asp310 can form the same interactions as glutamate; however, due to its one hydrocarbon shorter length, the connections are less stable or less optimal.
c.931C>A
H311N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H311N missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results are reported for FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the majority of evaluated tools predict pathogenicity, suggesting that H311N is most likely pathogenic. This prediction does not contradict ClinVar status, as no ClinVar classification is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-9.545Likely Pathogenic0.661Likely PathogenicLikely Benign0.82Ambiguous0.11.12Ambiguous0.97Ambiguous0.72Ambiguous0.475Likely Benign-5.35Deleterious0.997Probably Damaging0.992Probably Damaging1.89Pathogenic0.06Tolerated0.15660.238021-0.3-23.04
c.931C>G
H311D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H311D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that assess evolutionary conservation and protein function uniformly indicate a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as pathogenic. The majority‑vote consensus (SGM‑Consensus) also reports it as likely pathogenic. Tools that evaluate structural stability give inconclusive results: FoldX, Rosetta, Foldetta, and premPS are listed as uncertain. High‑accuracy assessments further support a damaging outcome: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (derived from the same set of predictors) reports likely pathogenic, while Foldetta’s combined FoldX‑MD/Rosetta stability analysis remains uncertain. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect, which is consistent with the absence of a benign ClinVar annotation and the lack of population frequency data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-13.513Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.27Ambiguous0.01.83Ambiguous1.55Ambiguous0.89Ambiguous0.633Likely Pathogenic-6.94Deleterious0.997Probably Damaging0.994Probably Damaging1.94Pathogenic0.02Affected0.23010.20081-1-0.3-22.05
c.931C>T
H311Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H311Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Tools with uncertain or inconclusive results—Rosetta, Foldetta, and AlphaMissense‑Default—are treated as unavailable for pathogenicity assessment. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta remains uncertain. Overall, the predictions are split, with five tools favoring benign, five favoring pathogenic, and three inconclusive. Based on the available evidence, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.229226Structured0.354792Uncertain0.9020.3140.125-4.513Likely Benign0.342AmbiguousLikely Benign-0.06Likely Benign0.2-1.58Ambiguous-0.82Ambiguous0.18Likely Benign0.456Likely Benign-3.80Deleterious0.997Probably Damaging0.992Probably Damaging1.86Pathogenic0.02Affected0.09650.4180021.926.03
c.932A>G
H311R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H311R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, SIFT, and AlphaMissense‑Optimized, whereas a majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic outcome. Tools with uncertain or inconclusive results are Rosetta, Foldetta, and premPS. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized indicates benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates pathogenic, and Foldetta remains uncertain. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-9.825Likely Pathogenic0.719Likely PathogenicLikely Benign0.43Likely Benign0.10.85Ambiguous0.64Ambiguous0.70Ambiguous0.532Likely Pathogenic-5.72Deleterious0.997Probably Damaging0.994Probably Damaging1.94Pathogenic0.14Tolerated0.19310.249020-1.319.05
c.934T>A
F312I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312I is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity uniformly classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect, so the benign group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-12.000Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.09Destabilizing0.33.10Destabilizing2.60Destabilizing1.72Destabilizing0.872Likely Pathogenic-5.52Deleterious0.997Probably Damaging0.994Probably Damaging1.23Pathogenic0.01Affected0.19970.2842101.7-34.02
c.934T>G
F312V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312V is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify the change as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-12.206Likely Pathogenic0.993Likely PathogenicLikely Pathogenic2.13Destabilizing0.13.46Destabilizing2.80Destabilizing1.80Destabilizing0.877Likely Pathogenic-6.43Deleterious0.997Probably Damaging0.992Probably Damaging1.25Pathogenic0.00Affected0.19980.2810-1-11.4-48.04
c.935T>A
F312Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a deleterious effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default, all of which classify the change as pathogenic. No tool in the dataset predicts a benign outcome. High‑accuracy assessments show the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta provide uncertain results. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-7.571In-Between0.949Likely PathogenicAmbiguous1.04Ambiguous0.10.89Ambiguous0.97Ambiguous0.99Ambiguous0.744Likely Pathogenic-2.76Deleterious0.997Probably Damaging0.987Probably Damaging1.21Pathogenic0.02Affected0.14430.272873-4.116.00
c.939G>C
E313D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E313D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and SIFT, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicating a likely pathogenic effect, and Foldetta yielding an uncertain stability change. Overall, the balance of evidence points to a pathogenic interpretation; this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125-8.309Likely Pathogenic0.636Likely PathogenicLikely Benign0.87Ambiguous0.00.96Ambiguous0.92Ambiguous0.60Ambiguous0.346Likely Benign-1.66Neutral0.997Probably Damaging0.992Probably Damaging1.88Pathogenic0.14Tolerated0.19700.4640320.0-14.03
c.939G>T
E313D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E313D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and SIFT, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicating a likely pathogenic outcome, and Foldetta yielding an uncertain stability change. Overall, the balance of evidence points to a pathogenic effect for E313D, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125-8.309Likely Pathogenic0.636Likely PathogenicLikely Benign0.87Ambiguous0.00.96Ambiguous0.92Ambiguous0.60Ambiguous0.346Likely Benign-1.66Neutral0.997Probably Damaging0.992Probably Damaging1.88Pathogenic0.14Tolerated0.19700.4640320.0-14.03
c.940T>A
F314I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a pathogenic effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict deleterious or pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. Tools with uncertain or inconclusive results include Rosetta, Foldetta, and ESM1b. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, while Foldetta’s stability prediction is uncertain. Overall, the majority of evidence points to a pathogenic effect, and this is consistent with the lack of ClinVar annotation (i.e., no benign classification). Therefore, the variant is most likely pathogenic, and there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-7.059In-Between0.992Likely PathogenicLikely Pathogenic2.23Destabilizing0.41.08Ambiguous1.66Ambiguous1.31Destabilizing0.534Likely Pathogenic-4.98Deleterious0.997Probably Damaging0.994Probably Damaging1.26Pathogenic0.01Affected0.20520.2308101.7-34.02
c.940T>G
F314V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314V is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). All available in silico predictors classify the variant as pathogenic: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect, so the benign group is empty. High‑accuracy methods—AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta—each return a pathogenic prediction. No predictions or stability results are missing or inconclusive. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-8.907Likely Pathogenic0.991Likely PathogenicLikely Pathogenic3.31Destabilizing0.42.54Destabilizing2.93Destabilizing1.44Destabilizing0.594Likely Pathogenic-5.90Deleterious0.997Probably Damaging0.992Probably Damaging1.26Pathogenic0.00Affected0.20540.2075-1-11.4-48.04
c.941T>A
F314Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and Rosetta, whereas a majority of tools (SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Predictions that are inconclusive—AlphaMissense‑Optimized, FoldX, and Foldetta—are treated as unavailable. High‑accuracy assessments further support pathogenicity: the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, while Foldetta’s combined stability analysis is uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-13.297Likely Pathogenic0.918Likely PathogenicAmbiguous1.33Ambiguous0.10.29Likely Benign0.81Ambiguous1.28Destabilizing0.374Likely Benign-2.62Deleterious0.997Probably Damaging0.987Probably Damaging1.20Pathogenic0.02Affected0.14270.217373-4.116.00
c.967C>A
L323M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L323M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The remaining tools—Foldetta, premPS, AlphaMissense‑Default, ESM1b, and Rosetta—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is also inconclusive. Taken together, the evidence leans toward a benign impact for the variant, and this assessment does not contradict any ClinVar annotation, as none exists for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.268042Structured0.428564Uncertain0.9560.3690.000-7.065In-Between0.427AmbiguousLikely Benign0.11Likely Benign0.11.82Ambiguous0.97Ambiguous0.93Ambiguous0.270Likely Benign-1.02Neutral0.997Probably Damaging0.939Probably Damaging0.64Pathogenic0.03Affected0.06370.301042-1.918.03
c.973C>A
L325M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and premPS. Two tools give uncertain results: Foldetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. No prediction or folding stability result is missing or inconclusive. Overall, the majority of tools (six pathogenic vs five benign) lean toward pathogenicity, but the high‑accuracy methods and several benign predictions introduce uncertainty. Thus, the variant is most likely pathogenic based on the collective evidence, and this assessment is not contradicted by any ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.424577Uncertain0.9550.4360.000-6.725Likely Benign0.445AmbiguousLikely Benign0.22Likely Benign0.02.04Destabilizing1.13Ambiguous1.05Destabilizing0.306Likely Benign-0.86Neutral0.997Probably Damaging0.939Probably Damaging1.36Pathogenic0.01Affected0.09340.394242-1.918.03
c.976C>A
H326N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326N has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and SIFT, whereas a majority (seven) predict a pathogenic outcome: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the balance of evidence points to a pathogenic impact for H326N, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.914Likely Pathogenic0.925Likely PathogenicAmbiguous0.81Ambiguous0.21.48Ambiguous1.15Ambiguous0.97Ambiguous0.409Likely Benign-5.63Deleterious0.997Probably Damaging0.992Probably Damaging1.95Pathogenic0.11Tolerated0.19290.255221-0.3-23.04
c.976C>G
H326D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326D missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only SIFT, which scores the variant as benign. All other evaluated algorithms—REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic outcome. Tools with inconclusive results are FoldX, Foldetta, and premPS, which are listed as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, reports an uncertain result. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-13.000Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.87Ambiguous0.62.00Destabilizing1.44Ambiguous0.96Ambiguous0.561Likely Pathogenic-7.67Deleterious0.997Probably Damaging0.994Probably Damaging2.04Pathogenic0.10Tolerated0.26120.16111-1-0.3-22.05
c.976C>T
H326Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas a majority of tools (REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of evidence points to a pathogenic effect for H326Y, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-10.896Likely Pathogenic0.855Likely PathogenicAmbiguous0.03Likely Benign0.40.25Likely Benign0.14Likely Benign0.07Likely Benign0.562Likely Pathogenic-5.32Deleterious0.997Probably Damaging0.992Probably Damaging1.92Pathogenic0.02Affected0.07960.4323021.926.03
c.977A>G
H326R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326R missense variant is not listed in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include SIFT and Foldetta, whereas the remaining tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports it as likely pathogenic; Foldetta, a protein‑folding stability approach that integrates FoldX‑MD and Rosetta outputs, predicts a benign effect. Because the majority of evidence points to a deleterious change, the variant is most likely pathogenic, and this assessment is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-12.369Likely Pathogenic0.980Likely PathogenicLikely Pathogenic-0.65Ambiguous0.11.40Ambiguous0.38Likely Benign0.83Ambiguous0.601Likely Pathogenic-6.89Deleterious0.997Probably Damaging0.994Probably Damaging1.97Pathogenic0.10Tolerated0.18320.241320-1.319.05
c.996C>A
D332E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332E missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split. Overall, the majority of evidence points to a benign effect. This conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.339168Structured0.336528Uncertain0.5370.4450.375-4.915Likely Benign0.320Likely BenignLikely Benign0.50Ambiguous0.20.04Likely Benign0.27Likely Benign0.35Likely Benign0.191Likely Benign-2.66Deleterious0.997Probably Damaging0.994Probably Damaging1.29Pathogenic0.24Tolerated0.09700.3915320.014.03
c.996C>G
D332E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign classification. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.339168Structured0.336528Uncertain0.5370.4450.375-4.915Likely Benign0.320Likely BenignLikely Benign0.50Ambiguous0.20.04Likely Benign0.27Likely Benign0.35Likely Benign0.188Likely Benign-2.66Deleterious0.997Probably Damaging0.994Probably Damaging1.29Pathogenic0.24Tolerated0.09700.3915320.014.03
c.1034T>C
L345P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L345P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.354989Uncertain0.9360.4780.125-10.994Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.33Destabilizing0.23.26Destabilizing3.30Destabilizing1.27Destabilizing0.335Likely Benign-4.80Deleterious0.998Probably Damaging0.889Possibly Damaging1.70Pathogenic0.02Affected0.35810.1342-3-3-5.4-16.04
c.1067G>C
R356P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R356P missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FoldX, whereas a majority of tools (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Predictions that are inconclusive are AlphaMissense‑Optimized, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for R356P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.219301Structured0.395028Uncertain0.8020.3730.250-12.956Likely Pathogenic0.919Likely PathogenicAmbiguous0.48Likely Benign0.10.72Ambiguous0.60Ambiguous1.05Destabilizing0.451Likely Benign-6.23Deleterious0.998Probably Damaging0.992Probably Damaging1.72Pathogenic0.02Affected0.22130.50330-22.9-59.07
c.1073T>C
F358S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F358S variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of algorithms predict a pathogenic outcome: FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Rosetta’s assessment is uncertain and is not taken as evidence. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the preponderance of pathogenic predictions and the agreement of the high‑accuracy tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.407113Uncertain0.9120.4410.250-9.316Likely Pathogenic0.977Likely PathogenicLikely Pathogenic2.32Destabilizing0.21.97Ambiguous2.15Destabilizing1.14Destabilizing0.493Likely Benign-6.48Deleterious0.998Probably Damaging0.986Probably Damaging4.07Benign0.20Tolerated0.38910.1333-3-2-3.6-60.10
c.1136C>G
S379W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S379W is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33438041‑C‑G). Prediction tools that indicate a benign effect include premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact comprise REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus as benign. Because the majority of conventional tools favor pathogenicity while the high‑accuracy subset is split, the overall evidence leans toward a pathogenic effect. This conclusion does not contradict the ClinVar uncertain status, which remains unresolved.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.728858Disordered0.433206Uncertain0.3270.9310.625Uncertain 16-33438041-C-G-8.898Likely Pathogenic0.388AmbiguousLikely Benign4.32Destabilizing3.43.56Destabilizing3.94Destabilizing0.16Likely Benign0.520Likely Pathogenic-1.02Neutral0.998Probably Damaging0.844Possibly Damaging3.82Benign0.01Affected4.32110.11960.6070-2-3-0.199.14271.3-75.71.41.00.60.5UncertainSer379 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like tryptophan are rarely tolerated. Although no major negative structural effects are observed in the variant simulations, Trp379 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn
c.1150G>T
G384C
2D
AIThe SynGAP1 missense variant G384C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts pathogenic; and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split and is treated as unavailable. Overall, the majority of predictions (seven pathogenic vs. five benign) and the pathogenic Foldetta result indicate that the variant is most likely pathogenic, with no contradiction to ClinVar status because the variant is not yet classified there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.728858Disordered0.427831Uncertain0.3230.9340.750-8.363Likely Pathogenic0.135Likely BenignLikely Benign2.41Destabilizing2.05.50Destabilizing3.96Destabilizing0.17Likely Benign0.456Likely Benign-1.07Neutral0.998Probably Damaging0.993Probably Damaging1.32Pathogenic0.01Affected0.15300.4240-3-32.946.09
c.1162G>T
G388C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 G388C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from AlphaMissense‑Default, AlphaMissense‑Optimized, premPS, and PROVEAN, while pathogenic predictions arise from REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized predicts benign, Foldetta predicts pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive. Because the majority of evidence points to pathogenicity and there is no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.736850Disordered0.420316Uncertain0.3190.8270.750-8.088Likely Pathogenic0.121Likely BenignLikely Benign4.01Destabilizing3.74.95Destabilizing4.48Destabilizing0.03Likely Benign0.603Likely Pathogenic-0.98Neutral0.998Probably Damaging0.993Probably Damaging1.32Pathogenic0.01Affected0.14970.4112-3-32.946.09
c.1207A>G
K403E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K403E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact for K403E, and this conclusion does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.424920Uncertain0.9600.3720.000-15.279Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.01Ambiguous0.10.79Ambiguous0.90Ambiguous0.70Ambiguous0.445Likely Benign-3.62Deleterious0.998Probably Damaging0.981Probably Damaging3.79Benign0.04Affected0.36500.1715010.40.94
c.1217A>G
Y406C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y406C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome, and the Foldetta stability assessment (combining FoldX‑MD and Rosetta) predicts a destabilizing, pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while both SGM‑Consensus and Foldetta are pathogenic. Overall, the preponderance of evidence points to a pathogenic effect for Y406C, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.393707Uncertain0.9460.2910.000-9.954Likely Pathogenic0.810Likely PathogenicAmbiguous2.47Destabilizing0.23.22Destabilizing2.85Destabilizing1.27Destabilizing0.229Likely Benign-6.72Deleterious0.998Probably Damaging0.851Possibly Damaging3.78Benign0.01Affected0.30260.28610-23.8-60.04
c.1222A>C
T408P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T408P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. FoldX, premPS, and Foldetta are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie and thus unavailable; Foldetta remains uncertain. Overall, the majority of available predictions (six pathogenic vs. four benign) indicate that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.161087Structured0.370935Uncertain0.9070.2390.000-10.384Likely Pathogenic0.230Likely BenignLikely Benign1.08Ambiguous0.32.27Destabilizing1.68Ambiguous0.73Ambiguous0.323Likely Benign-4.19Deleterious0.998Probably Damaging0.963Probably Damaging4.07Benign0.05Affected0.19850.57790-1-0.9-3.99
c.1231A>T
I411F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I411F is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; premPS is uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.339366Uncertain0.9270.1980.000-13.377Likely Pathogenic0.977Likely PathogenicLikely Pathogenic5.71Destabilizing0.14.53Destabilizing5.12Destabilizing0.73Ambiguous0.503Likely Pathogenic-3.69Deleterious0.998Probably Damaging0.973Probably Damaging3.30Benign0.00Affected0.05380.285310-1.734.02
c.1243G>A
E415K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E415K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus shows AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall balance of predictions—particularly the two high‑accuracy pathogenic calls versus one benign—the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.100716Structured0.330366Uncertain0.9150.2360.000-11.433Likely Pathogenic0.997Likely PathogenicLikely Pathogenic-0.07Likely Benign0.3-0.13Likely Benign-0.10Likely Benign0.46Likely Benign0.326Likely Benign-3.69Deleterious0.998Probably Damaging0.975Probably Damaging3.22Benign0.03Affected0.21740.386001-0.4-0.94
c.1244A>T
E415V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E415V missense variant is not reported in ClinVar or gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are reported by SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give a mixed signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) predicts benign. No evidence is missing or inconclusive. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.100716Structured0.330366Uncertain0.9150.2360.000-11.182Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.56Ambiguous0.20.14Likely Benign0.35Likely Benign0.40Likely Benign0.441Likely Benign-6.52Deleterious0.998Probably Damaging0.983Probably Damaging3.13Benign0.02Affected0.06500.4218-2-27.7-29.98
c.1255G>A
E419K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419K missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Tools that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Foldetta and Rosetta give uncertain results and are not counted in either group. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus predicts likely pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact for E419K. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.371949Uncertain0.9610.2610.000-12.257Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.01Likely Benign0.11.30Ambiguous0.66Ambiguous-0.03Likely Benign0.399Likely Benign-3.75Deleterious0.998Probably Damaging0.975Probably Damaging3.36Benign0.07Tolerated0.27590.689901-0.4-0.94
c.1256A>T
E419V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419V missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, FoldX, FATHMM, and premPS, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, the SGM Consensus also indicates Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. No evidence from the high‑accuracy tools contradicts the pathogenic prediction. Overall, the majority of computational evidence points to a pathogenic effect, which is consistent with the lack of ClinVar reporting and gnomAD absence, suggesting the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.371949Uncertain0.9610.2610.000-12.290Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.45Likely Benign0.01.41Ambiguous0.93Ambiguous0.27Likely Benign0.494Likely Benign-6.55Deleterious0.998Probably Damaging0.983Probably Damaging3.35Benign0.01Affected0.09530.6834-2-27.7-29.98
c.1259T>C
F420S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420S (ClinVar ID 981441.0) is reported as Pathogenic in ClinVar and is not present in gnomAD. Prediction tools largely agree on a deleterious effect: all listed predictors except FATHMM return a pathogenic or likely pathogenic call. The single benign prediction comes from FATHMM. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts Pathogenic. No predictions or folding‑stability results are missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000Likely Pathogenic 1-13.231Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.34Destabilizing0.15.73Destabilizing5.54Destabilizing2.14Destabilizing0.544Likely Pathogenic-7.43Deleterious0.998Probably Damaging0.938Probably Damaging3.09Benign0.00Affected3.37290.41670.0200-3-2-3.6-60.10213.357.80.00.0-0.40.1XPotentially PathogenicIn the WT, the phenyl ring of the Phe420 side chain, located on an α helix (res. Met414-Glu436), packs against hydrophobic residues in the interhelix area of the GAP domain (e.g., Leu689, Leu714, Leu717, Leu718). Although no large-scale adverse effects are seen in the variant simulations, the polar hydroxyl group of Ser420 is not suitable for the hydrophobic inter-helix space. Thus, the residue swap could affect protein folding. In theory, the introduced hydroxyl group could also lower the α helix integrity by H-bonding with the backbone atoms of neighboring residues in the same α helix. However, no such effect is seen in the variant simulations.
c.1259T>G
F420C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420C is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity largely agree: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. Only FATHMM predicts a benign outcome. When grouped by consensus, the benign prediction is singular (FATHMM), whereas the pathogenic predictions comprise the remaining eleven tools. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000-11.931Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.31Destabilizing0.15.11Destabilizing4.71Destabilizing2.49Destabilizing0.500Likely Pathogenic-7.40Deleterious0.998Probably Damaging0.869Possibly Damaging3.09Benign0.00Affected0.24580.0662-4-2-0.3-44.04
c.1264G>A
E422K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E422K missense variant is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split opinion: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM, while pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus also indicates Likely Pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign effect. Overall, the balance of evidence leans toward pathogenicity, and this assessment does not contradict any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.426709Uncertain0.9650.2550.000-13.042Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.30Likely Benign0.00.10Likely Benign0.20Likely Benign0.32Likely Benign0.346Likely Benign-3.52Deleterious0.998Probably Damaging0.975Probably Damaging3.39Benign0.04Affected0.19950.512901-0.4-0.94
c.1265A>T
E422V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E422V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, Foldetta, premPS, and FATHMM, while pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic effect. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus confirms a likely pathogenic outcome, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign effect. FoldX remains uncertain. Overall, the majority of high‑confidence tools lean toward pathogenicity, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.426709Uncertain0.9650.2550.000-12.371Likely Pathogenic0.982Likely PathogenicLikely Pathogenic0.90Ambiguous0.1-0.02Likely Benign0.44Likely Benign0.24Likely Benign0.489Likely Benign-6.38Deleterious0.998Probably Damaging0.983Probably Damaging3.29Benign0.00Affected0.06090.5457-2-27.7-29.98
c.1273A>T
T425S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, Rosetta) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (five benign vs. four pathogenic) lean toward a benign interpretation, and this assessment does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.041405Structured0.401218Uncertain0.9640.2800.000-7.420In-Between0.676Likely PathogenicLikely Benign0.22Likely Benign0.10.77Ambiguous0.50Ambiguous0.63Ambiguous0.275Likely Benign-3.05Deleterious0.998Probably Damaging0.994Probably Damaging3.42Benign0.07Tolerated0.25110.232411-0.1-14.03
c.1274C>G
T425S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, Rosetta) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (five benign vs. four pathogenic) lean toward a benign interpretation, and this assessment does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.041405Structured0.401218Uncertain0.9640.2800.000-7.420In-Between0.676Likely PathogenicLikely Benign0.22Likely Benign0.10.77Ambiguous0.50Ambiguous0.63Ambiguous0.184Likely Benign-3.05Deleterious0.998Probably Damaging0.994Probably Damaging3.42Benign0.07Tolerated0.25110.232411-0.1-14.03
c.1276A>C
N426H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Predictions that are uncertain or inconclusive are FoldX and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign; and Foldetta also predicts a benign outcome. No prediction tool is missing or inconclusive in this set. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-7.004In-Between0.248Likely BenignLikely Benign0.64Ambiguous0.0-0.14Likely Benign0.25Likely Benign0.24Likely Benign0.237Likely Benign-3.57Deleterious0.998Probably Damaging0.985Probably Damaging3.29Benign0.14Tolerated0.12670.3124210.323.04
c.1276A>G
N426D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Three tools (FoldX, premPS, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions (six benign vs. four pathogenic) and the two high‑accuracy benign calls suggest the variant is most likely benign, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.159Likely Pathogenic0.554AmbiguousLikely Benign0.80Ambiguous0.00.18Likely Benign0.49Likely Benign0.64Ambiguous0.173Likely Benign-3.09Deleterious0.998Probably Damaging0.980Probably Damaging3.34Benign0.09Tolerated0.17300.1746210.00.98
c.1277A>G
N426S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The high‑accuracy AlphaMissense‑Optimized score is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and the Foldetta stability assessment is inconclusive. No evidence from FoldX or Rosetta is available. Overall, the majority of predictions support a benign impact, and this is consistent with the absence of a ClinVar assertion. Therefore, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.042364Structured0.394941Uncertain0.9590.2870.000-5.215Likely Benign0.081Likely BenignLikely Benign0.81Ambiguous0.00.52Ambiguous0.67Ambiguous0.03Likely Benign0.131Likely Benign-2.37Neutral0.998Probably Damaging0.921Probably Damaging3.47Benign0.33Tolerated0.22240.3188112.7-27.03
c.1277A>T
N426I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N426I has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and the protein‑folding stability method Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicting pathogenicity, and Foldetta indicating a benign folding stability outcome. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-10.158Likely Pathogenic0.570Likely PathogenicLikely Benign0.67Ambiguous0.00.14Likely Benign0.41Likely Benign0.23Likely Benign0.216Likely Benign-5.71Deleterious0.998Probably Damaging0.991Probably Damaging3.31Benign0.09Tolerated0.06560.3244-2-38.0-0.94
c.1278C>A
N426K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426K resides in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give inconclusive results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which is currently unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.659Likely Pathogenic0.867Likely PathogenicAmbiguous0.03Likely Benign0.00.00Likely Benign0.02Likely Benign0.54Ambiguous0.197Likely Benign-3.86Deleterious0.998Probably Damaging0.978Probably Damaging3.38Benign0.12Tolerated0.19060.282210-0.414.07
c.1278C>G
N426K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N426K is located in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, SIFT, and FATHMM, while those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools report uncertainty: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect on protein stability. Overall, the majority of predictions lean toward pathogenicity, with a split in the most reliable methods. Therefore, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.659Likely Pathogenic0.867Likely PathogenicAmbiguous0.03Likely Benign0.00.00Likely Benign0.02Likely Benign0.54Ambiguous0.197Likely Benign-3.86Deleterious0.998Probably Damaging0.978Probably Damaging3.38Benign0.12Tolerated0.19060.282210-0.414.07
c.1297G>C
A433P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 A433P is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, SIFT, and FATHMM. Those that predict pathogenicity comprise FoldX, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. The remaining tools, premPS and AlphaMissense‑Optimized, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of evidence points to a pathogenic effect, which is consistent with the lack of ClinVar annotation and gnomAD absence. Therefore, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.098513Structured0.352258Uncertain0.9380.3020.000-9.887Likely Pathogenic0.883Likely PathogenicAmbiguous2.48Destabilizing0.07.09Destabilizing4.79Destabilizing0.55Ambiguous0.217Likely Benign-2.64Deleterious0.998Probably Damaging0.820Possibly Damaging3.37Benign0.07Tolerated0.14710.41501-1-3.426.04
c.1298C>A
A433E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A433E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Two tools (premPS and AlphaMissense‑Default) give uncertain results. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign prediction; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports benign. No prediction is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.098513Structured0.352258Uncertain0.9380.3020.000-8.210Likely Pathogenic0.506AmbiguousLikely Benign-0.20Likely Benign0.00.15Likely Benign-0.03Likely Benign0.58Ambiguous0.148Likely Benign-1.65Neutral0.998Probably Damaging0.824Possibly Damaging3.42Benign0.18Tolerated0.07830.16950-1-5.358.04
c.1307A>C
E436A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E436A is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include Foldetta, premPS, and FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. Two high‑accuracy predictors give concordant results: AlphaMissense‑Optimized predicts pathogenic, and the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a benign effect. No prediction is missing or inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for E436A, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.239899Structured0.321046Uncertain0.9340.2890.000-12.678Likely Pathogenic0.971Likely PathogenicLikely Pathogenic1.03Ambiguous0.0-0.88Ambiguous0.08Likely Benign0.23Likely Benign0.825Likely Pathogenic-5.68Deleterious0.998Probably Damaging0.991Probably Damaging4.65Benign0.05Affected0.39010.51160-15.3-58.04
c.1324A>C
K442Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K442Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.255766Uncertain0.9120.2250.000-10.410Likely Pathogenic0.562AmbiguousLikely Benign0.05Likely Benign0.10.03Likely Benign0.04Likely Benign0.25Likely Benign0.268Likely Benign-3.10Deleterious0.998Probably Damaging0.995Probably Damaging3.39Benign0.18Tolerated0.33530.1014110.4-0.04
c.1330A>C
K444Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K444Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (majority vote) is pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for K444Q, and this conclusion does not conflict with any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-12.876Likely Pathogenic0.992Likely PathogenicLikely Pathogenic1.34Ambiguous0.01.36Ambiguous1.35Ambiguous1.04Destabilizing0.382Likely Benign-3.82Deleterious0.998Probably Damaging0.997Probably Damaging3.43Benign0.07Tolerated0.41120.1057110.4-0.04
c.1337A>C
E446A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E446A is not reported in ClinVar and is absent from gnomAD. In silico predictors that classify the variant as benign include REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized. Predictors that classify it as pathogenic comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yielded an inconclusive result and is treated as unavailable. Overall, the majority of predictions lean toward pathogenicity, and this conclusion is not contradicted by the absence of a ClinVar entry. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.000-9.868Likely Pathogenic0.677Likely PathogenicLikely Benign1.66Ambiguous0.70.39Likely Benign1.03Ambiguous0.67Ambiguous0.443Likely Benign-5.60Deleterious0.998Probably Damaging0.996Probably Damaging3.28Benign0.01Affected0.31950.58770-15.3-58.04
c.1343C>G
A448G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A448G resides in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized, whereas those that predict pathogenicity are Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default; FoldX is inconclusive. High‑accuracy assessments further clarify the impact: AlphaMissense‑Optimized reports a benign effect, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates pathogenicity, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a pathogenic effect. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.225814Structured0.292774Uncertain0.9730.2570.000-9.984Likely Pathogenic0.640Likely PathogenicLikely Benign1.76Ambiguous0.02.45Destabilizing2.11Destabilizing1.00Destabilizing0.378Likely Benign-3.95Deleterious0.998Probably Damaging0.980Probably Damaging3.15Benign0.06Tolerated0.21350.293610-2.2-14.03
c.1343C>T
A448V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A448V is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic impact: FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools (Rosetta and premPS) yield uncertain results. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Overall, the preponderance of evidence indicates that A448V is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.225814Structured0.292774Uncertain0.9730.2570.000-10.372Likely Pathogenic0.992Likely PathogenicLikely Pathogenic3.31Destabilizing0.21.80Ambiguous2.56Destabilizing0.66Ambiguous0.487Likely Benign-3.95Deleterious0.998Probably Damaging0.955Probably Damaging3.26Benign0.02Affected0.09500.4955002.428.05
c.1349C>G
A450G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A450G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. The majority of other in silico predictors (SGM‑Consensus, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) classify the variant as pathogenic; FoldX is inconclusive. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized predicts benign, but the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta) both predict pathogenic. Overall, the preponderance of evidence indicates that A450G is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.000-11.090Likely Pathogenic0.695Likely PathogenicLikely Benign1.79Ambiguous0.02.29Destabilizing2.04Destabilizing1.23Destabilizing0.355Likely Benign-3.82Deleterious0.998Probably Damaging0.980Probably Damaging3.40Benign0.04Affected0.16700.307810-2.2-14.03
c.1349C>T
A450V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A450V is not reported in ClinVar and is present in gnomAD (ID 6‑33438254‑C‑T). Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments give mixed results: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of tools lean toward a benign effect, and there is no ClinVar entry to contradict this assessment. Thus, the variant is most likely benign based on current predictions, with a single high‑accuracy tool suggesting pathogenicity but not overturning the overall benign consensus.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.0006-33438254-C-T16.20e-7-11.489Likely Pathogenic0.578Likely PathogenicLikely Benign0.04Likely Benign0.20.27Likely Benign0.16Likely Benign0.46Likely Benign0.306Likely Benign-3.69Deleterious0.998Probably Damaging0.955Probably Damaging3.55Benign0.04Affected3.37320.07920.5638002.428.05
c.1358A>T
H453L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H453L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, premPS, SIFT, FATHMM, and the protein‑folding stability method Foldetta; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments indicate that AlphaMissense‑Optimized is uncertain, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts benign. Overall, the predictions are split, with a slight edge toward pathogenicity from the consensus and high‑accuracy tools, but the presence of several benign calls and the uncertainty of AlphaMissense‑Optimized temper this conclusion. Thus, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-10.438Likely Pathogenic0.834Likely PathogenicAmbiguous-0.59Ambiguous0.10.04Likely Benign-0.28Likely Benign0.31Likely Benign0.413Likely Benign-10.87Deleterious0.998Probably Damaging0.973Probably Damaging3.45Benign0.11Tolerated0.08410.4964-2-37.0-23.98
c.1360A>T
I454F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I454F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM. All other evaluated algorithms—FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. premPS is uncertain and does not influence the overall assessment. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, with no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.312811Uncertain0.9650.1820.000-12.468Likely Pathogenic0.960Likely PathogenicLikely Pathogenic4.15Destabilizing0.72.96Destabilizing3.56Destabilizing0.70Ambiguous0.464Likely Benign-3.95Deleterious0.998Probably Damaging0.973Probably Damaging3.33Benign0.00Affected0.04220.256010-1.734.02
c.1366C>G
Q456E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q456E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) yield uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) remaining uncertain. Overall, the predictions are split, but the high‑accuracy consensus leans toward pathogenicity. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.302348Uncertain0.9390.1640.000-12.982Likely Pathogenic0.503AmbiguousLikely Benign0.71Ambiguous0.10.87Ambiguous0.79Ambiguous0.65Ambiguous0.233Likely Benign-2.76Deleterious0.998Probably Damaging0.964Probably Damaging3.41Benign0.15Tolerated0.11910.1276220.00.98
c.1372A>T
T458S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T458S missense variant has no ClinVar entry and is not present in gnomAD. Functional prediction tools cluster into two groups: benign calls from REVEL, FoldX, Rosetta, SIFT, and FATHMM; pathogenic calls from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments further split the signal: AlphaMissense‑Optimized remains uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Because the majority of standard predictors are evenly divided and the high‑accuracy methods disagree, the variant’s effect cannot be confidently classified as benign or pathogenic. Thus, the variant is of uncertain significance, and this uncertainty does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.185198Structured0.294848Uncertain0.9150.1440.000-8.465Likely Pathogenic0.915Likely PathogenicAmbiguous0.44Likely Benign0.10.35Likely Benign0.40Likely Benign0.55Ambiguous0.260Likely Benign-3.49Deleterious0.998Probably Damaging0.994Probably Damaging3.48Benign0.13Tolerated0.35250.434911-0.1-14.03
c.1384A>G
K462E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462E is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Tools that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Rosetta and Foldetta are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta is uncertain. Overall, the majority of predictions (7 pathogenic vs. 5 benign) and the high‑accuracy tools support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-14.696Likely Pathogenic0.967Likely PathogenicLikely Pathogenic0.34Likely Benign0.01.56Ambiguous0.95Ambiguous0.33Likely Benign0.433Likely Benign-3.88Deleterious0.998Probably Damaging0.991Probably Damaging3.49Benign0.15Tolerated0.41450.1022010.40.94
c.1387G>T
D463Y
2D
3DClick to see structure in 3D Viewer
AIClinVar reports no entry for this SynGAP1 D463Y variant, and it is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain results come from AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of conventional tools lean toward pathogenicity, while the high‑accuracy Foldetta suggests benign. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-14.387Likely Pathogenic0.904Likely PathogenicAmbiguous-0.14Likely Benign0.10.77Ambiguous0.32Likely Benign0.07Likely Benign0.399Likely Benign-7.95Deleterious0.998Probably Damaging0.904Possibly Damaging3.35Benign0.14Tolerated0.05400.6213-4-32.248.09
c.1390T>A
F464I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are limited to FATHMM, while all other evaluated algorithms—including SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-11.210Likely Pathogenic0.996Likely PathogenicLikely Pathogenic4.77Destabilizing0.24.35Destabilizing4.56Destabilizing1.23Destabilizing0.539Likely Pathogenic-5.97Deleterious0.998Probably Damaging0.994Probably Damaging3.44Benign0.03Affected0.14390.2002101.7-34.02
c.1390T>C
F464L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are returned by SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability assessments. High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta’s combined FoldX‑MD and Rosetta output is uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with any ClinVar annotation because the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-10.482Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.63Ambiguous0.30.95Ambiguous1.29Ambiguous1.12Destabilizing0.435Likely Benign-5.97Deleterious0.998Probably Damaging0.987Probably Damaging3.93Benign0.22Tolerated0.16640.2883201.0-34.02
c.1390T>G
F464V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F464V variant is listed in ClinVar with an “Uncertain” status (ClinVar ID 1716596.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective predictions, the variant is most likely pathogenic, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000Uncertain 1-12.254Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.61Destabilizing0.12.89Destabilizing3.25Destabilizing1.40Destabilizing0.592Likely Pathogenic-6.96Deleterious0.998Probably Damaging0.996Probably Damaging3.36Benign0.04Affected3.37340.15870.2219-1-11.4-48.04210.140.5-0.10.0-0.90.3XPotentially PathogenicThe phenyl ring of Phe464, located in the middle of an α helix (res. Ala461–Phe476), packs against hydrophobic residues (e.g., Met468, Leu451, Leu455, and Tyr428) in the inter-helix space formed with two other α helices (res. Asn440-Lys460 and res. Pro413-Glu436). The iso-propyl side chain of Val464 is similarly hydrophobic but considerably smaller than the original phenyl ring of Phe464. To compensate for the size difference, neighboring residues need to fill in the gap in the variant simulations.The phenolic side chain of Tyr428, located at the middle bend of an α helix (res. Glu436-Pro413), assumes a new position in the inter-helix space or rotates inward next to the third α helix (res. Asn440-Lys460) when the stable H-bond between Tyr428 and Asp467 seen in the WT simulations breaks. The residue swap also leads to the loss of the methionine-aromatic interaction between the Met468 and Phe464 side chains, which could weaken the integrity of the parent α helix (res. Ala461-Phe476). Although the simulations likely underestimate the full adverse effect of the introduced mutation during folding, the two opposing α helices (res. Ala461–Phe476 and res. Glu436-Pro413) move substantially closer to each other in the variant simulations.
c.1392C>A
F464L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are returned by SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability assessments. High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta’s combined FoldX‑MD and Rosetta output is uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with any ClinVar annotation because the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-10.482Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.63Ambiguous0.30.95Ambiguous1.29Ambiguous1.12Destabilizing0.279Likely Benign-5.97Deleterious0.998Probably Damaging0.987Probably Damaging3.93Benign0.22Tolerated0.16640.2883201.0-34.02
c.1392C>G
F464L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are returned by SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability assessments. High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta’s combined FoldX‑MD and Rosetta output is uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-10.482Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.63Ambiguous0.30.95Ambiguous1.29Ambiguous1.12Destabilizing0.279Likely Benign-5.97Deleterious0.998Probably Damaging0.987Probably Damaging3.93Benign0.22Tolerated0.16640.2883201.0-34.02
c.1393C>A
L465I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L465I missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score classifies the variant as benign, whereas the Foldetta stability assessment is uncertain. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive due to a 2‑to‑2 split. Overall, the evidence is mixed; the balance of predictions leans toward a benign interpretation, and this does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.346032Structured0.319240Uncertain0.9560.2020.000-9.672Likely Pathogenic0.770Likely PathogenicLikely Benign1.21Ambiguous0.11.27Ambiguous1.24Ambiguous0.78Ambiguous0.258Likely Benign-1.99Neutral0.998Probably Damaging0.997Probably Damaging2.54Benign0.08Tolerated0.09670.3539220.70.00
c.1402A>G
M468V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468V is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from PROVEAN, SIFT, and AlphaMissense‑Optimized, while pathogenic predictions are made by REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. The remaining tools, premPS and AlphaMissense‑Default, return uncertain results. High‑accuracy assessments further clarify the variant’s impact: AlphaMissense‑Optimized predicts a benign effect; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also classifies the variant as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect, which does not contradict the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.284882Structured0.339253Uncertain0.9320.2570.000Uncertain 1-9.461Likely Pathogenic0.361AmbiguousLikely Benign2.69Destabilizing0.12.20Destabilizing2.45Destabilizing0.89Ambiguous0.570Likely Pathogenic-1.66Neutral0.998Probably Damaging0.993Probably Damaging-1.21Pathogenic0.08Tolerated3.37310.33090.3845122.3-32.06
c.1421A>T
D474V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D474V missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that indicate a benign effect include Rosetta, Foldetta, and premPS, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.373433Uncertain0.8640.2550.000-12.999Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.77Ambiguous0.00.18Likely Benign0.48Likely Benign0.18Likely Benign0.866Likely Pathogenic-7.69Deleterious0.998Probably Damaging0.997Probably Damaging-1.30Pathogenic0.04Affected0.06940.4510-2-37.7-15.96
c.1444C>T
L482F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L482F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from FoldX and premPS, while pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain results are reported by Rosetta, Foldetta, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further reveal AlphaMissense‑Optimized as Uncertain, SGM Consensus as Likely Pathogenic, and Foldetta as Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for L482F. This conclusion is consistent with the absence of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.426236Uncertain0.7950.2480.000-11.257Likely Pathogenic0.951Likely PathogenicAmbiguous0.48Likely Benign0.01.09Ambiguous0.79Ambiguous0.43Likely Benign0.724Likely Pathogenic-3.95Deleterious0.998Probably Damaging0.994Probably Damaging-1.22Pathogenic0.01Affected0.04570.181420-1.034.02
c.1445T>G
L482R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L482R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, while FoldX, Rosetta, and Foldetta return uncertain results. In a consensus framework, the SGM‑Consensus score is “Likely Pathogenic,” reflecting the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN. High‑accuracy assessments further support a damaging outcome: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus is Likely Pathogenic, and Foldetta remains inconclusive. Taken together, the overwhelming majority of evidence points to a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.426236Uncertain0.7950.2480.000-14.684Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.74Ambiguous0.11.31Ambiguous1.03Ambiguous1.53Destabilizing0.878Likely Pathogenic-5.92Deleterious0.998Probably Damaging0.996Probably Damaging-1.27Pathogenic0.01Affected0.12550.0679-3-2-8.343.03
c.1457A>T
E486V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E486V is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, SIFT, FATHMM, and Foldetta. Tools that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also pathogenic; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Uncertain results from FoldX and Rosetta are treated as unavailable. Overall, the majority of predictions support a pathogenic classification, and this conclusion does not contradict ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.196879Structured0.358545Uncertain0.8330.2450.125-15.115Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.54Ambiguous0.1-0.65Ambiguous-0.06Likely Benign0.31Likely Benign0.490Likely Benign-6.36Deleterious0.998Probably Damaging0.991Probably Damaging3.37Benign0.06Tolerated0.04930.6445-2-27.7-29.98
c.1461C>A
N487K
2D
AIThe SynGAP1 missense variant N487K lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM. The remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is labeled “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No other stability predictions are available. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.209395Structured0.338511Uncertain0.8900.2430.125-13.520Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.10Ambiguous0.91.28Ambiguous1.19Ambiguous0.80Ambiguous0.489Likely Benign-5.97Deleterious0.998Probably Damaging0.994Probably Damaging2.72Benign0.01Affected0.19530.272110-0.414.07
c.1461C>G
N487K
2D
AIThe SynGAP1 missense variant N487K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely disagree: benign predictions come from REVEL and FATHMM, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Stability‑related methods (FoldX, Rosetta, premPS, Foldetta) yield uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation (none is available). Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.209395Structured0.338511Uncertain0.8900.2430.125-13.520Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.10Ambiguous0.91.28Ambiguous1.19Ambiguous0.80Ambiguous0.488Likely Benign-5.97Deleterious0.998Probably Damaging0.994Probably Damaging2.72Benign0.01Affected0.19530.272110-0.414.07
c.1465C>G
L489V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L489V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic calls come from SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM, while only AlphaMissense‑Optimized predicts a benign outcome. Uncertain results are reported by Rosetta, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for L489V. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database record.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.326126Uncertain0.9490.2340.125-9.345Likely Pathogenic0.467AmbiguousLikely Benign2.09Destabilizing0.01.70Ambiguous1.90Ambiguous1.25Destabilizing0.586Likely Pathogenic-2.55Deleterious0.998Probably Damaging0.992Probably Damaging-1.34Pathogenic0.01Affected0.16650.4108210.4-14.03
c.1468G>A
A490T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A490T is listed in gnomAD (variant ID 6‑33438500‑G‑A) but has no ClinVar entry. Prediction tools that agree on a pathogenic effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Tools that are inconclusive or uncertain are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. No tool predicts a benign outcome. High‑accuracy assessments show that the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while AlphaMissense‑Optimized remains uncertain and Foldetta is also uncertain. Based on the preponderance of pathogenic predictions and the lack of any benign calls, the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.322979Uncertain0.9380.2100.1256-33438500-G-A16.20e-7-10.266Likely Pathogenic0.892Likely PathogenicAmbiguous0.80Ambiguous0.21.70Ambiguous1.25Ambiguous1.00Destabilizing0.821Likely Pathogenic-3.87Deleterious0.998Probably Damaging0.993Probably Damaging-1.34Pathogenic0.03Affected3.37350.10650.449501-2.530.03
c.1471A>G
T491A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T491A is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (gnomAD ID: 6‑33438503‑A‑G). Prediction tools that agree on a benign effect include FoldX, Rosetta, and Foldetta. Tools that predict a pathogenic effect include SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions (10 pathogenic vs. 3 benign) indicate a likely pathogenic impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.064632Structured0.325158Uncertain0.9290.1880.1256-33438503-A-G16.20e-7-11.033Likely Pathogenic0.934Likely PathogenicAmbiguous0.10Likely Benign0.3-0.27Likely Benign-0.09Likely Benign1.06Destabilizing0.851Likely Pathogenic-4.82Deleterious0.998Probably Damaging0.989Probably Damaging-1.47Pathogenic0.01Affected3.37350.39030.2874012.5-30.03
c.1477G>A
A493T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A493T missense variant is not reported in ClinVar and is absent from gnomAD. Consensus among most in silico predictors indicates a deleterious effect: REVEL, SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, premPS, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the change as pathogenic or likely pathogenic. Only Rosetta predicts a benign outcome; FoldX, Foldetta, and AlphaMissense‑Optimized are uncertain or unavailable. High‑accuracy tools give the following: AlphaMissense‑Optimized – uncertain; SGM Consensus – likely pathogenic; Foldetta – uncertain. Taken together, the preponderance of evidence supports a pathogenic effect for A493T. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.340081Uncertain0.9660.1820.000-10.366Likely Pathogenic0.892Likely PathogenicAmbiguous0.82Ambiguous0.00.39Likely Benign0.61Ambiguous1.10Destabilizing0.727Likely Pathogenic-3.41Deleterious0.998Probably Damaging0.993Probably Damaging-1.36Pathogenic0.04Affected0.09640.397210-2.530.03
c.1485A>C
E495D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E495D is listed in ClinVar with an uncertain significance (ClinVar ID 2000233.0) and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions from SIFT and ESM1b, and pathogenic predictions from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus (SGM Consensus) derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN classifies the variant as likely pathogenic. AlphaMissense‑Optimized also predicts pathogenicity, whereas Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Overall, the majority of evidence points to a pathogenic effect, which does not contradict the ClinVar uncertain status but suggests a higher likelihood of deleterious impact.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.364496Uncertain0.9330.1610.000Conflicting 2-3.574Likely Benign0.958Likely PathogenicLikely Pathogenic1.39Ambiguous0.11.03Ambiguous1.21Ambiguous0.98Ambiguous0.566Likely Pathogenic-2.52Deleterious0.998Probably Damaging0.989Probably Damaging-1.41Pathogenic0.17Tolerated3.37350.17780.3064320.0-14.03220.638.80.00.00.10.1XXUncertainGlu495 is located in the α-helix (res. Leu489-Glu519), and its carboxylate group forms salt bridges with the neighboring Lys492 and with Arg596 on an opposing α-helix (res. Glu582-Met603) in the WT simulations. In the variant simulations, the acidic carboxylate side chain of Asp495 can also form salt bridges with both Lys492 and Arg596. However, the shorter side chain of aspartate tends to favor forming a salt bridge with the nearby Arg499 on the same α-helix instead. Asp495 might not maintain the salt bridge with Arg596 on the opposing α-helix as efficiently as Glu495 in the WT, potentially weakening the tertiary structure. Regardless, the potential negative effect is likely to be minor, with no deleterious effects observed on the protein structure during the simulations. However, due to its location at the GAP-Ras interface, the effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1485A>T
E495D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E495D is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from SIFT and ESM1b, while pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus. Four tools (FoldX, Rosetta, Foldetta, premPS) give uncertain or inconclusive results and are treated as unavailable. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, and Foldetta provides no definitive stability change. Overall, the variant is most likely pathogenic based on the consensus of predictive algorithms, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.364496Uncertain0.9330.1610.000-3.574Likely Benign0.958Likely PathogenicLikely Pathogenic1.39Ambiguous0.11.03Ambiguous1.21Ambiguous0.98Ambiguous0.566Likely Pathogenic-2.52Deleterious0.998Probably Damaging0.989Probably Damaging-1.41Pathogenic0.17Tolerated3.37350.17780.3064320.0-14.03220.638.80.00.00.10.1XXUncertainGlu495 is located in the α-helix (res. Leu489-Glu519), and its carboxylate group forms salt bridges with the neighboring Lys492 and with Arg596 on an opposing α-helix (res. Glu582-Met603) in the WT simulations. In the variant simulations, the acidic carboxylate side chain of Asp495 can also form salt bridges with both Lys492 and Arg596. However, the shorter side chain of aspartate tends to favor forming a salt bridge with the nearby Arg499 on the same α-helix instead. Asp495 might not maintain the salt bridge with Arg596 on the opposing α-helix as efficiently as Glu495 in the WT, potentially weakening the tertiary structure. Regardless, the potential negative effect is likely to be minor, with no deleterious effects observed on the protein structure during the simulations. However, due to its location at the GAP-Ras interface, the effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1486G>C
E496Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E496Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). In silico predictors that classify the variant as benign include FoldX, Foldetta, premPS, SIFT, and AlphaMissense‑Optimized, whereas those that predict pathogenicity are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default; Rosetta is inconclusive. High‑accuracy tools give a mixed picture: AlphaMissense‑Optimized indicates a benign effect, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenicity, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign impact. Overall, the majority of predictions (8 pathogenic vs. 5 benign) and the consensus of high‑accuracy methods lean toward a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.000-11.868Likely Pathogenic0.651Likely PathogenicLikely Benign0.13Likely Benign0.10.61Ambiguous0.37Likely Benign0.50Likely Benign0.586Likely Pathogenic-2.68Deleterious0.998Probably Damaging0.993Probably Damaging-1.36Pathogenic0.15Tolerated0.08840.3262220.0-0.98
c.1496G>T
R499I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R499I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely indicate a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all classify the change as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports it as likely pathogenic. No tool predicts a benign outcome; the remaining predictions (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) are uncertain or inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Taken together, the overwhelming majority of evidence supports a pathogenic effect, and this is consistent with the absence of a ClinVar entry; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.071867Structured0.386723Uncertain0.8990.1460.000-9.069Likely Pathogenic0.861Likely PathogenicAmbiguous1.53Ambiguous0.10.61Ambiguous1.07Ambiguous0.57Ambiguous0.713Likely Pathogenic-5.50Deleterious0.998Probably Damaging0.922Probably Damaging-1.47Pathogenic0.00Affected0.14010.2146-2-39.0-43.03
c.1498C>G
L500V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L500V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on benign effect include SIFT and AlphaMissense‑Optimized, whereas a majority of tools predict pathogenicity: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Predictions that are inconclusive are FoldX, Rosetta, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple independent predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.382942Uncertain0.8930.1500.000-12.963Likely Pathogenic0.379AmbiguousLikely Benign1.92Ambiguous0.00.81Ambiguous1.37Ambiguous1.11Destabilizing0.565Likely Pathogenic-2.98Deleterious0.998Probably Damaging0.992Probably Damaging-1.24Pathogenic0.11Tolerated0.12050.1860210.4-14.03
c.1501A>T
I501F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I501F missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain (a stability method that integrates FoldX‑MD and Rosetta outputs). No predictions are missing or inconclusive. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.079919Structured0.366596Uncertain0.8860.1530.000-12.113Likely Pathogenic0.664Likely PathogenicLikely Benign3.06Destabilizing0.10.26Likely Benign1.66Ambiguous0.71Ambiguous0.385Likely Benign-3.88Deleterious0.998Probably Damaging0.993Probably Damaging3.40Benign0.03Affected0.05740.159410-1.734.02
c.1516C>A
L506I
2D
AIThe SynGAP1 missense variant L506I is not reported in ClinVar and is absent from gnomAD. Consensus from standard in‑silico predictors shows a split: benign calls come from REVEL, PROVEAN, and AlphaMissense‑Optimized, whereas pathogenic calls arise from polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Uncertain results are reported by FoldX, premPS, and AlphaMissense‑Default. High‑accuracy assessments give a pathogenic verdict from Foldetta (a combined FoldX‑MD/Rosetta stability analysis) and from the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). AlphaMissense‑Optimized, however, predicts benign. Overall, the majority of reliable tools and the high‑accuracy methods favor a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.034884Structured0.279180Uncertain0.9240.1960.000-10.386Likely Pathogenic0.501AmbiguousLikely Benign1.73Ambiguous1.02.85Destabilizing2.29Destabilizing0.98Ambiguous0.365Likely Benign-1.99Neutral0.998Probably Damaging0.997Probably Damaging1.65Pathogenic0.01Affected0.07450.2033220.70.00
c.1522G>C
D508H
2D
AISynGAP1 D508H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show an even split: benign calls come from REVEL, FoldX, premPS, SIFT, and FATHMM, while pathogenic calls come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by Foldetta, AlphaMissense‑Optimized, and Rosetta. High‑accuracy assessments give a pathogenic consensus from the SGM method (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), an uncertain outcome from AlphaMissense‑Optimized, and an uncertain outcome from Foldetta (combining FoldX‑MD and Rosetta). Overall, the balance of evidence leans toward pathogenicity, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.019401Structured0.255890Uncertain0.8900.2280.000-12.074Likely Pathogenic0.849Likely PathogenicAmbiguous0.15Likely Benign0.40.97Ambiguous0.56Ambiguous-0.14Likely Benign0.336Likely Benign-6.38Deleterious0.998Probably Damaging0.919Probably Damaging3.26Benign0.06Tolerated0.18040.50961-10.322.05
c.1549C>G
L517V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L517V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree that the change is deleterious: pathogenic predictions come from SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM, while benign predictions are made by SIFT and AlphaMissense‑Optimized; the remaining tools (Rosetta, Foldetta, AlphaMissense‑Default) are uncertain. High‑accuracy assessments further support a pathogenic bias: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the preponderance of evidence points to a likely pathogenic effect of the variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.147645Uncertain0.9380.2960.000-10.691Likely Pathogenic0.498AmbiguousLikely Benign2.04Destabilizing0.31.37Ambiguous1.71Ambiguous1.14Destabilizing0.577Likely Pathogenic-2.68Deleterious0.998Probably Damaging0.992Probably Damaging-1.26Pathogenic0.17Tolerated0.14050.2398210.4-14.03
c.1562A>C
E521A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E521A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign calls (REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM) and pathogenic calls (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). AlphaMissense‑Optimized is uncertain. High‑accuracy assessments give conflicting results: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. No prediction or stability result is missing. Overall, the evidence is evenly split, with six benign and six pathogenic calls, and the two high‑accuracy tools disagree. Therefore, the variant’s impact remains uncertain; it is not contradicted by ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.086953Structured0.062387Uncertain0.8650.3490.000-8.997Likely Pathogenic0.892Likely PathogenicAmbiguous0.18Likely Benign0.10.40Likely Benign0.29Likely Benign0.11Likely Benign0.395Likely Benign-4.12Deleterious0.998Probably Damaging0.999Probably Damaging3.28Benign0.13Tolerated0.40410.59180-15.3-58.04
c.1565A>C
E522A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E522A is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenicity; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the preponderance of evidence (10 pathogenic vs. 4 benign predictions) indicates that E522A is most likely pathogenic, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.046216Uncertain0.8230.3760.000-10.509Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.18Likely Benign0.10.01Likely Benign0.10Likely Benign0.40Likely Benign0.739Likely Pathogenic-5.67Deleterious0.998Probably Damaging0.999Probably Damaging-1.34Pathogenic0.02Affected0.31370.41280-15.3-58.04
c.1573G>C
E525Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E525Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely disagree: benign predictions come from Rosetta, Foldetta, and FATHMM, while pathogenic predictions are returned by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta) as benign. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.023618Uncertain0.9370.3820.125-13.722Likely Pathogenic0.961Likely PathogenicLikely Pathogenic1.05Ambiguous0.7-0.11Likely Benign0.47Likely Benign0.84Ambiguous0.516Likely Pathogenic-2.98Deleterious0.998Probably Damaging0.992Probably Damaging2.68Benign0.00Affected0.11730.3962220.0-0.98
c.157G>T
G53W
2D
AIThe SynGAP1 missense variant G53W is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign). Foldetta results are unavailable. Overall, the majority of available predictions (six pathogenic vs. three benign) indicate that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.268042Structured0.460894Uncertain0.3860.6660.000-11.012Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.243Likely Benign-1.69Neutral0.998Probably Damaging0.993Probably Damaging4.08Benign0.00Affected0.06780.5071-7-2-0.5129.16
c.1580A>T
D527V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D527V missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that are uncertain (FoldX, Rosetta, Foldetta, premPS) provide no definitive evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, while Foldetta remains uncertain. Overall, the majority of reliable predictors classify the variant as pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists. Thus, based on current computational evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.139895Structured0.021908Uncertain0.9130.4080.000-16.844Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.71Ambiguous0.70.84Ambiguous0.78Ambiguous-0.55Ambiguous0.938Likely Pathogenic-8.78Deleterious0.998Probably Damaging0.997Probably Damaging-2.40Pathogenic0.00Affected0.06590.3984-2-37.7-15.96
c.1593C>G
C531W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C531W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a deleterious effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, all of which classify the change as pathogenic. Tools with uncertain or mixed outputs are Rosetta (uncertain) and premPS (uncertain). High‑accuracy assessments further support a damaging impact: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also reports pathogenic. Based on the overwhelming agreement among pathogenic predictions and the corroborating high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-14.107Likely Pathogenic0.970Likely PathogenicLikely Pathogenic5.27Destabilizing3.40.63Ambiguous2.95Destabilizing0.70Ambiguous0.510Likely Pathogenic-9.12Deleterious0.998Probably Damaging0.871Possibly Damaging-1.25Pathogenic0.00Affected0.12340.3074-8-2-3.483.07

Found 8751 rows. Show 800 rows per page. Page 8/11 « Previous | Next »